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Abstract –Analysis of routine hospital administrative data (including Hospital 
Episode Statistics) to assess variation in process and outcomes in 
gastroenterology 
Author: Dr Katherine Bowering 
Background and Aims 
To explore outcomes following gastrointestinal endoscopy using a clinical dataset and then 
routinely collected administrative data linked to death registry data. Predictors of outcome 
were studied and variations in crude mortality were analysed.  
Methods 
Endoscopy cases from a single tertiary centre were identified retrospectively using a clinical 
endoscopy database. Sedation levels, type of procedure and demographic data were 
analysed. Adverse events following the procedures, including mortality were assessed 
before and after changes in sedation practice were introduced. 
For subsequent chapters national administrative data in the form of Hospital Episode 
Statistics (HES) were linked to the Office of National Statistics Death Registry. Data from 
2006 – 2008 were analysed. Episodes of care containing codes for therapeutic endoscopic 
procedures were extracted (Endoscopic retrograde cholangio-pancreatography (ERCP) and 
percutaneous endoscopic gastrostomy (PEG)). Finally, episodes of care containing new 
stroke diagnoses were extracted to analyse the use of percutaneous gastrostomies in the 
stroke population in England. Factors associated with death following endoscopy were 
identified. Crude and case-mix adjusted mortality were analysed at institutional level. 
Results 
7,234 endoscopy cases were identified from the endoscopy clinical database. Following 
changes in sedation practice 7,071 cases were assessed. Significant reductions in sedation 
doses were achieved but mortality rates did not fall (0.7% in 2004 and 0.8% in 2006 
(p=0.5)).  
40,938 episodes of care containing ERCP procedures were identified within the HES data. 
Logistic regression analysis confirmed age, sex, cancer, emergency admission, and non-
cancer co-morbidity as independent predictors of 30-day death after ERCP. Adjusted odds 
ratios for age were 6.2 for ≥85 yrs vs. <55 yrs; male sex 1.2 vs. female; emergency 
admission 2.0 vs. elective; cancer 8.6 vs. no cancer and non-cancer co-morbidity 1.5 vs. 
none. Trust volume of ERCP was not found to be a significant factor in post procedure 
mortality. Funnel plots of trust level mortality rates, both unadjusted and adjusted, showed 
all trusts lying within 3 standard deviations of the national mean. 
10,952 PEG cases were identified. All-cause mortality was 4.2% at 7 days and 14.6% at 30 
days. Logistic regression identified age over 85 years, male sex, emergency admission, 
motor neurone disease and dementia as predictors of death within 30 days of PEG 
procedure (p<0.03 for all). No correlation for 30-day death versus PEG volume was 
identified at NHS Trust level (Pearson r=0.04).  
1560 emergency stroke admissions that had a new PEG procedure were identified. 
Admission to Trusts with a high PEG procedure volume was associated with lower 7-day 
mortality after PEG procedure of 4.3%, compared to 7.8% and 6.8% in low and medium 
volume Trusts respectively (p=0.045). Although suggestive of a lower threshold for PEG 
insertion, the 5 Trusts with the highest rate of PEG insertions in stroke patients had a higher 
mortality at 30 days (3% compared to 0.9% in the other Trusts). 
Conclusions 
Patient factors are the main determinants of outcome following endoscopy. Analyses of 
clinical and administrative datasets both require significant man-hours to produce results. 
Assessing disease severity within HES data is unsatisfactory, limiting case-mix adjustment. 
However, the data have the advantage of allowing consistent methods of analysis across 
institutions at a national level providing a more real world analysis than smaller or single 
centre studies.   
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1.  Introduction 
Hypothesis – Administrative data are a valid resource for measuring quality in 
healthcare. Hospital Episode Statistics (HES) data can be used to describe variation 
in healthcare and to assess risk and outcomes.  
Aims and Objectives 
The aim of this study is to show that routinely collected hospital administrative data 
can be used to measure process and outcomes within the National Health Service 
(NHS). Endoscopy units in the UK are encouraged to audit 30-day mortality but the 
NHS lacks systems that can capture all procedures and link to subsequent outcome. 
Death following endoscopy is a rare event. The procedures themselves are generally 
low risk. However, endoscopy occasionally has to be performed in patients who are 
at high risk of death or adverse outcome due to their underlying disease. To assess 
factors affecting mortality following endoscopy requires large numbers of patients 
to be studied. 
I plan to show that hospital administrative data can provide an evidence base for 
decision making in the healthcare environment. This includes the development and 
support of clinical indicators and clinical metrics. I aim to demonstrate that this type 
of data can highlight variation in outcomes. Reasons for variation will be explored 
and a risk assessment tool will be developed. A number of outcomes will be 
investigated including mortality and emergency readmission rates. 
I will show that Hospital Episode Statistics (HES) can be used in a robust way to 
support quality improvement within the NHS with specific regard to outcomes in 
gastroenterology inpatient care. I will describe a large audit of sedation use in 
13 
 
endoscopy as an example of outcomes analysis using clinical data. I will then assess 
outcomes following endoscopic retrograde cholangio-pancreatography (ERCP) and 
percutaneous endoscopic gastrostomy (PEG) procedures using HES data. Finally, I 
will assess the use of PEG procedures in a selected patient population (stroke 
patients) using HES data.  
I will describe the different methods of assessing performance and outcomes in 
healthcare; the problems, pitfalls and the merits of different strategies.  
I will disseminate results to the Gastroenterology community in England as part of 
the validation process and also to investigate how analysis such as this can be 
usefully publicised.   
This study is part of a larger project (Aintree Health Outcomes Partnership - AHOP) 
aimed at engaging physicians with hospital administrative data.  
Work from the sedation and ERCP chapters has been published as scientific papers 
in peer reviewed scientific journals. 
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Variation in healthcare  
Variation in healthcare can be assessed at the level of the individual (doctor or 
surgeon for example), at institution level, Trust or strategic health authority or 
larger geographical area.  The differences can be in outcomes such as death rates or 
re-admission rates; in processes such as rates of knee replacements or outpatient 
visits; or in overall costs.  
Where an evidence base for a particular treatment exists, that care should be 
received by all those with need and should be similar across healthcare providers, 
with minimal variation. Evidence-based practice has become widely accepted over 
the last few decades. It is defined as ‘...the conscientious, explicit and judicious use 
of current best evidence in making decisions about the care of individual patients’ 1.  
However, there are many studies showing evidence of geographical variation in 
healthcare2-4. This is evident in healthcare activity for example, rates of surgical 
procedures and rates of hospitalization as well as in outcomes such as mortality and 
length of stay. Variation has even been shown between hospitals under the remit of 
one provider (the American Veterans Affairs Hospitals, whose homogenous patient-
base consists of males over 65 on low-incomes) 5.  
Types of variation  
Variation can occur with good reason. Variation may be due to differences in the 
patient population. The local demographic may be sicker, or they may be more 
likely to use private health care and are therefore not included in the statistics. It 
may be that Hospital X treats a younger population than Hospital Y. However, these 
15 
 
factors can be adjusted for. Indeed, over large populations these differences may be 
expected to even out.  
Patient preference for one treatment over another can cause variation. This is also 
acceptable variation and is to be encouraged in a patient-centred approach to 
healthcare, where patient choice is fundamental. Treatment choices should be 
based on giving the most effective treatment to an individual, who will benefit from 
that treatment. The patient should also want that treatment having been provided 
with appropriate information regarding the risks and benefits to them as an 
individual.  
These types of variation are understandable and can be explained. 
It is unwarranted variation that is of concern. Variation is ‘unwarranted’ when it 
cannot be explained by patient preference or controlled for i.e. it does not 
disappear when adjustments are made for the case-mix.  
“Variation in the utilization of health care services that cannot be explained 
by variation in patient or patient preferences” Right Care NHS Atlas4 
For example, why should two areas of broadly similar populations have significant 
differences in their use of CT scanning? Why should two hospitals have such 
different mortality rates for COPD patients, despite correcting for age and other 
patient factors?  
‘‘If all variation was bad, solutions would be easy. The difficulty is in reducing 
the bad variation which reflects the limits of professional knowledge and 
failures in its application, while preserving the good variation that makes 
care patient-centred.’’ Professor Al Mulley BMJ 2010 
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The Dartmouth Atlas, founded by John Wennberg, showed that high spending 
healthcare providers achieved outcomes that were no better and, in some cases, 
were worse than lower spending providers. This variation could not be explained by 
patient factors. In fact the increased availability and therefore increased utilization 
of services was a key factor in increased costs. The increased mortality was thought 
to relate to more time spent in hospital. By being in hospital more often the patient 
was exposed to increased errors, hospital acquired infection, procedure 
complications and unnecessary investigations. It was not because the patients were 
any sicker. These studies confirmed that having more doctors per capita was 
associated with more consultations and more tests; having more beds was 
associated with more hospitalisations2;3;5. 
‘‘It is the frequency of use of supply-sensitive services by chronically ill 
patients that distinguishes high cost regions from low cost ones.... Not 
improved care, not better 30-day mortality rates, and not higher procedure 
rates...’’ John Wennberg founder of the Dartmouth Health Policy Institute3 
Why should variation be measured? 
Lord Darzi outlined plans to improve measures of care quality in his 2007 report; 
‘High Quality Care For All – NHS Next Stage Review Final Report'6. This included 
outcomes that would be available to patients enabling them to make informed 
choices regarding their care. The report highlighted concerns over ‘unacceptable 
and unexplained variations in the clinical quality of care in every NHS region’. Lord 
Darzi acknowledged improvements brought about by the introduction of nationally 
accepted standards (National Service Frameworks). The report emphasised the 
need for good information. Information that would show clinical teams where 
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improvement is needed and allow clinicians to assess the effect of any changes they 
implemented.  
‘Awareness is the first important step in identifying and addressing 
unwarranted variation; if the existence of variation is unknown, the debate 
about whether it is unwarranted cannot take place.’ Right Care NHS Atlas 4 
Identifying unwarranted variation should not be punitive. The process should ask 
why there is a difference and identify better care processes which can be adopted 
by others. With improved systems the over-use of low value interventions can be 
avoided and the use of high value interventions encouraged.  By targeting 
unwarranted variation, healthcare can be made more efficient, more effective, 
higher quality and better value. These improvements can be seen in time, finances 
and in patient outcomes and ensure that evidence based care is received by all 
those with need. 
Methods of identifying variation  
Identifying variation requires the setting of an acceptable result, or range of results 
for a process or outcome. This might be a nationally set standard. It may be the 
national average. The standard may simply be your consultant colleagues or 
neighbouring hospital. This process of ‘benchmarking’ is widely used in industry to 
encourage performance improvement and the sharing of good practices. It is 
increasingly used within healthcare with the use of clinical indicators and clinical 
metrics. 
‘’A clinical indicator is a tool that can help identify possible problems and/or 
opportunities for improvement within a service or treatment. Used 
appropriately indicators can be used to compare variations in how the same 
services are provided in different areas or against national benchmarks. 
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Indicators can be used as a basis for reflection on current practice and act as 
the starting point for improvements in the quality of patient care.’’  
NHS Scotland (www.clinicalgovernance.scot.nhs.uk) 
 
How do we compare one hospital’s results with another? They are unlikely to be 
exactly the same. A statistically significant difference in results may not represent 
clinically significant differences in performance. Ranking results from different 
providers may give the impression that those ranked at the lower end are 
performing poorly, when it may be that all are performing at acceptable levels with 
a range of good to better performance. The difference between the top and bottom 
may not be statistically or clinically significant. Where a threshold of performance is 
set, it is easier for a provider to know if they are performing at acceptable levels but 
will not necessarily encourage quality improvement beyond that. This method does 
not promote the sharing of ideas between institutions.  
It is important to understand that statistically significant variation from an accepted 
normal result may not always be clinically important. It may represent the 
phenomenon of ‘over-dispersion’7. This may indicate that the indicator is not 
appropriate or that the necessary case-mix adjustment has not occurred. It may be 
that a range of results would be more appropriate rather than a single target result. 
It may be necessary to sub-classify institutions to make results comparable; for 
example, analysing tertiary hospitals and district general hospitals in separate 
groups.  
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Results may change over time. As poor outcomes tend to be rare, assessing 
outcomes over too short a period of time may miss the event entirely. Alternatively, 
a poor outcome for a provider in one year does not necessarily reflect poor 
performance. However, poor outcomes over several years would suggest there is 
something amiss. 
Comparing one provider with another or a small number of providers within a small 
geographic area may not be adequate to identify important variation. It may be that 
the populations are too small, or too different to make sensible comparisons. It may 
be falsely reassuring. The methodology for measuring results may be very different 
making any comparisons invalid. A wider assessment looking at many providers, 
with a uniform approach to data collection will provide more robust results.  
The use of routinely collected data is increasingly recognised as a mechanism for 
measuring performance. It allows data to be collected from a large number of 
providers across geographical areas that are consistent in format and continually 
updated. It has formed the basis of many outcome studies in the literature and is 
used by private organisations such as Dr Foster and CHKS, to provide benchmarking 
data to the NHS.  
Recognising variation, analysing reasons for variation and efforts to eliminate 
variation are continuing processes in manufacturing systems to ensure quality 
improvement and efficiency. In 1924, Walter Shewart proposed the use of statistical 
control charts to distinguish between warranted (or acceptable) variation and un-
warranted variation (also known as chance-cause and assignable-cause variation; or 
common-cause and special-cause). By identifying and eliminating special cause 
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variation, quality could be improved. This strategy has been employed by many 
industry companies over the years8. Statistical process control is one method of 
identifying variation in the healthcare setting and has been utilised in several 
studies. 
Statistical process control analysis can more easily be applied to large, national 
datasets as it incorporates defined outcomes such as mortality but measures the 
variation in this outcome over time and compared to a standard e.g. national mean, 
guideline. Each event has an a priori risk of occurrence for an individual so that if 
the event occurs in a low risk individual the ‘penalty’ is higher than if the event, for 
example death, occurs in an individual with pre-existing high risk e.g. due to older 
age and the presence of co-morbid disease. 7;9-18 
Case-mix adjustment 
For any comparisons to be just we must ensure we are comparing like with like as 
far as possible. Each patient arrives at hospital with their own unique set of factors 
that will affect the ultimate outcome of their admission (all patients are not created 
equal). Without correcting, or controlling for these factors it is impossible to assess 
the quality of hospital care received by a patient. These factors may interact and 
thus adjusting for them is complex.  
Case-mix involves the primary diagnosis and its severity; socio-demographic factors 
such as age, gender and socio-economic status; functional status and co-
morbidity.19 It is generally accepted that healthcare outcomes such as mortality 
cannot be compared across institutions without some form of risk-adjustment to 
account for these differences in case-mix. Many methods of risk-adjustment have 
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been developed but it is known that results for a hospital can differ depending on 
which method is used. This will obviously have significant impact on comparisons 
with other institutions20.  
How these factors are defined and their effect in a given population can vary, in 
which case they may add in bias. For example, the calculation of standardised 
mortality ratios (SMRs) can be effected by variation in definitions such that a 
healthcare institution may be given a falsely high SMR. This has been termed ‘the 
constant risk fallacy’ or ‘risk adjustment fallacy’ 21. It occurs where the presumption 
that a risk is constant across different institutions or different groups of patients is 
false 18;21-27. To explain this further, for a variety of possibly unknown reasons, 
Hospital A may have a lower threshold for admitting a patient with condition X, 
than Hospital B. This may be because Hospital A is in an area where social support is 
less available or because they do not have a pathway of care that encourages 
discharge of this particular patient (e.g. ambulatory care pathways).It may be that 
Hospital A simply has more beds available. Thus, although the theoretically identical 
patients are equally unwell, other factors mean that Hospital A will admit this 
patient whereas Hospital B will not admit the patient. Thus, Hospital A’s mortality 
rate will be diluted by admitting less sick patients than Hospital B.  
Factors external to the hospital may influence results. For example, more deprived 
areas can have a lower census completion rate which means the denominator 
population is falsely reduced in such areas.  
Currently the perfect risk-adjustor does not exist but to forego adjustment 
completely would make analyses meaningless. 
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Outcomes analysis in healthcare  
Which outcomes? 
There has long been a desire within Healthcare and Government to develop 
information strategies that provide routine, efficient capture of performance 
information within the NHS. There are many aspects of healthcare that can be 
measured but deciding which should be used to assess performance is a complex 
decision. Quality and performance are made up of many individual functions of 
healthcare. Measuring all of these would be inefficient, so which do we choose? We 
need factors that are relatively easy to measure and that provide pointers to 
reasons for poor performance so they can be rectified. The outcome measures need 
to provide timely results so that harm is minimised. The factors need to provide 
clinically relevant results that allow clinically significant improvements in healthcare 
to be developed. 
The purpose of healthcare is to maximise quality life years for an individual through 
the accurate detection, diagnosis and therapy of disease or injury. Factors such as 
life expectancy and disease incidence or prevalence can be used as measures of 
performance in healthcare. However, these factors are not specific enough to allow 
a provider to identify reasons for poor results and be able to target specific areas of 
care to improve performance. For example, life expectancy: If we are living longer, 
healthcare must be better? Life expectancy is affected by more than just 
healthcare. Education, social care, environment will all impact on life expectancy. It 
is not a specific enough measure even if used within certain disease states e.g. 
breast cancer. Life expectancy can though, be used as a valuable measure for longer 
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term analysis of healthcare quality and is used as a means of comparing overall care 
and quality of life across wider geographical areas e.g. one country with another. 
Volume of activity undertaken by a provider can be used to highlight variation 
between providers. Rates of elective surgical procedures can be compared to 
national averages. Outcome measures can assess the success of treatment with 
factors such as complication rates, readmission rates and mortality. These groups 
are relatively easy to measure and are necessary for identifying unwarranted 
variation. However, they will require additional analysis, perhaps at a local level to 
identify what needs to be done to improve performance.  
Measures that directly assess the process of care are more useful as they can 
provide a clear direction for improving practice. However, it can be the most 
difficult group of factors to measure. Factors in this group may include measuring 
adherence to evidence–based guidelines21. For example, the proportion of stroke 
patients cared for on a stroke unit, or the proportion of patients with a myocardial 
infarction discharged on a beta-blocker.  
Healthcare providers have a duty to monitor performance and maintain standards. 
Performance in the NHS encompasses many factors including; productivity, 
efficiency, cost-effectiveness, safety, improved survival, patient satisfaction, quality, 
innovation and research.  In 1997 the NHS executive published a framework for 
assessing performance and quality28 that moved beyond simple ‘bean counting’ of 
procedures. Quality care would be defined by six domains that could be assessed: 
Health improvement; fair access; effective delivery of appropriate care; efficiency; 
patient/carer experience and health outcomes of NHS care. It also described criteria 
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for assessing possible indicators stating that they should be: attributable; 
important; avoid perverse incentives; robust; responsive and possess usability and 
timeliness. In describing proposed performance indicators the report did 
acknowledge that performance can be affected by factors that are outside the 
control of NHS hospitals and that caution needed to be exercised in comparing 
results across institutions.  
Sheila Leatherman (Professor in health care systems and performance) wrote an 
editorial in the BMJ just after ‘The NHS Plan’ had been published in 200029. In it she 
described the unique setting of the NHS as a truly national system of care, where 
decisions for improving care, such as reducing waiting times, would cover the whole 
nation. She highlighted the core values of ‘equity, efficiency and effectiveness’ and 
the importance of learning ‘from its own best practices and innovations and spread 
those good ideas throughout the nation’. The NHS plan called for increased 
measurement and accountability, underlying the importance of good data and good 
data analysis.  
‘....we can only be sure to improve what we can actually measure.’ 
Performance Metrics – We Can Only Manage What We Measure Well 
(www.PMcrunch.com) 
In Leatherman and Sutherland’s review of the NHS plan for the Nuffield Trust in 
200330 their main recommendations included the formation of a quality information 
centre, engagement of public and patients and, finally, engagement of clinicians. 
They believed that change and improvement would not happen or be sustained 
without clinicians themselves being able to take ownership of the quality initiative.  
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Simply setting targets against which institutions can monitor their own performance 
will not always bring about quality improvement. Setting targets can affect 
behaviour which undermines the aim of improving performance. If the wrong 
outcome is being measured this can even be detrimental to overall performance 
with other aspects of care being neglected for the sake of hitting a target. For a 
(crude) example increasing rates of hip replacement may simply mean more 
inappropriate operations on frail patients rather than improving outcomes from hip 
fractures. 
What is ‘Quality’? In his 2008 review6 of the NHS, Lord Darzi stated quality should 
include the following measures: Patient safety, patient experience (quality of 
caring) and effectiveness of care. Measures would include clinical domains such as 
survival rates and mortality but also measures of patient perspective of 
effectiveness including the use of ‘PROMs’ – Patient reported outcome measures. 
The report described the concepts of ‘metrics’ and ‘quality indicators’. These consist 
of a national framework of comparable measures against which hospital 
departments can measure their performance. Measures include factors such as 
length of stay, operation time and ‘time to be seen’ and can be expanded to include 
measures developed locally to incorporate local circumstances. The report has a 
strong emphasis on transparency within the NHS; the importance of measuring 
performance and being accountable for the results is integral to the notion of 
quality improvement. Publishing details on performance is thus a key feature of 
improvement (and subsequently part of the NHS constitution31). The process 
enables patients to make informed choices; institutions to compare and improve 
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their performance and commissioners (and providers) of healthcare to be able to 
prioritise and plan appropriately (CQC, The Information centre, and NHS Choices 
website).  
The Darzi report discussed the role of incentives for quality improvement with a 
payment system that recognises clinical complexity and rewards innovation. This 
again underlines the importance of good accurate data in healthcare. 
Which indicators are good at identifying quality healthcare and which can be used 
to monitor improvement is not fully understood. Engagement with their use has 
been variable perhaps due to concerns of ‘gaming’ and not wishing to publicise 
results for fear of them being worse than your ‘competitors’.  Developing clinical 
indicators to monitor performance has been a challenge not just in the UK but also 
in the US and Australia. In particular, improving the effectiveness of healthcare 
requires complete and accurate clinical information that is easily accessible to those 
who work within it32. 
Data sources for outcomes analysis 
There are huge amounts of data produced by, and contained within, the NHS. 
Unfortunately, this data are often not used, not known about, used inappropriately 
or inconsistently. The need for transparency and a more rigorous and robust 
approach to data use in the NHS was highlighted in reports on the Bristol paediatric 
surgery inquiry33;34. In the following section I describe the various sources of data 
used within the NHS and outline their advantages and disadvantages. I will describe 
how HES data are already being used and suggest how its use can be improved.  
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Audit - All hospitals carry out local audit and will compare their results with 
previous years, other groups within the same hospital, other local hospitals and 
further afield, in addition to comparisons against national or international standards 
of practice. This local level audit can be clinically very rich and address issues 
specific to a particular hospital or geographic area. However, they are often 
modified every time they are done, or may not be done regularly. Methods of data 
collection vary between institutions making comparisons invalid. Often, audit is 
performed at too small a scale to be truly useful with case numbers of fewer than 
50 not uncommon. This reduces the power of such audits to bring about changes in 
practice. Audits can also be incredibly time consuming, requiring many man hours 
to complete data collection. There will continue to be a place for such work. 
However, larger scale analysis allows more statistically robust assessments of 
outcomes and analysis nationally is essential to improve healthcare for all.  
Larger scale audit can provide very useful data that can impact significantly on 
patient care. For example the Myocardial Ischaemia National Audit Project (MINAP) 
set up in 1998. This is based on standards set by the National Service Framework 
and allows individual units to track their performance against these targets over 
time. The project continues to collect data from all hospital in England and Wales 
and has shown significant improvements in performance. As with other data 
sources within the NHS, large audits are able to look very specifically at a particular 
diagnosis or group of diagnoses and require additional data collection to that which 
is routinely collected by hospitals.  
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Morbidity and mortality reviews including National Confidential Enquiries 
(NCEPOD) – Case by case review of unexpected outcomes or complex cases can 
highlight error or deficiencies in local care pathways and be a stimulus for 
improvement. They are of educational value in describing unusual cases or atypical 
presentations. They can help individuals to improve technique and practice. Where 
known, comparisons with accepted mortality rates for a given condition can be 
made but robust case-mix adjustment may be lacking to make comparisons 
meaningful. On a national level the National Confidential Enquiry into Patient 
Outcome and Death has published over 30 reports since it began in 1987 (as the 
National Confidential Enquiry into Peri-operative deaths). The reports look at the 
care of patients who have died following a particular operation, procedure or event. 
Cases are identified by local reporters and from HES data. Questionnaires are sent 
to the consultants involved in the care of the patient and extracts of case notes are 
requested. This information is anonymised and then reviewed by an expert panel. 
Deficiencies in care are identified, described and conclusions drawn as to where 
improvements in care could be made to reduce mortality. The NCEPOD method 
essentially follows the principles of the mortality and morbidity (M&M) meeting 
described above and therefore shares the M&M’s advantages and limitations. 
Additional limitations of the NCEPOD reports are the poor data capture and focus 
on deaths alone. For example, of 1756 deaths included in the report into surgery on 
elderly patients, only 600 full datasets were obtained and the questionnaires were 
completed by fewer than 65% of the surgeons and anaesthetists identified35.  
29 
 
Registries and Clinical datasets – There are an increasing number of registries 
being established within healthcare systems around the world. These cover a 
number of diseases and healthcare interventions, from joint replacement registries, 
inflammatory bowel disease and the more familiar cancer registries. There are 
eleven cancer registries in the UK. Standard datasets are submitted to the Office for 
National Statistics for national cancer incidence data. Data are acquired from many 
sources including HES, cancer centres and MDTs and death certificates36. These 
datasets provide incidence and prevalence data and can facilitate audit within a 
field. The data are not all routinely collected and therefore requires additional 
staffing and hours. Whether local, national or international, such datasets have the 
advantage of clinical depth over administrative datasets. However, constructing and 
maintaining clinical datasets requires money and man-power. If contribution to 
such datasets is not mandated capture of cases will not be 100% and there may be 
bias in which cases are included.  
Clinical trials – Randomised controlled trials will assess baseline characteristics 
and the impact of novel therapy on outcomes within a highly regulated population. 
Trials will provide evidence for best practice. They can be independent or funded by 
the pharmaceutical industry. Epidemiological studies may provide more ‘real-world’ 
results than controlled trials, but also focus on particular disease processes or 
patient groups. Trials require time and financial input and are not designed for 
continual assessment of outcome factors over a long period for an entire 
population.  
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Patient surveys - Surveys are conducted by healthcare organisations, 
governments and non-governmental organisations around the world. The problem 
with any survey is that it is completed by a self-selecting population unless fully 
mandated. Returns are rarely 100% and the number of individuals questioned may 
be insufficient to provide meaningful results. The style of questioning may lead to 
bias. Collecting and collating the data is time and labour intensive.  
Administrative databases - provide huge amounts of data but are seen as 
containing very limited clinical information. Historically there have been doubts 
about the accuracy and depth of information entered into the databases but with 
the advent of payment by results and increased public awareness of hospital 
outcome data and patient choice there has been a huge expansion in the number of 
publications using this data. The advantages of administrative datasets include their 
size and population coverage. They contain historic data going back many years 
allowing analysis of trends. In addition, the data are less prone to bias and 
phenomena such as the Hawthorne effect.37 
The ideal dataset is a nationally integrated system of fully electronic patient records 
with automated regular analysis that can provide useful information both at a local 
and national level on performance and practice that can be disseminated widely in 
a timely fashion. The data that are generated will be clinically relevant, non-
judgemental, and useful. Data will be stored indefinitely so that performance can be 
assessed over many years (often a more useful analysis). The electronic records will 
include clinical data such as blood results, radiology reports, medication and 
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physiological data such as blood pressure and weight, as well as demographic and 
sociological data.  
Patients will have access to clear data which will help them make choices but 
perhaps more frequently reassure them that care within the NHS is of a high 
standard and that the organisation as a whole is open, transparent and continually 
striving for improvement. The data will be used by clinicians, managers, the public, 
policy makers and regulatory bodies. It will allow benchmarking of performance 
over time and between healthcare providers. Clinicians would have ownership of 
the data. The process will highlight significant deviations from accepted ‘norms’ 
that allows hospitals to quickly investigate further to enable them to advertise 
better practice and isolate poor practices and instigate change. The database could 
be used for robust research including epidemiological analysis of particular diseases 
or patient groups, and perhaps even clinical trials.  
Although many hospitals do have electronic patient records we are a long way off 
the nationally integrated database described above. For reasons of cost, time, 
technology, patient confidentiality, ‘big brother’ concerns and other factors a 
complete ‘fit for purpose’ database has not yet been realised.  
What we do have is Hospital Episode Statistics. HES were devised as an 
administrative database to aid resource allocation and service planning in the 
National Health Service. From 2007 HES data have been used to calculate hospital 
income via development of ‘healthcare resource groups’ (HRGs), tariffs and 
‘payment by results’ (PbR). The potential for outcomes research based on HES data 
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has long been recognised with many papers looking at surgical procedure volume 
and outcome (usually mortality).  
Hospital Episode Statistics contain data about every episode of hospital inpatient 
care within the NHS in England. It is not speciality specific – the same data are 
collected for everyone. Analysis of data from many institutions can be performed in 
a consistent way, making comparisons more valid. Using HES for outcomes research 
is cost-effective and allows large numbers of admissions and patients to be studied 
over a long period of time (essentially an entire population). It cannot be used to 
identify poor quality care for an individual but is a means to assess patterns of care 
over time and highlight variation in outcomes that can then be studied more closely 
by other means. It can direct further, more expensive research.  
However, the datasets are huge and potentially unwieldy. Extracting data requires 
computer power and time. The data has been used by Government departments 
and private, external benchmarking companies such as Dr Foster38 and CHKS39, to 
provide outcomes analysis for providers and the public but this data interpretation 
must be viewed with caution and in context. 
In the next section I will describe how Hospital Episode Statistics are derived, with a 
detailed look at the coding process. I will discuss how HES data has been published 
and how I think HES based analysis can be improved.  
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ICD, OPCS classification systems  
ICD coding 
The International Classification of Diseases (ICD) system has existed under the 
auspices of the World Health Organization (WHO) since 1948. The need for an 
internationally agreed, consistent method of coding causes of death was first 
recognised in the 1850s. In 1893 the ‘International List of Causes of Death’ was 
introduced by the British epidemiologist William Farr (1807 – 1883). He is said to be 
one of the founders of medical statistics and urged the adoption of a uniform 
classification system40: 
“The advantages of a uniform statistical nomenclature, however imperfect, 
are so obvious, that it is surprising no attention has been paid to its 
enforcement in Bills of Mortality. Each disease has, in many instances, been 
denoted by three or four terms, and each term has been applied to as many 
diseases: vague, inconvenient names have been employed, or complications 
have been registered instead of primary diseases. The nomenclature is of as 
much importance in this department of enquiry as weights and measures in 
the physical sciences, and should be settled without delay.”41 
 
Over the decades the coding system has been developed and expanded. Early on, 
Farr recognised the need for a system of classification for non-fatal disease and this 
was endorsed by Florence Nightingale in her paper, ‘Proposals for a uniform plan of 
hospital statistics’ in 1860. Initially, however, non-fatal disease was classified in a 
separate, parallel list. Only from its sixth revision in 1948 has the ICD included codes 
for causes of morbidity as well as causes of death.  
The codes fit into broad categories, some based on disease type, others disease site 
and there are codes pertaining to symptoms and signs rather than specific diseases. 
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Modifier codes have been introduced to provide information on social factors, types 
of interaction with healthcare and mode of injury. Codes describing side effects and 
complications of treatments have been added more recently. The codes are created 
with 3 to 5 digits which progressively add detail to a clinical diagnosis42. The primary 
diagnosis is usually described by the first code attached to an episode of care. If a 
diagnosis is not apparent then the first code will describe the main symptom or 
sign. Additional codes can be added to describe secondary diagnoses. The total 
number of diagnostic codes that can be attached to an episode of care has risen 
from 7 before 2002 to a total of 20 since 2007. Between 2003 and 2007, 14 codes 
could be used. Most episodes of care will have fewer than the maximum number of 
codes attached to it.43 
ICD-10 was endorsed by World Health Organisation in 1990 and first used by its 
member states in 199444.  Some countries have added their own specific 
modifications. All member states are required to use the most up to date revision 
for collection of their mortality and morbidity statistics.  
There are weaknesses within the ICD coding system42. There are no values attached 
to codes. If someone is in respiratory failure and that is entered in the notes then 
the coders will apply the code J960 (acute respiratory failure), J961 (Chronic 
respiratory failure) or J969 (Respiratory failure, unspecified). There are no set 
criteria such as a range of oxygen or carbon dioxide saturation values to indicate 
when a particular code may be used. Similarly for anaemia, there are no set criteria 
for haemoglobin values at which the term can be applied. Whatever diagnosis is 
written in the notes will be coded. The above examples illustrate another area of 
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concern – the ‘unspecified’ codes. There are many of these codes which are clearly 
open to being used as a default code when limited information is present and may 
very much misrepresent the patients’ true clinical history. Diagnostic codes can 
overlap such that more than one could be used to describe the same illness. What is 
coded as bronchitis in one place (codes: J40X, J411, J418, J42X) may be coded as 
chronic obstructive pulmonary disease (J440, J441, J448, J449), or emphysema 
(J431, J432, J438, J439) elsewhere.  
More codes have been introduced that describe iatrogenic events, complications or 
side effects of treatment. Even with these explicit codes available their use is 
variable and the lack of dates associated with diagnostic codes may still make them 
difficult to interpret. It is difficult to paint a picture of a patient’s disease status with 
ICD codes alone. The chronology of disorders may not be apparent. Although there 
are some codes that do specifically state whether the condition is acute or chronic 
the order of occurrence in a patient’s admission will not be ascertainable. How 
severe a condition is and how the different diseases are interacting is a complex 
concept that ICD codes alone cannot illustrate. However, by viewing all codes 
attached to an episode of care, using the other information available within the 
database and by linking across an individual’s hospital admissions it is possible to 
make inferences about what has occurred. Robust conclusions about complications 
can be made45. It must be remembered that the OPCS codes for surgical procedures 
do have dates and therefore can be helpful in describing a patient’s journey. 
In 1983 in the US and in 2007 in the UK the current hospital reimbursement systems 
were introduced i.e. Medicare’s prospective payment system in the United States 
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and ‘Payment by results’ in the United Kingdom. These introduced vastly new roles 
for the ICD coding system: roles that the ICD was not necessarily designed for. What 
codes are used, how many are used and in what order (primary or secondary 
diagnosis) may impact significantly on how much a hospital gets paid for a specific 
admission or indeed how much a patient or insurer gets charged. There has been 
evidence in the past that this has led to manipulation of coding at discharge.42  
OPCS Coding 
OPCS (Office of Population, Censuses and Surveys Classification of Surgical 
Operations and Procedures - 4th revision) codes are 4-digit codes that are used to 
describe clinical procedures and interventions performed on patients. The first digit 
is a letter that denotes which body part or system is involved. The 4th digit provides 
an additional level of precision where required. They may be used singularly to 
describe a procedure such as a skin biopsy or they may be used in combination to 
describe a whole ‘operation’. Up to 12 codes can be attached to an episode within 
HES. There are more than 6,000 OPCS codes used at the 3- or 4-digit level.  
A classification of surgical operations was first introduced in the UK in 1944. The 4th 
revision of the OPCS system was implemented in the NHS in 1990. The system is 
reviewed annually to keep up with changes in current medical and surgical practice. 
Recent revisions have also taken place to support changes to the hospital 
reimbursement process: Payment by results (PbR) and the use of health resource 
groups (HRGs)46. 
OPCS codes are explicit with clear interpretation of what they represent. They have 
been seen, therefore, as more robust than ICD codes. Classifying surgical processes 
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is always going to be far more straightforward than classifying medical conditions 
where individual variation in disease manifestation is so great. There are many, 
many published papers using OPCS coding analysis to analyse surgical procedure 
volume and mortality.   
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Hospital Episode Statistics (HES) 
Background 
The HES database was devised in 1987 with data entry beginning in 1989. Prior to 
HES, data was collected on just 10% of hospital inpatients. More than 12 million 
new patient episodes are now added each year covering all patients admitted (as 
inpatients or day-cases) to English NHS hospitals. More recently, data from 
outpatient and emergency department attendances have also been collected. The 
rest of the UK have their own, similar systems all based on the international coding 
strategies for diagnoses and procedures (OPCS and ICD coding). Data collected in 
HES includes clinical information on diagnoses and operations, administrative 
information such as admission and discharge dates, standard demographic data as 
well as postal codes and deprivation indices. Unique patient identifier codes were 
introduced in 1997 and in 1998 consultant GMC codes were added to the original 
aggregate dataset to allow individual consultant activity to be assessed (in theory).  
Many of the data items in HES are included in the national Commissioning Data Set 
(CDS) and are generated by the patient administration systems (PAS) within each 
hospital43.  Clinical information is entered into the PAS by clinical coders using the 
ICD and OPCS coding systems (see below). Other information such as consultant 
allocation, type of admission, admission date and discharge date are added by 
hospital administrative staff e.g. ward clerks, ward staff, clinic receptionists. Extracts 
from PAS are submitted to the secondary uses service, a central secure data 
warehouse for the whole NHS. The data are processed and cleaned before being 
sent to HES and other users including public health, parliamentary questions and 
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NHS websites. Further data cleaning and derivation of additional fields occurs to 
complete the HES dataset43. 
Structure of HES data 
The period of inpatient care from the date of admission to discharge is termed an 
inpatient ‘Spell’. This may consist of periods of care under more than one individual 
consultant. These periods, attributable to a single consultant, are termed Finished 
Consultant Episodes (FCEs). These FCE are the basic unit of HES. Most spells will 
consist of only one FCE. The date of discharge defines the episode and indicates the 
year it occurred. If an episode runs across the end of one financial year into the next 
year the episode will be ascribed to the latter year, not the year of admission. This 
makes sense if it is remembered that complete information from an episode of care 
can only be entered into the patient administration system and then HES once the 
patient has been discharged. 
What is clinical coding?  
 ‘’...the translation of medical terminology, as written by the clinician, to 
describe a patient’s complaint, problem, diagnosis, treatment or reason for 
seeking medical attention, into a coded format which is nationally and 
internationally recognised.’’ - NHS Connecting for Health, Clinical Coding 
Instruction Manual.  
When a patient is discharged from hospital their case notes are accessed by clinical 
coders. Coders are specially trained, non-clinical, administrative staff. They review 
all the documentation relating to a patient’s admission including written notes, 
radiology and pathology results and procedure notes. Where present they will 
review the discharge summary. In some cases ICD and OPCS codes may have 
already been assigned by the medical or surgical teams. If not, the coder will read 
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through the notes applying codes to diagnoses and procedures documented. These 
codes are entered into the hospital patient administration system. How codes are 
applied must follow set methods. Certain codes are superseded by others to 
prevent long lists of similar codes being applied and included in the data. There are 
a number of rules that have to be adhered to by the clinical coders – they are not 
allowed to make assumptions about diagnoses. For example, if a question mark is 
placed next to a diagnosis that diagnosis cannot be coded. They can only code fact. 
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Limitations of HES data 
The use of HES data to perform risk-adjustment when analysing hospital outcome 
data has caused concern due to the perceived variation in how codes are applied 
within the HES dataset. The same general condition can often be coded using 
several different codes. In theory, the code in the first ICD position is the primary 
diagnosis but often this position is occupied by a symptom code. The relevance of 
codes in lower order positions is not easily or reliably interpreted. Knowing whether 
to look for your condition of interest in just the first one, two, three or perhaps all 
positions may significantly influence the results you obtain.  
Small variations in how institutions code their admissions can lead to significant 
differences in measured performance when compared to other institutions. Case-
mix adjustment is limited without the means to acknowledge disease severity or 
other confounding factors such as smoking status. 
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Improving the validity and value of HES data  
Several strategies will be employed in this study to make the analysis of HES data 
more robust. Running code frequencies for each position will illustrate where the 
majority of target codes are found and thus only cases with codes in those positions 
will be included in analysis. Cases with target codes in later positions will be 
presumed to have the condition as a co-morbid disease rather than as the primary 
reason for that admission and will be excluded. 
The data validity can be improved by several means. Coding errors on an individual 
patient level will be difficult to identify. However, results at Trust level will be 
assessed and cases from Trusts with ‘poor data’ will be excluded from final analysis. 
Poor data will be identified on face validity, comparison with results for other Trusts 
and comparison with results from other data sources e.g. local and national audit. 
Thus, data from Trusts with extreme results will be excluded. For example, Trusts 
with very low volumes of ERCP procedures or, Trusts with zero mortality despite 
very high case numbers. 
The value of HES data can be developed and enriched beyond simple volume 
analysis by linkage of data. Internal linkage allows tracking of individual patients 
over time and across institutions. Their journey through healthcare can be assessed 
and compared.  Linkage is performed using the unique identifier code assigned to 
individual patients within HES. Once the target population has been identified those 
unique codes can be used to search backwards and forwards to identify further 
admissions for those particular patients. Chosen events can be ‘flagged’ by creating 
additional variables that are attached to the patient code. Ultimately, data over a 
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specified time period can be collected for the target patients into a separate 
database for further analysis.   
HES data can be linked to external sources of data such as death status and date of 
death from the office of national statistics (HES data contains a variable for 
inpatient deaths only). This will provide much more robust mortality analysis. Data 
from cancer registries, networks and audit can also be linked using the patient 
identifiable data stored within the HES dataset. Where patient data cannot be 
directly linked the validity of HES data can be verified by comparing simple counts 
of patients or procedures with local level data or published research from other 
sources. This is particularly useful with Trust level data which can be checked 
against local audit or procedure reporting systems.  
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Publication of HES data analysis 
Publication of HES data is aimed primarily at healthcare providers and 
commissioners30. The data are used to aid budget setting, financial reimbursement, 
service planning and prioritising.  
It is also used to monitor trends in healthcare, to aid outcomes research and 
epidemiological studies. HES data allows comparisons to be made between 
institutions and facilitates performance monitoring. 
Performance ratings for acute NHS Trusts were first published by the Government 
in 2001. This was followed by publication of performance indicators in 200248. The 
Commission for Health Improvement (CHI) was the independent regulator set up to 
monitor NHS performance at that time. This body has been superseded by the Care 
Quality Commission.  
As the NHS is ultimately accountable to the general public for its performance, 
there has been a drive to put data within the public domain for public consumption. 
This, in theory, will empower patients and allow them to make more informed 
choices about how and where their healthcare occurs. However, unregulated 
publication of hospital data into the public domain, without clinical context or 
analysis of longer term trends, may be detrimental to patient Trust in the 
healthcare establishment. It may be misinterpreted not only by the public but also 
by other healthcare providers and commissioners.  
Although under the remit of the Department of Health, much of the actual analysis 
has been performed by private companies. Specifically; Dr Foster38 has provided 
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much of the outcomes analysis for patient consumption; CHKS39 provide data 
analysis for the Government and specific providers in primary and secondary care. 
The King’s Fund49 and The Nuffield Trust50 are both independent, charitable Trusts 
that aim to improve healthcare policy in England and the rest of the UK. Their 
publications are also aimed at professionals and policy makers rather than 
healthcare consumers or patients. 
“The main contribution of the Dr Foster group has been to bring a level of 
communication skills to performance reporting that government agencies 
have failed to achieve.” Professor Martin Marshall in ‘The quest for quality in 
the NHS’30 
 
Why publish HES data? 
Publishing data gives transparency to healthcare practices and allows planning of 
services. However, it is the potential to stimulate change and improve performance 
that is perhaps its most powerful attribute. For this to occur there must be 
confidence in the data. This requires engagement of clinicians with the production, 
analysis and use of healthcare data so that change can be implemented, monitored 
and managed in the best way. 
My thesis aims to show that HES data analysis can be improved. Firstly by having 
clinicians leading the data analysis and secondly, by engaging clinicians in general 
with the process of analysis. This will mean that results obtained provide useful 
information that can lead to improvements in clinical healthcare.  
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2. Sedation  
Abstract 
Background and aims: Gastrointestinal endoscopy plays a significant role in both 
diagnosis and treatment of gastrointestinal disorders.  Guidelines have suggested 
that poor outcomes after endoscopy are associated with higher sedation doses. 
However, adverse events following endoscopy are rare, making it difficult to gather 
robust data to identify important factors affecting outcome. Detailed information 
on sedation use is not contained within hospital administrative datasets (HES) and 
therefore this study was based on a clinical dataset.  
This chapter describes how a large clinical database was used to assess outcomes 
following endoscopic procedures. Specifically, it describes a single centre audit of 
endoscopy outcomes before and after interventions to improve sedation practice.  
Methods: Cases were identified retrospectively from the endoscopy unit’s 
electronic database. All endoscopic procedures (except ERCP) performed within a 6 
month period were identified and the endoscopy reports assessed.  
Following this audit, changes in local sedation practice were implemented. These 
changes included the creation of a unit sedation policy and the introduction of pre-
packed sedation syringes.  
Fifteen months after the implementation of the new sedation policy the audit was 
repeated. Again this was a retrospective analysis of 6 months of endoscopy 
including all endoscopic procedures except ERCP. Findings from the two audits were 
compared to assess if the changes in practice had brought about improvements in 
outcomes.  
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Results: In 2004 a total 7,234 procedures were identified in 5,999 patients. In 2006 
the total number of procedures was 7,071 in 5,946 patients. 
Mean sedation doses fell from the first to the second year for all types of 
endoscopic procedure and for both midazolam and fentanyl (Midazolam: 4.9mg to 
2.9mg p<0.0001; Fentanyl: 77mcg to 66.7mcg p<0.001.). In 2004 19% of unit 
endoscopists were using a mean dose of greater than 5mg midazolam. In 2006 none 
of the endoscopists had a mean dose of greater than 5mg (p=0.005).  
The rate of overall adverse events (death, immediate complications, use of reversal 
agent) did not change from the first to the second audit. The overall 30-day 
mortality rate was 0.7% in 2004 and 0.8% in 2006 (p=0.5). However, the rate of 
unsuccessful procedures due to patient intolerance did increase from 0.1% to 1.9% 
(p<0.0001).  
Conclusions: Despite achieving significant improvements in sedation practice, 
these improvements did not translate into improved outcomes in terms of 
mortality, complications or patient satisfaction.  Indeed lower sedation doses may 
have had a deleterious effect on outcome.  
The use of a clinical database gave clinical depth to the study with detailed analysis 
of sedation doses and causes of death. However, even with improvements made to 
the electronic endoscopy database it was still time consuming and required 
significant investment in time and manpower.    
It is hypothesised that using an administrative dataset such as HES to assess 
outcomes, including mortality, following endoscopy would be preferable to 
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analysing a clinical dataset as was done here. Administrative datasets would allow 
consistent, reproducible analysis of large numbers of cases over time.  
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Introduction 
This chapter centres around one method of analyzing performance in healthcare: 
audit. The process of recognizing a standard of practice and measuring one’s own 
practice against that standard is widely used in the National Health Service. Here I 
shall review the literature on measuring outcomes in endoscopy and describe a 
large, single centre audit. The advantages and disadvantages of this type of audit 
will be discussed.  
Background 
Endoscopy plays a significant role in both diagnosis and treatment of 
gastrointestinal disorders. Gastrointestinal endoscopy is performed in over a million 
people each year in the UK51.  This includes at least 136,000 therapeutic procedures 
including percutaneous endoscopic gastrostomy insertion (PEG), endoscopic 
retrograde cholangiopancreatography (ERCP), endoscopic stenting and 
polypectomy52. Currently 0.95% of the population are referred for upper 
gastrointestinal endoscopy by their general practitioners53.  
Although on the whole outcomes are good there is a morbidity and mortality 
attached to these procedures. Upper gastrointestinal endoscopy has been reported 
to have a morbidity of 1 in 200 and a mortality of 1 in 2000 54. Morbidity and 
mortality rates after colonoscopy have been reported at lower than 1 in 50055. 
There are a number of papers looking at outcomes following gastrointestinal 
endoscopy, but figures for complications and deaths following these procedures 
vary widely. Studies have reported morbidity rates from 0.2% to 10% and mortality 
rates of zero to 20% in emergency endoscopy for variceal bleeds to over 70% in 
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certain groups of patients having PEG (percutaneous endoscopic gastrostomy) 
insertion. This variation may relate to the small size of the study populations, often 
fewer than 2000 cases, the case mix and definition of a complication.  
The most commonly reported adverse events in endoscopy are cardiorespiratory. 
Cardiorespiratory events are also the most common cause of death following 
gastrointestinal endoscopy. The observed death rate in the four weeks after upper 
gastrointestinal endoscopy for pneumonia, myocardial infarction and 
cerebrovascular accident is 1.7 times the expected rate for the general 
population.54-60 
Several groups have proposed an association between higher doses of sedation and 
higher rates of morbidity and mortality54;61 Risks relating to the use of sedation 
include the use of reversal agents, respiratory depression, hypoxia, cardiac 
ischaemia and infarction, hypo- and hypertension, aspiration pneumonia and 
arrhythmias. Evidence from small observational and controlled studies has 
confirmed that significant hypoxia, tachycardia and arrhythmias can occur during 
upper and lower endoscopy and this is seen in sedated and unsedated patients.  
Some of these controlled studies have shown no significant differences between the 
two groups62. In other controlled studies the incidence of hypoxia and desaturation 
was significantly increased in sedated patients but this effect was abolished by the 
administration of supplementary nasal oxygen in sedated patients63-65.  
Cardiac ischaemia has been shown to occur in patients, with known coronary heart 
disease, during endoscopy with sedation,66 but the incidence may be less in sedated 
than in unsedated patients67. Conversely, it has been shown that gastroscopy can 
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stimulate changes in blood pressure and heart rate that are more pronounced in 
sedated patients 68. Using automated echocardiography, studies on healthy 
volunteers have shown an increase in cardiac stress during endoscopy. Further 
studies showed that this effect was unchanged in sedated patients.69;70  
There are very few randomised controlled trials (RCT) comparing sedation versus no 
sedation in diagnostic endoscopy. There are no RCTs of this nature looking at 
therapeutic procedures. Clearly, recruitment to and avoiding bias in such trials is 
difficult with many patients having firm wishes to have, or not to have sedation. A 
small UK RCT looked at 100 patients randomised to sedation or no sedation for 
diagnostic upper gastrointestinal endoscopy. There were no adverse events in 
either group but non-sedated patients had a trend towards faster and easier 
procedures71. There are several studies looking at sedation free colonoscopy, where 
the need for sedation is perhaps less convincing than for upper gastrointestinal 
endoscopy. For example, a Norwegian study looked at 451 patients who had 
colonoscopy without sedation. 95% of participants found the procedure moderately 
uncomfortable (45%) or not uncomfortable (50%), the remaining 5% finding the 
procedure very uncomfortable. 90% of participants stated they would have a repeat 
procedure in another 5 years. However, the study group concluded that although 
feasible, unsedated colonoscopy may lead to longer procedure times, reduced 
caecal intubation rates and possibly higher miss rates for adenomas and cancers.72 
A Japanese group performed sedation free colonoscopy in 675 consecutive patients. 
97.6% (659/675) of patients stated they had ‘no’ or ‘mild’ pain. This was 
corroborated by nurse assessment of pain where 98.8% (667/675) of patients had 
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nil or only mild pain during the procedure.73 An American study concluded that 
unsedated colonoscopy should be at least offered to selected patients (older, male, 
absence of abdominal pain). This study suggested that not using sedation could save 
time and money both for the patient and healthcare provider.74  
There are risks associated with the use of sedation in endoscopy and it has been 
shown that the rate of complications is higher in sedated patients. It has not been 
shown though that higher dose of sedation, or sedation alone is responsible for the 
worse outcomes. Other factors will confound and have been shown to predict poor 
outcome in endoscopy such as patient’s age, ASA grade, inpatient status, and 
trainee participation75. Also, several studies have questioned the role of pharyngeal 
anaesthesia and use of other drugs such as hyoscine in complications at 
endoscopy54;56;76.  
We use sedation to make unpleasant healthcare procedures more acceptable to 
patients 77.  Randomised controlled trials have shown that sedation improves 
patient satisfaction with their endoscopy in terms of willingness to have a repeat 
procedure. It has also been shown that sedation improves endoscopists’ satisfaction 
with the procedure and that procedures are more likely to be completed where 
sedation is used78-80.  
Current guidelines for the use of sedation in endoscopy, both in the UK and abroad, 
emphasize the risks of sedation, highlight the association between sedation and 
cardiorespiratory complications and recommend minimising the doses of sedation 
given, particularly when using a combination of agents and particularly in elderly 
patients52;81-83. The aim is to achieve a level of sedation adequate to ensure 
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tolerability, procedure completion and patient satisfaction whilst maintaining verbal 
contact and ensuring protective airway reflexes remain intact.  
Sedation use varies around the world in terms of the types used and the amount. In 
some countries routine sedation is not the norm at all whereas in others full general 
anaesthesia is more frequently used. In the US 2,000,000,000 patients receive 
sedation for endoscopic procedures(ASGE)84, or over 98% of patients undergoing 
gastroscopy or colonoscopy. In many European endoscopy units fewer than 25% of 
patients receive sedation for upper gastrointestinal endoscopy.85;86 In Switzerland it 
is nearly 80%.87 A study involving 14 centres in Norway showed a range of sedation 
rates from 6% to 97% of patients.88  
Clearly sedation is not the only factor to influence outcome in GI endoscopy. The 
patient, the indication, the procedure type and therapeutic intervention will all 
influence outcomes and will each confound the other factors. The existing literature 
on sedation and endoscopic outcomes includes several prospective studies with 
only a few hundred participants. The largest randomised studies (at the time I 
started my MD) contained fewer than 500 patients79 although there has since been 
a larger cohort study89 looking at the effect of sedation on minor complications of 
colonoscopy. This contained over a thousand patients and concluded that sedation 
reduced the incidence of minor complications such as abdominal pain and 
distension post procedure. Of the non-randomised, prospective studies most 
contained only small numbers of patients with some notable exceptions. A large 
prospective audit of endoscopy outcomes including sedation use was carried out in 
the UK in the mid-1990s that included over 14,000 diagnostic and therapeutic (not 
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ERCP) upper endoscopy procedures54. This invited endoscopists to complete a 
questionnaire and report all adverse events for every procedure performed over a 
four month period. Self-reporting is likely to lead to underestimation which is 
acknowledged by the authors but the returns rate was high and a validation process 
suggested 95% accuracy and over 84% compliance. A more recent UK based study 
looked at colonoscopy outcomes following 9223 procedures55. Endoscopists were 
again asked to fill out a questionnaire for consecutive colonoscopies performed 
over a 4 month period.  
The largest studies of endoscopy outcomes are retrospective studies. Many of these 
are survey based with questionnaires sent out to patients, endoscopists56;87;90, 
endoscopy units85 or national endoscopy societies86. Others made use of electronic 
databases59;75;91. The largest study was a survey published in 2009 by Baudet et al. 
This included 588,326 procedures performed at 197 units across Spain over 12 
months. Questionnaires were sent out to each of 300 gastrointestinal endoscopy 
units rather than individual endoscopists. The study described the proportion of 
patients receiving any sedation rather than an exact dose but gives an illustration of 
the wide variation in sedation rates even within a single country. The largest of the 
database studies was published in 2007 and looked at cardiopulmonary 
complications following endoscopy75. It included 324,737 procedures, all performed 
under sedation, over 5 years. The database covered 81 endoscopy sites with 593 
endoscopists across the United States. Units were based in university and non-
university hospitals, as well as Veterans Administration Medical Centres. The 
reported complication rate was 1.4% overall and 0.9% for cardiopulmonary events.  
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The trigger for the single centre study described in the next section was the 
publication of the National Confidential Enquiry into Patient Outcomes and Death 
(NCEPOD) report ‘Scoping our practice’ in 2004. This made recommendations to 
minimise sedation use in an attempt to reduce deaths following endoscopy92.  
The group looked at 1818 deaths that occurred within 30-days of a therapeutic 
gastrointestinal endoscopic procedure. Cases were collected retrospectively and 
reviewed by an NCEPOD panel. All deaths occurring in hospital over a 12 month 
period were reported to NCEPOD by local reporters. The last 6 procedure codes for 
each case were identified from HES data. Where a procedure code identified a 
therapeutic endoscopy occurring within 30-days of death the case was included in 
the final study group.  
The consensus opinion of this panel was that deaths were related to higher doses of 
sedation and poor patient selection – i.e. futile procedures. They concluded that 
14% of patients that died were over-sedated. The NPSA bulletin and Lord et al 
report93 (based on sub-analysis of the NCEPOD data and the East Anglia database), 
concluded that poor mortality outcomes were partly due to higher doses of 
sedation in the elderly, defined as patients over the age of seventy.  
The NCEPOD report quoted overall figures for mortality after therapeutic 
endoscopy in 2002/2003, in England, of 3669 deaths in 128,563 patients (3%) 
according to data extracted from Hospital Episode Statistics. Recommendations 
were made and national guidelines issued requiring sedation doses to be reduced, 
particularly in the elderly. Other bodies such as the British Society for 
Gastroenterology (BSG), Royal College of Anaesthetists (RCA), National Patient 
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Safety Association (NPSA) have also issued guidelines to reduce sedation dosage. 
Endoscopy units in the UK are also now assessed using the Global Rating Scale 
(GRS). This includes quality and safety indicators and auditable outcome standards 
for endoscopy units including sedation use81.  
The NCEPOD report ‘Scoping our Practice’ does have limitations. Only deaths 
occurring in hospital were identified. Patients who died at home were not included. 
The NCEPOD report looked only at those who died. It did not look at the majority of 
patients who survived their procedure. It may be that the population who died 
differed in some significant way to those patients who survived that had nothing to 
do with their sedation. HES (Hospital Episode Statistics) data include only hospital 
inpatients. Therefore any patients who were designated ‘outpatients’ for their 
endoscopy would not have been reported in the HES data and therefore not 
included in the NCEPOD data. Clearly this could lead to overestimation of mortality 
as the population studied was restricted to those that had their procedure and died 
in hospital suggesting that they are a ‘sicker’ population than those who were 
designated outpatients and/or died at home. Whether procedures are coded as 
occurring in an ‘outpatient’ or as ‘day case’ (and therefore included in HES data) is 
dependent on local practice. As HES data forms the basis of tariff calculations and 
therefore income, hospitals are increasingly coding all endoscopy as day case 
procedures.  
After the NCEPOD recommendations were published I became involved in an audit 
of current Endoscopy practice at a single UK centre; University Hospital Aintree in 
Liverpool94. Aintree is a large teaching hospital serving a local population of about 
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330,000 people. The Digestive Diseases Centre is one of the busiest in the country 
performing some 14,500 gastrointestinal endoscopic procedures each year 
including tertiary referrals. This gave us the opportunity to audit a much larger 
number of patients than had been studied in the majority of previously published 
work on endoscopic outcomes.  We looked at overall outcomes of mortality and 
morbidity and a number of factors that might affect outcomes, including sedation 
use. 
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Methods 
The aims of this audit were based on the hypothesis that adherence to endoscopy 
guidelines would improve sedation practice which, in turn, would result in better 
endoscopic outcomes. We assessed baseline endoscopy performance for workload, 
complications and mortality, introduced improvements in practice according to 
guidelines and then attempted to measure change in outcomes. 
Cases were identified retrospectively from ‘Endoscribe’, the unit’s electronic 
database used at the time to record all endoscopies performed within the 
endoscopy unit. All endoscopic procedures except ERCP performed within a 
predetermined 6 month period were identified and details from the endoscopy 
report entered into a separate Access database.  ERCP procedures were not 
included as they were the subject of a separate audit. Patients younger than 16 
years of age were excluded as were any procedures performed under general 
anaesthesia. Additional patient information and their alive/dead status were 
extracted from the hospital Patient Administration System (PAS), and case notes. 
The main outcomes measured were: mortality within 30-days of the procedure, 
sedation type and quantity, use of reversal agents, adverse events and patient 
procedure tolerance. Routine demographic information about the patient, grade of 
endoscopist and the procedure type were documented.  
Following this audit, changes in local practice were implemented in light of the 
NCEPOD report, BSG guidelines and the national endoscopy team guidance (Global 
rating scale quality indicators). The changes made were: 
i. Creation of a multidisciplinary Endoscopy Steering Group 
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ii. Introduction of a unit sedation policy  
iii. Pre-filled, pre-packed syringes containing 5mg midazolam supplied by Pharmacy to 
encourage adherence to guidelines (no more than 5mg midazolam to be given in 
one procedure) 
iv. Adverse event logbooks introduced into each theatre 
v. Regular audit of adverse events with dissemination of results to all endoscopy unit 
staff. (Use of more than 5mg of midazolam in a single procedure was deemed to be 
an adverse event) 
Fifteen months after the implementation of the above measures the audit was 
repeated. Again this was a retrospective analysis of 6 months of endoscopy at 
Aintree including all endoscopic procedures except ERCP and procedures performed 
under general anaesthetic. Those under 16 years of age were again excluded. Cases 
were again identified using an electronic endoscopy database. Findings from the 
two audits were compared to assess if the changes in practice had brought about 
improvements in outcomes.  
Following the first audit the endoscopy unit updated its electronic database to one 
with in-built audit facilities. This helped to improve data collection and analysis as it 
saved us having to print off each individual endoscopy report and re-entering data 
into a new database.  
Statistical analysis 
Sedation doses were compared using non-parametric statistical methods (Mann-
Whitney U). Adverse outcome rates were compared using Chi-squared test. 
Significance levels were set at p <0.05.   
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Results 
In 2004 a total 7234 procedures were identified in 5999 patients. In 2006 the total 
number of procedures was 7071 in 5946 patients. 
Patient demographics from the two audit years were very similar (Table 2.1), as 
were the procedure types performed and the designation of the endscopist (Figures 
2.1 and 2.2). The mean age of the patients in group 1 (2004) was 59.6% and was 
60.4% in group 2 (2006).  Midazolam was given in 53.5% and 56% of patients 
respectively. Diagnostic gastroscopy made up just over 50% of procedures in both 
groups, with therapeutic procedures forming 8-9% of the workload. There were 32 
endoscopists working in the unit in 2004 and 38 in 2006. Of the 48 endoscopists 
working in the unit during the audit period, 22 (46%) endoscopists worked in the 
unit over both years. This included all the nurse endoscopists, staff grades and most 
of the surgical and gastroenterology consultants i.e. the majority of the workload 
for both years. 
Table 2.1 Patient populations for 2004 and 2006 
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Figure 2.1 Proportion of specific endoscopy procedures for each audit period 
 
  
 
 
 
 
 
Figure 2.2 Workload by endoscopist type  
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Figure 2.3 a-c Reduction in sedation doses from 2004 to 2006 
a. Midazolam 
 
 
 
 
b. Fentanyl 
 
 
 
 
 
c. Midazolam dose reduction by procedure type 
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Sedation doses fell from the first to the second year with an overall mean 
midazolam dose in 2004 of 4.9mg (SD=2.5mg) and a mean of 2.9mg (1.2) in 2006 
(p<0.0001) (Figure 2.3). The reduction in mean midazolam dose was also seen when 
looking at just those patients over 70 years of age with a fall from 4.3mg (2) to 
2.4mg (1) (p<0.0001). A reduction in mean midazolam dose was seen in all 
procedure types included in this study. Mean fentanyl doses also fell across the two 
study periods from 77mcg (SD=38.5) to 66.7mcg (27) (p<0.001) and in patients over 
70 years old from 67.7mcg (46) to 54.8mcg in 2006 (p<0.0001).  
In 2004 19% of unit endoscopists were using a mean of greater than 5mg 
midazolam. In 2006 none of the endoscopists had a mean midazolam use of greater 
than 5mg (p=0.005). Anonymised results for each individual are shown in Figure 2.4.  
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Figure 2.4 Mean midazolam dose given by individual endoscopist. Grey columns indicate 
unit average; black columns indicate mean midazolam dose over 5mg  
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The absolute number of procedures that were unsuccessful due to patient 
intolerance was small in both years but there was still a significant increase in the 
rate in the second year of analysis; 0.1% in year one and 1.9% in year two 
(p<0.0001). (See Figure 2.5) 
Figure 2.5 Percentage of procedures that was unsuccessful due to patient intolerance  
 
 
 
 
 
 
 
 
 
 
Reversal agents are used to reverse the effect of a sedating medication where a 
patient has inadvertently become over-sedated and there is a risk to the patient’s 
ability to breathe and protect their own airway. It is generally used as an emergency 
measure rather than as a planned medication to ‘allow’ larger doses of sedation to 
be given. The use of the reversal agents flumazanil (to counteract benzodiazepines 
including midazolam) and naloxone (to reverse the effects of opiates including 
fentanyl) did not change over the two study periods with a rate of 0.6% of 
procedures in 2004 and 0.7% in 2006 (p=0.74). (Fig.2.6)  
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Figure 2.6 Percentage of procedures where reversal of sedation occurred 
 
 
 
 
 
 
 
 
 
 
 
 
All deaths within 30-days of endoscopy were subject to full case note review and 
review of death certification to ascertain the cause of death and to allow some 
judgement as to whether the endoscopy procedure contributed to or was the cause 
of death. Although all points on the death certificate were assessed the diagnosis 
documented in part 1a of the death certificate was the one used for the following 
analysis. Pneumonia (18% in 2004, 27% in 2006), malignancy (29%, 29%), 
cardiovascular disease (6%, 18%), chronic liver disease (16%, 8%) and 
gastrointestinal bleed (15%, 8%) covered the majority (over 80%) of the 30-day 
deaths following endoscopic procedures for both years (Fig. 2.7a&b).  
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Figures 2.7 a+b Primary diagnosis as stated on death certificate for deaths within 30-days 
of endoscopy - 2004 and 2006 
a. 2004 
 
 
 
 
 
 
 
 
 
b. 2006 
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The absolute number of 30-day deaths was small; 53 individuals in 2004 and 60 in 
2006. This gave an overall 30-day death rate that was unchanged across the two 
data periods of 0.7% and 0.8% (p=0.5). Mortality among just the sedated patients 
was similar across both datasets 1% and 1.3% (p=0.23) with the mortality rate for 
un-sedated patients significantly lower for each dataset; 0.5% in 2004 (p=0.01) and 
0.35% in 2006 (p<0.0001). (Fig 2.8) 
Figure 2.8 All-cause mortality rates within 30-days of endoscopy 2004 & 2006 
 
Looking at just those patients who died the mean age of these individuals was 73.3 
years (SD=17) in 2004 and 74.5 years (12) in 2006. There was an increase in the 
proportion of these patients who had received sedation from 70% to 82% (37/53 in 
2004, 49/60 in 2006). The dose of midazolam received by patients who died within 
30-days of a procedure was significantly lower than the overall mean midazolam 
dose given to patients in each dataset. In 2004 patients who died received a mean 
midazolam dose of 3.5mg (SD=1.8) compared to an overall mean midazolam dose of 
4.9mg (2.5) (p<0.0001). In 2006 the mean midazolam dose was 1.96mg (1.3) in 
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those patients who died within 30-days of their procedure compared to a mean of 
2.9mg (1.1) given to those patients who were still alive at 30-days following their 
procedure (p<0.0001). The reduction in midazolam dose from 2004 to 2006 
maintained significance when looking at just those patients who died within 30-days 
of the endoscopic procedure (p<0.0001).  
We performed a sub-analysis of those patients who were over 70 years of age at 
the time of endoscopy. Of those aged over 70 that received sedation, 30-day 
mortality was 2.7% in 2004 and 4.1% in 2006 (p=0.06). Guidelines suggest that 
sedation doses should be reduced in the elderly and if we compare those elderly 
patients receiving more than 2mg of midazolam to those that received up to 2mg 
midazolam we find that 30-day mortality was higher in the group receiving more 
than 2mg of midazolam. This was statistically significant in 2006 (3% vs. 1.2%, 
p=0.01) but not in 2004 (1.8% vs. 0.9% p=0.22). However, if data was combined for 
both years significance was lost: 30-day mortality in those aged over 70 receiving 
more than 2mg of midazolam was 2.3%, compared to 1% in those receiving a 
maximum of 2mg midazolam (p=0.5). (Figure 2.9a & b) 
The rate of overall adverse events (death, immediate complications, use of reversal 
agent) did not change from the first audit to the next (1.7% to 2%. p=0.44) (Figure 
2.10). Additionally, in the first audit, we looked at total adverse event rate for those 
receiving up to 5mg midazolam sedation and those receiving more than 5mg of 
midazolam and found no significant increase in the number of adverse events (1.0% 
and 1.4%, p=0.4).  
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Figures 2.9 a +b Mortality in patient over 70 years of age  
a. Overall mortality 
 
 
 
 
 
 
b. Comparison of mortality for high and low dose midazolam in those over 70 years old 
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Figure 2.10 Overall rates of adverse events (death, immediate complications and use of 
reversal agents  
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Discussion 
Despite achieving significant improvements in practice, particularly sedation dose, 
these improvements did not translate into improved outcomes in terms of 
mortality, complications or patient satisfaction.  Indeed lower sedation doses may 
have had a deleterious effect on outcome.  
There are no conclusive studies in the literature showing that higher doses of 
sedation or indeed, sedation alone, are responsible for worse outcomes following 
endoscopy. Mortality and morbidity associated with these procedures is likely to be 
multi-factorial in aetiology. Overall, the Aintree study did not show significant 
changes in mortality despite showing clear reductions in sedation dose and 
improved performance. Patients given over 5mg of midazolam and therefore ‘over-
sedated’ by BSG and RCA recommendations did not have worse outcomes. 
Improved performance as judged by adherence to sedation guidelines was seen in 
the second year of analysis, with no endoscopists using a mean dose of midazolam 
greater than 5mg, but measured outcomes did not improve.  
Interestingly, the mean dose of midazolam used in patients who died within 30 days 
of their procedure was lower than the overall mean dose used in both years of 
study. The mean dose amongst this group of patients was also lower in 2006 than in 
2004. The average age of patients who died was over 70 and the mortality rate 
amongst older (over 70 years of age) patients was higher in the second year of 
analysis. This is suggestive, but by no means conclusive of, reduced sedation doses 
having a negative effect on mortality in this group of patients. Conversely, sub-
analysis of all patients over the age of seventy in the Aintree study showed a 
doubling of mortality in those receiving greater than 2mg of midazolam compared 
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to those receiving less than or equal to 2mg. This was not statistically significant and 
numbers were very small making the validity of these findings somewhat debatable.  
This was a large in-house audit using a local, clinical database. Capture of cases was 
felt to be complete. Most, if not all cases performed in theatres or intensive care 
were captured and the number of cases not entered into the electronic reporting 
system due to system failure would have been negligible. However, the project was 
time consuming and labour intensive. This did improve substantially in the second 
round of audit with the introduction of an electronic endoscopy reporting system 
that had basic audit facilities.  
There are several limitations to the Aintree study which must be taken into account 
when interpreting its conclusions. A large randomised control trial of sedation 
versus no sedation in age, disease and procedure matched cases would provide 
more robust results but would be almost impossible to do. Particularly in 
therapeutic endoscopic procedures, restricting sedation would be unethical. 
Patients who agree to have procedures without sedation may have many different 
reasons for that decision and may be selecting themselves out as a ‘different’ 
population to those that choose to have sedation.  
Adverse events in endoscopy are rare. The maximum adverse event rate was 2% in 
the Aintree study, looking at over 14,000 procedures. Thus despite having a very 
large ‘sample’ size it may still not be adequate to detect differences as the event 
rate is so low . However, our event rates were in keeping with those found by 
NCEPOD and other studies. The trend towards worse outcomes in the second year 
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of study, rather than the expected improvement, would also seem to make a Type 2 
error less likely.  
Although large, this audit was performed in a single centre. Single centre studies are 
often criticised due to the potential for selection bias and as George Gallup (of 
‘Gallup polls’) realised in the 1930’s 95, simply having a very large sample does not 
negate this risk. However, with the Aintree study it was felt that findings were still 
representative of current endoscopy practice across the UK due to the large 
number and variety of cases studied and the number of endoscopists involved. In 
particular, that the endoscopists were from a range of medical, surgical and nursing 
backgrounds and their endoscopy experience was wide-ranging, with a number of 
the endoscopists still in training.  
Determining cause of death retrospectively is difficult even with access to full case-
notes. Deciding if a death is directly due to a procedure, rather than progression of 
underlying disease or coincidence, can be a very subjective decision. Inter-observer 
variability in the interpretation of a case could lead to bias. In any group of deaths 
following a medical or surgical procedure there will be a group of deaths that are 
clearly not related to the procedure and some deaths that definitely are related to 
the procedure or a complication thereof. However, there will be a large group of 
deaths that could be a result of the procedure and therefore potentially avoidable 
but equally could have happened anyway. Some studies have attempted to provide 
a clearer causal relationship by grading deaths. For example, deaths definitely 
caused by the procedure, probable cause, possible cause, probably not cause, 
definitely not cause.  The use of all-cause post procedure mortality within 30 days 
75 
 
of an endoscopic procedure in the Aintree study was felt to be the pragmatic 
solution to this problem. 
The outcome measures used in the Aintree study were limited to hard-endpoints 
that were relatively easy to assess from the endoscopy reports and hospital patient 
administration system. Again this was a pragmatic approach when looking at a large 
number of cases but the lack of clinical depth is a weakness of the study. Patient 
status at time of endoscopy in terms of ASA grade for example was not possible to 
assess in the first year of the study. Repeat procedures were not highlighted nor 
their outcomes compared to solitary procedures. The procedure indication, primary 
diagnosis, co-morbid diagnoses, length of stay in hospital after procedure, 
readmission rate, patient satisfaction with procedure, details of late procedure 
complications are all factors that are important in assessing outcomes in endoscopy 
but were not included in this study. This was a retrospective study and assessing for 
all confounding factors in endoscopy outcomes would require many more man 
hours and access to all patient case notes. The study did take a relatively long time 
which could be a weakness in terms of its relevance to current practice. However, 
sedation use and measurement of outcomes in endoscopy continues to be very 
topical.  
Case notes were studied for all deaths as were the death certificates. However, 
there are many studies showing that death certification is not always accurate96-102.  
There have been many studies on the physiological changes that occur during 
endoscopy which may provide some scientific basis to different rates of adverse 
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outcome in endoscopy69;103-116. That sort of analysis was not within the remits of the 
Aintree study which was primarily a clinical audit. 
Despite these concerns the study had many strong points. The reproducibility of 
population characteristics over the two years is reassuring and adds to the validity 
of the study findings. It is one of the largest studies in this area, certainly in the UK. 
The mortality rate was consistent with other studies such as NCEPOD (1,818 deaths 
out of 136,000 procedures assessed is a mortality rate of 1.3%). The study looked at 
all patients undergoing endoscopy rather than just those that died or sustained 
complications. This provides a more balanced and honest view of endoscopy 
outcomes. The significant drop in sedation use following the introduction of a 
sedation policy was convincing, with a 40% reduction. Although the methods for 
assessing patient tolerance in the Aintree study were fairly crude, the rise in 
incomplete procedures due to patient intolerance has been shown in other 
studies71;78-80. 
Conclusion 
Adverse outcomes and mortality are rare events in endoscopy. Poor outcomes are 
likely to have multi-factorial causes which may include ‘under’ or ‘over-sedation’. 
However, it is likely that outcome is largely determined by the patient’s pre-existing 
diagnoses and risk profile, rather than by the procedure itself. For example, a 
patient with oxygen dependent chronic obstructive pulmonary disease who is 
admitted with a significant gastrointestinal bleed is likely to have a greater risk of 
poor outcome following gastroscopy than a 21 year old otherwise fit and well man 
who has an elective gastroscopy to investigate reflux symptoms. The procedure is 
not the main determinant of outcome.  
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Complications in endoscopy are rare events. Large numbers of cases are therefore 
needed in any study of endoscopy outcomes to reduce the occurrence of a type 2 
error. Prospective studies of this size are difficult to achieve. Questionnaires can 
lead to recall bias and subjective interpretation of events. The use of sedation will 
itself contribute to recall bias! Endoscopy datasets allow large numbers to be 
studied but still may only represent a subsection of a population. The data sets rely 
on accurate, consistent data entry.  Improvements in electronic reporting systems 
for endoscopy with more sophisticated, real-time recording of patient status at 
endoscopy and the ability to add in early and late complications linked to wider 
hospital administrative databases will allow a more realistic assessment of outcome 
and risk.  
Overall this large internal audit provided evidence to guide sedation use that is 
useful at both a local and national level. The latter because of the very large 
numbers involved. However, with current endoscopy reporting systems this would 
not be a process that could be repeated easily on a regular basis to monitor 
performance over time. Audit cycles are generally repeated annually or biannually. 
On this scale a permanent team of administrators would be required to collect and 
analyse the data.  
Thus it is hypothesised that using an administrative dataset such as HES to assess 
outcomes following endoscopy would be preferable to analysing a clinical dataset 
as was done here. Administrative datasets would allow consistent, reproducible 
analysis of large numbers of cases. This is particularly useful where an outcome, 
death, is such a rare occurrence.  
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3. ERCP 
Abstract 
Background and aims: In selecting patients for ERCP, clinicians must balance the 
benefits of intervention versus disease prognosis, co-morbid conditions and 
procedural risks.  
The primary aim of this study was to explore the potential for using routinely 
collected Hospital Episode Statistics linked to death registry information to generate 
estimates of mortality in patients requiring ERCP in England and to identify simple 
predictors of outcome. Our secondary aim was to analyse variation in crude 30-day 
mortality statistics at institutional level. A key component of the study was to 
engage with front-line teams in order to better understand issues of data quality, 
appropriate clinical interpretation and to demonstrate the value of measuring post-
ERCP mortality from routine hospital coding. 
Methods: We obtained HES data for two consecutive data years: 1st April – 31st 
March 2006/07 and 1st April – 31st March 2007/08. From these master datasets we 
extracted all episodes of care containing ERCP procedures. Mortality outcomes 
were assigned to each case by linkage to the Office of National Statistics Death 
Registry.  
ERCP episodes were analysed for demographics, admission method, diagnoses and 
co-morbidity and last-coded diagnosis before death. Factors associated with death 
within 30 days of ERCP procedure were identified by univariate and multiple logistic 
analyses. Crude and case-mix adjusted mortality were analysed at institutional level. 
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Preliminary data outputs were shared with front-line clinicians and feedback led to 
refinement of the original study with final analysis using data for first ERCP rather 
than last ERCP.  
Results: The raw HES data contained 10,753,151 episodes of care for 2006/07 and 
11,296,023 episodes for 2007/08. Following data cleaning a study population of 
20,246 patients for 2006 to 2007 and 20,692 for 2007 to 2008 was extracted.  
ICD-10 codes contained within each ERCP episode were categorised according to 
diagnosis with 57.3% relating to gallstones, 12.6% cancer, 2% gallstones and cancer 
and other diagnoses in 28.1%. All-cause 30-day mortality rate was 5.3%. The 
mortality rate in patients with no cancer diagnosis was 2.4%.  
Binary logistic regression analysis of the 2006/07 data set confirmed age, sex, 
emergency admission, and cancer and non-cancer co-morbidity as independent 
predictors of 30-day death. Adjusted odds ratios for mortality were 6.2 for age ≥85 
yrs v <55 yrs; for male sex 1.2 v female; emergency admission 2.0 v elective; cancer 
8.6 v no cancer and non-cancer co-morbidity 1.5 v no co-morbidity.  
Specific procedural complication codes were found in 1.2% of deaths (0.06% of 
ERCPs). At institutional level, mortality rates were within expected statistical limits 
and regression analysis showed no significant trend between procedure volume and 
all-cause mortality risk at 30 days (r=-0.05; p>0.05; n=150 Trusts). 
Conclusions: All-cause mortality after ERCP is largely explained by the natural 
history of underlying disease. Much of the early mortality occurs in older, acutely 
unwell (emergency) patients with co-morbid medical conditions and underlying 
cancer. Administrative, routinely collected data allows robust analysis of mortality 
after ERCP at a national level.   
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Introduction 
Endoscopic retrograde cholangiopancreatography (ERCP) is an advanced and 
challenging endoscopic technique that plays a vital role in the management of 
benign and malignant pancreatic and biliary diseases. Its use as a diagnostic 
procedure has diminished with the increasing availability of alternative, less invasive 
diagnostic modalities such as MRCP and EUS.117 
In selecting patients for ERCP, clinicians must balance the benefits of intervention 
versus disease prognosis, co-morbid conditions and procedural risks. Complications 
such as pancreatitis, sepsis, bleeding or perforation occur in 5-10%.118 The 
independent UK report  published by NCEPOD in 2004 examined 237 deaths within 
30 days of ERCP and concluded that death was a ‘definite risk’ or ‘expected’ risk in 
69% of cases and that most mortality reflected the progression of underlying 
disease (e.g. malignancy). However, the report suggested that ERCP was ‘futile’ in 
68% of deaths and made a number of recommendations aimed at optimising 
patient selection and pre-procedure medical condition.52 
Difficulties arise in interpreting results from these studies due to variations in how 
complications and adverse events are defined. For the American Society for 
Gastrointestinal Endoscopy (ASGE) a complication is “an adverse event that 
necessitates intervention”. For other groups a complication is “any event occurring 
during the 30-day period after the procedure that changed the health status of a 
patient negatively for any length of time”119. Some define a complication as an 
adverse event that requires additional hospitalisation or readmission120;121. Cotton 
et al developed a grading system for complications following endoscopic 
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sphincterotomy which has been used by some but not all groups in subsequent 
studies to classify complications following ERCP generally and endoscopic 
sphincterotomy specifically122. Procedural failure rate and length of stay were used 
as outcome measures rather than specific complications by one American group123. 
Failed procedures were defined as the ‘need to perform percutaneous transhepatic 
biliary drainage or open common bile duct exploration after ERCP’. 
Overall complication rate for ERCP is generally quoted in the region of 5% and 
appears to have remained static over the last decade. However, figures vary widely 
from as low as 4% to as high as 15.9%120;124-129.  Overall 30-day mortality ranges 
from 0.5% to 5.8%. These ranges may reflect differences in data collection, patient 
follow-up and definitions. Using telephone follow-up at 30 days in addition to case 
note review, one study increased its overall 30-day adverse event rate by 50%126. 
Some studies only recorded data up to the point of discharge121. This may explain 
their relatively low mortality of 0.12%, although their overall complication rate of 
4.95% is in keeping with the 30-day figures from other studies. 
The proportion of therapeutic procedures has increased over time with current 
practice guidelines suggest that over 90% of ERCPs should be of therapeutic intent 
and that therapy should be successful in more than 80% of attempts128. Therapeutic 
ERCP carries higher risks of complications and mortality than diagnostic ERCP. 
Several studies have shown almost double the rates of complications and mortality 
in therapeutic procedures compared to diagnostic121;124;125;130. Of note, the ‘Barthet’ 
study defined a complication as any adverse event that required more than one 
night of hospitalisation. This single centre study of 1159 ERCP procedures had a 
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complication rate for endoscopic sphincterotomy of nearly 8% by this definition. 
One single centre, prospective study found that diagnostic procedure was a 
significant risk for complications in univariate analysis119. This study, as with many 
others had much lower rates of therapeutic ERCP than is recommended. 
Christensen et al looked prospectively at 1177 ERCPs performed over 2 years, in one 
tertiary centre. Only 56.2% were therapeutic. It is also noteworthy that their 
success at selective duct cannulation was only 63% for bile duct opacification. 
Successful duct opacification should occur in greater than 80%131;132.  Three of their 
thirteen endoscopists had performed fewer than 100 ERCPs prior to the study, yet 
performed over 10% of the final number. Despite this there was no difference in 
complication rates between less experienced and highly experienced endoscopists. 
The overall complication rate was 15.9% with a 30-day mortality of 5.8%.  
Studies looking at ERCP outcomes are small in number. Many are single centre 
studies looking at a few hundred procedures. Even the largest prospective, 
multicentre studies generally identified fewer than 6000 which is a small proportion 
of the total performed in a single country. For example, it is estimated that 48 000 
ERCPs are performed each year in the UK, yet the largest study to date of UK ERCP 
was a multi-centre study that identified just 5264 procedures over a 6 month 
period133.  The number of cases identified by each centre in this study also varied 
from single figures to almost 300. Even accounting for non-consenting patients 
these figures may not be representative of all patients undergoing ERCP in the UK.  
One of the largest studies of ERCP outcomes was conducted by an American group 
from Birmingham, Alabama and published in 2006. They used a US national hospital 
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administrative database of inpatients (similar to the HES database) to analyse 
199,625 ERCPs in 1662 hospitals over 4 years.  The number of procedures 
performed in each hospital ranged from 1 to 1004 in 12 months. The group used 
logistic and multiple regression to show an association between procedure volume 
and ERCP outcomes: an increased length of stay and higher rate of failed 
procedures was associated with a smaller volume whereas no effect was seen on 
inpatient mortality 123. However, high volume institutions were defined as 
performing 200 or more ERCP procedures in 12 months which accounted for only 
5% of all the centres included in the study. The median number of ERCPs performed 
was 49 and only 25% of hospitals performed over 100 procedures in a year. It may 
be that results from the very low volume centres (fewer than 50 ERCPs a year for 
example) may have ‘obscured’ results from those hospitals performing 100 to 200 
procedures a year that would compare well to those (presumably tertiary) centres 
with the highest procedure volume. Although odds ratios for mortality and failed 
ERCP procedures were provided for a number of variables, absolute mortality rates 
were not provided in this study. 
Many studies are based in tertiary centres where case and skills mix will differ from 
smaller hospitals. One multi-centre study showed significant differences between 
tertiary and other hospitals for rates and indications for biliary sphincterotomy, 
pancreatic sphincterotomy and pre-cut papillotomy134.  
Endoscopy units in the UK are encouraged to audit 30-day mortality as part of the 
accreditation and quality assurance program 135 but the NHS lacks systems that can 
capture all procedures and link to subsequent outcome. Hence, expected levels of 
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mortality for unselected cohorts of patients requiring ERCP are poorly defined. A 
voluntary survey of 66 English hospitals reported an all-cause mortality rate of 2.7% 
within 30 days of first ERCP but procedural-related death rate was low at just 
0.4%.129 However, this study covered fewer than half of institutions and each 
hospital captured only a sample of total workload. Knowledge of real-world 
mortality risk for patients requiring ERCP for specific indications is limited and 
better understanding of the predictors of survival would help inform the process of 
case-selection and patient consent. Disclosure of risks to patients requiring ERCP 
has been shown to be inconsistent both in the UK and in other countries136;137and a 
common theme in litigation claims after poor outcome.138 
When studying relatively uncommon events and with so many variables involved, as 
with the sedation studies discussed in the first chapter, prospective studies can 
become unwieldy and prohibitively labour-intensive. Although clinical depth may be 
somewhat limited, pre-existing administrative datasets, such as HES, do give access 
to huge numbers of cases that can give more robust outcomes data, in terms of 
providing adequate power for statistical analysis.   
The primary aim of this study was to explore the potential for using routinely 
collected Hospital Episode Statistics linked to death registry information to generate 
estimates of mortality in patients requiring ERCP in England and to identify simple 
predictors of outcome. These data were used to produce a bedside tool for 
estimating all-cause mortality risk. Our secondary aim was to analyse variation in 
crude 30-day mortality statistics at institutional level. A key component of the study 
was to engage with front-line teams in order to better understand issues of data 
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quality, appropriate clinical interpretation and the value of measuring post-ERCP 
mortality from routine hospital coding. 
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Methods 
We obtained HES datasets in SPSS format for two consecutive data years: 1st April – 
31st March 2006/07 and 1st April – 31st March 2008/9. (Provided by Northgate 
Information Solutions139.) Each 12-month dataset contains around 15 million 
episodes of inpatient care from NHS hospitals in England. Our aim was to create a 
master dataset for each year containing all episodes of adult, inpatient care, within 
specified specialities, carried out in NHS acute Trusts in England from 1st April 2006 
to 31st March 2008.  
From these master datasets we then extracted all episodes of care containing ERCP 
procedures. These episodes were then held in new ERCP datasets for further 
analysis. Where a patient had more than one ERCP episode we identified the order 
of episodes, particularly the first and last episodes. Each episode contains a number 
of codes describing diagnoses, procedures and demographic detail. From these 
codes further categorical variables were added to describe ERCP indication and the 
patients’ health status in terms of co-morbidity and age. Each episode has a 
mortality outcome assigned to it at 7 and 30 days. This was achieved by linkage to 
the Office of National Statistics Death Registry. 
Below we describe the methodology of extracting the episodes of interest from the 
‘raw’ HES data and creating datasets of ERCP procedures. The specific syntax used 
within SPSS to perform each data extraction and subsequent analysis can be found 
in Appendix 7.1.  
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The Master Datasets 
Each episode of care is assigned to a particular speciality. The medical and surgical 
specialities included in this study are listed in Table 3.1 along with their code 
identifiers. All other episodes were excluded from further analysis. The datasets 
were further reduced to include only acute care NHS Trusts. This excluded episodes 
of care within other institutions such as hospices and long term psychiatric facilities 
which were not relevant to this study. Codes for the NHS Trusts included for 
analysis are listed in Appendix 7.2.  
Please note: In 2007/08 Charing Cross and Hammersmith NHS Trust merged with St 
Mary’s NHS Trust to form Imperial College Healthcare NHS Trust. By using the 
Transform data>recode into same variables option in SPSS, data for the two original 
Trusts could be merged. 
Deletions 
Each episode has a code identifying the method of admission. Any episodes with 
inappropriate admission codes e.g. ’31 – admitted ante-partum’ were excluded. The 
remaining admission methods are listed in Table 3.2 and were further assigned as 
‘Emergency’ and ‘Elective’. Episodes with blank ages, age younger than 16 and 
invalid ages (4-digit) were deleted.  
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Table 3.1 Speciality codes included in analysis   
 
  
Code Name Status 
300 General medicine Medical 
301 Gastroenterology Medical 
302 Endocrinology Medical 
303 Clinical haematology Medical 
305 Clinical pharmacology Medical 
313 Clinical immunology and allergy Medical 
314 Rehabilitation Medical 
315 Palliative medicine Medical 
320 Cardiology Medical 
330 Dermatology Medical 
340 
Respiratory medicine (also known as thoracic 
medicine) 
Medical 
350 Infectious diseases Medical 
352 Tropical medicine Medical 
360 Genitourinary medicine Medical 
361 Nephrology Medical 
370 Medical oncology Medical 
400 Neurology Medical 
410 Rheumatology Medical 
430 Geriatric medicine Medical 
823 Haematology Medical 
100 General surgery Surgical 
101 Urology Surgical 
110 Trauma & orthopaedics Surgical 
120 ENT Surgical 
130 Ophthalmology Surgical 
140 Oral surgery Surgical 
145 Oral & maxillo-facial surgery Surgical 
150 Neurosurgery Surgical 
160 Plastic surgery Surgical 
170 Cardiothoracic surgery Surgical 
180 Accident & emergency Surgical 
190 Anaesthetics Surgical 
192 Critical care medicine Surgical 
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Table 3.2 Admission methods and codes included in study  
 
Linking ONS Death Data 
Linkages were created between HES data and death registry information (Office of 
National Statistics; ONS) to establish alive-dead status and date of death for all 
patients. The register is the national record of death from any cause whether in or 
out of hospital and information was available for deaths registered more than 30-
days beyond the end of each data year included in this study. Linkage was done 
using the unique HES number (HESID) identifying each individual patient.  
We were provided with death registry data from the Office of National Statistics in 
SPSS format files. We were then able to merge the death dates into our Master 
files. This was achieved by first sorting both the ONS file and our Master Datasets by 
HESID. Then, the death dates are merged from the ONS file onto our Master file 
using the SPSS functions ‘Merge data’ and ‘Adding variables’.  
A new HESID system was introduced for the 2007/08 data year. To capture all 
deaths we had to match an individual’s old HESID with their new HESID code. A key 
Admission 
method code Admission description 
11 Elective waiting list 
12 Elective booked 
13 Elective planned 
21 Emergency via AED 
22 Emergency via GP 
23 Emergency via bed bureau 
24 Emergency via outpatient clinic 
28 Emergency other 
81 Transfer of patient from other hospital not emergency 
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based on the unique identifier for each episode (EPIKEY) was provided by Northgate 
Information Solutions139 which allowed the new HESID to be assigned to patients 
having episodes of care in 2006/07 which matched their HESID in 2007/08 dataset 
allowing the two sets of data to be merged.  
We were provided with all death dates for 2006 to over 30 days beyond the end of 
the 2007/08 data.  
The ERCP Datasets 
We then extracted the ERCP episodes to create our ERCP datasets. In 2006/07 data 
from the following Trusts, RAX and RK5, were not included as they had HES data for 
fewer than 10 ERCP procedures.  
The final ERCP datasets contain a row of data for each whole ERCP procedure 
performed on an individual within the two data years. If a patient had two ERCPs on 
different dates (even if in the same episode) this would be counted as two ERCPs 
and appears as two rows in the dataset, but a patient who has two ERCP codes on 
the same date should be counted as only one ERCP procedure and therefore have 
only one entry for this procedure.  The date on which a procedure is performed is 
contained within the HES dataset under a date variable.  
There are 42 OPCS codes pertaining to ERCP in HES (See Table 3.3). Hence, there is 
variability in the precise combination of codes used to describe any one procedure.  
Additional Y and Z codes are also used to identify the types of biopsy taken. Thus, 
one ERCP procedure may have more than one procedure code assigned to it and 
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there can be many different code combinations, all indicating that an ERCP has 
been performed, within the datasets.  
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Table 3.3 ERCP OPCS procedure codes  
Procedure 
code Procedure description 
J381 
Endoscopic incision of sphincter of Oddi, Endoscopic sphincterotomy of 
sphincter of Oddi and removal of calculus 
J382 
Endoscopic incision of sphincter of Oddi, Endoscopic sphincterotomy of 
sphincter of Oddi and insertion of tubal prosthesis into bile 
J388 Endoscopic incision of sphincter of Oddi, Other specified 
J389 Endoscopic incision of sphincter of Oddi, Unspecified 
J391 
Other therapeutic endoscopic operations on ampulla of vater, Endoscopic 
sphincterotomy of accessory ampulla of vater 
J398 Other therapeutic endoscopic operations on ampulla of vater, Other specified 
J399 Other therapeutic endoscopic operations on ampulla of vater, Unspecified 
J401 
Endoscopic retrograde placement of prosthesis in bile duct, Endoscopic 
retrograde insertion of tubal prosthesis into both hepatic ducts 
J402 
Endoscopic retrograde placement of prosthesis in bile duct, Endoscopic 
retrograde insertion of tubal prosthesis into bile duct nec 
J403 
Endoscopic retrograde placement of prosthesis in bile duct, Endoscopic 
retrograde renewal of tubal prosthesis in bile duct 
J404 
Endoscopic retrograde placement of prosthesis in bile duct, Endoscopic 
retrograde removal of tubal prosthesis from bile duct 
J405 
Endoscopic retrograde insertion of expanding covered metal stent into bile 
duct 
J406 Endoscopic retrograde insertion of expanding metal stent into bile duct NEC 
J407 Endoscopic retrograde renewal of expanding metal stent in bile duct 
J408 Endoscopic retrograde placement of prosthesis in bile duct, Other specified 
J409 Endoscopic retrograde placement of prosthesis in bile duct, Unspecified 
J411 
Other therapeutic endoscopic retrograde operations on bile duct, Endoscopic 
retrograde extraction of calculus from bile duct 
J412 
Other therapeutic endoscopic retrograde operations on bile duct, Endoscopic 
dilation of bile duct nec 
J413 Endoscopic retrograde lithotripsy of calculus of bile duct 
J414 Endoscopic retrograde photodynamic laser therapy of lesion of bile duct 
J418 
Other therapeutic endoscopic retrograde operations on bile duct, Other 
specified 
J419 
Other therapeutic endoscopic retrograde operations on bile duct, 
Unspecified 
J421 
Therapeutic endoscopic retrograde operations on pancreatic duct,    
Endoscopic retrograde insertion of tubal prosthesis into pancreatic duct 
J422 
Therapeutic endoscopic retrograde operations on pancreatic duct,    
Endoscopic retrograde renewal of tubal prosthesis in pancreatic duct 
J423 
Therapeutic endoscopic retrograde operations on pancreatic duct,    
Endoscopic retrograde removal of calculus from pancreatic duct 
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J424 
Therapeutic endoscopic retrograde operations on pancreatic duct,    
Endoscopic retrograde drainage of lesion of pancreas 
J425 
Therapeutic endoscopic retrograde operations on pancreatic duct,    
Endoscopic retrograde dilation of pancreatic duct 
J428 
Therapeutic endoscopic retrograde operations on pancreatic duct,    Other 
specified 
J429 
Therapeutic endoscopic retrograde operations on pancreatic duct,    
Unspecified 
J431 
Diagnostic endoscopic retrograde examination of bile duct and pancreatic 
duct,    Endoscopic retrograde cholangiopancreatography and biopsy of lesion 
of ampulla of Vater 
J432 
Diagnostic endoscopic retrograde examination of bile duct and pancreatic 
duct,    Endoscopic retrograde cholangiopancreatography and biopsy of lesion 
of biliary or pancreatic 
J433 Endoscopic retrograde cholangiopancreatography and collection of bile 
J438 
Diagnostic endoscopic retrograde examination of bile duct and pancreatic 
duct,    Other specified 
J439 
Diagnostic endoscopic retrograde examination of bile duct and pancreatic 
duct,    Unspecified 
J441 
Diagnostic endoscopic retrograde examination of bile duct, Endoscopic 
retrograde cholangiography and biopsy of lesion of bile duct 
J448 Diagnostic endoscopic retrograde examination of bile duct,  Other specified 
J449 Diagnostic endoscopic retrograde examination of bile duct, Unspecified 
J451 
Diagnostic endoscopic retrograde examination of pancreatic duct,    
Endoscopic retrograde pancreatography and biopsy of lesion of pancreas 
J452 
Diagnostic endoscopic retrograde examination of pancreatic duct,    
Endoscopic retrograde pancreatography and collection of pancreatic juice 
J453 
Diagnostic endoscopic retrograde examination of pancreatic duct,    
Endoscopic retrograde pancreatography through accessory ampulla of vater 
J458 
Diagnostic endoscopic retrograde examination of pancreatic duct,    Other 
specified 
J459 
Diagnostic endoscopic retrograde examination of pancreatic duct,    
Unspecified 
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To identify all episodes containing ERCP procedures we searched for all 42 codes 
within each procedure position. The specific syntax used to do this within SPSS can 
be found in Appendix 7.1. We first extracted a new dataset containing all episodes 
of care with an ERCP code in the ‘PROCEDURE 1’ variable. Within this new dataset 
we created a new variable ‘ERCPDATE’ which was updated to equal the date 
Procedure 1 was performed. Then a variable ‘ERCPPOSITION’ was created and 
updated to show a ‘1’ to indicate the Procedure 1 position. This process was then 
repeated for procedure positions 1-14, each time creating a new separate dataset. 
In each separate dataset the new variables, ERCPDATE and ERCPPOSITION, were 
created and updated to show the date and position for the procedure extracted i.e. 
When ERCP codes were searched for in ‘PROCEDURE 4’ the new dataset extracted 
would be updated with the two new variables; ERCPDATE showing the date for the 
procedure in position 4, and the variable ERCPPOSITION which would equal ‘4’ to 
indicate ERCP procedure code in position 4. The resulting seven datasets should 
have identical variable headings in the same order so that they can then be merged. 
This process was repeated for both data years.  
Identifying Duplicates 
Duplicate entries were then identified and deleted. This leaves a single entry for 
each ERCP procedure. This involved sorting the datasets by HESID, ERCPDATE and 
ERCPPOSITION. Duplicates were identified based on the HESID and ERCPDATE 
variables using the ‘identify duplicates’ function in SPSS. Duplicate entries (rows of 
data with identical ERCP code dates) were then deleted, leaving one row of data for 
each unique ERCP episode that contains all the episode information. If a patient had 
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two ERCPs on two different dates within an episode of care, then they will have a 
separate entry for each procedure i.e. two rows of data.  
Deletions 
Records with missing or invalid procedure dates were then deleted. Episodes with 
inconsistent dates for procedures, admission, discharge or death were deleted. 
Episodes with invalid or blank ages, age under-16 years old or 4-digit ages were 
deleted. Those Trusts not included in our study had all their episodes deleted. 
Episodes with an admission method not to be included in the study were erased 
(e.g. maternity codes). 
Additional Variables 
In addition to the new variables created during the process of dataset extraction 
(see above), further variables had to be derived to assist data analysis. The 
following section describes each additional variable and the methods used to create 
them, with reference to specific SPSS syntax in Appendix 7.1.  
The HES data set contains a unique code for each patient allowing them to be 
identified across all data years. It is generated using their NHS number, local patient 
identifier, provider code, patient’s postcode, sex and date of birth. This variable is 
called HESID or EXTRACT_HESID in data extracts requested by customers. As the 
method of generating the unique code changed between our datasets we renamed 
our HESID variables as follows: 
‘OLDHESID’: This is a six digit unique identifier for each individual patient. This was 
present in the original 2006 – 2007 dataset provided by Northgate 
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‘NEWHESID’: The method of assigning unique identifiers for patients changed 
between 2007 and 2008. The dataset for 2007 – 2008 was provided with the new 13 
digit identifiers. Some patients had episodes of care in both years so Northgate 
provided a look-up file containing the EPIKEY of the episodes in 2006 – 2007 
attached to the patients new 13 digit HESID from 2007 – 2008. The NEWHESID 
variable was then added to the 2006 – 2007 dataset by merging the two files. This 
was done by sorting the 2006 – 07 data file and the look-up file into the same order 
with the same variable names. The ‘Data’ tool in SPSS was then used to ‘Merge 
Files’ by ‘Adding variables’ and ‘Matching cases’ on key fields in sorted files. This 
would add the ‘NEWHESID’ variable to the 2006 – 2007 dataset.  
The additional variables we derived are described here: 
‘DATAYEAR’: This is simply a marker to indicate which year the ERCP procedure 
took place. If the ERCP procedure in this row of data occurred between April 1st 
2006 and March 31st 2007 then the DATAYEAR marker would show 200607. 
Likewise if the procedure took place between April 1st 2007 and March 31st 2008 
the marker would show 200708. Once the two datasets were merged this marker 
would allow the two years to be easily identified. 
‘FIRSTERCP’: In this column a ‘1’ indicates that the ERCP procedure in this row of 
data was the first to occur for that individual in that data year. A ‘0’ indicates that it 
was not the first ERCP procedure in that data year but a subsequent one. A ‘0’ does 
not indicate the last ERCP procedure in the data year. The ‘FIRSTERCP’ variable was 
derived from HESID and ERCPDATE. The dataset was first sorted in ascending order 
by HESID and ERCPDATE. Using the ‘Identify duplicates’ function in SPSS all ERCP 
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procedures for each HESID / individual were identified, with a marker ‘1’ indicating 
the first occurrence by date.  
‘LASTERCP’: In this column a ‘1’ indicates that the ERCP procedure in this row of 
data is the last to occur for that individual in that data year. A ‘0’ indicates that the 
procedure was not that last but a previous procedure. Again ‘LASTERCP’ was 
derived using HESID, ERCPDATE and the ‘Identify Duplicates’ function in SPSS. The 
data set was sorted by HESID and ERCPDATE in ascending order but this time the 
identify duplicates function was used to mark the last occurring procedure as ‘1’ 
(‘PrimaryLast’).  
 ‘DEATHDATE’: This shows the date of death for a patient. Hospital Episode 
Statistics data does not include information on patient deaths. The Office of 
National Statistics provided a file containing dates of all deaths from April 2006 
through April 2008. The dates were attached to HESID so we were able to merge 
this file with our Northgate files to create the DEATHDATE variable. All deaths had 
to be merged with both data year files as some patients who had a procedure in 
2006 – 2007 will have died in 2007 – 2008. The date of death for a patient was 
attached to all their episodes of care, not just their last episode.  
‘DODMINUSERCPDATE’: This variable was derived from ERCPDATE and DEATHDATE 
using the ‘Date and time wizard’ tool in SPSS. The date of the ERCP procedure was 
subtracted from the date of death to give a number of days between the two 
events. 
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 ‘AGEGROUP’: Age was divided up into ten year age groups labelled as 1 to 5. This 
variable shows which of the five age groups an individual belongs to for that 
particular episode. The syntax to derive this variable is in Appendix 7.1 
‘AGEBAND’: This variable indicates which five year age band an individual belongs 
to in that episode. See Appendix 7.1 
 ‘SPECIALITYTYPE’: A ‘1’ indicates a surgical speciality and a ‘2’ indicates a medical 
speciality. The syntax to generate this variable can be found in Appendix 7.1. 
 ‘ADMIMETHTYPE’: This variable was added to identify if an episode of care 
occurred during an emergency admission or non-emergency admission. Each 
episode was assigned to one of four groups, labelled 1 to 4. Group 1 includes 
‘Elective ordinary’ admissions, Group 2 are ‘Elective day case’ admissions, Group 3 
‘Elective regular attendance’ admissions and Group 4 are ‘Emergency’ admissions. 
These variables were derived from ‘Admission Method’ and ‘Patient 
Classification’140. Appendix 7.1 shows the syntax. 
‘DEATH7’: A ‘1’ indicates the individual died within seven days of their ERCP 
procedure. This is derived from ‘DODMINUSERCPDATE’, where if that variable is 
equal to or less than 7, DEATH7 equals 1. Otherwise DEATH7 equals zero. DEATH7 
equal to zero means the individual died more than seven days after their ERCP 
procedure or, they are still alive.  
‘DEATH30’: This variable was derived in a similar way to DEATH7 but a ‘1’ indicates 
the individual died within 30 days of their ERCP procedure. The ‘DEATH30’ group 
will include all those who are also ‘DEATH7’.  
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‘DIEDCATEGORY’: Individuals are categorised into 4 groups. ‘0’ equals ‘ALIVE’, ‘1’ 
equals died within seven days of ERCP, ‘2’ =equals died between 8 and 30 days of 
ERCP and ‘3’ equals died 31 days or more after ERCP. 
‘DIEDINHOSPITAL’: This variable where a ‘1’ indicates the patient died in hospital is 
derived from the ‘DISMETH’ variable. 
‘YZCODES’: This variable simply indicates if there are ‘Y’ or ‘Z’ procedure codes 
present in this episode of care. The syntax and code details are in Appendix 7.1. 
 ‘DEATHMARKERALL’: A one indicates the patient has died since their ERCP. 
‘NOOFERCPOCCASSIONSINTHISDATAYR’:  This provides the number of ERCP 
occasions each patient has had in the data year. For example, if in one episode a 
patient has two ERCPs on different dates, the number for this patient will be 2.  
‘NOOFERCPPROCSONTHISOCCASSION’: This is the number of ERCP procedures 
performed at the ERCP occasion, for a full list of ERCP codes see Table 3.3. 
‘NOOFADMISSIONSINYEARFORTHISPATIENT’: This indicates the total number of 
admissions this patient has had in this data year. It includes all admissions, not just 
those containing ERCP procedures.  
‘TOTALNOOFALLPROCSONTHISDATE’: This variable indicates the total number of 
procedure codes for this ERCP date. It includes non-ERCP codes as well as ERCP 
codes.  
‘CO-MORBIDITY1 – 14’: A binary variable was used to identify the presence or 
absence of one of the diagnoses listed in the Charlson co-morbidity index141-143 in 
102 
 
each of the diagnostic fields (DIAG01 – 14). This entailed creating fourteen new 
datasets which were then merged with the original to give variables for each 
position (See Appendix 7.1 for syntax and Appendix 7.3 for the list of diagnoses 
contained within our modified Charlson Index). Coding practice is known to vary 
across institutions in terms of precision and depth25;26. Hence we took the decision 
to look for diagnoses in all diagnostic fields and not just the first position. (A 
description of the Charlson Co-morbidity index can be found at the end of this 
chapter.) 
‘SUMCOMORB’: Using the ‘Transform’ tool within SPSS the total number of co-
morbid diagnoses for a given episode was calculated. For example, if codes in 
DIAG01 and DIAG05 referred to diagnoses in the Charlson co-morbidity index then 
CO-MORBIDITY1 and CO-MORBIDITY5 would both contain a ‘1’, the other CO-
MORBIDITY fields would contain a ‘0’. The SUMCOMORB variable for this episode of 
care would therefore equal two. 
‘CO-MORBIDITY’: This was a binary variable to show the presence or absence of any 
co-morbidity, as per the Charlson Index, for each episode of care. The above 
example would therefore have a ‘1’ in this field. This was calculated using the 
‘Transform’ tool such that if SUMCOMORB > 0 then CO-MORBIDITY = 1. This marker 
includes patients with cancer. It was decided to create a further variable for co-
morbidity that excluded cancer to avoid distorting results – see below at non-cancer 
co-morbidity. 
‘CANCER1 – 14’; ‘SUMCANCER’; ‘CANCER’: Using the list of cancer diagnoses in 
Appendix 7.1 instead of the co-morbidity codes the process outlined above for 
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marking the presence of co-morbidity was repeated to produce variables marking 
the presence of a cancer diagnosis.  
The process was repeated using different lists of diagnostic codes (all contained 
within Appendix 7.1) to create the following variables: 
‘HPBCA1 – 14’; ‘SUMHPBCA’; ‘HPBCA’: For hepato-pancreatobiliary cancer 
‘PANC1 – 14’; ‘SUMPANC’; ‘ACUTEPANCREATITIS’: For acute pancreatitis 
‘GS1 – 14’; ‘SUMGS’; ‘GALLSTONES’: For gallstones 
‘NONCANCERCOMORB1–14’, ‘SUMNONCANCERCO-MORBIDITY’ and 
‘NONCANCERCO-MORBIDITY’: 
The variables marking the presence of codes for non-cancer co-morbidity were used 
for further analysis of co-morbidity effect, rather than the original ‘CO-MORBIDITY’ 
marker as it was recognised that cancer was often an indication for ERCP and 
therefore using the original ‘CO-MORBIDITY’ marker we would be double counting 
patients and distorting results. 
‘NONHPBCANCER’: This variable marks the presence of cancers that do not affect 
the liver, pancreas or biliary tree. For example patients with a diagnostic code for 
lung cancer or gastric cancer will have a ‘1’ in this field. 
‘BSGPARTICIPANT’: This variable is derived from the admitting Trust for this 
episode (PROCODE). A ‘1’ indicates that the Trust contributed to the audit carried 
out by the British Society of Gastroenterology in 2006129;133. Syntax for this variable 
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is held in Appendix 7.1 and the list of participating Trusts in Appendix 7.5 Table 
A3.1. 
‘BSGTOTAL’: The number in this field indicates the number of ERCP cases the 
admitting Trust contributed to the BSG audit (see above). 
Final ERCP dataset 
The original analysis was performed on a dataset containing only the last ERCP 
procedures performed on a patient within the designated time frame (April 1st 2006 
to March 31st 2007). At that point we only had data for the year 2006/07 and so to 
allow 30-day follow-up we looked just at the first 11 months of the data year i.e. 
April 1st 2006 to February 28th 2007. Results from this work were disseminated to all 
doctors performing ERCP in England along with a feedback questionnaire (see 
‘Engagement with Clinicians’ section below) and also presented in abstract form at 
the British Society of Gastroenterology conference144. A major source of comment 
and feedback was concern over the use of ‘last ERCP’ rather than first. Other studies 
looking at ERCP outcomes have looked at ‘first ERCP’129 on the basis that the 
analysis is more robust with fewer confounding factors affecting outcomes – the 
data are ‘cleaner’. So, following this feedback the original methodology was refined 
and subsequent analysis was performed on first ERCP procedures only. This entailed 
identifying procedures in the last nine months of each data year and extracting 
these episodes into a new dataset for further analysis. Avoiding procedures in the 
first three months of each year minimised contamination from previous years.   
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Data quality issues 
Initial analysis was done with only the data for 2006/07 available. When it came to 
merging this dataset with the one subsequently developed from the 2007/08 data a 
number of issues arose which meant we had to go back to the original 2006/07 data 
and repeat the data extraction and creation of our 2006/07 dataset before re-
merging our two years of data to create the final dataset.  
When we first merged the two datasets it became apparent that there were 
duplicates within the ‘FIRST ERCP’ variable i.e. for an individual HESID more than 
one ERCP entry was designated as the first. We went back to the ‘0607 all 
occasions’ dataset and re-calculated ‘FIRSTERCP’. For most entries the duplicate and 
primary status was unchanged for first ERCP but in a few instances where originally 
a ‘FIRSTERCP’ procedure has been designated as a primary, on re-calculation they 
were now duplicates. The reverse was also seen to occur. Further investigation 
uncovered the source of error: The original procedure for identifying duplicates was 
based on sorting procedures according to HESID, ADMDATE and ERCPDATE. At that 
time it had not been noted that some patients had ERCPDATE that was before 
ADMDATE and thus when running the ‘identify duplicates’ function in SPSS the 
dataset was incorrectly sorted. Having identified the problem, episodes with 
incompatible dates were deleted and the analyses run again sorting cases by HESID 
and ERCPDATE only.  
Validation of results 
Hospital Episode Statistics data have been used to analyse mortality following 
several procedures and diseases145-155 but have not previously been used to look 
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specifically at ERCP outcomes in the UK.  Linkage to death registration status should 
improve capture of mortality by including deaths outside of hospital.  We wished to 
validate the robustness of the data for ERCP procedures by undertaking a series of 
checks.  
First, we compared the demographic and basic clinical diagnoses of ERCP cases 
identified from HES data with the characteristics of the patient population reported 
in a previous survey of ERCP practice in England which used a clinically detailed 
prospective dataset129.  
Second, in our own hospital, we were able to compare our own records for 30-day 
post-ERCP deaths with the anonymous national data and infer from age, gender, 
diagnosis and procedure date if there was or was not consistency.   
Third, our engagement with front-line teams sought feedback from all hospitals on 
the overall approach to analysis and the data coded and submitted by their local 
institution.  This also involved a steering group of representatives from the British 
Society of Gastroenterology, NHS information centre, medical and surgical 
gastroenterologists and public health experts.  
Engagement with Clinicians 
A key component of the study was the sharing of preliminary data outputs with 
front-line clinicians, seeking advice on refinements to the analytical approach, views 
on coding quality and interpretation and usefulness or otherwise of the analyses. 
There is no ‘official’ list of Gastroenterologists or of those who perform ERCP.  By 
combining listings held by the specialist society (British Society of Gastroenterology; 
107 
 
BSG) and NHS staff records we constructed an e-mail list of gastroenterologists that 
covered all acute Trusts in England. Through direct contact with Trusts we were also 
able to identify, contact and include other clinicians including surgeons and 
radiologists who perform ERCP. Pilot analyses of institutional-level comparative 
data were sent out electronically to each clinician along with a questionnaire and 
the data presented at a national conference.144 Feedback was used to inform the 
final analytical approach and to assess the validity of our initial findings. 
The following questions were asked: 
1. Does the pilot data for your Trust accurately reflect the volume of ERCP 
procedures performed annually?  This was asked to assess the accuracy and validity 
of our basic findings. 
2. Are ERCPs performed on more than one hospital site within your Trust? We 
wanted to make this exercise as fruitful as possible and therefore included some 
additional data gathering questions. This was also an attempt to gather information 
about service structure and how that might vary. 
3. Does your unit accept transfer of patients for ERCP from other local Trusts? Again 
this was an attempt to get more information about service structure that was not 
available from HES data. This was specifically trying to look for differences in 
workload that might explain differences in outcome cross Trusts 
4. Does your unit perform day case ERCP (discharge home the same day)? Does 
service structure account for any variability in outcomes between Trusts? 
5. Does your Trust undertake ERCP in critically-ill patients requiring intensive care 
and/or ventilation? This question is looking for variation in practice and workload. 
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6. Are you aware of local coding or administrative factors that might result in 
incomplete recording of ERCP procedures? We had already found results that 
made some units outliers in ERCP outcomes and wished to confirm that a significant 
cause for this was simply data retrieval and accuracy rather than poor practice. 
7. Does your unit perform in-house audit for all-cause mortality within 30-days of 
ERCP? Answers given here would obviously validate answers given to earlier 
questions but also contribute to the potential need for our project. 
8. Does the pilot crude mortality figure generated for your Trust appear accurate? A 
straightforward request that would highlight any discrepancies with our own 
findings.  
The questionnaire was sent out in Excel format with space for free text comment 
available for several of the questions. Responses are summarized and discussed in 
the results section of this chapter.  
Statistical analysis  
The Hospital episode data were stored, manipulated and analysed using the SPSS 
statistical package (SPSS Inc., Chicago, USA). National-level analyses of factors 
associated with all-cause death were identified by univariate analysis and binary 
logistic regression models. Funnel plots of institutional-level data were generated 
using analytical tools provided by the Association of Public Health Observatories.156  
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The Charlson Index of co-morbidity 
Patient outcomes following a particular surgical event or disease occurrence can be 
affected by the presence of other disease states. Co-morbidity has been defined by 
Feistein157 as ‘’any distinct additional entity that has existed or may occur during the 
clinical course of a patient who has the index disease under study’’. These co-
morbid conditions can act as confounders to the particular event being studied 
leading to loss of internal validity or bias within studies. The co-morbidity may also 
act as an effect modifier and therefore cause inaccurate results or loss of external 
validity. Therefore it is desirable to correct or adjust for these effects when 
conducting outcome studies. Identifying the presence and nature of co-morbid 
conditions will therefore also allow predictions to be made about patient outcomes 
such as mortality.  
The Charlson Index was developed in the 1980s as a means to estimate or predict 
risk of death from assessment of co-morbid conditions, for use in longitudinal 
studies.142 Other scoring systems also exist that attempt to predict risk for 
outcomes such as death, length of stay and resource use. For example, the APACHE 
scoring systems for use in critically ill patients, the Kaplan & Feinstein model for 
classifying diabetic patients and the Elixhauser score. However, it is the Charlson 
Index and its modifications that have been used most widely in the literature. 
The Charlson Index was developed empirically from the 1 year mortality data of a 
cohort of 604 patients admitted to New York Hospital with a wide variety of primary 
diagnoses. It was validated in a second cohort of 685 patients, treated for primary 
breast cancer at Yale New Haven Hospital, over 10 years. The resulting index 
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provides weighted scores (1, 2, 3 or 6) for 19 predefined co-morbid conditions. The 
total of these scores gives a measure of the burden of co-morbid disease for an 
individual, from which predictions about mortality risk can be made. Outcomes 
from population studies and trials can then be adjusted according to co-morbid 
burden to improve the generalizability of results.  
The Charlson Index has been validated and used widely. Several adaptations 
including the Deyo and Dartmouth-Manitoba adaptations have been developed to 
enable it to be used with administrative databases and the International 
Classification of Disease (ICD) coding system. Here specific ICD-9 codes are selected 
to represent the individual co-morbid conditions stated in the original Charlson 
Index. Compared to direct case note review Charlson scores for individual co-
morbid conditions derived from administrative databases may be less accurate but 
the overall mortality prediction is similar whether the score is derived from case 
notes or administrative datasets. Similarly, the differences between adaptations 
such as the two adaptations mentioned above are ‘modest’. Depending on the aims 
of a study one adaptation may have slight advantage over another due to the 
inclusion or omission of codes describing procedures specific to certain conditions 
e.g. peripheral arterial bypass surgery for peripheral vascular disease, or renal 
dialysis. 19 For this reason it has been suggested by Romano et al and Ghali et al that 
the weighting of conditions in the Charlson Index can be derived from the 
population being studied by multivariate analysis and ‘tailored’ to the outcome 
being studied.  
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The advantages in time, cost and overall feasibility of using administrative 
databases with the Charlson Index over other methods of outcomes research may 
outweigh the disadvantages of a slightly less robust risk adjustment 19;37;143;158-178. 
There are only a few studies that describe in detail how they adapt the Charlson 
Index for use in such studies159;179;180;180. We based our coding classification of co-
morbid conditions on that used by the Dr Foster group.177;181 For the ERCP data 
analysis we decided not to assign weighted scores to co-morbidity codes. Instead 
we indicated for each episode of care whether one of our selected co-morbidity 
codes was present or not (See Appendix 7.1 for the syntax used to identify co-
morbid diagnostic codes and Appendix 7.3 for a list of the codes included). Further 
variables were included to indicate the number of co-morbid codes present for an 
episode of care and binary indicators were added for specific conditions. The 
number of co-morbid conditions was not used in the final analysis. The method of 
providing an ordinal index for co-morbidity has been used previously to look at post 
surgical outcomes45.  
Comparisons of the different methods of measuring co-morbid burden are 
numerous161. The Elixhauser method was published in the late 1990s and intended 
specifically for use with large, administrative inpatient datasets.182 It was 
constructed to predict, specifically; hospital charges, length of stay and in-hospital 
mortality. By using DRG (Diagnostic resource groups) assignment it attempted to 
separate codes relating to the primary diagnosis from those relating to the 
secondary diagnoses. Only the secondary diagnoses were evaluated for co-morbid 
burden. Codes suggesting complications of medical care and procedures were 
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excluded as were several conditions that previous studies have shown to have low 
impact on mortality and other outcomes when not cited as a primary diagnosis. 
These exclusions included acute diagnoses such as pneumonia, urinary tract 
infection and respiratory failure as potential complications of treatment and 
conditions such as benign prostatic hypertrophy and diverticulosis as unimportant.  
Secondary diagnoses such as dementia, renal disease, cerebrovascular disease and 
inflammatory bowel disease were also excluded as co-morbid conditions as these 
were found to be statistically unrelated to length of stay, total charges or in-hospital 
mortality following univariate and multivariate analysis of the population used in 
the Elixhauser study. The Elixhauser group definitions of co-morbid conditions and 
complications are conservative which may explain why their correlation with 
mortality was weaker than that in other studies. Other potential limitations of this 
model are its exclusion of any patients discharged to another hospital or long-term 
care facility and its use of ‘in-patient mortality’ rather than all deaths.  
The Acute Physiology and Chronic Health Evaluation (APACHE) score is a more 
clinically rich system of assessing short term risk of death in the critically ill patient. 
It utilises real-time measures of patient physiological status and is therefore difficult 
to apply in retrospect. Scores are determined within the first 24 hours of admission 
to a critical care unit and only re-calculated if a patient is re-admitted to critical care 
after discharge to ward or home. It has been extensively utilised in critical care 
literature with some treatment protocols dependent on a patient’s APACHE score. It 
is not validated in non-critically ill patients, which along with the cost and time 
burdens of using this score, limits its use in population-based studies.  Counter to 
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that though is that the Charlson Index has compared well to the APACHE II score in 
some critically ill patient groups, for example, acute myocardial infarction, although 
the APACHE II is better at predicting in-hospital mortality.37;159  
The Charlson Index does have limitations. The co-morbid conditions it describes are 
based on those found within a relatively small sample size. The weightings used for 
the different diagnoses may not be appropriate for all patient groups, e.g. surgical 
patients. The impact of a particular disease on outcome may also change over time 
with the development of new therapies.  
Clearly, the validity of the Charlson Index and many of the risk assessment tools will 
be dependent on the accuracy of clinical coding. There is strict guidance on coding 
which clerks must follow but misinterpretation can occur. The design of the HES 
database means that it is not always possible to accurately assign significance to a 
particular code. The code in the first position is presumed to be the main condition 
requiring admission to hospital with subsequent positions representing co-morbid 
conditions. But it is not possible to indicate within that episode of care, which 
conditions are ‘active’, pre-existing, new or old. Diagnoses can be assigned as co-
morbid or secondary conditions when in fact they are iatrogenic complications. 
Codes for now inactive conditions may be carried forward from previous episodes. 
The chronology of diagnoses is difficult to ascertain as dates of use and origin are 
not attached to diagnostic codes as they are with procedure codes.  Attaching dates 
to the codes has been shown to improve accuracy of such scores.183 Coding bias, 
whereby the more severe the patient’s primary condition the less likely their more 
‘mundane’ diagnoses would be coded has been highlighted in previous 
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studies.182This will obviously affect measures of co-morbid burden. The accuracy of 
administrative data should increase as more of the code positions are used. 
Previously there were only 7 positions within HES available to provide secondary 
diagnostic codes, now there are 14. This change occurred between our two data 
years and as well as the average number of codes being given increasing; the 
proportion of the positions used increased. This, at least partially, may reflect 
changes in coding practice related to hospital funding. 
Results 
The Master files extracted from the raw HES data provided by Northgate contained 
10,753,151 episodes of care for 2006/07 and 11,296,023 episodes for 2007/08.  
From these datasets 58,955 episodes of care containing an ERCP code were 
extracted for the financial year 2006/07 (60,786 episodes for 2007/08). Following 
deletions of duplicates and erroneous data we retrieved 37,386 unique ERCP 
procedure episodes for 2006/07 of which 410 (1.1%) were excluded owing to invalid 
data entries (e.g. default/nonsense dates or missing key data fields).  ERCPs were 
coded by 149 acute NHS Trusts in England. Procedure numbers were similar for 
2007/08 (38,108 unique ERCP procedures; 518 (1.4%) episodes deleted due to 
invalid or missing data).  
Last ERCP Analysis 
Our initial analysis was performed using only the last performed ERCP procedures. 
Following feedback from front-line teams and the steering group we continued 
analysis on first ERCP procedures for individual patients. Results for the original 
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analysis on ‘last ercp’ were very similar to those on ‘first ercp’, with broadly similar 
conclusions. See Table 3.4.  
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Table 3.4 Results for 'Last ERCP'. Patient characteristics and univariate analysis of factors 
associated with all-cause mortality after last ERCP procedure  
Variable 2006-2007 p 
Total ERCPs 34,817  
Last occurring ERCP (First 11 months) 26,171  
Mean age in years (range, SD) 66 (16-105, 17)  
Male Gender (n) 40.4% (10,585)   
Emergency admission (n) 47.5% (12,418)  
Cancer diagnosis (n) 17.4% (4,562)  
Co-morbidity  (n) 30.5% (7,974)  
Mortality at 7 days (n) 
- Overall 
- Emergency admission 
- Non-emergency admission 
- Cancer 
- Non-cancer 
- Age 85+ 
- Age under 55 years  
 
1.6%  (427 of 26,171) 
2.7% (333 of 12,418) 
0.7% (94 of 13,753) 
5.7% (259 of 4,562) 
0.7% (168 of 21,609) 
3.8% (121 of 3188) 
0.25% (15 of 5949) 
 
 
p<0.001 
 
p<0.001 
 
p<0.001 
Mortality at 30 days (n) 
- Overall 
- Emergency admission 
- Non-emergency admission 
- Cancer 
- Non-cancer 
- Age 85+ 
- Age under 55 years 
 
6.4% (1,670 of 26,171) 
9.7% (1205 of 12,418) 
3.4% (465 of 13,753) 
23.7% (1080 of 4562) 
2.7% (590 of 21,609) 
12.9% (410 of 3188) 
1.5% (88 of 5949) 
 
 
p<0.001 
 
p<0.001 
 
p<0.001 
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First ERCP Analysis 
Within each data year a cohort of patients who underwent their first ERCP 
procedure between 1st July and 31st March were selected (Quarters 2-4). By 
excluding cases from the first quarter of the data year we were able to avoid 
including patients who may have undergone an earlier procedure within the 
preceding 3 months. This yielded a study population of 20,246 patients for 2006 to 
2007 and 20,692 for 2007 to 2008.  
The characteristics of patients at the time of first ERCP are summarised in Table 3.5.  
The cohorts from 2006/07 and 2007/08 were similar in terms of total numbers, 
demographics and clinical features.  
Over half the patients were female (59.3% in 2006/07 and 58.9% in 2007/08). The 
mean age of patients was approximately 66 years old in both years (66.2 and 66.6 
years) with the age range also being fairly consistent between the two data years 
(16 to 105 years old in 2006/07 and 16 to 108 years old in 2007/08). Just over half 
of all ERCP episodes took place within an emergency admission (53.1% and 52.0%).  
The commonest coded diagnoses for first ERCP were gallstone-related (57.3% and 
58% of patients in each year). Cancer diagnoses were coded in 14-15% of patients. 
This included 2% of patients having codes for both cancer and gallstones and nearly 
13% of patients with codes for cancer alone with no codes for gallstones. 
Approximately one quarter of all patients were coded as having one or more non-
cancer co-morbid conditions.  
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Across the two years, 711 individual ICD codes were utilised in the first diagnostic 
code position. 90% (36,928) of primary diagnoses were made with just 40 individual 
codes. The remaining 10% (4,010) consisted of 671 codes. Nearly half (45%) of the 
ICD codes used were only used only once over the two years.  
Table 3.5 Patient characteristics and crude all-cause mortality for first ERCP procedures 
performed in England during the second, third or fourth quarters of the 2006/07 and 
2007/08 data years  
 2006/07 2007/08 
Patients, n 20,246 20,692 
Female gender, n (%) 12,001 (59.3%) 12,194 (58.9%) 
Age, mean (SD) 
 
66.2 (17) years 
(Range: 16-105) 
66.6 (17) years 
(Range: 16-108) 
Admission type, n (%) 
- Elective 
- Non-elective (emergency) 
 
9,476 (46.9%) 
 10,750 (53.1%) 
 
9,935 (48.0%) 
10,757 (52.0%) 
Diagnosis, n (%) 
- Gallstones (no cancer) 
- Cancer (no gallstones) 
- Cancer and gallstones 
- Other diagnoses 
 
11,595 (57.3%) 
2,552 (12.6%) 
401 (2.0%) 
5,698 (28.1%) 
 
11,992 (58.0%) 
2,644 (12.8%) 
441 (2.1%) 
5,615 (27.1%) 
Any non-cancer co-morbidity, n (%) 
- Absent 
- Present 
 
15,717 (77.6%) 
4,529 (22.4%) 
 
15,678 (75.8%) 
5,014 (24.2%) 
Died within 7 days of first-recorded ERCP, n 
(%) 
253 (1.3%) 286 (1.4%) 
Died within 30 days of first-recorded ERCP, n 
(%) 
1,078 (5.3%) 1,093 (5.3%) 
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All-cause mortality after first ERCP in England 
All-cause mortality within seven days of first ERCP was below 1.5% and at 30 days 
was 5.3% (Table 3.5). Cases with a coded cancer diagnosis accounted for 57.2% of 
deaths within 30 days in 2006/07 and 61.2% in 2007/08. Cases with a coded hepato-
pancreatobiliary cancer accounted for 43.2% of deaths within 30 days of first ERCP 
(Table 3.6). This is consistent with the role for ERCP in palliating biliary obstruction 
in incurable pancreatic or biliary malignancy. Of patients without a cancer diagnosis 
coded, all-cause mortality was 2.4% at 30-days in both years. The most common 
primary diagnosis in this group of patients was ‘K83.1 Obstruction of bile duct’ 
which was the ICD code in position one for 21% (n=95) of deaths in non-cancer 
patients. The next most common codes were ‘K80.5 Calculus of bile duct without 
cholangitis or cholecystitis’, ‘K80.2 Calculus of gallbladder without cholecystitis’ and 
‘K80.3 Calculus of bile duct with cholangitis’. Together, these three codes accounted 
for first diagnostic codes in a further 27% of deaths in non-cancer patients. The 
codes ‘K80.2 Calculus of gallbladder without cholecystitis’ and ‘K83.1 Obstruction of 
bile duct’ were the two commonest codes in second position and I10.X Essential 
(primary) hypertension the most common in the third position.  
All these code frequencies were taken from the last episode before death (within 30 
days of ERCP). 
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Table 3.6 Diagnostic code frequencies for deaths within 30 days of ERCP in 2006/07  
Diagnostic Group n % 
Hepatobiliary or pancreatic malignancy 466 43.2% 
Other benign hepatobiliary or pancreatic conditions 163 15.1% 
Other malignancy 150 13.9% 
Gallstones 97 9.0% 
Other infections 46 4.3% 
Other gastrointestinal conditions (excluding infections) 41 3.8% 
Respiratory conditions (including infections) 33 3.1% 
Cardiovascular conditions 29 2.7% 
Renal conditions 15 1.4% 
Procedural complication codes 13 1.2% 
Others 11 1.0% 
Orthopaedic conditions 7 0.6% 
Neurological conditions 7 0.6% 
Total 1078 100.0% 
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Univariate and logistic regression analysis 
Univariate analysis of the 2006/07 cohort showed that those dying within 30 days 
were older (mean age (sd): 76 years (12) versus 66 years (17) years; p<0.001), 
included more males (49.9% versus 40.2%; p<0.001), more patients treated during 
an emergency admission (74.1% versus 51.9%; p<0.001), more cases of cancer 
(58.5% versus 12.1%; p<0.001) and more patients with non-cancer co-morbidities 
(36.1% versus 21.6%; p<0.001) than patients still alive. Univariate analysis for 
2007/08 was almost identical.  
Binary logistic regression analysis of the 2006/07 data set confirmed age, sex, 
emergency admission, and cancer and non-cancer co-morbidity as independent 
predictors of 30-day death (Table 3.7). As would be expected, a cancer diagnosis 
was a strong predictor of 30-day death with an eight-fold increase in odds of death 
compared to non-cancer cases. Patients undergoing ERCP during an emergency 
admission had a two-fold increase in odds of death compared to electively 
scheduled cases. 
The optimised model containing the five predictor variables was found to predict 
death with 75.6% sensitivity and 77.9% specificity when tested internally on the 
same dataset (i.e. the 2006/07 data).  When re-tested against the 2007/08 dataset, 
performance was comparable with a sensitivity of 79.6% and specificity of 77.1%. 
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Table 3.7 Factors associated with all-cause mortality within 30 days of first ERCP 
procedure. Binary logistic regression analysis of procedures performed in England during 
the second, third or fourth quarters of 2006/07 data year  
(n=20,246 patients). Odds ratios with 95% confidence intervals 
Independent variable Odds ratio 95% CI p 
Age Group 
- <55 years 
- 55-64 years 
- 65-74 years 
- 75-84 years 
- >84 years 
 
1.00 
2.196 
2.343 
3.788 
6.163 
 
- 
1.593-3.028 
1.734-3.165 
2.842-5.048 
4.578-8.296 
 
- 
<0.001 
<0.001 
<0.001 
<0.001 
Sex 
- Female 
- Male 
 
1.00 
1.220 
 
- 
1.068-1.394 
 
- 
0.003 
Admission type 
- Elective 
- Non-elective (emergency) 
 
1.00 
2.017 
 
- 
1.741-2.337 
 
- 
<0.001 
Diagnosis 
- Non-cancer 
- Cancer 
 
1.00 
8.611 
 
- 
7.539-9.836 
 
- 
<0.001 
Non-cancer co-morbidity † 
- Absent 
- Present 
 
1.00 
1.472 
 
- 
1.279-1.694 
 
- 
<0.001 
 
Figures 3.1a&b show survival curves for patients with and without a cancer 
diagnosis, undergoing ERCP procedures. Given the strong influence of cancer 
diagnosis on risk of death at 30 days, we performed separate regression analyses 
for cases with cancer alone and non-cancer cases alone (Table 3.8).  In non-cancer 
cases, the variables for increasing age-group, male gender, emergency admission 
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status and non-malignant co-morbidity retained their significant independent 
associations with death.  However, among cancer cases alone only advanced age 
groups and emergency admission status were associated with significantly 
increased odds of all-cause death. 
HES data contains a composite measure of socioeconomic deprivation, the Index of 
Multiple Deprivation, which allows patients to be ranked into quintiles (‘fifths’) 
according their area of residence (most deprived to least deprived).  However, for 
patients undergoing their first ERCP, this variable did not demonstrate a significant 
association with 30-day mortality either on univariate analysis or when added to the 
binary regression models. 
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Figures 3.1 a + b Survival curves 
a. Benign diagnosis 
Age strata: <55 years old (blue line): 55-64; 65-74; 75-84; 85+ (yellow line) 
 
b. Cancer diagnosis.  
Age strata: <55 years old (blue line): 55-64; 65-74; 75-84; 85+ (yellow line) 
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Table 3.8 Factors associated with all-cause mortality within 30 days of first ERCP 
procedure. Binary logistic regression analysis of procedures performed in England during 
the second, third or fourth quarters of 2006/07 data year  
(n=20,246 patients). Adjusted odds ratio with 95% confidence intervals. Reference case 
for each predictor is the first category (e.g. for age group, reference category is < 55 years 
of age) 
Predictor variable All patients 
(n=20,246) 
Benign diagnosis only 
(n=17,293) 
Cancer diagnosis 
(n=2,953) 
OR 95% CI OR 95% CI OR 95% CI 
Age Group 
< 55 years 
55-64 years 
65-74 years 
75-84 years 
>84 years 
 
1 
2.20* 
2.34* 
3.79* 
6.16* 
 
- 
1.59-3.03 
1.73-3.17 
2.84-5.05 
4.58-8.30 
 
1 
2.67* 
3.49* 
5.69* 
10.76* 
 
- 
1.61-4.41 
2.20-5.53 
3.68-8.80 
6.94-16.70 
 
1 
1.49 
1.36 
2.17* 
2.77* 
 
- 
0.97-2.29 
0.91-2.04 
1.46-3.22 
1.82-4.21 
Sex 
Female 
Male 
 
1 
1.22* 
 
- 
1.07-1.39 
 
1 
1.46* 
 
- 
1.20-1.77 
 
1 
1.01 
 
- 
0.84-1.21 
Admission type 
Elective 
Non-elective 
(emergency) 
 
1 
2.02* 
 
- 
1.74-2.34 
 
1 
2.32* 
 
- 
1.85-2.89 
 
1 
1.76* 
 
- 
1.44-2.15 
Non-cancer co-
morbidity † 
Absent 
Present 
 
 
1 
1.47* 
 
 
- 
1.28-1.69 
 
 
1 
1.94* 
 
 
- 
1.59-2.36 
 
 
1 
1.12 
 
 
- 
0.92-1.37 
Cancer diagnosis 
Absent 
Present 
 
1 
8.61* 
 
- 
7.54-9.84 
 
N/A 
 
N/A 
 
N/A 
 
N/A 
†Presence of one or more Charlson co-morbidities (excluding cancer-related codes), *p<0.05  
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A bedside tool for predicting mortality risk after ERCP 
We pooled the data from 2006/07 and 2007/08 to yield a dataset containing 40,938 
patients coded as having their first ERCP. These data were used to construct a ‘look-
up’ table to provide an estimate of 30-day risk of death according to method of 
admission, underlying cancer diagnosis, presence of any major non-cancer co-
morbid illness and age group (Table 3.9).  A final diagnosis of cancer may not be 
firmly established at the time of ERCP but modern cross-sectional imaging and 
endoscopic ultrasound mean that malignancy is strongly suspected or known in 
most cases.  This table could serve as a valuable resource in providing realistic 
expectations of prognosis at the time of selecting and consenting patients for ERCP. 
The death rate among patients in the lowest risk category was just 0.4% (elective 
cases, under the age of 55 years, without co-morbidity and undergoing ERCP for a 
benign indication).  We did not have access to cause of death and our linkage 
analysis of routinely coded data cannot distinguish reliably between deaths due to 
progression of underlying disease, additional interventions (e.g. surgical 
operations), unrelated chance events (e.g. traffic accidents), or procedural 
complications.  However, a pooled estimate of procedural-related mortality for 
ERCP from 21 published surveys (16,855 patients in total) produced a figure of 
0.33%.118 The rate of procedure-related death in the previous English survey was 
0.4%.184 
At the other end of the mortality risk spectrum, mortality risk was almost 40% for 
the oldest patients (85 years and above) admitted as an emergency with underlying 
cancer and co-morbidity.  Intervention in the highest-risk cases might be deemed 
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‘futile’ if only deaths are audited 185 but these data suggest that 60% of poorest-risk 
cases survive beyond 30 days. Mortality without intervention would likely be higher. 
ERCP has a key role in palliating malignant biliary obstruction and the ‘look-up’ table 
could support and inform more realistic, individualised discussions of risk and 
outcome between clinicians, patients and carers.  
Table 3.9 All-cause mortality within 30 days of first ERCP according to age group (y), 
admission method (elective or emergency), cancer diagnosis and presence of co-morbid 
conditions  
Pooled data for quarters 2-4 of 2006/07 and 2007/08 for acute hospital Trusts in England 
(n=40,938 patients). 
Emergency Cancer Co-morbidity <55 55-64 65-74 75-84 85+ 
No No No 0.4% 0.7% 1.2% 1.6% 2.4% 
No No Yes 0.7% 1.0% 1.5% 2.4% 6.2% 
No Yes No 9.4% 12.4% 12.3% 14.2% 22.7% 
No Yes Yes 9.4% 19.0% 15.5% 21.3% 27.3% 
Yes No No 0.2% 1.4% 2.2% 3.9% 7.9% 
Yes No Yes 1.9% 3.3% 4.2% 8.3% 11.3% 
Yes Yes No 16.0% 20.0% 21.4% 27.2% 30.6% 
Yes Yes Yes 14.3% 20.6% 23.2% 33.2% 39.8% 
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Validation of the routine data and clinical engagement 
The demographic profile and basic clinical characteristics of patients in the present 
study were closely comparable to that reported in a previous large-scale 
prospective survey of ERCP in which the mean age of participating patients was 65 
years, females accounted for 57%, and the suspected diagnosis was ductal stones in 
54% and malignancy in 20%.184  However, all-cause mortality was higher in our 
study at 5.3% compared with the previous UK survey (2.7%).184  The latter study 
may have missed higher-risk cases as informed consent was required – mortality 
among non-participating patients in the survey was 5.6%.184 We identified all 
hospitals (n=66) that participated in the earlier English survey and undertook sub-
group analyses for patients treated at participating (n=16,026 patients) and non-
participating hospitals (n=24,912 patients). Crude all-cause 30-day mortality was 
5.37% for participating hospitals compared to 5.26% for non-participants (no 
significant difference). We conclude that the higher rate of all-cause death in the 
present study probably reflects more complete case ascertainment and better 
inclusion of high risk cases. Table 3.10 shows a comparison of findings from the BSG 
audit and the NCEPOD data. 
  
129 
 
Table 3.10 Comparison of outcomes from previous UK based audits of ERCP practice  
 BSG AUDIT NCEPOD NCEPOD HES COMMENT 
Total no. ercp 6910 Presume 23,606 23,606  
Total ercp 
deaths 
121 (30d first 
ercp) 
21 procedure 
related  
 
237 (30d last ercp) 381 (30d last 
ercp) 
 
Denominator  5264 
(= total number 
of patients who 
gave consent 
for data 
transfer and 
follow-up) 
3,853 deaths 23,606 BSG felt their 
figure 
represented 
20% of the 
total 
performed in 
the UK during 
the 6month 
study period in 
2004. 
Mortality  2.7% 30d 
0.4% 
procedure 
related 
3.4% 30d if 
excluded 
patients 
included 
? (1% if 
denominator = 
23606) 
1.6% 30d last  
Time scale  6 months 2004 12 months 
01/04/02 – 
31/03/03 
12 months 
01/04/02 – 
31/03/03 
 
Geography 5 metropolitan 
regions (NW, 
W. Midlands, 
Trent, N. 
Thames, S. 
Thames.).  
81 hospitals.  
England, NI, 
Wales, Guernsey, 
IoM, Defence, 
Independent 
hospitals (252 NHS 
and 11 non-NHS 
hospitals) 
England  
Case 
identification  
Prospective 
data collection 
by participating 
endoscopists. 
Questionnaire 
filled out for 
each 
consecutive 
ERCP 
Retrospective. 
Designated local 
reporters 
identified all 
deaths. 
J38, J40, J41, J42  
Within last 6 OPCS 
codes, within 30d 
of death 
 
Retrospective. 
HES 
J38, J40, J41, 
J42  
Within last 6 
OPCS codes, 
within 30d of 
death 
 
 
Death 
identification 
Designated 
liaison officer 
in each within 
each unit 
Retrospective 
questionnaire to 
responsible 
physician at time 
HES  
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of death 
Inclusions  All ERCPs 
performed by 
participating 
endoscopists 
where patient 
consent 
obtained. In 
selected 
hospitals. 
1,818 (47% all 
therapeutic 
endoscopy) 
237 ercp 
Inpatient 
deaths 
 
Exclusions  Non 
participating 
endoscopists. 
No consent 
from patient.  
= 1646 
2,035 (53% of all 
therapeutic 
endoscopy) 
620 =  three 
questionnaire 
maximum 
exceeded 
222 = endoscopy 
+/or death 
occurred at a 
different 
hospital/duplicates 
298 miscoded 
Outpatient 
deaths   
 
Patient type IP and OP IP  IP  
Returns  30d follow-up 
achieved for 
92% of 5264 
recorded 
ERCPs.  
66% Presume 100%  
 
Our comparison of anonymous HES data to local data within one Trust confirmed 
that there was a corresponding case for each recorded death (n=20), implying that 
the mortality linkage processes between HES and ONS are reliable and that this 
study is examining genuine clinical cases of post-ERCP mortality. However, one case 
identified from local data was not identified by HES data. On review of the case 
notes an electronic report of the ERCP procedure was not present. Instead, the 
report was hand written in the notes. This may not have been identified by the 
coding clerks and the ERCP procedure had therefore not been coded.  Although 
most (but not all) units now use an electronic reporting system to record their 
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endoscopic procedures there are occasional circumstances where an electronic 
report may not be produced. For example, if a procedure is performed out-with the 
endoscopy unit without access to the reporting system or, if there are technical 
problems with the electronic reporting system. Without an easily identifiable report 
sheet in the notes it will become less likely that the procedure is identified by the 
clerks. How often this happens is unknown. From our clinician feedback the 
numbers of procedures identified was generally thought to be accurate and where 
there was a significant discrepancy it was due to recording ERCP as an outpatient 
procedure rather than not recording the procedure at all. However, most 
respondents did have concerns regarding the accuracy of coding and it may be that 
small numbers of procedures were missed. Our total numbers of procedures do 
compare well with other studies of workload and in comparison to our total number 
of procedures analysed this small number of potential omissions would not affect 
our overall conclusions. Procedures that are missed because an electronic report 
has not been produced are likely to have been performed in venues other than the 
endoscopy unit. The common alternative locations for performing ERCP are the 
hospital main theatres or in the intensive care unit. This group of patients is likely to 
be sicker than the average ERCP patient with a higher mortality. So, if we have 
missed these patients our mortality figures are underestimates of the true mortality 
associated with ERCP and our conclusion that ERCP has a higher mortality than 
previously quoted holds true. 
In total, 114 clinicians from 98 Trusts replied to our questionnaire with several 
centres nominating one individual to respond – hence feedback was obtained from 
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65% of institutions. Responses are shown in Table 3.11. Basic ERCP activity data 
were judged accurate by 66% of respondents but 93% expressed concerns that local 
coding issues might result in incomplete capture of all ERCPs. It is worth noting that 
the numbers we sent out were for 11 months of ERCP. This was to allow 30 days of 
follow-up for mortality calculations. Although this was stated in the information 
sent out to clinicians it was apparent that some were comparing our 11 month 
totals to their ERCP numbers over 12 months. Reassuringly, if this is taken into 
account with some of the figures returned by respondents’ then the accuracy of our 
figures did improve in some cases. 
29% of respondents stated that ERCP was performed on more than one site within 
their Trust. This may have implications for data capture. Two respondents stated 
that ERCP was not performed at their Trust at all. All ERCP procedures were 
performed at the local tertiary Trust. One of the consultants did travel and perform 
ERCP lists at the tertiary Trust and this probably explains why his base Trust had 
ERCPs coded as occurring there. This base Trust and its handful of wrongly assigned 
ERCPs were excluded from our final analysis (Trust RK5).  
66% took transfers from other Trusts for ERCP at least occasionally with some 
stating it represented more than 50% of their activity. 80% perform day case ERCP 
although the frequency that this occurs appeared to vary quite considerably from 
the free text comments. One respondent stated that day case ERCP was a rare 
occurrence whereas others stated 30-40% of all cases, others the majority of 
elective ERCP. 93% will perform ERCP on patients in ITU (including ventilated 
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patients), although this appeared to happen very rarely from the free-text 
comments. Generally, this was fewer than a handful of occasions in a year.  
Routine local audit of 30-day mortality was being undertaken by 65% of 
respondents and 74% of specialists indicated that the crude mortality figures 
derived from HES data appeared valid for their unit.  This was corroborated by 
figures provided by some respondents. For example, their calculated 30-day 
mortality was 5.36%, our HES derived mortality for that Trust was 6.2%, another 
Trust stated 3.4%, our data showed 4.2% and 7.6% vs. 10% in another Trust. 77% of 
respondents agreed that the crude unadjusted mortality data was potentially useful 
to local teams and 91% wished to have routine access to more detailed information 
on any local cases of 30-day mortality that appear in the dataset. However, 45% 
suggested modifications to the pilot analyses and this feedback informed the final 
analytical plan.  Of those suggesting modifications to the pilot analysis (n=53), key 
themes were measurement of procedure-related mortality, as opposed to all-cause 
mortality (23.7%); a need to adjust crude all-cause mortality rates for case-mix 
(17.5%), procedural complexity (6.1%) or patient performance status (2.6%); and 
the suggestion to extend linkages to registered cause of death (10.5%). 
We received 116 free text comments from 53 respondents about how institutional-
level all-cause mortality data might be misinterpreted or used. Concerns relating to 
lack of case-mix adjustment were the main focus (21.1%).  Other concerns included 
inaccuracy of local data coding (8%); the potential to unfairly penalise low volume 
units (9%); the potential for such data to discourage intervention in high risk or 
palliative cases (‘risk aversion’) (6%) and misinterpretation of crude mortality as a 
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marker of ERCP procedure quality by the public or media (6%).  There were also 
encouraging comments supporting the use of this type of data to promote 
transparency and honesty in healthcare; to highlight good practice as much as 
identify poor performance. There was support for this type of data analysis to 
improve standards.  
Institutional-level analysis 
NHS Trusts vary in size from single-site district general hospitals to larger 
organisations which provide acute services on several hospital sites. Unadjusted all-
cause mortality was plotted against institutional case volume in a funnel plot for 
each data year with confidence limits around the national mean (Figure 3.2a and 
3.2b).  Without adjustment for case-mix variables we observed a typical funnel-
shaped distribution and no evidence of over-dispersion.  No Trust lay outside the 
outer 99.8% binomial confidence limit in any data year, nor did any single Trust 
occupy a position outside the 95% limit in both data years. Regression analysis 
showed no significant trend between procedure volume and all-cause mortality risk 
at 30 days (r=-0.05; p>0.05; n=150 Trusts). 
Using the national-level mortality risk from the look-up table (Table 3.9) and 
analysing the pooled data from both years we performed standardisation of Trust-
level all-cause mortality rates by calculating expected deaths for each Trust 
according to their local case mix based on age groups, admission status, cancer 
diagnosis and our binary co-morbidity variable. ‘Excess’ deaths were calculated by 
subtracting expected deaths from observed deaths in each sub-group and the 
institutional mortality rate standardised by conventional methods using the 
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estimated excess (or deficit). The unadjusted (Figure 3.2c) and case-mix adjusted 
rates were plotted (Figure 3.2d).  As with the unadjusted crude rates, the 
distribution of case-mix adjusted data showed a typical funnel-shape, with all Trusts 
lying within the arbitrary outer statistical confidence limits (3 standard deviations, 
SD) but with a greater degree of clustering close to the national mean.  
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Figures 3.2 a-d Funnel plots for all-cause mortality following first ERCP  
a. 2007-2008 
 
b. 2006-2007 
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c. Combined 2006-2008 
 
d. Adjusted all-cause mortality following first ERCP 2007-2008 
 
(Funnel plots constructed using Association of Public Health Observatories. 
Analytical tools for public health: Funnel plot for proportions and percentages 156) 
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Table 3.11 Responses to Clinician Questionnaire  
S1.1 Does the pilot data for your Trust accurately reflect the volume of ERCP procedures 
performed annually? 
1. '..on our reporting system 262 procedures over 12mmonths and 221 over 11, 229 in your 
data' 
2. 'The data under estimates numbers by at least 25%'  
3. 'Yes in terms of true 30-day mortality (actually 2.3%) but a bit out in terms of numbers 
(338 last year).' 
4. 'Our computerised endoscopy reporting system identifies 396 ERCPs done during this 
time. Your audit reports 334 ERCPs' 
5. 'There have been 3 ERCP procedure shown whereas we carry out nearly 300 ERCPs per 
year' 
6. 'I think the number (261) is an underestimate of around 100.' 
7. 'The Trust is an oncology centre serving 3 counties and this may account for slightly 
higher percentage performed for cancer and the resultant mortality rate.' 
8. 'Some Botox injections using side viewing scope may be coded as ERCP but have no risk 
attached.' 
9. 'This matches our internal Web reporting Tool for Endoscopic complications' 
10. 'there is approx 85% capture' 
11. 'Unisoft system recorded 177 ERCPs for the 12 months from 1/4/06 (not 127)' 
12. '180 procedures in time period, not 153 as recorded on your statistics' 
S1.2 Are ERCPs performed on more than one hospital site within your Trust?  
1.’Approx 130 at [xxx hospital] and 230 at [xxx hospital], but a single database, which was 
sometimes malfunctioning during 2006/07.  We now have a new cross-site database, but 
we still have problems with malfunctioning at times.’ 
S1.3 Does your unit accept transfer of patients for ERCP from other local Trusts? 
1. '> 50% of our activity' 
2. 'We are a tertiary referral practice for biliary/liver work with a regional liver MDT. A 
significant proportion do consistent of inter-hospital transfers' 
S1.4 Does your unit perform day case ERCP (discharge home the same day)? 
1. 'Probably a third of our cases are day cases' 
2. 'Have done so for a number of years. Virtually all elective ERCP is day case' 
3. 'Very rarely' 
4. 'However, all 'day case' patients have been coded instead as 'outpatients' until April 
2008. These patients are now coded as 'day case' since then.' 
5. 'About 40% are discharged home on the same day.' 
S1.5 Does your Trust undertake ERCP in critically-ill patients requiring intensive care and/or 
ventilation? 
1. 'rarely but occasional severe cholangitis' 
2. 'We do significant numbers of these, with over 80 critical care beds in the Trust.' 
3. 'max 1-2 per year' 
4. 'very very infrequently, if at all' 
S1.6 Are you aware of local coding or administrative factors that might result in incomplete 
recording of ERCP procedures? 
1. 'Coding notoriously inaccurate and relies on junior doctor recording each intervention' 
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2. 'Unclear to use as to whether all inpatient ERCPs are accurately captured, but data that 
you have presented suggests that if there is a miss rate - it would appear to be small.' 
3. '50% of activity recorded, problem across all endoscopy' 
4. '......understand the difference between day cases, in patients and hospital to hospital 
transfers for the day never being admitted.' 
5. '......patients are not assigned correctly to me as the operator.' 
6. 'Historically the Dr Foster statistics for [hospital] suggested a high overall relative 
mortality, but that has improved recently with better coding of co morbidities. Therefore it 
is possible that there is incomplete recording of ERCP procedures. However I recorded the 
same number of procedures during the audit period on my personal database. 
S1.7 Does your unit perform in-house audit for all-cause mortality within 30-days of ERCP? 
1. 'We look for complications rather than 30-day all-cause mortality' 
2. 'When done matches the approx 5% figure you give - very rarely procedure related.' 
3. 'Audit of 01/07 to 03/8 suggested all-cause mortality of 5.36%'  
4. 'The latest audit covers May-Nov 2008. 106 ERCPs. All-cause mortality within 30 days of 
3.4% (2 deaths, neither related to procedure).'  
5. '24 deaths out of 318 ERCPs in 2006/07 (7.5%)'  
S1.8 Does the pilot crude mortality figure generated for your Trust appear accurate? 
1. 'Probably. Difficult to know as I only monitor in hospital mortality.' 
2. 'We had 8 deaths in the 245 cases, one of which was ERCP-related; the others were co-
morbidity-or underlying pathology-related.'  
3. 'It seems too low' 
4. 'ERCP mortality rate appears high most likely because we coded most of our ERCPs as OP 
rather than day case. Therefore the few ERCPs we do code as inpatients (the sick patients) 
create an artificially high "mortality". The acceptance of probably sicker/ more complicated 
patients from other hospitals may be another contributing reason.' 
5. 'The number of procedures has been underestimated by 50% as has the mortality figures 
so percentage 30-day mortality figures about right.' 
S2.1 Do you think the present analysis represents a potentially useful measure for local 
Teams? 
1. 'It gives no data on complication and cannulation rates which are extremely important.' 
2. 'I think mortality is largely related to cause for ERCP (i.e. stenting for cancer) and CBD 
stone in sick elderly patients with other co-morbidity. I think mortality data should be 
picked up more accurately through JAG - 6monthly local ERCP audits and 28 day mortality 
data picked dup on a monthly basis through endoscopy systems.'  
3. Despite the less than 100% ascertainment, it gives a reasonable snapshot, and figures are 
similar to those from the earlier national audit. 
4. 'Because as mentioned in your letter needs to correlate with clinical condition. And the 
inevitable delay in obtaining mortality link prevents timely useful analysis. Would highlight 
units out of synch, the benchmarking may be useful' 
5. 'Really helpful (and reassuring)' 
6. 'There are too many other factors.  Many patients would like a palliative procedure in 
spite of their poor short term prognosis and many elderly patients do very well after - it is 
hard to predict who may die and this measure may put clinicians off attempting these 
cases' 
7. 'As noted, crude mortality figures reflect case-mix and practice. More useful measure of 
ERCP performance include: primary CBD cannulation rate, repeat procedure rate and direct 
ERCP complication rate, perhaps as surrogate IP stay length post procedure.' 
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8. '1 not broken down by operator 2 we are often doing procedure to give quality of life to 
ill sometimes terminal patients 3 if this was used it would deter Trusts from performing on 
ill patients who would benefit but might die 3 it is expensive collecting such data we would 
rather have more hands on front line staff than data analysts.' 
9. 'Yes - this has to be useful. I think there should be a mortality 'norm' - probably of about 
2-4%, possibly higher. Lower mortality than this implies inappropriate case refusal which is 
as bad as inappropriate case performance' 
10. 'to highlight the deficiency in coding' 
11. 'The case mix will be different, as will the local skill mix and this will undermine the 
value of comparing data between sites.' 
12. 'Crucial to GRS audit.' 
13. 'Rather like the Dr Foster mortality statistic, this should encourage careful local review 
of the cases if the unit is an outlier.' 
S2.2 The present analysis considers all-cause mortality after any ERCP (including repeat 
procedures). Would you modify the analysis in any way? 
1. 'Inpatient mortality, complication rate, 90-day mortality (for palliative stents)' 
2. '...unplanned admissions after ERCP and surgery rates within 30days of procedure...' 
3. 'Age standardised data' 
4. '...exclude death from underlying diagnosis particularly ca pancreas' 
5. 'One would obviously like to know about preventable deaths and complications.  If an 
elderly cholangitic patient dies after a desperate attempt to save their life, it has different 
implications than if a young woman with SOD succumbs to post-procedure pancreatitis 
(fortunately, I do not think we have any of the latter).  Consequently, one needs to know 
about pancreatitis, perforation, bleeding and infection caused by the ERCP, if one is to 
make real sense of the figures.  We do not want a more risk-averse attitude to ERCP, which 
is potentially life-saving in the acute situation.' 
6. 'Modify on the basis of indication (Stones, malignancy) and on the basis of first 
procedure, follow-up procedure and on the basis on any intervention undertaken' 
7. 'It would be very nice to know whether these deaths were procedure related 
complications, tumour deaths or unexpected strokes, infarcts etc. Also whether they were 
in hospital or at home.' 
8. 'Safety could be better assessed with 30-day mortality following sphincterotomy, or 
failed therapy, or repeat procedure within 30 days.'  
9. 'Causes of death are essential to enable any meaningful interpretation of this data' 
10. 'Procedure specific mortality. Patients' baseline performance status.' 
S2.3 Would you be interested in having routine access to more detailed information for any 
local ’30-day mortality’ cases identified for your Trust (e.g. age/coded diagnoses/episodes 
of care/other surgical procedures)?   
1. 'Often a very crude measure.  I suspect if you plotted crude all-cause mortality for a 
range of diseases, the variation would be relatively small for different Trusts.  UK practice at 
the end of the day is pretty similar across the land and to draw out differences between 
Trusts is unlikely unless detail of service delivery is analysed.' 
2. 'for all endoscopic procedures' 
3. 'if timely data available would be very useful to prevent us all beavering [sic] away with 
steam driven data/audits' 
4. 'Yes - all data are helpful because it is presently inaccurate and needs to get better. It will 
not improve without being 'aired' or published.' 
5. 'I already keep an audit of all my personal ercps with learning points which is more useful 
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than these sort of very crude statistics' 
6. 'I think there is a danger of trying to read too much into this data.' 
7. 'To work out why our PAS / HES data is so inaccurate [sic] in addition to providing 
benchmark standards for future audits' 
S2.4 Please list any concerns you have about how this sort of data might be misinterpreted 
or used. 
1. 'No concerns.  It helps to focus on meaningful outcomes after high risk procedures.' 
2. 'If the numbers/coding are not accurate then it reflects poorly on workload/throughput. 
This data is then used to challenge services by misinformed NHS managers.' 
3. 'Low volume centres with good results could be pressured to close or move work away. 
Care  needed to  link results with case mix' 
4. '....'all-cause mortality following ERCP' may be an example of that: low numbers, wide 
CIs, possibly measuring the wrong thing, etc.' 
5. 'Crude all-cause mortality does not take into account the pre-procedure health of the 
patient, and at present we often undertake ERCP in patients considered too unwell for 
surgical procedures.  If Trusts get concerned about these figures, there is a danger that 
doctors will start to refuse to perform ERCP on unwell patients in order to 'improve' the 
figures for their Trust.' 
6. 'It is vital that this sort of information is available accurate open fed back and acted on, 
on a regular basis.' 
7. 'Clearly, there is gross misuse of poor quality data (in League Tables for example) and this 
makes people worried and unwilling to be open let alone honest. Also, the simplistic 
interpretation of data by media and politicians (sometimes deliberate misinterpretation 
dare I say) does not create an atmosphere of openness and candid disclosure. We have to 
fight against this however, not just for revalidation purposes but because we really need to 
let practitioners know just how well (or indeed badly) they are performing. And the service 
needs a mechanism whereby concerns about aspects of service performance can be flagged 
up. So keep it up as we cannot advance without better quality data.' 
8. 'All-cause mortality needs to be interpreted with caution and never be misinterpreted as 
procedure related mortality.' 
9. 'People may not understand small number effect i.e. increase of 25% in mortality year on 
year may only be 3-4 extra cases but may not be understood by some' 
10. 'No concerns only comment. Collection of all-cause mortality as part of the BSG audit 
was difficult and I think this represents a very helpful contribution. As you allude to in your 
letter, if you were able to link mortality data to a more comprehensive description of co-
morbidity, then it may be possible to model an expected range for mortality that controls 
for case mix. Whilst you may achieve this with improved coding I suspect it would require 
some prospective data collection. If such data were collected within units would it be 
possible to marry it to your outcome data via NHS number? This would form the basis for 
an interesting study/project in which I would be happy to collaborate.' 
11. '.....the case mix needs to be looked at before any comparisons are made.' 
12. 'Units risk being labelled 'poor' because they happen to have higher mortality figures 
resulting from random variation. Year-on Year cumulative data would be more useful.' 
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Discussion 
Our analyses show that all-cause mortality after ERCP is explained largely by the 
natural history of underlying disease. Much of the early mortality occurs in older, 
acutely unwell (emergency) patients with co-morbid medical conditions and 
underlying cancer. Palliation of malignant biliary obstruction is a key indication for 
ERCP and the late-stage presentation of such pathologies makes short-term 
prognosis poor for many. Our real-world estimates of relatively high 30-day 
mortality for such cases should not necessarily deter intervention - even in the 
highest risk groups the majority of cases survive. They are a basis for an informed 
discussion of risk versus benefit. The information contained within the ‘look-up’ 
table provides clinicians with a means to communicate risk with patients and their 
families to justify intervention, or non-intervention where appropriate.  
This analysis of routinely coded data yielded a funnel-shaped distribution of crude 
mortality statistics when analysed at Trust level, both before and after simple case-
mix adjustment. This suggests a process that is under ‘control’ with variation likely 
to reflect common-cause factors such as differing case severity and complexity. 
Such reassuring results probably reflect the training and accreditation systems 
instituted by the professional society, the British Society of Gastroenterology, over 
the last 10 years that have ensured a common set of standards for units and 
operatives providing ERCP services in England81. The questionnaire respondents 
were concerned about coding completeness and accuracy and the fact that HES 
data does not code the clinical severity of acute illness (e.g. the ASA score, a known 
predictor of post-ERCP mortality) 129. Nevertheless, at a national-level routinely 
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coded variables such as emergency admission status and co-morbid illness have 
highly significant associations with risk of death and so appear valid as proxy case-
mix adjusters. However, the ‘constant risk fallacy’ is a potential problem when 
analyses are taken down to institutional level – any given risk factor may not confer 
the same degree of risk at every centre25;26.  
Coding of co-morbid conditions was limited in this study. Just a quarter of cases had 
any codes for co-morbid conditions listed in their ERCP episode. This will limit the 
ability to adjust for case mix when comparing different institutions. Assessing for 
co-morbid conditions may be improved by linkage of episodes for any given 
individual using their unique identifier within the HES datasets. The episodes of care 
prior to the ERCP episode can be identified and may yield more complete coding of 
co-morbid conditions. 
We did not find a correlation between all-cause mortality and procedure volume, in 
agreement with an American database study of mortality after inpatient ERCP123. 
The monitoring of crude 30-day mortality rates using routine data has been 
advocated as an institutional performance indicator for interventions that have a 
high procedural-associated mortality risk186. Although the headline mortality risk of 
5% after ERCP might suggest a potential for institutional comparisons, the very low 
rate of mortality among cases lacking risk factors for disease progression (e.g. 0.4% 
for younger patients with benign indications) suggests a very low signal-to-noise 
ratio. Whilst the relatively narrow scatter of all-cause mortality across units in 
England is reassuring for patients, it is important to note that very few deaths are 
likely to be procedure-related. Specific codes relating to possible technical 
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complications of ERCP were recorded as the primary diagnosis in only 1.2% of 
patients who died within 30 days of ERCP (just 0.06% of total procedures, a similar 
rate to that reported in a single-centre U.S. study)187. Our linkage analysis of last-
coded primary inpatient diagnosis suggested that it would not be possible to 
distinguish the effects of natural progression of disease (e.g. pneumonia arising in 
the setting of advanced cancer) from specific post-procedure complications (e.g. 
pneumonia as a result of aspiration during ERCP). Clearly, it would not be 
appropriate to use all-cause mortality as an index of the quality of individual ERCP 
operator performance – better measures exist188, such as cannulation rates. Overall 
mortality rates are more likely to reflect global performance of a team or institution 
and the underlying disease process.   
Nevertheless, clinical engagement in the analysis of routine hospital episode and 
mortality data offers the potential to better-understand real-world outcomes and to 
generate information that is meaningful to clinicians and patients in planning care 
but avoids inappropriate institutional comparisons.  
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4. Percutaneous Endoscopic Gastrostomy  
Abstract 
Background and aims: Studies have shown variable outcomes following 
percutaneous endoscopic gastrostomy (PEG) insertion raising concerns about its 
widespread use. Subjects who may benefit from PEG may be elderly and/or have 
significant co-morbidities such that short-term prognosis without intervention is 
poor. However, PEG insertion is an invasive procedure with associated risks 
including mortality. Robust data from large multi-centre studies for outcomes 
following gastrostomy insertion are scarce.  
The primary aim of this study was to show that analysis of routinely collected data 
can be used to assist clinicians, patients and carers in their decision making 
regarding the risks and benefits of PEG insertion.  
Specific aims included the assessment of all-cause mortality at 7 & 30 days following 
PEG insertion using linkage to Office of National Statistics death certification data; 
identification of factors associated with crude mortality rates and variation in 
procedure volume and outcomes at Trust level. 
Methods: Care episodes containing procedure codes (OPCS-4) for gastrostomy-
related interventions were extracted from our two years of HES data and deaths 
identified. Diagnostic fields (ICD-10 codes) were analysed for indication and co-
morbidity. Factors associated with death were identified by univariate and multiple 
logistic analyses. Crude mortality rate at each hospital Trust was analysed versus 
PEG number to explore ‘volume’ effect. 
147 
 
Results: 30,781 patients had gastrostomy-related procedure codes of which 14,055 
were coded with G44.5 (‘Fibreoptic endoscopic percutaneous insertion of 
gastrostomy (PEG)’). Excluding cases with codes for cancer yielded 10,952 PEG 
patients. The mean age was 68.4 years (16-99 yrs). 51% were male and emergency 
admissions accounted for 72% of all episodes. Codes for Stroke were found in 40%; 
Motor Neurone Disease (MND) in 7.2%; Parkinson’s Disease in 5.4%; Multiple 
Sclerosis in 4.9% and Dementia in 7.2%.  
All-cause mortality rates were 4.2% at 7 days and 14.6% at 30 days. Binary logistic 
regression identified the following predictors of death within 30 days of the 
procedure: Age over 85 years, male sex, emergency admission, motor neurone 
disease and dementia (p<0.03 for all). In elderly patients (85+) during emergency 
admissions, dementia was associated with 7-day mortality of 14.6% compared to 
7.8% in stroke. No correlation for 30-day death versus PEG volume was identified at 
NHS Trust level (Pearson r=0.04).  
Conclusions: Hospital Episode Statistics data allow national-level analysis to 
provide real-world estimates of prognosis in subjects selected for PEG in England 
and identify factors associated with all-cause death. 
  
148 
 
Introduction 
This study aims to:  
1. Determine feasibility of analysing all-cause mortality at 7 & 30 days following PEG 
insertion using Hospital Episode Statistics (HES) linked to Office of National Statistics 
(ONS) death certification data 
2. Identify factors associated with crude mortality rates.   
3. Assess variation in procedure volume and outcomes at Trust level  
Background 
Percutaneous endoscopic gastrostomy (PEG) is a method by which nutrition can be 
maintained via the enteral route in patients whose oral intake is inadequate and 
who may otherwise require intravenous feeding or repeat insertions of naso-gastric 
feeding tubes. First described in 1980189, studies have shown variable outcomes 
following PEG insertion raising concerns about its widespread use. In 1990 over 
85,000 patients in the U.S. aged 65 years and older were discharged from hospitals 
with a gastrostomy. This figure includes around 1% of the US population aged over 
85 years190. Percutaneous gastrostomy tube insertion is indicated in patients who 
are likely to need enteral feeding for more than four weeks191. There are complex 
ethical issues surrounding enteral feeding that need to be taken into consideration 
before PEG tubes are inserted. Patients having PEGs inserted are, by definition not 
100% fit and healthy. Guidelines as to who is appropriate for PEG feeding vary and 
are changing192. In the UK indications for PEG insertion include stroke, other 
neurological conditions, head and neck cancers, intestinal failure requiring 
supplementary intake and head injury. In these circumstances PEG feeding 
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improves the quality of life, enables people to be discharged home and may prolong 
life191;193-195. Guidelines published by the Royal College of Physicians in 2008 
recommended that gastrostomy feeding should be considered for stroke patients 
who are unable to tolerate naso-gastric feeding within the first four weeks; are 
unable to maintain adequate oral intake at 4 weeks; and, those who are at long-
term, high risk of malnutrition. Swallowing will be affected in up to 40% of stroke 
patients with 30% having evidence of poor nutrition, malnutrition and dehydration 
after their stroke. All these factors are associated with worse outcome196.  For those 
with head and neck cancers, pre-operative PEG feeding can optimise the patient for 
surgery, improving outcomes197-201.  
Gastrostomy tubes may be placed endoscopically, surgically or radiologically 
(radiologically inserted gastrostomy or ‘RIG’).  All methods are invasive and have 
associated risks, including mortality. This study generally confines itself to 
endoscopically placed gastrostomy tubes (PEG) which is the most common and 
widely used method of insertion. Complications can relate to the endoscopy, to the 
percutaneous insertion itself or later complications such as tube displacement, tube 
blockage and discomfort due to tube position. Complications can also arise from the 
process of enteral feeding – reflux and aspiration, diarrhoea, bloating and 
potentially more dangerous, metabolic disturbance including refeeding 
syndrome202. All these factors contribute to the mortality associated with PEG 
insertion but do not explain all deaths following the procedure. Indeed these events 
probably only explain a very small number, with procedure related mortality 
previously reported as below 1%197;203.  
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There are many studies looking at outcomes following gastrostomy. However, these 
are generally retrospective, small or single centre. Follow-up is limited and often no 
more than 30 days. Although recurrent themes do emerge, robust data from large 
multi-centre studies for outcomes following gastrostomy insertion in particular 
groups of patients are scarce.  
Reports of 30-day mortality following PEG insertion varies widely with some studies 
suggesting rates of over 25%204. Other studies suggest much lower 30-day mortality 
rates of under 10%205;206. There is evidence that mortality is higher in patients who 
have their PEG insertion whilst hospitalised for acute illness compared to those 
admitted electively for the procedure207-209. The NCEPOD report of 2004 looked at 
deaths in England within 30 days of a PEG procedure. They considered that nearly 
20% of these procedures were probably futile with 43% deaths occurring within 1 
week of the procedure52;210. Of note, the NCEPOD report used codes pertaining to 
gastrostomy problems, replacement and removal as well as specific insertion codes 
to identify PEG procedures for their mortality analysis. Thus, a (small) number of the 
deaths identified in the NCEPOD report probably did not occur within 30 days of a 
PEG insertion, but within 30 days of a post insertion event.  
The National Patient Safety Agency (NPSA) issued guidance on gastrostomy 
insertion following reports of 22 serious incidents following gastrostomy insertion, 
including 11 deaths, between 2003 and 2010211.  
Studies have often been based on single centre cohorts of patients and accepted 
indications for PEG insertion vary from country to country. The largest study used 
data from the US Medicare claims database to perform a retrospective cohort 
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study. They looked at 81,105 cases of gastrostomy insertion from 1991. The in-
hospital mortality was 15.3% whilst the overall 30-day mortality was 23.9%. 
Mortality at 1 and 3 years was 63% and 81.3% respectively212. Another large study 
of PEG outcomes to date was a retrospective study using data from two large 
electronic databases from Veteran’s Affairs in the United States213. This looked at 
7,369 patients having PEG insertions over two years in the early 1990s and followed 
them up for a period of three years. This cohort of patients were mostly male 
(98.6%), with ages ranging from 18 to 102 years. Nearly 20% had cerebrovascular 
disease, 29% had other neurological disease and 16% had head and neck cancer. 
The in-hospital mortality was 24%. A figure for 30-day mortality was not provided 
but figures at 1, 2 and 3 years were 59%, 71% and 77% respectively. Age was found 
to be the important determinant for mortality. Other co-morbid conditions (i.e. not 
indications for PEG insertion) were not assessed. A meta-analysis of five cohort 
studies confirmed that the majority of older patients (>65 years old) who undergo 
PEG insertion did not survive 12 months214.  
Co-morbidity clearly affects outcomes with studies showing higher mortality in 
populations with a higher proportion of cancer patients. Deaths are often related to 
the underlying diagnosis rather than the procedure itself. Pre-procedure 
assessment of the patient by the Nutrition team / gastroenterologist / endoscopist 
can reduce PEG mortality by excluding those patients whose underlying diagnosis 
makes their life expectancy too short to benefit from PEG insertion215. Local audit at 
my base hospital (University Hospital Aintree, Liverpool, UK) showed a 30-day 
mortality of 17% in 2003-2004. Since then a more stringent pre-procedure 
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assessment of patients referred for PEG has been introduced and the 30-day 
mortality has fallen to 9%.  
A British retrospective study found that a tenfold rise in number of PEG insertions 
over 10 years was accompanied by a threefold increase in 30-day mortality from 8% 
to 22%. Multivariate analysis showed three independent predictors of 30-day 
mortality: pre-procedure fast of 7 days or more, albumin below 30 and history of 
cardiac disease. However, confidence intervals were wide (though none including 0 
or 1), and overall numbers small (particularly in the first cohort). What they did note 
was that the proportion of PEGs inserted for non-evidence based indications e.g. 
dementia and pneumonia, had increased (p=0.048) which is obviously of concern206. 
Outcomes following PEG insertion in patients with severe dementia are known to 
be poor, with reported 30-day mortality rates of over 50% 216.  
In the US, Kobayashi et al looked at outcomes for all patients referred for PEG 
insertion to identify factors predictive for survival166. This was a prospective study 
with 12 months of follow-up including a total of 67 cases referred for PEG 
assessment. The 30-day mortality in the 50 patients who eventually underwent PEG 
insertion was 20%. Interestingly, 5 patients died within 7 days of the referral being 
made, 3 before they had even been assessed by the Gastroenterology team, 
underlining the importance of physician education regarding timing and indication 
for PEG insertion. The only factor significantly associated with mortality (Kaplan-
Meier and multivariate analysis) post-PEG was a Charlson Index of 4 or more. The 
Charlson Index is a validated measure of co-morbidity used to predict mortality in 
longitudinal studies142. Low albumin levels were not found to be associated with 
153 
 
mortality. 62% of patients referred for PEG in this study were fully dependent in all 
ADLs with dysphagia secondary to dementia the primary indication for PEG 
insertion in 10 patients. This may differ from UK institutions and indeed is likely to 
change in the US as there is good evidence that PEG insertion in severe dementia is 
associated with much worse outcomes and is not appropriate. In this study 14% 
patients regained their swallow and had their PEG removed during follow-up. 
Indications for these PEGs were stroke (n=2), other neurological disorder (n=1), 
head and neck cancer (n=2), aspiration pneumonia (n=1) and near drowning (n=1). 
Few studies have looked at the effect of PEG feeding on quality of life. Some have 
confirmed improved nutritional status in patients following PEG feeding217 and 
improvement in swallow function sufficient to allow removal of PEG in up to 16% of 
patients166;204. The ‘Feed or Ordinary Diet (FOOD)’ Trial reported that early enteral 
feeding reduced the risk of dying following stoke, although functional outcome at 2-
3 weeks was better with naso-gastric tube feeding than with PEG feeding218. Other 
studies have confirmed superiority of PEG feeding over naso-gastric feeding in the 
longer term217;219. 
Advancing age and its association with higher mortality has been confirmed by 
other studies. A retrospective study showed a 1.9% increased risk of dying before 
discharge for each additional year of age220. This study also found being married; 
mechanical ventilation and dialysis were associated with in-hospital death on multi-
variate analysis. These findings may say more about US healthcare practices than 
anything else but the overall 30-day mortality of 22% and in-hospital mortality of 
11% are in keeping with other studies. Being married generally reduces mortality 
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but Smith et al suggest that a spouse is a surrogate decision maker who will make 
the choice to withdraw care. Conversely, patients without a spouse or ‘Next of Kin’ 
are less likely to seek medical care and won’t have anyone requesting PEG insertion.  
The decision to insert a gastrostomy is a complex one. Careful patient selection is 
vital if outcomes are to be in the best interests of the patient. Evidence based 
guidance; using robust data will assist physicians, patients and relatives, in assessing 
the risks and benefits of insertion for an individual.  
Doctors, patients and carers require realistic expectations of outcome when 
considering PEG placement. Subjects who may benefit from PEG may be elderly 
and/or have significant co-morbidities such that short-term prognosis without 
intervention is poor. We hope to show that a national database of routinely 
collected data can provide useful and robust data about outcomes following PEG 
insertion that can be used by clinicians to guide their decision making and enable 
them to fully inform patients and relatives regarding the risks and benefits of such 
procedures.  
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Methods 
From our master files for 2006/07 and 2007/08 (see ERCP Method section: The 
Master Datasets), episodes of care (including day cases) containing OPCS-4 
procedure codes for gastrostomy-related interventions were extracted and deaths 
within 7 and 30 days identified. Diagnostic fields (ICD-10 codes) were analysed for 
diagnosis and co-morbidity. Factors associated with death were identified by 
univariate and multiple logistic analyses. Crude mortality rate at each hospital Trust 
was analysed versus PEG number to explore ‘volume’ effect. 
The PEG Datasets  
Cases of PEG insertion were identified using the 13 OPCS codes listed in Table 4.1. 
For the initial data extraction all codes pertaining to gastrostomy insertion were 
used. However, for the final analysis we looked only at episodes containing the 
G445 code. This is the only code that specifically describes endoscopic 
percutaneous insertion of a gastrostomy tube. Some of the other codes do not 
specify the exact method of insertion and could therefore be used to describe 
surgical and radiological insertions as well as the standard endoscopic method. 
Remaining codes describe gastrostomy tube associated events such as replacement, 
displacement, removal, blockage or other problems. The primary aim of this study is 
to assess mortality following insertion of PEG therefore it was felt appropriate to 
exclude these other codes from the final analysis.  
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 Table 4.1 List of OPCS codes used to select PEG and PEG related procedures  
The syntax used in SPSS to produce the datasets can be found in Appendix 7.1. PEG 
codes were identified in each of the 12 procedure fields and those episodes of care 
copied into a new data set corresponding to each field. This process produced 12 
files with a line of data for each PEG procedure patient, identified by their unique 
HESID. These files were named ‘PEGextractposition1’, ‘PEGextractposition2’ and so 
on, up to ‘PEGextractposition12’. Where a patient had a PEG code in diagnostic 
code position 1 and 4 for example, there would be an entry in both the files 
‘PEGextractposition1’ and ‘PEGextractposition4’. At this stage this would occur 
regardless of the dates associated with the two codes.  
The aim is to create one file containing a line of data for each PEG procedure. 
Before this can happen we have to identify which codes pertain to an individual 
procedure. Each procedure code has a date held within the corresponding 
‘OPERDATE’ field. If PEG codes have the same date and HESID then they are 
Code Definition 
G34.1 Artificial opening into stomach,    Creation of permanent gastrostomy 
G34.2 Artificial opening into stomach,    Creation of temporary gastrostomy 
G34.3 Artificial opening into stomach,    Reconstruction of gastrostomy 
G34.4 Artificial opening into stomach,    Closure of gastrostomy 
G34.5  Artificial opening into stomach,    Attention to gastrostomy tube 
G34.8 Artificial opening into stomach,    Other specified 
G34.9 Artificial opening into stomach,    Unspecified 
G36.1  Other repair of stomach,    Gastropexy nec 
G36.3 Other repair of stomach,    Closure of abnormal opening of stomach 
nec 
G36.8 Other repair of stomach,    Other specified 
G36.9 Other repair of stomach,    Unspecified 
G44.5 Fibreoptic endoscopic percutaneous insertion of gastrostomy (PEG) 
G44.8 Other fibreoptic therapeutic endoscopic operations on upper 
gastrointestinal tract,    Other specified 
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presumed to represent one PEG procedure and will be represented by one line of 
data in the final dataset. It is highly unlikely a patient would undergo more than one 
PEG insertion in a day. If PEG codes for the same HESID have different dates then 
the patient identified by that HESID had PEG procedures on two different days and 
would therefore have two lines of data in the final dataset.  
In each extract the corresponding OPERTDATE variable was copied and the 
duplicate field renamed to create a ‘PEGDATE’ variable (i.e. From the 
‘PEGextractposition1’ file, copy the ‘OPERDATE1’ column and paste into new 
column and rename PEGDATE; in ‘PEGextractposition2’ copy and paste OPERDATE2 
to create PEGDATE variable etc).  
A further new variable must be created before merging the datasets. This is 
‘PEGPOSITION’ and will aid with the removal of duplicate entries (see below). In 
‘PEGextractposition1’ the ‘PEGPOSITION’ variable equals 1 for all episodes, in 
‘PEGextractposition2’ it equals 2 for all episodes, in ‘PEGextractposition3’ it equals 3 
and so on. 
The 12 files can then be merged (see below).  A copy of the ‘PEGextractposition1’ 
file is made before merging so that at the end of the process we still have all 12 
individual ‘PEGextractposition’ files, as well as the final merged data file. This is a 
safety measure to allow cross-checking of totals and allow the process to be 
repeated if discrepancies are found. 
To merge the files, first open ‘PEGextractposition1’. Use the SPSS function ‘MERGE 
FILES’ by ‘ADDING CASES’ and merge data from the ‘PEGextractposition2’ file then 
158 
 
position3 etc. Check totals as you proceed and compare with sum of individual 
position files.  To merge, all files must have identical variables in the same order 
(usually ascending) and format e.g. numeric, string, date format. If these differ for a 
particular variable, it won’t merge. 
Once the files are merged (do data years separately) they are saved as 
‘PEG0607MERGEDextracts.sav’ and ‘PEG0607MERGEDextracts.sav’. These files 
contain all episodes containing a PEG procedure code in each data year. 
Removing duplicates 
At this stage the files contain a line of data for each PEG code. We have to delete 
rows of data attached to codes that pertain to the same procedure i.e. have the 
same date, to leave us with a row of data for each procedure. 
First, the dataset must be ordered using the ‘Sort’ function in SPSS to sort data in 
ascending order by HESID, PEGDATE and PEGPOSITION. Then, ‘Identify duplicate 
cases’ by matching for HESID then PEGDATE. This will label identical duplicate 
episodes as ‘0’, with ‘1’ identifying unique or first episodes. By using ‘Select cases’ 
where ‘primaryfirst’ = 1 data can be copied into a new dataset: 
‘PEG0607DUPLICATESREMOVED’. This file contains all separate PEG episodes for 
each patient with one row of data for each different episode. By sorting the data 
according to ‘PEGPOSITION’ the final dataset will contain the codes used in the 
highest procedure position and should therefore contain the most patient 
information. The secondary codes used on the same date will be contained within 
that row of data. 
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Deletions 
Initial data cleaning to exclude paediatric cases, invalid age data, and inappropriate 
admission types e.g. ‘admitted ante-partum’ is described in the ERCP Chapter 
‘Method’ section. No Trusts were excluded from the PEG analysis. It was expected 
that there would be substantial variation in the number of PEG procedures 
performed over 12 months across different institutions with very low numbers not 
necessarily indicating missing or inaccurate data.  
Further data cleaning of the merged PEG datasets was performed to eliminate 
episodes with PEG procedures dates outside the target time period or outside the 
extracted episode time period (i.e. did not occur in that episode). Episodes with PEG 
procedure dates after the date of death were deleted. 
Additional Variables 
Additional variables were added to the PEG dataset to allow further analysis. Many 
of these are described in the ERCP Method section. Those variables specific for the 
PEG analysis are described in Table 4.2.  
Final PEG Datasets - Exclusions 
As we wanted to analyse only gastrostomy insertions rather than all PEG related 
procedures, we elected to include only episodes containing the OPCS code G445 in 
our final dataset. This meant we could lose some gastrostomy insertion episodes 
where insertions were coded without the G445 code (a minority) but our data 
would not be contaminated with episodes of care relating to post-insertion events.  
The commonest scenario for a patient with cancer to be having a PEG tube inserted 
is a patient with a head and neck cancer who is having the gastrostomy inserted 
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prior to them undergoing major surgery and /or radiotherapy. This enables them to 
maintain oral nutrition throughout their treatment. The PEG will be inserted during 
an elective admission and will often be removed in the months following 
completion of treatment. This population is entirely different to the vast majority of 
PEG patients who have lost the ability to swallow safely due to an acute or chronic 
neurological process and are having their PEG inserted during an emergency 
admission. For these reasons our final dataset was reduced further by excluding all 
cancer cases.  
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Table 4.2 Additional variables added to create final PEG dataset 
Variable name Description 
FIRSTPEGEPISODE 1 = First PEG code containing episode in 
data year; 0 = Repeat PEG episode. 
Created by matching on HESID  after 
sorting data on HESID and PEGDATE 
LASTPEGEPISODE 1 = Last PEG episode in the data year – see 
above 
EPISODEsequence 0 = Only PEG episode in data year 
1 = First PEG episode in data year where 
patient has more than one episode; 2 = 
Second PEG episode in a sequence of 
more than one; 3 = Third episode; etc 
DAYSTOPEG Days from admission date to PEGDATE 
calculated using the Date and Time Wizard 
function in SPSS 
PEGDATE Date of PEG procedure 
DAYSTODEATH Days from PEGDATE to DEATHDATE 
DEATH7 Marker to indicate death less than 8 days 
after PEGDATE 
DEATH30 Marker to indicate death less than 31 days 
after PEGDATE 
STROKE1-17 1=stroke code present in position 1-17. 
For this analysis, codes selected to identify 
a stroke were those used in Sundararajan 
et al’s177 version of the Charlson Index. See 
Appendix 7.1 - PEG Syntax. The method 
for deriving marker variables is described 
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in the ERCP Chapter, method section 
STROKEMARKER Indicates a stroke code is present in any of 
the diagnosis code fields 
SUMSTROKE Indicates the total number of stroke codes 
present from a care episode 
G445 Indicates the presence of the G445 code in 
any of the procedure code fields 
NONSTROKENONCANCERCOMORB 
(Derived via 
NONSTROKENONCANCERCOMORB1-17 as 
above for STROKE) 
Indicates the presence of a co-morbidity 
code that is not stroke or cancer related. 
See Appendix 7.1 - PEG Syntax 
DEMENTIA 
(Derived via DEMENTIA1-17) 
Indicates a dementia code is present in 
any of the diagnosis code fields. See 
Appendix 7.1 - PEG Syntax 
MND 
(Derived via MND1-17) 
Indicates a code for motor neurone 
disease is present in any of the diagnosis 
code fields. See Appendix 7.1 - PEG Syntax 
MS 
(Derived via MS1-17) 
Indicates a code for multiple sclerosis is 
present in any of the diagnosis code fields. 
See Appendix 7.1 - PEG Syntax 
PARKINSONS 
(Derived via PARKINSONS1-17) 
Indicates a code for Parkinson’s disease is 
present in any of the diagnosis code fields. 
See Appendix 7.1 - PEG Syntax 
 
Statistical Analysis 
The Hospital episode data were stored, manipulated and analysed using the SPSS 
statistical package (SPSS Inc., Chicago, USA). National-level analyses of factors 
associated with all-cause death were identified by univariate analysis and multiple 
logistic regression models. Funnel plots of institutional-level data were generated 
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using analytical tools provided by the Association of Public Health Observatories.156 
Significance was set at p<0.05. 
Univariate analysis 
Analysis was performed to assess the effects of the following variables on mortality 
following PEG insertion at 7 and 30 days: 
 admission method type 
 age and gender 
 presence or absence of co-morbid conditions 
 presence of stroke and /or dementia 
Multiple logistic analysis 
All variables found to be significant at the univariate level were then assessed for 
effect as part of a multiple logistic regression analysis. Again this was performed 
using SPSS. 
Volume vs. Mortality effect 
Crude mortality rate at each hospital Trust was analysed versus PEG number to 
explore ‘volume’ effect. At Strategic Health Authority (SHA) level the proportion of 
patients with a particular diagnosis e.g. dementia, who had a PEG inserted was also 
assessed for effect on mortality rates.  
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Results 
Following initial data extraction from the raw HES data sent from Northgate we had 
10,753,151 episodes of care (9,207,734 admissions) for 2006/07 and 11,296,023 
episodes of care (9,703,791 admissions) for 2007/08. From this data we identified 
30,781 unique episodes of care pertaining to one of the 13 PEG procedure codes 
across the two years. Further processing and deletion of erroneous data (Table 4.3) 
gave 14,055 episodes of care containing the G445 code. Analysis was further 
restricted to 10,952 episodes of care with no cancer codes present. 
Table 4.3 Total deletions from PEG dataset  
Deletions by EPIKEY 
200607 
n 
PEGDATE 1600 54 
PEGDATE B4 01/04/06 633 
PEGDATE AFTER 31/03/07 1 
PEGDATE B4ADMIDATE 6 
EPIEND 1582 9 
DISMET 4 WITH NO DOD 35 
TOTAL DELETIONS 738 
 
All PEG codes 
133,126 diagnostic codes were contained within these 30,781 episodes. However, 
this total contained only 3413 unique codes. Most codes (3184, 93.3%) were used 
fewer than 100 times but accounted for nearly a quarter (23%) of all diagnoses. 
Nearly a thousand codes were used only once, representing 0.72% of all diagnoses. 
The most commonly used diagnostic code was for ‘Essential (primary) 
hypertension’, followed by ‘Attention to gastrostomy’, ‘Dysphagia’, ‘Atrial 
fibrillation and flutter’, ‘Cerebral infarction, unspecified’, ‘Pneumonitis due to food 
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and vomit’, ‘Non-insulin-depend diabetes mellitus without complication’,  ‘Personal 
history of diseases of the circulatory system’, ‘Urinary tract infection, site not 
specified’ and ‘Epilepsy, unspecified’. Together, these ‘Top 10’ diagnostic codes 
accounted for 22.3% (29,671) of all the diagnoses made.  
Using either the broader HES coding groups or a more detailed grouping system 
(see Tables 4.4a&b) the most common group of codes used were the ‘Z’ codes. 
These codes represent ‘factors influencing health status and contact with health 
services’140. They accounted for 16.5% of all diagnoses. Nearly 75% of all diagnoses 
were covered by the following categories of codes: ‘Z’ codes; Diseases of the 
digestive system; Diseases of the circulatory system; Diseases of the nervous 
system; ‘R’ codes; Diseases of the respiratory system and Neoplasms. (‘R’ codes 
represent ‘symptoms, signs and abnormal clinical and laboratory findings, not 
elsewhere classified). Infection accounted for 7264 diagnoses (5.46% of the total) 
using 247 individual codes. Cancer codes accounted for 5.9% of all diagnoses.  
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Tables 4.4a+b Frequency of diagnostic codes 
a. By HES categories 
Code categories (HES categories) 
Count of individual 
codes 
Sum of 
Total 
% of all 
diagnoses 
Factors influencing health status and 
contact with health services 260 21959 16.49 
Circulatory system 249 21696 16.30 
Digestive system 260 15680 11.78 
Symptoms, signs & abnormal clinical 
and laboratory findings 179 10640 7.99 
Diseases of the nervous system 212 10568 7.94 
Respiratory system 125 10151 7.63 
Neoplasms 251 7860 5.90 
Endocrine, nutritional & metabolic 144 6590 4.95 
Injury, poisoning & other consequences 
of external causes 394 6332 4.76 
Infectious & parasitic diseases 172 5535 4.16 
Mental & behavioural disorders 145 3487 2.62 
Genitourinary 128 3289 2.47 
External causes of morbidity and 
mortality 246 2751 2.07 
Musculoskeletal and connective tissue 191 2211 1.66 
Skin & subcutaneous tissue 79 1336 1.00 
Diseases of the blood & blood forming 
organs, disorders of immune 
mechanism 66 1318 0.99 
Eye & adenexa 70 566 0.43 
Benign neoplasm 101 489 0.37 
Congenital 107 475 0.36 
Ear & mastoid 31 189 0.14 
Perinatal 2 2 0.00 
Pregnancy, childbirth & puerperium 1 2 0.00 
Grand Total 3413 133126 100 
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b. By detailed bespoke categories 
Code categories (bespoke) Count of individual codes Sum of codes % of all diagnoses 
Z codes 260 21959 16.49 
Gastroenterological 236 15818 11.88 
Cardiovascular 178 13964 10.49 
Neurological 261 10723 8.05 
R codes 179 10640 7.99 
Cancer 251 7860 5.90 
Stroke 30 7343 5.52 
Infection 247 7264 5.46 
Respiratory 68 6816 5.12 
T codes 165 3905 2.93 
Renal 94 3212 2.41 
Diabetes 31 2827 2.12 
S codes 229 2427 1.82 
Rheumatological 198 2425 1.82 
Psychiatric 121 2140 1.61 
Y codes 109 2042 1.53 
Pneumonia 19 1928 1.45 
Dementia 21 1574 1.18 
Haematological  63 1303 0.98 
Electrolyte imbalance 10 1186 0.89 
Metabolic disease 36 1067 0.80 
Endocrine (excl diabetes) 40 972 0.73 
Dermatological 62 811 0.61 
Nutrition 26 498 0.37 
W codes 63 492 0.37 
Benign tumours 101 489 0.37 
ENT 28 339 0.25 
Eye 42 329 0.25 
Congenital 84 242 0.18 
Max-Facial 31 146 0.11 
X codes 40 128 0.10 
Gynaecological 40 89 0.07 
V codes 34 89 0.07 
Eating disorders 5 34 0.03 
Unclassified 8 27 0.02 
Delirium 3 18 0.01 
Grand total 3413 133126 100 
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Final Analysis on G445 coded procedures only 
This rest of the results presented here relate only to patient episodes containing the 
code G44.5 (‘Fibre optic endoscopic percutaneous insertion of gastrostomy’). After 
excluding patients with cancer, 10,952 PEG patients were included in the final 
analysis. (Table 4.5)  
Male patients accounted for 51%. The mean age for all patients was 68.4 years with 
a range from 16-99 years of age. Over two-thirds (71.7%) of patients had their PEG 
inserted during an emergency admission.  
The diagnostic codes within the reduced dataset were assessed for all patients. All 
diagnostic code positions were analysed and all codes within each position were 
totalled. A stroke code was found in 40.1% of patients; a code for motor neurone 
disease (MND) in 7.2%; Parkinson’s disease in 5.4%; multiple sclerosis in 4.9% and 
dementia in 7.2%. These disease states thus incorporated 64.8% of patients. The 
remaining 35.2% of patients did not have a code within any of these groups, which 
is in keeping with other studies221. 
31.6% of cases had at least one co-morbidity coded (using the modified Charlson 
definitions – see ERCP chapter). 
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Table 4.5 Patients characteristics and crude all-cause mortality for PEG insertions 
performed in England 2006-2008  
 2006-08 
Patients, n 10,952 
Female gender, % (n) 49% (5,366) 
Age, mean (range) 68.4 years (16-99) 
Admission type, % (n) 
- Elective 
- Non-elective (emergency) 
 
28.3% (3,099) 
71.7% (7,853) 
Diagnosis, % (n) 
- Stroke 
- Motor neurone disease 
- Parkinson’s disease 
- Multiple sclerosis 
- Dementia 
- Other 
 
40.1% (4,392) 
7.2% (788) 
5.4% (591) 
4.9% (537) 
7.2% (788) 
35.2% (3,855) 
Any non-cancer co-morbidity, % (n) 
- Absent 
- Present 
 
68.4% (7,491) 
31.6% (3,461) 
Died within 7 days of PEG insertion, % (n) 4.2% (459) 
Died within 30 days of PEG insertion, % (n) 14.6% (1,598) 
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The crude all-cause mortality rate at 7 and 30 days was 4.2% and 14.6% 
respectively. Univariate analysis (Table 4.6) confirmed emergency admission and 
increasing age as risk factors for mortality at both 7 and 30 days (p<0.001). The 
presence of a code for co-morbidity, stroke or dementia was also significantly 
associated with mortality at 7 and 30 days (p<0.001). Longer term all-cause 
mortality was 27.5% at 3 months and 35.5% at 6 months. At one year mortality was 
44.3%. 
Binary logistic regression identified age, male sex, emergency admission, motor 
neurone disease and dementia as predictors of 30-day death. Details are described 
in Table 4.7. 
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Table 4.6 Factors associated with all-cause mortality following PEG insertion. Univariate 
analysis for procedures performed 2006-2008.  
(n=10,952) 
Variable 30-day all-cause 
mortality 
7-day all-cause 
mortality 
p 
Admission 
 
- Elective 
 
- Non-elective 
(emergency) 
 
 
 
6.8% 
 
17.6% 
 
 
1.7% 
 
5.1% 
 
 
 
p<0.001 
Age 
 
- < 55 years old 
 
- 55-64 
 
- 65-74 
 
- 75-84 
 
- >84 years old 
 
 
 
4.0% 
 
9.6% 
 
13.6% 
 
18.3% 
 
25.6% 
 
 
 
1.2% 
 
2.4% 
 
4.1% 
 
5.1% 
 
7.3% 
 
 
 
 
 
 
 
 
 
 
 
p<0.001 
Co-morbidity 
 
- Absent 
 
- Present 
 
 
 
 
11.6% 
 
21.1% 
 
 
 
3.0% 
 
6.6% 
 
 
 
p<0.001 
Stroke diagnosis 
 
- Absent 
 
- Present 
 
 
 
 
12.1% 
 
18.3% 
 
 
 
3.5% 
 
5.1% 
 
 
 
p<0.001 
Dementia diagnosis 
 
- Absent 
 
- Present 
 
 
 
14.0% 
 
22.1% 
 
 
 
3.8% 
 
8.7% 
 
 
 
p<0.001 
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Table 4.7 Factors associated with all-cause mortality within 30 days of PEG insertion: 
Binary logistic regression analysis of procedures performed in England 2006-2008.  
 (n=10,952 patients).  Odds ratios with 95% confidence intervals.  
Independent variable Odds ratio 95% CI p 
Age Group 
- <55 years 
- 55-64 years 
- 65-74 years 
- 75-84 years 
- >84 years 
 
1 
2.4 
3.3 
4.5 
6.8 
 
- 
1.9-3.2 
2.6-4.2 
3.5-5.7 
5.3-8.7 
 
 
 
 
 
p<0.03 
Sex 
- Female 
- Male 
 
1 
1.3 
 
- 
1.1-1.4 
 
 
p<0.03 
Admission type 
- Elective 
- Non-elective 
(emergency) 
 
1 
2.2 
 
- 
1.9-2.6 
 
 
p<0.03 
Motor Neurone Disease 
- Absent 
- Present 
 
1 
1.3 
 
- 
1.1-1.7 
 
 
p<0.03 
Dementia 
- Absent 
- Present 
 
1 
1.2 
 
- 
1.0-1.5 
 
 
p<0.03 
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In older patients (≥85 years old) having a PEG insertion during emergency 
admission, dementia was associated with 7-day mortality of 14.6% compared to 
7.8% in stroke. In patients with PEG insertion and a stroke diagnosis code (n=4,389) 
there was a significant increase in mortality at 7 and 30 days for those with 
dementia compared to those without a code for dementia (Figure 4.1). At 7 days 
mortality was 9% in those with dementia compared to 4.8% in those without. At 30 
days mortality was 23.8% with and 17.9% without dementia (p<0.01). 
Figure 4.1 All-cause mortality for stroke patients with and without dementia 
 
 
At Trust level no correlation was seen for all-cause 30-day death versus PEG volume 
(Figure 4.2). At strategic health authority level wide variation was seen in the rate of 
PEG insertions and also in the rate for different disease groups. Overall, for the 10 
SHAs, the mean PEG insertion rate per 100,000 population was 21.6. Figures ranged 
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from 18.5 to 27 per 100,000 across the ten SHAs. The proportion of insertions 
performed in patients with a dementia diagnosis ranged from 4.1% to 10.3% (6.8% 
overall), whilst the proportion performed in patients with a stroke diagnosis ranged 
from 23.1% to 46.6% (40% overall). 
Figure 4.2 All-cause 30 day mortality against volume of PEG procedures performed in 
each Trust over 2006-2008 
 
 
 
 
A bedside tool for predicting mortality risk after PEG 
Look-up tables were created for predicting outcomes (Tables 4.8 & 4.9) from the 
target population of 10,952 patients with PEG insertion coded with the G445 OPCS 
code. The denominator population was zero in some categories but a trend of 
increasing mortality with additional risk factors can be seen. This was the case for 
mortality within 7 and 30 days of PEG procedure.   
 
 
Pearson r=0.04  
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Table 4.8  All-cause mortality within 7 days of PEG according to age group, admission 
method (elective or emergency) and presence of co-morbid conditions  
Pooled data for 2006/07 and 2007/08 for acute hospital Trusts in England (n= 10,952) 
Emergency  Dementia  Stroke  <55 years old  85+  
No  No  No  0.8%  2.8%  
No  No  Yes  2.6%  4.8%  
No  Yes  No  0% (n=10)  9.1%  
No  Yes  Yes  N/A (n=0)  14.3%  
Yes No  No  1.3%  6.1%  
Yes  No  Yes  1.2%  6.9%  
Yes  Yes  No  17.6%  13.6%  
Yes  Yes  Yes  0% (n=2) 15.4%  
 
Table 4.9  All-cause mortality within 30 days of PEG according to age group, admission 
method (elective or emergency) and presence of co-morbid conditions  
Pooled data for 2006/07 and 2007/08 for acute hospital Trusts in England (n= 10,952) 
Emergency  Dementia  Stroke  <55 years old  85+  
No  No  No  2.4%  12.8%  
No  No  Yes  6.4%  22.2%  
No  Yes  No  0% (n=10)  27.3%  
No  Yes  Yes  N/A (n=0)  14.3%  
Yes No  No  4.9%  26.8%  
Yes  No  Yes  4.2%  25.3%  
Yes  Yes  No  23.5%  35.0%  
Yes  Yes  Yes  0% (n=2) 32.5%  
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Discussion 
These national-level linkage analyses provide real-world estimates of prognosis in 
subjects selected for PEG in England and identify factors associated with all-cause 
death. Elderly subjects with dementia are a particularly high-risk group and present 
an ethical dilemma for PEG placement. This is the largest-scale UK-based study 
available for all-cause mortality after PEG.  
Results generated in this study are in keeping with previous studies. The 30-day 
mortality rate is perhaps better than expected from previous literature but may be 
explained by the exclusion of cancer patients.  
The raw data on which our analysis is based is routinely collected and therefore 
systematic bias is avoided. The number of PEG insertions captured for our own 
Trust was in keeping with local audit figures and we believe generally capture was 
good. Linkage of data to ONS mortality data ensures accurate mortality figures and 
allows full assessment of 30-day mortality but also longer term mortality rates 
which is particularly useful for PEG outcomes analysis. Few studies have been able 
to provide robust data on survival beyond one month of PEG insertion. 
Currently gastrostomy insertion can be coded with codes other than the most 
specific G445 code. NCEPOD reported 16,648 PEG procedures being performed in 
England in 2002/03 with an overall 30-day mortality of 6%52. They extracted these 
figures from HES data for that financial year using OPCS codes G34. The G445 code, 
which is specific for endoscopic placement of gastrostomy tube, was only 
introduced in 2006/07. The G34 group is shown in Table 4.8140.  
177 
 
Table 4.10  OPCS code descriptions 
OPCS Code Description 
G34.1 Artificial opening into stomach,    Creation of permanent gastrostomy 
G34.2 Artificial opening into stomach,    Creation of temporary gastrostomy 
G34.3 Artificial opening into stomach,    Reconstruction of gastrostomy 
G34.4 Artificial opening into stomach,    Closure of gastrostomy 
G34.5 Artificial opening into stomach,    Attention to gastrostomy tube 
G34.8 Artificial opening into stomach,    Other specified 
G34.9 Artificial opening into stomach,    Unspecified 
 
Thus, NCEPOD data may have included patients with a PEG already in-situ and not 
those undergoing PEG insertion. This would potentially dilute the mortality rate and 
account for their lower mortality estimate of 6%.  
The NCEPOD report looked at 719 deaths within 30 days of a PEG procedure. 
17.75% (126) had a coded malignancy; 19.44% (138) had dementia, 82.54% (586) 
had a neurological condition coded and 42.25% (300) had nutritional failure due to 
non-malignant disease. The groups were not mutually exclusive and were the 
groups specified in the retrospective questionnaire sent to endoscopists. ICD codes 
were not specified.  
Limitations of this study include concerns regarding the accuracy of HES data. With 
particular reference to the PEG datasets the introduction of the G445 code should 
improve coding compared to previously where a number of codes were used in 
more than one combination to identify a procedure. It is not possible to ascertain 
the primary indication for the PEG procedure form HES data. This can only be 
inferred from the diagnoses included in the PEG episode. Our decision to exclude 
cancer cases may be a limitation in that as well as excluding those patients with 
head and neck cancer having peri-operative or peri- radiotherapy PEG insertions 
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(our intention) we may have also excluded many patients with other indications for 
PEG insertion who had a cancer coded that was not necessarily the primary illness 
at the time of PEG insertion e.g. patients with a code for prostate cancer.  However, 
we believe that this exclusion would strengthen our results rather than weaken 
them.  
Analysis of diagnostic codes and attempts to categorise patients was hampered by 
the wide number of diagnostic codes used. A significant number of patients could 
not be assigned to a particular diagnostic group for further analysis. This issue has 
been highlighted elsewhere221. Solutions include encouraging clinicians to 
document specific diagnoses rather than symptoms and engagement of clinicians in 
the use of coded administrative data. 
As in the ERCP study the rate of coding for co-morbid conditions was very low and 
limited the ability to adjust for case-mix. This echoed the problem with trying to 
define the indication for PEG and identifying specific causes of death.  
PEGs are inserted to improve or maintain quality of life in those who are unable to 
take adequate nutrition by other means. Specific quality of life outcomes were not 
analysed in this study. Potential measures within HES include discharge destination 
and readmission rates. However, measuring quality of life as opposed to quantity 
will require some form of patient reported outcomes which are currently not 
available within HES.  
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The general trend of increasing mortality with additional risk factors, illustrated by 
the look-up tables, is not unexpected. The inconsistent results are probably due to 
the small numbers of patients in those categories.  
 
Further work  
This chapter has provided data on overall outcomes for patients having PEG 
insertion. Administrative data can be used to assess the impact of PEG insertion on 
outcomes for particular groups of patients in the long term (see Stroke chapter). 
PEG insertion is an invasive procedure with potentially significant risks. Providing 
more long term survival and quality of life data such as discharge destination and 
readmissions for particular patient groups who have had PEGs, e.g. stroke patients, 
will aid clinicians in their decision making and guide their discussions with patients 
and their families. 
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5. Stroke 
Abstract 
Background and aims: Stroke affects between 174 and 216 people per 100,000 
people in the UK each year. Swallowing can be affected in up to 40% of stroke 
patients, with 30% having evidence of poor nutrition, malnutrition and dehydration 
after their stroke. The aim of gastrostomy insertion (PEG) is to allow those without a 
safe swallow to maintain adequate nutrition. However, PEG insertion is not without 
risk and the overall impact of gastrostomy insertion on outcome in stroke patients is 
unclear. There is a lack of good evidence to assist in making decisions regarding PEG 
insertion in stroke. 
The aim of this study is to show that HES data can be used to describe the stroke 
population in England; assess patterns of PEG insertion in stroke patients and 
identify the factors that affect outcome in this specific group of patients. 
Specifically, we want to assess whether early mortality after PEG procedure in acute 
stroke is lower in those units performing a larger volume of PEG procedures and 
whether this measure has potential as a clinical indicator for care quality. 
Methods: Episodes of care containing ICD-10 diagnosis codes for stroke were 
extracted from the HES datasets. OPCS-4 codes for PEG procedures were identified 
within these episodes.  
Inclusion criteria for the denominator stroke population were a new diagnosis of 
stroke, emergency admission and length of stay greater than 7 days.  Final analysis 
was restricted to those cases with a PEG procedure during their index admission, 
occurring at least 8 days after admission.  Variables for mortality within 7, 30, 90 
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and 180 days were added using data from the Office of National Statistics death 
registry. Cases were analysed for stroke type, co-morbidity, deprivation, age and 
gender. Trusts were classified by stroke case volume and by total PEG procedure 
volume to assess for effect on survival. Factors associated with mortality were 
identified by univariate and multivariate analyses. 
Results: Of 87,507 new stroke admissions in 12 months, there were 42,550 stroke 
cases meeting our inclusion criteria. This included cases from 137 out of 151 Trusts 
in England. A total of 1560 eligible PEG cases were identified. 
Within our denominator population of strokes (n=42,550) the proportion of eligible 
stroke patients having a PEG procedure in their index stroke admission ranged from 
0.8% to 15.1% at each Trust. Compared to stroke patients in general, those 
requiring gastrostomy insertion during their index admission stayed longer in 
hospital (mean stay 65 days vs. 29 days), were less likely to be discharged to their 
own home (25% vs. 53%), and had higher mortality at 6 months (46% vs. 31%). They 
were slightly older (mean age 79 years vs. 78 years) and were more likely to have 
suffered a haemorrhagic stroke (13% vs. 10%).  
The presence of co-morbid conditions was independently associated with higher 
mortality after gastrostomy insertion with an odds ratio of 2.040 (CI 1.269-3.278, 
p=0.003) for 7-day mortality compared to those without a co-morbid condition 
coded. Older age was not associated with any increased risk of mortality. Admission 
to Trusts with a high PEG procedure volume was associated with lower 7-day 
mortality after PEG procedure of 4.3%, compared to 7.8% and 6.8% in low and 
medium volume Trusts respectively (p=0.045). Adjusted odds ratio for 7-day 
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mortality after PEG in low volume Trusts, compared to high volume Trusts was 
1.842 (CI 1.065-3.189, p=0.029). 
Conclusions: Early mortality after PEG procedure in stroke patients is a potential 
indicator for the quality of care received by such patients. Differences in 7-day post-
procedure mortality may reflect variation in case selection, technical ability and 
medical care around the time of a PEG procedure.  
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Introduction 
The aims of this chapter are to assess outcomes for stroke patients using HES data. 
It continues work from the previous chapter and looks at the impact of PEG 
insertion on outcomes in stroke. Specifically, the aims are:  
1. To generate national and hospital-level measures of process (length of stay) and 
outcome (all-cause mortality) for patients admitted to NHS hospitals with a first 
acute stroke using a two-year download of Hospital Episode Statistics (2006/07 and 
2007/08);  
2. To identify a sub-population of emergency stroke admissions requiring placement 
of percutaneous gastroscopy (PEG), based on coded procedures and describe their 
characteristics;  
3. To test a specific hypothesis about the volume-outcome relationship across English 
hospitals. Specifically, to test the hypothesis that those institutions performing the 
highest annual volume of PEG procedures are likely to have the lowest rates of 
short-term mortality after PEG placement in acute stroke (reflecting greater 
experience and expertise in patient selection, peri-procedure care and safety in 
relation to the PEG procedure). 
Background  
Stroke has been defined by the World Health Organisation196 as a ‘clinical 
syndrome, of presumed vascular origin, typified by rapidly developing signs of focal 
or global disturbance of cerebral functions lasting more than 24 hours or leading to 
death.’ 
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Stroke affects between 174 and 216 people per 100,000 people in the UK each year. 
Stroke accounts for 11% of all deaths in England and Wales. 69% of strokes are due 
to cerebral infarction196. The Stroke Association states that about a third of those 
having a stroke will die within 10 days. The Framingham Study222 showed an overall 
30-day mortality of 28%, with rates for ischaemic stroke of 19% at 30 days and 23% 
at 1 year. 
Guidelines published by NICE and the Royal College of Physicians in 2008196;223  state 
that swallowing can be affected in up to 40% of stroke patients with 30% having 
evidence of poor nutrition, malnutrition and dehydration after their stroke. All 
these factors are associated with worse outcome. These guidelines recommend that 
gastrostomy feeding should be considered for the following stroke patients:  
- Those who are unable to tolerate naso-gastric feeding within the first four weeks; 
- Those unable to maintain adequate oral intake at 4 weeks;  
- Those who are at long-term, high risk of malnutrition.  
An American study found that 11.6% (77/664) of stroke patients with dysphagia 
required gastrostomy tube insertion224. In one study of 187 patients, 17.6% had PEG 
insertion during their stroke admission. These patients were older, had more severe 
strokes (defined using the National Institute of Health Stroke Scale; NIHSS225) and a 
longer length of stay when compared to those patients not requiring PEG insertion. 
Independent predictors for PEG insertion were bulbar symptoms at onset, higher 
NIHSS score, stroke in the middle cerebral artery territory, and aspiration 
pneumonia226.  Stroke was the indication for 40.7% of PEG insertions in another 
study looking at PEG insertions in the elderly population227.  This was followed by 
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neurodegenerative conditions (34.7%) and cancer (13.3%). Overall mortality for all 
PEG insertions was 22% at 30 days and 50% at one year. This is consistent with 
other data reporting mortality rates at 1, 6, and 12 months of approximately 20%, 
40% and 50%. Lower 30-day mortality rates e.g. 10.7% have been described228. One 
year mortality rates as high as 90% have been reported in patients with 
dementia216. The use of NIHSS scores to predict PEG insertion is supported by 
results from a retrospective study of 77 patients with acute stroke and severe 
dysphagia, 20 of whom required PEG insertion229. Patients in this study were 
identified using ICD codes for acute ischaemic stroke, OPCS codes for gastrostomy 
and specific coding indicating formal speech and language swallow assessment. An 
in-hospital mortality of 28% was recorded in a Welsh study of stroke patients 
requiring PEG insertion230. 
A German paper used a national database of geriatric patients to explore PEG 
insertion rates and outcomes231. They suggested that 140,000 PEG insertions occur 
each year in Germany, 65% of which are in patients over the age of 65 years. Their 
database analysis of 27,775 geriatric patients found a PEG insertion rate of 1.4%. 
Two-thirds of these were in stroke patients and PEG patients tended to have poorer 
Barthel Index scores232. In-hospital mortality was 17.6% in PEG patients, compared 
to 4.3% in those patients not requiring PEG insertion. 
The British Artificial Nutrition Survey (BANS) reports annually on nutrition support in 
the UK (all indications). It found a prevalence of enteral tube feeding in the 
community of 21,858 people in 2007221. The vast majority were being fed via 
gastrostomy (18,075, 82.7%). Over half were in their own home but 31.2% were in 
187 
 
nursing homes. Of those in nursing homes 93% were fed via gastrostomy. The main 
diagnostic categories for patients were central nervous system disorders and 
mental health (50% - nearly half of whom have a stroke diagnosis); cancer (36%); 
non-malignant gastrointestinal diagnoses (8%) and other conditions (6%).  
PEG insertion has been widely used for many years. However, it is becoming 
recognised that PEG insertion may not improve long term outcomes for certain 
groups of patients227. For example, there is compelling evidence that PEG insertion 
in patients with significant dementia increases mortality216;233. Requiring PEG 
insertion has been shown as marker for poor long term outcome in stroke 
patients234;235. There has been controversy surrounding the timing of PEG insertions 
in patients with acute stroke and evidence of wide variation between hospitals236. 
Gastroenterologists will often be asked to insert gastrostomy tubes in stroke 
patients early in the course of the illness and often in an emergency or urgent basis. 
There is little good evidence to assist in making these decisions and the few studies 
that exist show conflicting results. The ‘Feed Or Ordinary Diet’ (FOOD) project 
enrolled over five thousand patients with recent stroke between 1996 and 2003218. 
One of the three RCTs within the FOOD project looked at PEG vs. NG feeding in 
dysphagic stroke patients. Patients were allocated to PEG or NG within 30 days of 
admission. Numbers were small and the populations heterogeneous with 321 
patients across 47 hospitals in 11 countries. They concluded that initiation of PEG 
feeding following acute stroke was associated with poorer functional outcome and 
increased mortality. However, their findings were not statistically significant with 
PEG insertion associated with an increase in absolute risk of death of 1.0% (95% CI -
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10.0 to 11.9; p = 0.9) and an increased risk of death or poor outcome of 7.8% (95% 
CI 0.0 to 15.5; p = 0.05).  
The FOOD trial did not support the early initiation of PEG feeding in stroke patients. 
Other authors have suggested a ‘cooling off’ period before PEG insertion 237-239 208. 
One of the few randomised trials to look at naso-gastric versus PEG feeding 
concluded that PEG at 14 days post acute stroke was superior to naso-gastric 
feeding. It was a small study of thirty patients with acute dysphagic stroke who 
were randomised to either naso-gastric feeding or PEG insertion. Outcomes at 6 
weeks were significantly better in the PEG group including mortality, length of stay 
and nutritional intake217. 
A Cochrane review of stroke literature in 2000 concluded that there was some 
evidence supporting PEG insertion in stroke patients improving outcomes but that 
overall there were too few studies, consisting of too few patients240. A further 
literature review published in 2008 again commented on the paucity of robust trial 
data233.  
Hospital episodes statistics provide data on a large number of patients including 
those patients with strokes. I aim to show that HES data can be used to provide 
robust analysis to assist in decision making surrounding PEG insertion following 
stroke and assess the effect of PEG insertion on long term outcomes.   
(Please see the introduction of the PEG chapter for more background information on 
PEG insertions.)  
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Methods  
From our master files for 2006/07 and 2007/08 (see ERCP Method section: The 
Master Datasets), episodes of care containing ICD-10 diagnosis codes for stroke 
were extracted. OPCS-4 codes for PEG procedures were identified within these 
episodes.  
Deaths within 7, 30 and 180 days were identified. Diagnostic fields were analysed 
for diagnoses and co-morbidity. PEG and stroke volume were assessed at Trust and 
national level. Place of discharge was identified for all episodes. Factors associated 
with death were identified by univariate and multiple logistic analyses.  
The Stroke Datasets 
From the Master Datasets described in the ERCP chapter method section we 
extracted episodes containing an ICD-10 stroke code in diagnostic code positions 1 
and/or 2.  These episodes were then saved as two new stroke datasets, one for 
each data year. Appendix 7.1 contains the syntax used to extract these episodes. 
The full list of stroke codes used in this analysis is found in Table 5.1. 
Table 5.1 ICD-10 codes for stroke used in study 
ICD-10 Code Description 
G450 Vertebro-basilar artery syndrome 
G451 Carotid artery syndrome (hemispheric) 
G460 Middle cerebral artery syndrome 
G461 Anterior cerebral artery syndrome 
G462 Posterior cerebral artery syndrome 
G463 Brain stem stroke syndrome 
G464 Cerebellar stroke syndrome 
G465 Pure motor lacunar syndrome 
G467 Other lacunar syndromes 
G468 Other vascular syndromes of brain in cerebrovascular disease 
G810 Flaccid hemiplegia 
G811 Spastic hemiplegia 
G819 Hemiplegia, unspecified 
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I610 Intracerebral haemorrhage in hemisphere, subcortical 
I611 Intracerebral haemorrhage in hemisphere, cortical 
I612 Intracerebral haemorrhage in hemisphere, unspecified 
I613 Intracerebral haemorrhage in brain stem 
I614 Intracerebral haemorrhage in cerebellum 
I615 Intracerebral haemorrhage, intraventricular 
I616 Intracerebral haemorrhage, multiple localized 
I618 Other intracerebral haemorrhage 
I619 Intracerebral haemorrhage, unspecified 
I629 Intracranial haemorrhage (nontraumatic), unspecified 
I630 Cerebral infarct due to thrombosis of precerebral arteries 
I631 Cerebral infarction due to embolism of precerebral arteries 
I632 Cerebral infarct due unspecified occlusion or stenosis precerebral arteries 
I633 Cerebral infarction due to thrombosis of cerebral arteries 
I634 Cerebral infarction due to embolism of cerebral arteries 
I635 Cerebral infarct due unspecified occlusion or stenos cerebral arteries 
I636 Cerebral infarct due cerebral venous thrombosis, nonpyogenic 
I638 Other cerebral infarction 
I639 Cerebral infarction, unspecified 
I64X Stroke, not specified as haemorrhage or infarction 
I650 Occlusion and stenosis of vertebral artery 
I651 Occlusion and stenosis of basilar artery 
I652 Occlusion and stenosis of carotid artery 
I653 Occlusion and stenosis of multiple and bilateral precerebral arteries 
I658 Occlusion and stenosis of other precerebral artery 
I659 Occlusion and stenosis of unspecified precerebral artery 
I660 Occlusion and stenosis of middle cerebral artery 
I661 Occlusion and stenosis of anterior cerebral artery 
I662 Occlusion and stenosis of posterior cerebral artery 
I663 Occlusion and stenosis of cerebellar arteries 
I664 Occlusion and stenosis of multiple and bilateral cerebral arteries 
I668 Occlusion and stenosis of other cerebral artery 
I669 Occlusion and stenosis of unspecified cerebral artery 
I670 Dissection of cerebral arteries, nonruptured 
I672 Cerebral atherosclerosis 
I678 Other specified cerebrovascular diseases 
I679 Cerebrovascular disease, unspecified 
I688 Other cerebrovascular disorders in diseases EC 
I691 Sequelae of intracerebral haemorrhage 
I692 Sequelae of other nontraumatic intracranial haemorrhage 
I693 Sequelae of cerebral infarction 
I694 Sequelae of stroke, not specified as haemorrhage or infarction 
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Achieving a 12-month cohort of new strokes  
In order to capture new strokes and achieve 12-month mortality data for all cases 
we selected cases without stroke codes evident in the first 6 months of our two year 
period and excluded cases with a new stroke diagnosis in the last 6 months of our 
dataset. Only cases coded in position 1 or 2 were included as we wished to capture 
acute strokes rather than longstanding diagnoses. Code counts for each of the ICD 
code positions revealed that the number of codes for stroke was much lower but 
more stable from position 3 onwards, compared to the first two code positions. This 
is consistent with the primary admission diagnosis being coded in the first two 
positions and the remaining positions being utilised to describe co-morbid or pre-
existing disease. 
Before merging the two stroke datasets two variables were added to each dataset. 
These were ‘YEAR’, to indicate which financial year the episode occurred; and 
‘MONTHTAG’ to indicate in which month the episode ended. The two datasets were 
then merged using the ‘Merge data; Add cases’ function in SPSS. The ‘MONTHTAG’ 
variable then allowed us to extract the middle 12 months of data (months 7-18) to 
create our final Stroke dataset. 
Deletions and identifying duplicates 
Patients within the 12-month cohort, with an episode length of stay over 6 months 
were deleted in order to exclude those admitted with a stroke prior to the start of 
our study period. All related data for patients identified by these episodes were 
deleted.  The dataset was reduced further by selecting only completed admissions 
(identified by the binary variable ‘SPELLEND’= Y within SPSS). Data for patients with 
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a PEG date before their stroke admission were also deleted as this would suggest 
they had a pre-existing reason for their PEG (See below for methodology). 
Duplicate entries were removed by first sorting the data by the NEWHESID, 
ADMIDATE, DIAG 01, DIAG 02 and PROC 1 variables; then searching for duplicates 
by NEWHESID and ADMIDATE using the ‘Identify duplicates’ function in SPSS. To get 
the first admission for every patient, data were sorted by NEWHESID and EPIORDER 
variables then the ‘primary first’ episode selected into our final dataset using the 
‘Identifying duplicates’ function. 
Identifying PEG procedures 
This procedure is described in both the ERCP and PEG chapter method sections. 
Going back to our original master datasets all PEG procedures were identified for 
those patients contained within our final stroke dataset using their unique patient 
identifiers (HESID or NEWHESID). An interim dataset was created containing a row 
of data for each PEG code identified. A ‘PEGDATE’ variable was added, derived from 
the procedure dates (1-14). The interim dataset was ordered by HESID/NEWHESID 
and PEGDATE and the first occurring procedure copied into a new dataset. This data 
could then be merged with our final stroke dataset as the PEGDATE variable.  
Additional Variables 
Please see the ERCP and PEG chapters for details of the HES variables and generic 
additional variables. New variables specific to the stroke dataset are described here 
and in Table 5.2. 
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Table 5.2 Additional variables added to create final Stroke dataset  
Variable Description 
HOWMANYDAYSAFTERADMWASFIRSTPEG Number of days from admission to 
PEG procedure calculated using the 
‘date and time wizard’ function in 
SPSS 
PEGINFIRSTSTROKEADM 1=PEG procedure occurred in stroke 
admission; 2=No PEG or PEG 
procedure occurred in subsequent 
admission. See Appendix 7.1 - 
Stroke Syntax 18 
ALIVEDEAD30DAYAFTERPEG 1 = died within 30 days; 2 = died 
after 30 days of PEG; 3 = did not die. 
See Appendix 7.1 - Stroke Syntax 
19. Can be modified to give 7-day 
marker. 
IMDQUINTILE Deprivation quintile 1-5 with 1 the 
most deprived. See Deprivation 
scores section 
READMIT 7 & READMIT 30  1= Readmission within 7 or 30 days 
of stroke discharge 
See Appendix 7.1 - Stroke Syntax 23 
DISCHNURSINGHOME 1=Discharged to Nursing home 
following stroke admission 
See Appendix 7.1 - Stroke Syntax 22 
DIED7DAYS; DIED30DAYS; DIED90DAYS; 
DIED180DAYS 
1=Death within 7, 30, 90 or 180 days 
of stroke admission. See Appendix 
7.1 - Stroke Syntax 8 
PEGDEATH7 AND 30 1=Death within 7 or 30 days of PEG 
procedure date 
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LOWPEGVOLTRUST; MEDVOLPEGTRUST; 
HIGHVOLPEGTRUST 
1 denotes which tertile the treating 
Trust belongs to according to the 
total number of PEG procedures 
performed over the 2 year study 
period for all indications. Totals 
were taken from the PEG datasets 
used in the last chapter. See 
Appendix 7.1 – Stroke Syntax 25 
LOWSTROKEVOL; MEDSTROKEVOL; 
HIGHSTROKEVOL 
The total number of strokes 
admitted to each selected Trust over 
the 2 year study period was 
extracted from our original stroke 
dataset. Trusts were divided into 
tertiles according to their total. See 
Appendix 7.1 – Stroke Syntax 26 
SINAPTERTILE1, SINAPTERTILE2, 
SINAPTERTILE3 
The average of 9 domain scores was 
calculated for each Trust. Trusts 
were then categorised according to 
their score with SINAPTERTILE1 
having the lowest scores. 
See Appendix 7.1 – Stroke Syntax 
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Deprivation Scores  
Deprivation is measured for geographical areas called super output areas (SOA). 
Scores are calculated within seven domains which are listed below. Each domain 
contains a number of indicators and the weighting of each domain is given in 
brackets.  
 Income (22.5%) 
 Employment (22.5%) 
 Health Deprivation and Disability (13.5%) 
 Education, Skills and Training (13.5%) 
 Barriers to Housing and Services (9.3%) 
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 Crime (9.3%) 
 Living Environment (9.3%)  
The domain scores are combined, according to the weighting, to give the Index of 
Multiple Deprivation (IMD) score. A score of 1 is the most deprived, 32,482 the least 
deprived area241. The super output areas are then ranked according to their score 
and divided into quintiles, with quintile 1 the most deprived areas and 5 the least 
deprived.  
The HES data provided to us by Northgate contains a variable ‘IMD04RK’. This is the 
overall rank of the IMD scores for the super output area (SOA) in which the patient 
lives (Note: Not where they are being treated). By organising the dataset in 
ascending order of IMD04RK the corresponding national quintile level could then be 
merged and assigned to our datasets.  
Readmission markers 
Readmissions were identified by first saving the HESID of all patients in our final 
stroke dataset into an interim dataset. Using the original datasets and this HESID 
dataset all emergency admissions within the two year study period were identified 
for these HESID and saved as the interim dataset.  The stroke admission date for 
each of these patients was then added to the interim dataset. Using the Date and 
Time Wizard in SPSS the number of days between each emergency admission and 
the stroke admission was calculated. Emergency admissions occurring before the 
stroke admission were deleted. Following this, using the ‘identify duplicates’ 
function with sequential numbering, the next emergency admission following the 
stroke admission could be identified. The admission dates for these episodes were 
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saved and merged onto our final stroke dataset. Markers for readmission within 7 
and 30 days of discharge from the stroke admission could then be calculated.  
PEG and Stroke volume Tertiles 
Using the original PEG datasets (Chapter 3), Trusts were categorized into High, 
Medium and Low volume Trusts for PEG procedures. This was based on the total 
number of PEG procedures for all indications, not just in stroke patients, for both 
years. A similar procedure was performed to produce markers for stroke volume 
tertiles. The total number of strokes, admitted to each Trust over the two year 
period, was extracted from our original stroke dataset. Our selected Trusts were 
then divided into tertiles according to the total number of stroke admissions.  
National stroke audit performance 
SINAP is a national audit run by the Royal College of Physicians242. It aims to monitor 
standards of stroke care in the first 72 hours of admission across England. The 2008 
stroke audit assessed performance across 9 indicators of stroke care with a final 
score given for the proportion of all stroke patients that received all 9 indicators 
(bundle of care). All results were given as a percentage of eligible patients. 
The 9 indicators were: 
1. Screening for swallowing disorders within 24 hours of admission 
2. Brain scan within 24 hours of stroke 
3. Physiotherapist assessment within 72 hours of admission 
4. Occupational therapy assessment within 4 working days of admission 
5. Patient weighed during admission 
6. Patient’s mood assessed by discharge 
7. Rehabilitation goals agreed by the multidisciplinary team 
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8. Aspirin or Clopidogrel given by 48 hours after stroke 
9. Patients spent at least 90% of stay on a stroke unit 
 
The Royal College of Physicians published data from the 2008 stroke audit243 which 
included results for 132 of the 137 Trusts in our final analysis. Trusts were asked to 
provide data on a minimum of 20 and maximum of 60 consecutive patients 
admitted with stroke between April 1st 2008 and June 30th 2008. An audit proforma 
was completed for each patient. A ‘Total Process Score’ was derived from 
information on 26 standards, divided into 6 domains of care. An average of nine key 
process indicator scores was also calculated which was found to correlate well with 
the Total Process Score. It is this average score that I have used in the following 
analysis. 
We assessed the scores in each domain and calculated the average score for each of 
the 132 Trusts we had SINAP data for (out of 137 of our selected Trusts). Trusts 
were then ranked and data assessed for correlation between stroke indicator 
performance and mortality following stroke and PEG insertion in stroke. Raw data 
are shown in Table A5.1 in Appendix 7.5.  
The Final Stroke Datasets 
At this point we had a dataset containing data for all patients presenting with stroke 
during a 12-month period. The focus of this study was to assess outcomes for 
patients admitted with a significant acute stroke that required a PEG procedure as a 
result of dysphagia caused by the neurological insult. Thus, we decided to create a 
more selective dataset for further analysis. Inclusion criteria for the denominator 
stroke population were:  
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 Emergency admission 
 First diagnosis of stroke 
 Length of stay of more than 7 days 
We then selected a sub-population of those cases having a PEG procedure 
according to the following criteria: 
 PEG procedure during the index stroke admission 
 PEG procedure at least 8 days after admission 
These criteria were selected to try and eliminate atypical cases and reduce skewing 
of data. Stroke admissions of less than a week are likely to be catastrophic strokes 
with early death, non-disabling strokes, and miscoded readmissions with old strokes 
or potentially not strokes at all. PEG procedures within the first week of an acute 
stroke are very unusual and such cases are likely to be miscoded readmissions for 
PEG procedures following old stroke or PEG insertions for other indications.  
Exclusions 
All stroke cases from Trusts that had fewer than 2 PEG cases meeting the above 
criteria were excluded from the datasets. Episodes following transfer of patients 
from other Trusts were also excluded. Linkage to the pre-transfer admission is 
possible, but complex and the numbers of such episodes were too small to make it 
practical. Cases with a length of stay greater than 6 months were excluded. This was 
because we could not be sure when they had their stroke, or if this was coding 
error. Genuine admissions this long represented a small number of the total but 
would cause significant skewing of certain results.  
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Statistical analysis  
The Hospital episode data were stored, manipulated and analysed using the SPSS 
statistical package (SPSS Inc., Chicago, USA). National-level analyses of factors 
associated with all-cause death and other outcome measures were identified by 
univariate analysis and multiple logistic regression models. Statistical significance 
was achieved with p<0.05. 
Results  
The Master files for 2006/07 and 2007/08 contained 10,753,151 and 11,296,023 
episodes of inpatient care, respectively. From these files a total of 390,905 episodes 
containing stroke diagnosis codes in positions 1 or 2 were extracted (Table 5.3).  
The dataset was then reduced to contain only the middle 12 months of new stroke 
admissions. In the first 6 months, (April to September 2006), 96,344 episodes for 
56,094 patients were deleted. The HESID for these patients were then used to 
delete a further 112,493 related episodes of care from our core 12 months of data. 
This left 278,935 episodes in the dataset. The same process was applied to remove 
strokes occurring in the last 6 months of data (October 2007 to March 2008) and all 
associated episodes of care form the core 12 months. This left 181,082 episodes in 
the main stroke dataset. 
Table 5.3 Number of stroke codes in ICD-10 code positions 1 and 2 for 2006/07 and 
2007/08 
  Year ICD code position 1 ICD code position 2 Number of episodes 
0607 158,277 52,536 193,039 
0708 162,212 54,922 197,866 
TOTAL 320,489 107,458 390,905 
The final column shows how many episodes contained a stroke code (an episode can 
contain a stroke code in position 1 and 2 but would only generate one row of data) 
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Further deletions were made due to poor quality data (Table 5.4) leaving 96,221 
stroke admissions for a 12-month period. The dataset was then reduced to the first 
admission for each patient (n=87,507). We then selected just those admitted as an 
emergency as it is this population of acute first stroke that we wished to study. In 
total there were 80,113 new, emergency stroke admissions between September 
2006 and September 2007.   
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Table 5.4 Summary of deletions made to create 12-month All Strokes dataset 
Reasons for deletion 
Patient episode finished in first 6 months (Apr 06 - Sep 06) 
Related episodes from first 6 month deletions 
Episode had missing episode end date 
Patient episode finished in last 6 months (Oct 07 - Mar 08) 
Related episodes from last 6 month deletions 
Episode end date set to 15.10.1582 
Spell length of stay greater or equal to 183 days  
Episode length of stay greater or equal to 183 days  
Related episodes from length of stay deletions 
Missing deprivation score 
Duplicate entries 
 
We then selected 45,409 cases with a length of stay of greater than 7 days. 
Following exclusion of transfers (n=60) and Trusts without enough eligible PEG 
cases the denominator stroke population was finalised at 42,550 cases. This 
included 1560 PEG cases.  
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Figure 5.1 Algorithm for stroke case selection 
 
The Final Datasets 
Denominator stroke population n=42,550 
The denominator population was defined as a new stroke diagnosis admitted as an 
emergency with an inpatient length of stay of greater than 7 days. 
The mean age of these patients was 77.6 years (range 16-106, SD 12.323). Mean 
length of stay was just over 30 days, with a mode of 8 days and median stay of 20 
days (range 8-182, SD 26.25).  PEG procedures were performed in 1937 patients on 
average 42 days after admission (range 0-517, mode 19, and median 30, SD 48.262). 
Table 5.5 shows descriptive and outcome data for the denominator stroke 
population.  
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Table 5.5: MASTER TABLE showing the patient characteristics and outcomes for selected 
stroke populations: i. Denominator stroke population of emergency admissions with new 
stroke with length of stay greater than 7 days; ii. Target population of stroke patients 
from the denominator population having a gastrostomy procedure more than 7 days 
after admission but before discharge; iii. Remaining stroke patients from the 
denominator stroke population who did not have a gastrostomy. (377 patients from the 
denominator population had gastrostomy procedures within the first 7 days of admission 
and were therefore outside our target population criteria. They were not included in 
further analysis.) 
Variable Denominator 
stroke 
population 
Target stroke 
population 
with PEG 
Stroke with no 
PEG 
p 
(PEG vs. 
no PEG) 
Number of patients 42,550 1560 40,613 - 
Male gender (n) 43.7% (18,587) 46.7% (728) 43.6% (17,700) 0.05 
Mean age in years 
(range, median, sd) 
77.6  
(16-106, 80, 
12.323) 
79.2  
(23-100, 81, 
10.169) 
77.6  
(16-106, 80, 
12.391) 
<0.001† 
 
Age groups (y) 
-  <55 
- 55 – 64 
- 65 – 74 
- 75 – 84 
- 85 + 
 
5.7% (2422) 
8.0% (3390) 
17.5% (7425) 
36.9% (15,700) 
32.0% (13,613) 
 
2.6% (40) 
5.8% (90) 
16.4% (256) 
42.4% (661) 
32.9% (513) 
 
5.8% (2355) 
8.1% (3270) 
17.5% (7090) 
36.7% (14,893) 
32.0% (13,005) 
 
<0.001 
 
Co-morbidity  
- No co-morbidities 
-  
- One coded 
 
- More than one 
 
57.8% (24,578) 
 
26.8% (11,414) 
 
15.4% (6558) 
 
56.3% (879) 
 
29.6% (462) 
 
14.0% (219) 
 
57.8% (23,479) 
 
26.7% (10,848) 
 
15.5% (6286) 
 
0.25 
 
 
Haemorrhagic 
stroke % 
10.5% (4470) 13.1% (204) 10.3% (4196) <0.001 
Dementia % 9.0% (3848) 7.7% (120) 9.1% (3701) 0.06 
Deprivation 
Quintiles 
- Most deprived 
- 2 
- 3 
- 4 
- Least deprived 
 
 
21.9% (9313) 
21.4% (9105) 
20.6% (8778) 
19.6% (8331) 
16.5% (7009) 
 
 
24.7% (386) 
21.8% (340) 
19.4% (303) 
17.9% (279) 
16.1% (251) 
 
 
21.7% (8829) 
21.4% (8689) 
20.7% (8398) 
19.7% (7986) 
16.5% (6698) 
 
 
0.005 
 
Discharge 
destination (n) 
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- Own home 
- Nursing home 
- Other 
- Died in admission 
51.3% (21,822) 
10.6% (4516) 
17.0% (7236) 
21.1% (8976) 
24.6% (383) 
26.6% (415) 
22.4% (349) 
26.5% (413) 
52.5% (21,304) 
10.0% (4042) 
16.6% (6744) 
21.0% (8523) 
 
<0.001 
 
Mean length of stay 
in days (range, 
median, sd) 
30.25 
(8-182, 20, 
26.250) 
65.44 
(9-178, 59, 
33.030) 
28.8 
(8-182, 20, 
24.863) 
<0.001† 
Number of days 
from admission to 
PEG procedure 
(range, sd) 
 
 
42.5 
(0-517, 48.262) 
n=1937 = ALL PEGs 
 
32.8 
(8-148, 
19.788) 
 
na 
 
 
- 
Emergency 
readmission (n) 
- 7-day 
- 30-day 
 
 
3.8% (1635) 
9.4% (3992) 
 
 
4.0% (63) 
10.4% (163) 
 
 
3.8% (1527) 
9.2% (3731) 
 
 
0.57 
0.09 
Mortality from 
admission (n) 
- 30-day 
- 90-day 
- 180-day 
 
 
16.0% (6823) 
26.6% (11,333) 
31.1% (13,236) 
 
 
5.2% (81) 
32.2% (502) 
46.0% (718) 
 
 
16.6% (6727) 
26.5% (10,764) 
30.6% (12,412) 
 
 
<0.001 
<0.001 
<0.001 
Mortality from PEG 
procedure (n) 
- 7-day 
- 30-day 
 
 
0.2% (100) 
0.9% (397) 
 
 
5.8% (91) 
22.0% (343) 
 
 
na 
na 
 
 
- 
- 
†ANOVA. All others are χ2 
 
Within the denominator stroke population the proportion of patients having a PEG 
procedure in their index stroke admission ranged from 0.8% to 15.1% across Trusts. 
Of the 137 Trusts included only 5 had a PEG insertion rate of 10% or more and 96 
Trusts had a rate of below 5%. The 5 Trusts with the highest rate of PEG insertion 
had a mean 30-day mortality rate post PEG insertion of 3% compared to a mean 
rate of 0.9% in the remaining 132 Trusts. However, there did not appear to be any 
relationship between insertion rates and mortality at 7-days post PEG insertion or 
205 
 
at 30 days post admission with acute stroke. This may suggest that these Trusts 
were putting PEGs in stroke patients who were ultimately going to die of the stroke 
within 30 days anyway i.e. futile procedures but the comparable 7-day mortality 
figures after PEG insertion argues against this. No correlation was observed 
between insertion rates and total PEG procedure volume or stroke volume. 
The Target PEG population n=1560 
The primary aim of this study was to assess outcomes in patients with acute, 
significant stroke who require a PEG procedure as a result of their stroke. By using 
our inclusion and exclusion criteria the risk of contaminating our final results with 
erroneous data from miscoding and atypical cases has been minimised. Table 5.5 
shows descriptive data and outcome results for our selected PEG population.  
The stroke population requiring a gastrostomy was compared to those stroke 
patients without a gastrostomy procedure. The target gastrostomy population had a 
higher proportion of men than the stroke population without gastrostomies: 46.7% 
compared to 43.6% (p=0.05). Patients without gastrostomy were younger: 77.6 
years old compared to 79.2 years in the group with gastrostomy (p<0.001) and this 
was reflected in the spread of patients across the ten year age groups. Fewer than 
half of patients had a co-morbid condition coded with no significant difference 
between the two groups. The level of deprivation was similar in both groups except 
for the proportion from the most deprived areas. 24.7% of stroke patients having a 
gastrostomy were from the most deprived wards compared to only 21.7% in the 
stroke patients not requiring a gastrostomy (p=0.005). The proportion of patients 
with a code for haemorrhagic stroke was higher in the gastrostomy population 
(13.1% vs. 10.3%, p<0.001).  
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Mean length of stay was considerably longer in the PEG group (65.4 days vs. 28.8 
days, p<0.001). This reflects the more severe and disabling strokes that will require 
alternative feeding methods. Readmission rates were similar for both groups. About 
10% of patients were readmitted as an emergency within 30 days of discharge from 
their index stroke admission. 
Overall mortality was 5.2% at 30 days post admission with acute stroke. This is 
much lower than that seen in the population without a gastrostomy (16.6%, 
p<0.001). By definition the patients in both datasets had to survive to 8 days of 
admission but for our selected PEG population they also had to survive to the point 
of PEG procedure. The mean time to PEG procedure was more than 42 days from 
admission. The higher mortality in the absent gastrostomy population represents 
patients clearly not suitable for PEG insertion due to frailty and poor prognosis that 
will have died within the first month of admission. There were marked differences 
in discharge destination between the two groups. Amongst those with a 
gastrostomy, discharge destination was fairly evenly split between own home 
(24.6%), nursing home (26.6%), other (22.4%) and dying during admission (26.5%). 
In the stroke population not requiring a gastrostomy over half the patients were 
discharged to their own home (52.5%) with only 10% going to nursing homes. Long 
term mortality was significantly higher in the gastrostomy group, rising to 46% at 6 
months compared to 30.6% in the stroke group without gastrostomy. This is 
consistent with PEG insertion as a consequence of more severe strokes having 
excluded early catastrophic events. Mortality post PEG procedure was 5.8% and 
22% at 7 and 30 days respectively.  
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Factors associated with all-cause, early mortality, within 7 days of 
gastrostomy procedure in first stroke  
It was expected that patient characteristics including age and co-morbidity would 
be significant factors in post-procedure mortality consistent with our previous 
studies. Deprivation and type of stroke were also assessed. It was hypothesised that 
institutional factors including case volume may also influence short term (7-day) 
survival post gastrostomy insertion. In addition, performance in the national stroke 
audit (SINAP) was assessed for relationships with outcomes following gastrostomy 
insertion in acute stroke. 
Univariate Analysis 
Univariate analysis (Table 5.6) confirmed the presence of co-morbidity as a risk 
factor for early all-cause (crude) mortality following stroke with PEG procedure 
during index admission. Gender, haemorrhagic stroke, the presence of a code for 
dementia, age or level of deprivation had no significant effect on mortality. Odds 
ratio for mortality at 7 days post PEG procedure was significantly higher in low PEG 
volume Trusts, compared to high volume Trusts (OR 1.879, CI 1.090-3.238, p=0.02). 
Absolute values for mortality at 7 days were 7.8%, 6.8% and 4.3% in low, medium 
and high volume Trusts respectively (p=0.045). The relationship with stroke volume 
was less clear with a higher odds ratio for 7-day mortality observed for medium 
volume Trusts compared to highest volume Trusts but not for the Trusts seeing the 
lowest volume of stroke cases.  
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Figure 5.2 Graph showing the association between Trust volume of PEG procedures and 
mortality for stroke patients at selected Trusts having PEG procedures in index stroke 
admission n=1560 
 
Figure 5.3 Graph showing the association between Trust volume of PEG procedures and the 
unadjusted odds ratios for mortality for stroke patients at selected Trusts having PEG 
procedures in index stroke admission n=1560 
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Table 5.6 Univariate analysis of patient and Trust factors associated with all-cause 
mortality at 7 days after PEG procedure during stroke admission (n=1560) 
 Unadjusted 7-day post-PEG mortality 
Patient and Trust Factors Odds 
ratio 95% CI p 
Age groups (y) 
-  <55 
- 55 – 64 
- 65 – 74 
- 75 – 84 
- 85 + 
 
1 
2.294 
2.256 
2.115 
3.032 
 
- 
0.259-20.299 
0.288-17.645 
0.282-15.858 
0.405-22.691 
 
- 
0.455 
0.438 
0.466 
0.280 
Co-morbidity 
- Absent 
 
- One 
 
- More than one 
 
1 
 
2.039 
 
2.097 
 
- 
 
1.270-3.273 
 
1.167-3.769 
 
- 
 
0.003 
 
0.013 
IMD quintiles 
- Most deprived 
- 4 
- 3 
- 2 
- Least deprived 
 
1 
0.787 
0.818 
0.983 
0.523 
 
- 
0.393-1.580 
0.416-1.607 
0.521-1.845 
0.259-1.059 
 
- 
0.501 
0.559 
0.958 
0.072 
Gender 
- Female 
 
- Male 
 
1 
 
0.933 
 
- 
 
0.610-1.428 
 
- 
 
0.751 
Haemorrhagic stroke 
- Present 
 
- Absent 
 
1 
 
1.100 
 
- 
 
0.575-2.103 
 
- 
 
0.773 
Dementia code 
- Present 
 
- Absent 
 
1 
 
1.343 
 
- 
 
0.657-2.745 
 
- 
 
0.419 
SINAP score 
- High  score Trusts 
 
- Medium score Trusts 
 
 
1 
 
1.560 
 
 
- 
 
0.887-2.746 
 
 
- 
 
0.123 
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- Low score Trusts 1.670 0.963-2.894 0.068 
PEG volume 
- High  volume Trusts 
 
- Medium volume Trusts 
 
- Low volume Trusts 
 
1 
 
1.628 
 
1.879 
 
- 
 
0.990-2.676 
 
1.090-3.238 
 
- 
 
0.055 
 
0.023 
Stroke volume 
- High  volume Trusts 
 
- Medium volume Trusts 
 
- Low volume Trusts 
 
1 
 
1.689 
 
1.562 
 
- 
 
1.027-2.778 
 
0.912-2.678 
 
- 
 
0.039 
 
0.105 
 
Multivariate analysis 
Variables were analysed for independence using binary logistic regression (Table 
5.7). Only those factors significant on univariate analysis were included i.e. co-
morbidity, PEG volume and stroke volume. Analysis was performed in SPSS using 
the forward conditional method. 
Compared to high volume Trusts the odds ratio for death within 7 days of PEG 
procedure at low volume Trusts was significantly higher at 1.869 (CI 1.082-3.227, 
p=0.025). The presence of one or more co-morbid conditions was confirmed as a 
risk factor for mortality, with an odds ratio for mortality of one co-morbid condition 
compared to no co-morbidity of 2.04 (CI 1.269 -3.278, p=0.003). Stroke volume was 
not significant with p-values for medium volume Trusts and low volume Trusts of 
0.168 and 0.605 respectively. 
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Table 5.7  Multivariate logistic regression analysis of factors associated with all-cause 
mortality following acute stroke admission with PEG procedure during index admission. 
Odds ratios for multiple categories (n=1560)  
 Adjusted 7-day post-PEG mortality 
Patient and Trust Factors Odds 
ratio 95% CI p 
Co-morbidity 
- Absent 
 
- One 
 
- More than one 
 
1 
 
2.040 
 
2.105 
 
- 
 
1.269 -3.278 
 
1.169-3.790 
 
 
- 
 
0.003 
 
0.013 
PEG volume 
- High  volume Trusts 
 
- Medium volume Trusts 
 
- Low volume Trusts 
 
1 
 
1.646 
 
 
1.869 
 
- 
 
0.999-2.712 
 
 
1.082-3.227 
 
 
- 
 
0.05 
 
 
0.025 
 
 
Look-up tables were created for predicting outcomes (Tables 5.8 & 5.9) from the 
target population of 1,560 cases of new, acute stroke with PEG insertion during the 
index admission. The denominator population for each category ranged from 5 to 
198 cases. There is a general increase in predicted risk of mortality with increasing 
age and presence of risk factors identified by this study. This is seen for mortality 
within 7 and 30 days of PEG procedure.   
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Table 5.8  All-cause mortality within 7 days of PEG insertion according to age group (y), 
presence of co-morbid conditions and admission to high PEG volume unit. Target 
population of new acute stroke admission with PEG procedure during index admission 
(n=1,560 patients). 
Co-morbidity High PEG volume 
Trusts 
<55 55-64 65-74 75-84 85+ 
No Yes 0 0 1.3% 1.9% 4.8% 
No No 7.7% 4.3% 6.7% 5.6% 5.1% 
Yes Yes 0 7.7% 3.2% 7.5% 7.9% 
Yes No 0 13.6% 12.3% 5.8% 12.7% 
 
Table 5.9  Table 5.8b All-cause mortality within 30 days of PEG insertion according to age 
group (y), presence of co-morbid conditions and admission to high PEG volume unit.  
Target population of new acute stroke admission with PEG procedure during index 
admission (n=1,560 patients). 
Co-morbidity High PEG volume 
Trusts 
<55 55-64 65-74 75-84 85+ 
No Yes 6.2% 9.4% 13.2% 17.0% 18.5% 
No No 15.4% 13.0% 15.0% 18.7% 24.7% 
Yes Yes 16.7% 15.4% 22.2% 29.3% 35.6% 
Yes No 20.0% 22.7% 26.3% 20.5% 32.7% 
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PEG procedure volume  
Having found that procedure volume is a potential factor in early mortality after 
gastrostomy insertion, it was important to try and identify any differences between 
low and high volume Trusts that might account for this result - What is it about 
those institutions performing higher numbers of PEG procedures that means their 
post procedure mortality in stroke is significantly lower than lower volume 
hospitals? Is it better case selection, better stroke services in general, or simply that 
practice makes perfect? Table 5.8 shows the results of these comparisons. The total 
stroke population (n=42,550) was compared across each tertile and statistically 
significant differences were seen. The mean age of those patients in low volume 
centres was higher than in the medium and high volume Trusts. The spread of 
patients across the age groups differed between the tertile groups with a higher 
proportion of younger patients in the high PEG volume tertile population. However, 
age was not found to be a significant factor in early PEG mortality. Additionally, 
people admitted to high PEG volume Trusts were more likely to be from the more 
deprived wards compared to the low and medium volume tertiles. The most 
deprived accounted for 27% of stroke admissions to high volume Trusts compared 
to 18% in the low PEG volume tertile (p<0.001). Similarly, only 14% of patients 
admitted to the high volume centres were from the least deprived areas compared 
to 18% in the lowest volume Trusts (p<0.001). Higher levels of deprivation tend to 
be associated with worse outcomes although deprivation tertiles were not found to 
have significant effects on mortality by univariate analysis. Comparing the stroke 
population who had a gastrostomy insertion across the volume tertiles gave similar 
findings (Table 5.9). Low volume Trusts had slightly older patients but they were 
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likely to be less deprived than in the high volume centres. No significant difference 
in the number of co-morbid conditions coded was found. It should also be noted 
that the average time to PEG insertion from admission with acute stroke did not 
differ between the volume tertiles. This may indicate equivalent access to PEG 
services and similar decision making with regards to nutrition support in stroke. 
Although the high PEG volume tertile group of Trusts had greater absolute numbers 
of stroke cases and hence the greatest share of total PEG-stroke cases in the study, 
the proportion of these Trusts with any 7-day mortality case was not significantly 
higher than the other tertiles. (Low PEG volume tertile: 46% of Trusts had no 7-day 
deaths; Middle: 50%; High PEG volume tertile: 44%; p>0.05) 
We also compared performance in the national stroke audit 2008 using the mean 
composite score for each Trust and comparing the overall mean for each volume 
tertile (see next section). No significant difference in composite score across the 
volume tertiles was found.  Although there was a trend for those Trusts with the 
lowest average SINAP score to have the highest PEG mortality at 7 days this was not 
statistically significant as shown in Figure 5.5. The swallow assessment score did not 
show any correlation with mortality rates. 
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Table 5.9 Comparison of population characteristics for PEG volume tertiles for total stroke 
population n=42,550 
 Low PEG volume 
Trusts 
n= 9826 
Medium PEG 
volume Trusts 
n= 13919 
High PEG volume 
Trusts 
n= 18805 
p 
(†ANOVA. 
Others all 
χ
2) 
Mean age in years  
(range, sd) 
78.25  
(16-103, 11.962) 
77.96  
(17-103, 12.073) 
77.00  
(16-106, 12.661) 
p<0.001† 
Age groups (n) 
-  <55 years 
- 55 – 64 
- 65 – 74 
- 75 – 84 
- 85 + 
 
5.1% (497) 
7.6% (749) 
16.4% (1612) 
37.0% (3639) 
33.9% (3329) 
 
5.1% (712) 
7.7% (1067) 
17.0% (2373) 
37.3% (5188) 
32.9% (4579) 
 
6.5% (1213) 
8.4% (1574) 
18.3% (3440) 
36.5% (6873) 
30.3% (5705) 
 
p<0.001 
Male (n) 43.2% (4242) 43.6% (6069) 44.0% (8276) p=0.39 
Co-morbidity Group  (n) 
- No co-morbidity 
- One coded 
- More than one  
 
58.6% (5757) 
26.6% (2616) 
14.8% (1453) 
 
57.7% (8038) 
27.2% (3791) 
15.0% (2090) 
 
57.3% (10783) 
26.6% (5007) 
16.0% (3015) 
 
p=0.127 
 
Haemorrhagic stroke (n) 9.3% (917) 10.4% (1441) 11.2% (2112) p<0.001 
Dementia (n) 9.2% (908) 8.8% (1230) 9.1% (1710) p=0.54 
Deprivation Quintile (n) 
- Most deprived 
- 2 
- 3 
- 4 
- Least deprived 
(14 cases missing) 
 
17.7% (1738) 
21.8% (2142) 
22.0% (2161) 
21.0% (2067) 
17.5% (1717) 
 
17.4% (2418) 
20.7% (2879) 
21.5% (2998) 
21.7% (3021) 
18.7% (2600) 
 
27.4% (5157) 
21.7% (4084) 
19.3% (3619) 
17.3% (3243) 
14.3% (2692) 
 
p<0.001 
 
 
Mean length of stay in days 
(range, sd) 
30.76 
(8-179, 27.147) 
30.10 
(8-178, 25.838) 
30.25 
(8-182, 26.073) 
p=0.095† 
Mean SINAP score for Trusts 
within each tertile 
70.6 
(39.9-90.9, 11.96) 
72.9 
(40.5-96.1, 11.69) 
71.8 
(50.7-97.6, 11.28) 
p=0.64 
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Figure 5.4 Chart showing the association between the volume of PEG procedures at 
hospital Trusts and the mean of the SINAP average scores for Trusts within each volume 
tertile (n=137Trusts) 
 
Figure 5.5 Chart showing the association between average SINAP score for hospital Trusts 
and mortality within 7 days of PEG procedure for acute stroke patients having PEG 
procedures during their index stroke admission (n=1560) 
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Table 5.10 Comparison of population characteristics for PEG volume tertiles for those 
stroke patients having gastrostomy insertion during their index admission (n=1560) 
 Low PEG volume 
Trusts 
n= 322 
Medium PEG 
volume Trusts 
n= 515 
High PEG volume 
Trusts 
n= 723 
p 
(†ANOVA. 
Others all 
χ
2) 
Mean age in years  
(range, sd) 
80.7  
(28-98, 8.830) 
79.3  
(38-99, 9.966) 
78.5  
(23-100, 10.785) 
p=0.004† 
Age groups (n) 
-  <55 years 
- 55 – 64 
- 65 – 74 
- 75 – 84 
- 85 + 
 
1.2% (4) 
3.7% (12) 
13.4% (43) 
45.0% (145) 
36.6% (118) 
 
2.7% (14) 
6.4% (33) 
14.4% (74) 
43.5% (224) 
33.0% (170) 
 
3.0% (22) 
6.2% (45) 
19.2% (139) 
40.4% (292) 
31.1% (225) 
 
p=0.227 
 
Male (n) 43.2% (139) 46.4% (239) 48.4% (350) p=0.3 
Co-morbidity Group  (n) 
- No co-morbidity 
- One coded 
- More than one  
 
55.0% (177) 
29.2% (94) 
15.8% (51) 
 
57.3% (295) 
30.3% (156) 
12.4% (64) 
 
56.3% (407) 
29.3% (212) 
14.4% (104) 
 
p=0.81 
 
Haemorrhagic stroke (n) 13.7% (44) 10.7% (55) 14.5% (105) p=0.13 
Dementia (n) 5.9% (19) 6.8% (35) 9.1% (66) p=0.13 
Deprivation Quintile (n) 
- Most deprived 
- 2 
- 3 
- 4 
- Least deprived 
 
17.7% (57) 
20.2% (65) 
21.4% (69) 
21.1% (68) 
19.6% (63) 
 
20.0% (103) 
25.0% (129) 
20.0% (103) 
18.6% (96) 
16.3% (84) 
 
31.3% (226) 
20.2% (146) 
18.1% (131) 
15.9% (115) 
14.4% (104) 
 
p<0.001 
 
Mean number of days from 
admission to PEG procedure 
(range, sd) 
 
33.8 
(8-148, 19.196) 
 
31.4 
(8-119, 18.082) 
 
33.3 
(8-144, 21.136) 
 
p=0.13† 
Length of stay in days 
(range, sd) 
68.7 
(9-178, 34.584) 
63.8 
(9-174, 31.766) 
65.1 
(13-178, 33.147) 
p=0.11† 
 
 
 
 
 
  
218 
 
Validation and comparison with national audit results 
The Royal College of Physicians published data from the 2008 stroke audit243 which 
included results for 132 of the 137 Trusts in our final analysis.  
The 2008 SINAP audit limited the number of stroke cases that could be submitted. 
Therefore, to validate our case capture, we used data from the 2011 national stroke 
audit which provided data on 12-month totals for stroke admissions and did not 
limit the number of cases that could be entered by each Trust. Stroke numbers are 
compared in Table A5.2 in Appendix 7.5. Of our 137 selected Trusts SINAP 2011 had 
data for 48. Some data could not be assigned due to merges of Trusts particularly in 
the London area. Audit data was from a 3 month period with historical totals 
provided for the 12 months April 2010 – March 2011. Subarachnoid haemorrhage, 
subdural and extradural haemorrhage were excluded as in our study. TIAs were 
included in initial counts in the SINAP audit but excluded from final analysis. The 
numbers presented here exclude TIAs. The SINAP data suggests incomplete data 
capture with yearly totals of stroke patients fewer than the total for 3 months in 
some cases. Where the 12-month totals were greater than that for 3 months the 
number was frequently still fewer than would be expected (i.e. fewer than 4 times 
the 3 month total). Apart from 2 Trusts our totals from HES were greater than the 
SINAP data. At least one of these Trusts is a tertiary neurosurgical centre from 
where patients may be repatriated to other Trusts. The SINAP data cleaning process 
attempted to account for duplicate entries due to this repatriation but it was not 
clear where the final assignment was made (the local or tertiary hospital). This may 
account for the HES totals being lower for these Trusts. Overall these comparisons 
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suggest that our HES capture is good. Cases are not being missed but old cases may 
have inadvertently been included. 
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Discussion 
This study has shown an association between PEG procedure volume and early 
post-procedure mortality in patients with new acute stroke. Mean mortality within 
7 days of PEG procedure in high volume Trusts was half that of low volume Trusts 
(Fig 5.2 p=0.045).  
Early mortality after a procedure is suggestive of poor patient selection (too sick to 
benefit), or poor quality procedure (procedure complications). Volume of exposure 
(to disease or procedure) may be seen as a surrogate marker for service quality. It 
was hypothesised that those Trusts performing higher numbers of PEG procedures 
would be more likely to have established nutrition services, nurse specialists, 
designated endoscopists for PEG procedures and that patient selection and 
procedural expertise is better. The higher mortality in patients with co-morbid 
disease may indicate poor patient selection; however the co-morbid load appeared 
to be higher in the high PEG volume tertile population which had the lowest 
mortality. Overall, the population characteristics were very similar across the 
volume tertiles for patients having a gastrostomy inserted. This would support the 
theory that rather than poor patient selection it is the procedure itself that is the 
cause of differences in mortality. 
Our stroke and PEG mortality rates were consistent with those previously reported 
in the literature 196;227;228;230 . The stroke rate reported in the national guideline for 
Stroke196 for the whole of the UK was 174 to 216 people per 100,000 people per 
year. This would give a range for England of 90,480 to 112,320, given a population 
in England of about 52 million. These figures included TIA and subarachnoid 
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haemorrhage, conditions that we excluded. Thus, our figure of 87,507 new stroke 
admissions (80,113 emergency admissions) would appear to be genuine. The rate of 
PEG insertions in stroke patients varies amongst studies with significant differences 
found in the denominator populations studied. There are also acknowledged 
differences in practice internationally that makes comparisons difficult. The SINAP 
2011 study242 included far fewer patients than the number we captured within HES 
data. This is explained by their acknowledged incomplete data collection from many 
units, and relied on stroke teams entering their own data into the SINAP dataset.  
By using the SINAP audit data it was hoped to create a useful clinical indicator that 
could be derived from HES data and used to assess performance in stroke care. It 
was hypothesised that PEG mortality figures would correlate with scores in the 
SINAP swallow assessment indicator. No such relationship was found. There was the 
suggestion of a numerical trend for reducing 7-day mortality across the SINAP 
performance tertiles (low through medium to high) but this did not reach 
significance.   
Fewer than half the patients in our dataset had co-morbid conditions coded. This 
seems surprisingly low. The higher number of co-morbid conditions coded by the 
high procedure volume Trusts may well reflect better coding rather than a true 
difference in population characteristics.  Evaluation of previous admissions and 
episodes of care using linkage of data via HESID is possible and could provide 
further detail on co-morbid diseases.  
Mortality rates without specific adjustment for stroke severity may be seen as 
inadequate for use as a performance measure. However, our analysis did look at a 
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defined sub-population of stroke patients; those requiring a minimum length of stay 
and a PEG procedure. As such, those with very mild strokes or those with 
catastrophic strokes would have been excluded.  
Given the relatively low event rate there is a possibility of a Type II error. However, 
if a power calculation is performed for a doubling of mortality rate from 
approximately 4% to 8% as we saw for 7-day mortality between high volume 
centres and low volume centres then the sample size required for a power of 80% 
with 0.05% significance is 553. The low volume population contained 322 patients, 
the high volume population 723. (See Fig 5.2 and Table 5.11) 
HES data does not allow assessment of stroke severity other than by surrogate 
markers such as mortality, length of stay and place of discharge. We did not make 
an assessment of where a patient was admitted from (e.g. own home or nursing 
home) which could provide additional predictors for poor outcome and allow 
further risk adjustment. The use of other methods of feeding such as naso-gastric 
tube and parenteral nutrition are not specifically or reliably coded for in HES (X90.4 
is intravenous nutrition; X90.8 & X90.9 are both high cost haematology and 
nutrition drugs). Incorporation into HES of scores from validated stroke severity 
measures e.g. NIHSS, would facilitate further assessment of the impact of PEG 
insertions in stroke. Unfortunately it is not possible to derive such scores from data 
held within the HES database at this time. 
Those patients requiring a PEG following acute stroke are presumed to be different 
to those stroke patients not requiring a PEG. If the aim is to assess the impact of 
PEG on stroke outcomes then both populations need to be assessed with 
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appropriate case-matching. Without an assessment of stroke severity it is difficult 
to exclude the possibility that those institutions with lower mortality rates are 
placing PEGs in lower risk cases. As it appeared that those institutions with a high 
volume of PEG insertions generally had a lower mortality rate this may simple 
reflect that they have a lower threshold for inserting PEGs in stroke patients. 
The ‘look-up’ tables developed for predicting outcome following PEG insertion in 
stroke were limited by small numbers for some sub-groups. The increasing risk was 
not consistent with the addition of our defined risk factors. So, for example, in some 
age groups being in a high volume centre gave a higher risk of death within 30 days 
compared to being in a low volume centre. This suggests that there are other 
factors at play in determining outcome for these patients. The most significant 
factor is probably stroke severity which we were not able to adequately define 
using HES data.  
Conclusions 
Having a PEG procedure following stroke is a marker of worse long-term outcome 
consistent with a more severe stroke. Short-term mortality varies amongst hospital 
Trusts with those performing the highest volumes of PEG procedures having the 
lowest post procedure mortality (within 7 days of gastrostomy procedure). Short-
term mortality after PEG procedures is a candidate marker for the quality of 
hospital care for acute dysphagic stroke. Further work is required to identify the 
precise reasons for lower mortality in high volume institutions so that appropriate 
performance management can be directed to those with higher mortality rates. 
Studying a larger number of events by looking at sequential years of data may make 
the study more statistically robust and reduce the risk of a Type II error.  
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6. Discussion 
Our general clinical findings are perhaps not that surprising - patient factors are the 
major determinants of future health and outcomes. However, these unsurprising 
results are reassuring in our quest to show that routinely collected administrative 
data and in particular HES data, can be used for good quality outcomes analysis. Our 
message is in keeping with previous work. What we have been able to do is qualify 
and quantify our results with robust statistics for a whole population, rather than 
being based on single-centre experiences or on a sub-group of volunteer units118. 
Case ascertainment is likely to be without systematic bias since inpatient episodes 
are recorded routinely in HES irrespective of case severity or outcome.  
Mortality is derived from the official statutory national death registry. This is the 
most accurate record of alive-dead status available. In terms of providing accurate 
figures for use in discussion with health professionals, patients and carers this is 
invaluable. We have identified variation at Trust level most of which appears to be 
within acceptable limits. We have highlighted areas for further analysis and 
improved case-mix adjustment.  
We sought feedback from clinicians to guide our analyses and focussed on first 
rather than repeat procedures and tracked information contained in readmissions 
to examine last-coded diagnoses before death. The use of case linkage is an area to 
be developed so that performance can be tracked over years – likely to be far more 
useful than 12-month data. It will allow measurement of improvement following 
implementation of new policies and guidance.  
The large numbers of cases accessible with HES data are particularly important 
when monitoring for rare events e.g. complications post endoscopy. This is a major 
advantage over internal audit and clinical databases. Endoscopy units in the UK are 
encouraged to audit 30-day mortality and morbidity but the NHS currently lacks 
systems that can capture all procedures and link to subsequent outcome. Our 
analysis shows HES data, in combination with death registry status, can be used for 
Trust level monitoring. 
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We analysed mortality rates after procedures up to 30 days and beyond. It is our 
belief that measuring mortality rates within 7 days of a procedure provides a better 
marker of procedure quality and outcome. Beyond 7 days the influence of other 
factors, particularly disease progression, has a significant effect on outcomes and 
the procedure itself becomes less relevant.  
Weaknesses of our approach relate mainly to the relative paucity of clinical data 
within HES data and the potential for coding incompleteness or inaccuracy. Hence, 
global grading of illness severity and other clinical or laboratory indices of acute 
illness are not recorded and it is not possible to judge the severity of the presenting 
illness from the basic ICD-10 diagnostic coding system. However, the basic case mix 
observed in the present study was very similar to a prospective study based on 
richer clinical datasets129 suggesting that HES data contains a representative sample 
of patients undergoing endoscopic procedures.  
There is published evidence that administrative data can match clinical data sets244 
and that the coding quality for specific procedures is good245. There have been a 
number of incentives to drive improvements in coding accuracy in recent years. 
These include financial incentives such as ‘payment by results’ whereby patient-
level coding determines a hospital’s tariff-based income and the publication of HES 
based performance data e.g. Dr Foster’s The Good Hospital Guide. The number of 
ICD diagnostic code positions within HES has increased with upgrades of the HES 
dataset. It was evident from our two datasets that coding depth had increased. 
Phenomena such as ‘death code creep’ where more diagnoses are listed where a 
patient dies than in patient episodes where they survive can add to variation in 
coding practice20. Under-coding of co-morbid conditions is recognised but is likely to 
improve with increasing front-line awareness of tariff calculations and HES data in 
general. 
Our use of mortality as an outcome measure by which hospital performance can be 
measured has limitations. Mortality rates do not necessarily equate to quality of 
care. Many factors affect mortality and not all can be controlled for. Even if 
complete risk adjustment is performed, caution in interpreting results is required as 
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risk will not be the same across all institutions or geographic area – the ‘constant 
risk fallacy’. Rates of hospitalization and mortality vary across hospitals, regions and 
nations. This variation can persist even after risk-adjustment. What remains does 
not necessarily equate to variation in quality20;246. Practice may simply be different 
and finding variation should thus be a stimulus for investigating further. 
Grouping cases by diagnosis proved difficult and unsatisfactory. A single episode of 
care can be coded in many ways with several combinations of ICD and OPCS codes 
possible. Most codes were used very infrequently and even the most commonly 
used accounted for a minority of patients – the top ten diagnostic codes accounted 
for fewer than a quarter of all diagnoses in our PEG study population. Grouping 
codes together is not straightforward although it theoretically makes comparing 
groups of patients easier and the data more manageable. Grouping of codes is used 
for tariff calculations with HRGs. However, these are not always clinically coherent 
groups and thus have limited use in outcomes research.  
Analysis of HES data is not a simple process and there are significant issues with the 
level of coding of co-morbidities and allocating care to the right consultant.  
Investigating the data at a national level has proved more difficult than originally 
anticipated. Acknowledging a significant learning curve to learn how to manipulate 
data and perform analysis, it still took many months of work to produce the data for 
my thesis. HES analysis may not be quicker than traditional clinical audit but it does 
have some advantages in terms of data consistency and evaluation of time. These 
factors make it a more suitable tool for benchmarking performance and outcomes.  
Currently most Trusts use outside agencies to analyse their HES data e.g. Dr Foster 
and CHKS. These agencies are employed to analyse performance, against evolving 
national standards of care and targets. They have the manpower, skill sets and IT 
support to manipulate these huge datasets and produce results in a relatively short 
space of time.  
HES analysis by individual clinicians is probably unrealistic at this point without the 
appropriate IT and data analyst support and as such is not going to entirely replace 
the more traditional methods of clinical audit using direct case note review. 
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Individual Trusts do not have routine access to HES data for other Trusts, only the 
final published outcome results. Thus, investigation of HES data on a national level 
is likely to be limited to the commercial sector and individual research groups. 
However, using HES data at local Trust level to monitor outcomes and performance 
is feasible and is happening and clinicians do need to engage with that process. The 
development of clinical metrics will involve HES data and requires clinician 
engagement to make them meaningful.  
Data can be misinterpreted and there are many caveats to presenting the data in 
terms of case mix adjustment and clinical context. Analysis of HES data requires a 
multi-disciplinary team of investigators with appropriate IT skills and clinical 
experience i.e. needs clinicians as well as data analysts.  
Are HES a useful resource for process and outcomes analysis? I have shown that 
HES can be used to assess outcomes within gastroenterology on a national level and 
at Trust level but that it will not entirely replace more traditional methods of clinical 
audit. Results from HES analysis may be a trigger for more clinically detailed local 
audit and enable fuller case ascertainment.  
Assessing process proved more difficult. Correlating results from HES analysis with 
measures of process such as the SINAP audit in the Stroke chapter was 
unsatisfactory but linkage of episodes, such as that done in the ERCP chapter, can 
begin to describe processes within healthcare. Further work on the processes 
involved in healthcare has been carried out and published on, by colleagues in the 
Aintree Health Outcomes Partnership group.  
The Future 
Future analysis using provider spells of care rather than finished consultant 
episodes may provide more clinically coherent analysis and enable appropriate 
comparison with American healthcare datasets. 
Variables within the HES dataset such as admission source, postcode and 
deprivation score need to be investigated further as potential means of measuring 
patients’ pre-morbid status which would allow further case-mix adjustment.  
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A more complete picture of a patient’s journey through the healthcare system is 
achievable through linkage of episodes of care over time and across institutions. 
The HES dataset could be improved with the introduction of codes that provide 
information on the stage or grade of disease. These would provide greater clinical 
depth, aid case-mix adjustment and perhaps reduce inaccuracies and bias (non-
clinical variation in diagnostic practice; geographical variation in coding practices). 
For example, NIHSS stroke severity, providing a value for ejection fraction alongside 
a diagnosis of heart failure, or TMN staging for neoplasms would improve the 
clinical validity of coded data. Likewise, codes for risk factors such as smoking would 
benefit risk-adjustment processes247. Providing dates with diagnostic codes akin to 
the OPCS procedure coding system e.g. the first time they are used for a patient 
could improve interpretation of data and allow for more in-depth analysis of cause 
and effect. 
Improving the quality of the data that is put into HES relies significantly on engaging 
the clinicians themselves and encouraging them to liaise more closely with their 
hospital coding teams. Self-coding by clinicians already occurs with surgeons 
entering OPCS codes themselves when completing theatre reports. The use of tick-
box discharge summaries with specific diagnoses and their codes is becoming more 
widespread across all specialities. This encourages true diagnostic codes to be used 
rather than non-specific symptom codes. Both strategies will improve the quality of 
and confidence in coding data. Education on specific complication codes and 
improvement in that code set would greatly assist outcomes analysis. 
As clinicians, hospital IT and audit staff become more familiar with HES, the process 
of analysing the data will become more streamlined and efficient. It is important for 
groups using HES data to be transparent about the methods they use. This is not 
just to enable appropriate comparisons and interpretation of their results but to 
allow sharing of knowledge. Cleaning and manipulating HES data into a useable 
form is a complex process. As strategies and techniques, pitfalls and quirks are 
recognised this information needs to be disseminated so that rigorous methods can 
be universally applied to data analysis.  
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Appropriately trained and skilled staff from both clinical and IT backgrounds are 
required to handle data and data collection and to perform analysis and 
interpretation. This has probably been lacking in the NHS so far. Better IT can help 
improve efficiency. Other than staff numbers this is perhaps the major factor 
explaining the US, non-profit, health maintenance organisation, Kaiser 
Permanente’s better cost efficiency compared to the NHS248 
Increased efficiency in HES analytical methods will result in more timely analysis 
increasing its usefulness for performance monitoring. Caution is still required 
however. The problem of unstable data and quality measures has been 
recognised30. Performance indicators change over time (e.g. time to be seen, door 
to needle times etc). Definitions change, leading to changes in the numerator and 
denominator populations. Defining the baseline performance becomes difficult and 
assessing trends over time may become meaningless because of this instability. 
Data entry performance can change due to increased depth of coding; revisions of 
the OPCS and ICD code systems and focus on particular diseases or procedures at 
local or national level. 
In 2010 the Standardized Nomenclature of Medicine - Clinical Terms (SNOMED CT) 
system was linked with the WHO Family of Classifications system following 
collaboration between WHO and International Health Terminology Standards 
Development Organisation. Data from the two systems are now complementary 
and can be used to summarize information from patient care episodes into 
aggregated results for healthcare research, policy and service provision44. 
The publication of HES based analysis must be in context with appropriate caveats 
made clear. This is particularly so when in the public domain. League tables for 
hospitals (e.g. Dr Foster’s Good Hospital guide) may over-simplify to the detriment 
of the hospitals concerned. By ranking hospitals it is implied that those at the 
bottom of the league are performing badly when in fact their performance may be 
within acceptable limits (and safe) with scores simply below the average at the time 
of assessment. The difference between and the implications of ‘common-cause’ 
variation rather than ‘special cause’ must be made clear. How much variation is 
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allowed in healthcare is a complex issue for debate. The importance of clinical 
versus statistical significance must be made clear. 
Using HES data for individual doctor level analysis is happening within the NHS but 
is unreliable at this time. The consultant code applied to an episode was frequently 
incorrect when data for our own institution was analysed. Even if the code denotes 
the correct consultant team, procedures within that episode may not have been 
performed by that individual. The consultant identified may not physically have 
seen that patient. Even if the correct consultant is identified it would be dangerous 
and inappropriate to assign all outcomes to that individual. A patient’s journey 
involves many members of staff and complex decision processes – it is a team 
effort. 
At national level HES has a place in generating robust answers to clinical questions 
that can be used in guiding and advising clinicians, patients and their carers. For 
example, what is the risk of a poor outcome following ERCP in a 35 year old fit and 
well woman with gallstones? What is the risk in an 85 year old admitted as an 
emergency with cholangitis? What is the prognosis for a 50 year old man with a 
stroke who requires nutritional support via PEG? And perhaps, which hospital 
should he be going to?  
At Trust level I believe HES can be used to highlight variation in performance 
between institutions, assess whether the variation is of concern and provide 
direction for further investigation. However, we need to move beyond crude 
mortality rates to more sophisticated indicators.  
I do not believe that the full potential of HES data analysis has yet been realised. It 
is not the perfect solution to outcomes analysis and performance monitoring in 
healthcare but the more we engage with it the more valuable a resource it will 
become. 
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 “The scientific purist, who will wait for medical statistics until they are 
nosologically exact, is no wiser than Horace’s rustic waiting for the river to 
flow away”249 - Major Greenwood English; epidemiologist and statistician 
(9th August 1880 - 5th October 1949) 
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7. Appendices 
7.1. Syntax 
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ERCP Syntax 1 – ERCP present 
COMPUTE 
ERCPPRESENT = 0. 
EXECUTE. 
IF (OPERTN1='J381'| 
OPERTN1='J382'| 
OPERTN1='J388'| 
OPERTN1='J389'| 
OPERTN1='J391'| 
OPERTN1='J398'| 
OPERTN1='J399'| 
OPERTN1='J401'| 
OPERTN1='J402'| 
OPERTN1='J403'| 
OPERTN1='J404'| 
OPERTN1='J405'| 
OPERTN1='J406'| 
OPERTN1='J407'| 
OPERTN1='J408'| 
OPERTN1='J409'| 
OPERTN1='J411'| 
OPERTN1='J412'| 
OPERTN1='J413'| 
OPERTN1='J414'| 
OPERTN1='J418'| 
OPERTN1='J419'| 
OPERTN1='J421'| 
OPERTN1='J422'| 
OPERTN1='J423'| 
OPERTN1='J424'| 
OPERTN1='J425'| 
OPERTN1='J428'| 
OPERTN1='J429'| 
OPERTN1='J431'| 
OPERTN1='J432'| 
OPERTN1='J433'| 
OPERTN1='J438'| 
OPERTN1='J439'| 
OPERTN1='J441'| 
OPERTN1='J448'| 
OPERTN1='J449'| 
OPERTN1='J451'| 
OPERTN1='J452'| 
OPERTN1='J453'| 
OPERTN1='J458'| 
OPERTN1='J459')ERC
PPRESENT = 1. 
EXECUTE. 
 
IF (OPERTN2='J381'| 
OPERTN2='J382'| 
OPERTN2='J388'| 
OPERTN2='J389'| 
OPERTN2='J391'| 
OPERTN2='J398'| 
OPERTN2='J399'| 
OPERTN2='J401'| 
OPERTN2='J402'| 
OPERTN2='J403'| 
OPERTN2='J404'| 
OPERTN2='J405'| 
OPERTN2='J406'| 
OPERTN2='J407'| 
OPERTN2='J408'| 
OPERTN2='J409'| 
OPERTN2='J411'| 
OPERTN2='J412'| 
OPERTN2='J413'| 
OPERTN2='J414'| 
OPERTN2='J418'| 
OPERTN2='J419'| 
OPERTN2='J421'| 
OPERTN2='J422'| 
OPERTN2='J423'| 
OPERTN2='J424'| 
OPERTN2='J425'| 
OPERTN2='J428'| 
OPERTN2='J429'| 
OPERTN2='J431'| 
OPERTN2='J432'| 
OPERTN2='J433'| 
OPERTN2='J438'| 
OPERTN2='J439'| 
OPERTN2='J441'| 
OPERTN2='J448'| 
OPERTN2='J449'| 
OPERTN2='J451'| 
OPERTN2='J452'| 
OPERTN2='J453'| 
OPERTN2='J458'| 
OPERTN2='J459')ERC
PPRESENT = 1. 
EXECUTE. 
 
IF (OPERTN3='J381'| 
OPERTN3='J382'| 
OPERTN3='J388'| 
OPERTN3='J389'| 
OPERTN3='J391'| 
OPERTN3='J398'| 
OPERTN3='J399'| 
OPERTN3='J401'| 
OPERTN3='J402'| 
OPERTN3='J403'| 
OPERTN3='J404'| 
OPERTN3='J405'| 
OPERTN3='J406'| 
OPERTN3='J407'| 
OPERTN3='J408'| 
OPERTN3='J409'| 
OPERTN3='J411'| 
OPERTN3='J412'| 
OPERTN3='J413'| 
OPERTN3='J414'| 
OPERTN3='J418'| 
OPERTN3='J419'| 
OPERTN3='J421'| 
OPERTN3='J422'| 
OPERTN3='J423'| 
OPERTN3='J424'| 
OPERTN3='J425'| 
OPERTN3='J428'| 
OPERTN3='J429'| 
OPERTN3='J431'| 
OPERTN3='J432'| 
OPERTN3='J433'| 
OPERTN3='J438'| 
OPERTN3='J439'| 
OPERTN3='J441'| 
OPERTN3='J448'| 
OPERTN3='J449'| 
OPERTN3='J451'| 
OPERTN3='J452'| 
OPERTN3='J453'| 
OPERTN3='J458'| 
OPERTN3='J459')ERC
PPRESENT = 1. 
EXECUTE. 
 
IF (OPERTN4='J381'| 
OPERTN4='J382'| 
OPERTN4='J388'| 
OPERTN4='J389'| 
OPERTN4='J391'| 
OPERTN4='J398'| 
OPERTN4='J399'| 
OPERTN4='J401'| 
OPERTN4='J402'| 
OPERTN4='J403'| 
OPERTN4='J404'| 
OPERTN4='J405'| 
OPERTN4='J406'| 
OPERTN4='J407'| 
OPERTN4='J408'| 
OPERTN4='J409'| 
OPERTN4='J411'| 
OPERTN4='J412'| 
OPERTN4='J413'| 
OPERTN4='J414'| 
OPERTN4='J418'| 
OPERTN4='J419'| 
OPERTN4='J421'| 
OPERTN4='J422'| 
OPERTN4='J423'| 
OPERTN4='J424'| 
OPERTN4='J425'| 
OPERTN4='J428'| 
OPERTN4='J429'| 
OPERTN4='J431'| 
OPERTN4='J432'| 
OPERTN4='J433'| 
OPERTN4='J438'| 
OPERTN4='J439'| 
OPERTN4='J441'| 
OPERTN4='J448'| 
OPERTN4='J449'| 
OPERTN4='J451'| 
OPERTN4='J452'| 
OPERTN4='J453'| 
OPERTN4='J458'| 
OPERTN4='J459')ERC
PPRESENT = 1. 
EXECUTE. 
 
IF (OPERTN5='J381'| 
OPERTN5='J382'| 
OPERTN5='J388'| 
OPERTN5='J389'| 
OPERTN5='J391'| 
OPERTN5='J398'| 
OPERTN5='J399'| 
OPERTN5='J401'| 
OPERTN5='J402'| 
OPERTN5='J403'| 
OPERTN5='J404'| 
OPERTN5='J405'| 
OPERTN5='J406'| 
OPERTN5='J407'| 
OPERTN5='J408'| 
OPERTN5='J409'| 
OPERTN5='J411'| 
OPERTN5='J412'| 
OPERTN5='J413'| 
OPERTN5='J414'| 
OPERTN5='J418'| 
OPERTN5='J419'| 
OPERTN5='J421'| 
OPERTN5='J422'| 
OPERTN5='J423'| 
OPERTN5='J424'| 
OPERTN5='J425'| 
OPERTN5='J428'| 
OPERTN5='J429'| 
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OPERTN5='J431'| 
OPERTN5='J432'| 
OPERTN5='J433'| 
OPERTN5='J438'| 
OPERTN5='J439'| 
OPERTN5='J441'| 
OPERTN5='J448'| 
OPERTN5='J449'| 
OPERTN5='J451'| 
OPERTN5='J452'| 
OPERTN5='J453'| 
OPERTN5='J458'| 
OPERTN5='J459')ERC
PPRESENT = 1. 
EXECUTE. 
 
IF (OPERTN6='J381'| 
OPERTN6='J382'| 
OPERTN6='J388'| 
OPERTN6='J389'| 
OPERTN6='J391'| 
OPERTN6='J398'| 
OPERTN6='J399'| 
OPERTN6='J401'| 
OPERTN6='J402'| 
OPERTN6='J403'| 
OPERTN6='J404'| 
OPERTN6='J405'| 
OPERTN6='J406'| 
OPERTN6='J407'| 
OPERTN6='J408'| 
OPERTN6='J409'| 
OPERTN6='J411'| 
OPERTN6='J412'| 
OPERTN6='J413'| 
OPERTN6='J414'| 
OPERTN6='J418'| 
OPERTN6='J419'| 
OPERTN6='J421'| 
OPERTN6='J422'| 
OPERTN6='J423'| 
OPERTN6='J424'| 
OPERTN6='J425'| 
OPERTN6='J428'| 
OPERTN6='J429'| 
OPERTN6='J431'| 
OPERTN6='J432'| 
OPERTN6='J433'| 
OPERTN6='J438'| 
OPERTN6='J439'| 
OPERTN6='J441'| 
OPERTN6='J448'| 
OPERTN6='J449'| 
OPERTN6='J451'| 
OPERTN6='J452'| 
OPERTN6='J453'| 
OPERTN6='J458'| 
OPERTN6='J459')ERC
PPRESENT = 1. 
EXECUTE. 
 
IF (OPERTN7='J381'| 
OPERTN7='J382'| 
OPERTN7='J388'| 
OPERTN7='J389'| 
OPERTN7='J391'| 
OPERTN7='J398'| 
OPERTN7='J399'| 
OPERTN7='J401'| 
OPERTN7='J402'| 
OPERTN7='J403'| 
OPERTN7='J404'| 
OPERTN7='J405'| 
OPERTN7='J406'| 
OPERTN7='J407'| 
OPERTN7='J408'| 
OPERTN7='J409'| 
OPERTN7='J411'| 
OPERTN7='J412'| 
OPERTN7='J413'| 
OPERTN7='J414'| 
OPERTN7='J418'| 
OPERTN7='J419'| 
OPERTN7='J421'| 
OPERTN7='J422'| 
OPERTN7='J423'| 
OPERTN7='J424'| 
OPERTN7='J425'| 
OPERTN7='J428'| 
OPERTN7='J429'| 
OPERTN7='J431'| 
OPERTN7='J432'| 
OPERTN7='J433'| 
OPERTN7='J438'| 
OPERTN7='J439'| 
OPERTN7='J441'| 
OPERTN7='J448'| 
OPERTN7='J449'| 
OPERTN7='J451'| 
OPERTN7='J452'| 
OPERTN7='J453'| 
OPERTN7='J458'| 
OPERTN7='J459')ERC
PPRESENT = 1. 
EXECUTE. 
 
IF (OPERTN8='J381'| 
OPERTN8='J382'| 
OPERTN8='J388'| 
OPERTN8='J389'| 
OPERTN8='J391'| 
OPERTN8='J398'| 
OPERTN8='J399'| 
OPERTN8='J401'| 
OPERTN8='J402'| 
OPERTN8='J403'| 
OPERTN8='J404'| 
OPERTN8='J405'| 
OPERTN8='J406'| 
OPERTN8='J407'| 
OPERTN8='J408'| 
OPERTN8='J409'| 
OPERTN8='J411'| 
OPERTN8='J412'| 
OPERTN8='J413'| 
OPERTN8='J414'| 
OPERTN8='J418'| 
OPERTN8='J419'| 
OPERTN8='J421'| 
OPERTN8='J422'| 
OPERTN8='J423'| 
OPERTN8='J424'| 
OPERTN8='J425'| 
OPERTN8='J428'| 
OPERTN8='J429'| 
OPERTN8='J431'| 
OPERTN8='J432'| 
OPERTN8='J433'| 
OPERTN8='J438'| 
OPERTN8='J439'| 
OPERTN8='J441'| 
OPERTN8='J448'| 
OPERTN8='J449'| 
OPERTN8='J451'| 
OPERTN8='J452'| 
OPERTN8='J453'| 
OPERTN8='J458'| 
OPERTN8='J459')ERC
PPRESENT = 1. 
EXECUTE. 
 
IF (OPERTN9='J381'| 
OPERTN9='J382'| 
OPERTN9='J388'| 
OPERTN9='J389'| 
OPERTN9='J391'| 
OPERTN9='J398'| 
OPERTN9='J399'| 
OPERTN9='J401'| 
OPERTN9='J402'| 
OPERTN9='J403'| 
OPERTN9='J404'| 
OPERTN9='J405'| 
OPERTN9='J406'| 
OPERTN9='J407'| 
OPERTN9='J408'| 
OPERTN9='J409'| 
OPERTN9='J411'| 
OPERTN9='J412'| 
OPERTN9='J413'| 
OPERTN9='J414'| 
OPERTN9='J418'| 
OPERTN9='J419'| 
OPERTN9='J421'| 
OPERTN9='J422'| 
OPERTN9='J423'| 
OPERTN9='J424'| 
OPERTN9='J425'| 
OPERTN9='J428'| 
OPERTN9='J429'| 
OPERTN9='J431'| 
OPERTN9='J432'| 
OPERTN9='J433'| 
OPERTN9='J438'| 
OPERTN9='J439'| 
OPERTN9='J441'| 
OPERTN9='J448'| 
OPERTN9='J449'| 
OPERTN9='J451'| 
OPERTN9='J452'| 
OPERTN9='J453'| 
OPERTN9='J458'| 
OPERTN9='J459')ERC
PPRESENT = 1. 
EXECUTE. 
 
IF 
(OPERTN10='J381'| 
OPERTN10='J382'| 
OPERTN10='J388'| 
OPERTN10='J389'| 
OPERTN10='J391'| 
OPERTN10='J398'| 
OPERTN10='J399'| 
OPERTN10='J401'| 
OPERTN10='J402'| 
OPERTN10='J403'| 
OPERTN10='J404'| 
OPERTN10='J405'| 
OPERTN10='J406'| 
OPERTN10='J407'| 
OPERTN10='J408'| 
OPERTN10='J409'| 
OPERTN10='J411'| 
OPERTN10='J412'| 
OPERTN10='J413'| 
OPERTN10='J414'| 
OPERTN10='J418'| 
OPERTN10='J419'| 
OPERTN10='J421'| 
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OPERTN10='J422'| 
OPERTN10='J423'| 
OPERTN10='J424'| 
OPERTN10='J425'| 
OPERTN10='J428'| 
OPERTN10='J429'| 
OPERTN10='J431'| 
OPERTN10='J432'| 
OPERTN10='J433'| 
OPERTN10='J438'| 
OPERTN10='J439'| 
OPERTN10='J441'| 
OPERTN10='J448'| 
OPERTN10='J449'| 
OPERTN10='J451'| 
OPERTN10='J452'| 
OPERTN10='J453'| 
OPERTN10='J458'| 
OPERTN10='J459')ER
CPPRESENT = 1. 
EXECUTE. 
 
IF 
(OPERTN11='J381'| 
OPERTN11='J382'| 
OPERTN11='J388'| 
OPERTN11='J389'| 
OPERTN11='J391'| 
OPERTN11='J398'| 
OPERTN11='J399'| 
OPERTN11='J401'| 
OPERTN11='J402'| 
OPERTN11='J403'| 
OPERTN11='J404'| 
OPERTN11='J405'| 
OPERTN11='J406'| 
OPERTN11='J407'| 
OPERTN11='J408'| 
OPERTN11='J409'| 
OPERTN11='J411'| 
OPERTN11='J412'| 
OPERTN11='J413'| 
OPERTN11='J414'| 
OPERTN11='J418'| 
OPERTN11='J419'| 
OPERTN11='J421'| 
OPERTN11='J422'| 
OPERTN11='J423'| 
OPERTN11='J424'| 
OPERTN11='J425'| 
OPERTN11='J428'| 
OPERTN11='J429'| 
OPERTN11='J431'| 
OPERTN11='J432'| 
OPERTN11='J433'| 
OPERTN11='J438'| 
OPERTN11='J439'| 
OPERTN11='J441'| 
OPERTN11='J448'| 
OPERTN11='J449'| 
OPERTN11='J451'| 
OPERTN11='J452'| 
OPERTN11='J453'| 
OPERTN11='J458'| 
OPERTN11='J459')ER
CPPRESENT = 1. 
EXECUTE. 
 
IF 
(OPERTN12='J381'| 
OPERTN12='J382'| 
OPERTN12='J388'| 
OPERTN12='J389'| 
OPERTN12='J391'| 
OPERTN12='J398'| 
OPERTN12='J399'| 
OPERTN12='J401'| 
OPERTN12='J402'| 
OPERTN12='J403'| 
OPERTN12='J404'| 
OPERTN12='J405'| 
OPERTN12='J406'| 
OPERTN12='J407'| 
OPERTN12='J408'| 
OPERTN12='J409'| 
OPERTN12='J411'| 
OPERTN12='J412'| 
OPERTN12='J413'| 
OPERTN12='J414'| 
OPERTN12='J418'| 
OPERTN12='J419'| 
OPERTN12='J421'| 
OPERTN12='J422'| 
OPERTN12='J423'| 
OPERTN12='J424'| 
OPERTN12='J425'| 
OPERTN12='J428'| 
OPERTN12='J429'| 
OPERTN12='J431'| 
OPERTN12='J432'| 
OPERTN12='J433'| 
OPERTN12='J438'| 
OPERTN12='J439'| 
OPERTN12='J441'| 
OPERTN12='J448'| 
OPERTN12='J449'| 
OPERTN12='J451'| 
OPERTN12='J452'| 
OPERTN12='J453'| 
OPERTN12='J458'| 
OPERTN12='J459')ER
CPPRESENT = 1. 
EXECUTE. 
 
IF 
(OPERTN13='J381'| 
OPERTN13='J382'| 
OPERTN13='J388'| 
OPERTN13='J389'| 
OPERTN13='J391'| 
OPERTN13='J398'| 
OPERTN13='J399'| 
OPERTN13='J401'| 
OPERTN13='J402'| 
OPERTN13='J403'| 
OPERTN13='J404'| 
OPERTN13='J405'| 
OPERTN13='J406'| 
OPERTN13='J407'| 
OPERTN13='J408'| 
OPERTN13='J409'| 
OPERTN13='J411'| 
OPERTN13='J412'| 
OPERTN13='J413'| 
OPERTN13='J414'| 
OPERTN13='J418'| 
OPERTN13='J419'| 
OPERTN13='J421'| 
OPERTN13='J422'| 
OPERTN13='J423'| 
OPERTN13='J424'| 
OPERTN13='J425'| 
OPERTN13='J428'| 
OPERTN13='J429'| 
OPERTN13='J431'| 
OPERTN13='J432'| 
OPERTN13='J433'| 
OPERTN13='J438'| 
OPERTN13='J439'| 
OPERTN13='J441'| 
OPERTN13='J448'| 
OPERTN13='J449'| 
OPERTN13='J451'| 
OPERTN13='J452'| 
OPERTN13='J453'| 
OPERTN13='J458'| 
OPERTN13='J459')ER
CPPRESENT = 1. 
EXECUTE. 
 
IF 
(OPERTN14='J381'| 
OPERTN14='J382'| 
OPERTN14='J388'| 
OPERTN14='J389'| 
OPERTN14='J391'| 
OPERTN14='J398'| 
OPERTN14='J399'| 
OPERTN14='J401'| 
OPERTN14='J402'| 
OPERTN14='J403'| 
OPERTN14='J404'| 
OPERTN14='J405'| 
OPERTN14='J406'| 
OPERTN14='J407'| 
OPERTN14='J408'| 
OPERTN14='J409'| 
OPERTN14='J411'| 
OPERTN14='J412'| 
OPERTN14='J413'| 
OPERTN14='J414'| 
OPERTN14='J418'| 
OPERTN14='J419'| 
OPERTN14='J421'| 
OPERTN14='J422'| 
OPERTN14='J423'| 
OPERTN14='J424'| 
OPERTN14='J425'| 
OPERTN14='J428'| 
OPERTN14='J429'| 
OPERTN14='J431'| 
OPERTN14='J432'| 
OPERTN14='J433'| 
OPERTN14='J438'| 
OPERTN14='J439'| 
OPERTN14='J441'| 
OPERTN14='J448'| 
OPERTN14='J449'| 
OPERTN14='J451'| 
OPERTN14='J452'| 
OPERTN14='J453'| 
OPERTN14='J458'| 
OPERTN14='J459')ER
CPPRESENT = 1. 
EXECUTE. 
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ERCP Syntax 2 – HESIDpresent 
COMPUTE HESIDPRESENT = 0. 
EXECUTE. 
IF (HESID = 18800060| 
HESID = 70913961| 
HESID = 8780583| 
HESID = 45766269| 
HESID = 43578500| 
HESID = 34888107| 
HESID = 63550836| 
HESID = 45192211| 
HESID = 1446345| 
HESID = 71792184| 
HESID = 1751740| 
HESID = 22108071| 
HESID = 51714698| 
HESID = 72252617| 
HESID = 4211157| 
HESID = 33027459| 
HESID = 32745262| 
HESID = 63349552| 
HESID = 1455726| 
HESID = 65708126| 
HESID = 68939140| 
HESID = 64858981| 
HESID = 75952149| 
HESID = 19998269| 
HESID = 1116986| 
HESID = 51827795| 
HESID = 15461225| 
HESID = 76035284| 
HESID = 75954017| 
HESID = 32855553| 
HESID = 7470099| 
HESID = 72661721| 
HESID = 34525771| 
HESID = 1109754| 
HESID = 8825707| 
HESID = 76000930| 
HESID = 25644418| 
HESID = 14546682| 
HESID = 22987502| 
HESID = 1542822| 
HESID = 10073431| 
HESID = 8277847| 
HESID = 8863616| 
HESID = 76010404| 
HESID = 13517688| 
HESID = 2191457| 
HESID = 1253637| 
HESID = 74163783| 
HESID = 32004108| 
HESID = 3489522| 
HESID = 717978| 
HESID = 14949519| 
HESID = 51693971| 
HESID = 1483217| 
HESID = 2115559| 
HESID = 46905165| 
HESID = 1725999)HESIDPRESENT 
= 1. 
EXECUTE. 
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ERCP Syntax 3 – New HESID present 
COMPUTE HESIDPRESENTNEW = 0. 
EXECUTE. 
IF (EXTRACTHESID = 
'0D6B2D906C735DFEF775528AF58C1B06'| 
EXTRACTHESID = '2EABF067C69154B6BD5A916F39F9B41F'| 
EXTRACTHESID = '0A9453FECEB4F918D094FB00C1D1A7D0'| 
EXTRACTHESID = '1A246B96AE163B068A07F4BC43A1FA30'| 
EXTRACTHESID = '02E9726685C636F288CC2E639C749513'| 
EXTRACTHESID = '2EE6C3F080B86BDDC6417B875A47B09D'| 
EXTRACTHESID = '31A3E871847319E5906C614DCAED4BC4'| 
EXTRACTHESID = '23D8FC7134BAB4CE65C4F488388A8B57'| 
EXTRACTHESID = '0D12AAB7C543DEEBB5C6859E2361CCB5'| 
EXTRACTHESID = '0DFB85D2823E9B9549397737431F6719'| 
EXTRACTHESID = '25930710EE518DC1B1A9ACB8B9FBBF23'| 
EXTRACTHESID = '26ADBCADA4A8C8AB62B7868CB1E8A35C'| 
EXTRACTHESID = '2BA7D52F0B80A84EA27EFD69E5D63318'| 
EXTRACTHESID = '18A421614FCF65D8F59200E8BF5E885C'| 
EXTRACTHESID = '31298DC3DE7F4D03E10621AC531759AD'| 
EXTRACTHESID = '347CA70490D1808A598CC8FCC1652FCF'| 
EXTRACTHESID = '2A650C34207D921E46460010B6B92885'| 
EXTRACTHESID = '085C3754A2DD808F34135804A1C03C1B'| 
EXTRACTHESID = '07F702ABD81D666862DBDD7B1FA59D13'| 
EXTRACTHESID = '0A724184360BDD9D2E319CEA43AFC9E5'| 
EXTRACTHESID = '06E88646B0AB1729DEC2314B856DB2D3'| 
EXTRACTHESID = '1A7F8A628D3238F31B940B9E80164AED'| 
EXTRACTHESID = '29E72FF78A7911A6A7C562F889881BAF'| 
EXTRACTHESID = '0D145729FCE71C2134C6952BA2A4BB39'| 
EXTRACTHESID = '0044D2F65FA3C0C34C0588D8F0127F0E'| 
EXTRACTHESID = '04F97C73287022EFF77DD3D46EAD1E86'| 
EXTRACTHESID = '1D726E0A74589D7B99D984C74993F09E'| 
EXTRACTHESID = '064834F1AC713F83832C24006F6F24EF'| 
EXTRACTHESID = '1986577590772E0677A6245433E00891'| 
EXTRACTHESID = '2F326DD3E28119919A3EB51E78AFFDA7'| 
EXTRACTHESID = '3362860BC70A859BF1C2807F34853EC6'| 
EXTRACTHESID = '1BF46A914525A5BB42E7A4192C173CB3'| 
EXTRACTHESID = '0D74F7D175705B693C15E46E404C8238'| 
EXTRACTHESID = '3563A98D9B97FB9BED97A3AC17918ECD'| 
EXTRACTHESID = '07B05EC2DD469514527B8E709C2D5F31'| 
EXTRACTHESID = '2C8E63C85D1556CB16844900CF178457'| 
EXTRACTHESID = '10578361EC71359638E56870FEE40C81'| 
EXTRACTHESID = '309AB0F3FA01DE8A0F069AAB87F1127C'| 
EXTRACTHESID = '23271DBE8137434FE929EC625B10F491'| 
EXTRACTHESID = '07D3B43FA64AE42E3DF5C8542F272F81'| 
EXTRACTHESID = '0C613203032095862D917BEED833D700'| 
EXTRACTHESID = '13DC7020C7C94108BD5061C5F0106560'| 
EXTRACTHESID = '087686C49A6E5AAA42494F23DFE3E01B'| 
EXTRACTHESID = '108AFC1AE71EBC1D734B370408774216'| 
EXTRACTHESID = '1473EA131D06BAC366574BE2523024D9'| 
EXTRACTHESID = '164086AE5C5CE1F6335922D945F19BC9'| 
EXTRACTHESID = '0667D8A923761CEB7560AFBA8EA3CCB1'| 
EXTRACTHESID = '11519C363C5902AFB5A329D1928FBED4'| 
EXTRACTHESID = '32320C0420F80435470144809A06880B'| 
EXTRACTHESID = '0D677E2447D9914984D57B02B1D82AA0'| 
EXTRACTHESID = '27B3F0E956E5A0A50AE36143E338522F'| 
EXTRACTHESID = '23D266FE296397CBA1DB8FB7FE47E51C'| 
EXTRACTHESID = '369068444F83EE81C13A04673CF96898'| 
EXTRACTHESID = '0992AA45F7BF54AB5DD3750CEE1B8B1E'| 
EXTRACTHESID = '09A0F99DE147C160C412B356C639B7B0'| 
EXTRACTHESID = '220C2D2FF3DBEF24F4B79C6E1818B6C4'| 
EXTRACTHESID = '188431C09BC1E424AA629D67FD3473B4'| 
EXTRACTHESID = '0F5144D322F221A22745154754071813'| 
EXTRACTHESID = '12F9305115830FEAD486A98B9DE28FE4'| 
EXTRACTHESID = '1CF6E91744CA6D039D6DFF672DAC3280'| 
EXTRACTHESID = '0F29E7E4D2978D8DD8DCC2D5CFCAE041'| 
EXTRACTHESID = '1FA04A17BFC729E034FCCDCF4EE13886'| 
EXTRACTHESID = '124843B0500EAFDE03F7B52390ECB321'| 
EXTRACTHESID = '0B5DB05E760EE9916D42A4F11578A25B'| 
EXTRACTHESID = '0ABA55CB930F4CA9F10CCA97CECB46FB'| 
EXTRACTHESID = '02C18719025D0855BA1F20DFE52FA066'| 
EXTRACTHESID = '0F6B957FAC7802916DCCD4DAC803655C'| 
EXTRACTHESID = '231E6E6C887EAD4381DE9D7753A4E84E'| 
EXTRACTHESID = '2DEC89E4FF75993ECDC43C9D67BFFF40'| 
EXTRACTHESID = '0AD9662F3932F5F98714D7FEB8D442C9'| 
EXTRACTHESID = '24F392818BFFA272E6E186D90020419A'| 
EXTRACTHESID = '2110C86A8228A1AEEC40419A9CC70050'| 
EXTRACTHESID = '07465CA3B22AE043FE365C0BC4A18DCE'| 
EXTRACTHESID = '10D3B58D00715F2F9F3CDB6ACCB39458'| 
EXTRACTHESID = '100EF4FAD6C7DF91500E2DAC2E44DF3A'| 
EXTRACTHESID = '20110096025B36F1CB62E539FE437153'| 
EXTRACTHESID = '319A9DDCDFC65BADCB046E6663230D53'| 
EXTRACTHESID = '29EFF541B99B5FF8A12068C7E07EF55C'| 
EXTRACTHESID = '298AE775850879ECED4A2FB5E26772AE'| 
EXTRACTHESID = '119128C8727AC13F29524E415C738F1D'| 
EXTRACTHESID = '2355B86D02546F2C27C310C70C764047'| 
EXTRACTHESID = '1A82E27310B54A1E0097BD73A4353860'| 
EXTRACTHESID = '2FB302F8C5E0CF5492140B2FBC8F9047'| 
EXTRACTHESID = '1AC9BC082795F490C5826762272AA985'| 
EXTRACTHESID = '06AECB4B9D9505988A071BCAC4179E2B'| 
EXTRACTHESID = '218A5FFADAA44B2197EFEA66DA5D3CD6'| 
EXTRACTHESID = '164515677986EB07DB8B1B309CD44CC9'| 
EXTRACTHESID = '0A40E0ECEBDCEA6F4D2A05C76FD6EDAF'| 
EXTRACTHESID = '26ABA7C9BF12839EDCB62D092A5F59D2'| 
EXTRACTHESID = '274005D27F4652BFD4B95F7E0D9287C3'| 
EXTRACTHESID = '0B65D94596A4091F88251D9FC48A7139'| 
EXTRACTHESID = '1676F3DC6E221205A56325D476B09CC4'| 
EXTRACTHESID = '1904A1405E7D458D935E5820D7A810EB'| 
EXTRACTHESID = '1F89B87C7A63E410FD27C295E94F2D20'| 
EXTRACTHESID = '05E0B9FDDEA1856907C9F3CD8E8FA035'| 
EXTRACTHESID = '363E1298A485625628D4FDB304F9E64F'| 
EXTRACTHESID = '16EE05E7A98951BF596CDF6BAE717C91'| 
EXTRACTHESID = '2BAF296EB2F8FD832B0D9BA69AC99319'| 
EXTRACTHESID = '2AF0262A5D98CA470F04F93ED35A8E82'| 
EXTRACTHESID = '17F8D1CB5B52B5E3F002BFBDA0C1712C'| 
EXTRACTHESID = '2C517C2CC3E90E39A71A58CD1B66D04D'| 
EXTRACTHESID = '0DCD6EA61E8A9F70A9E24CDF44CFBB87'| 
EXTRACTHESID = '21432F79650FEE3C5412C36F92E6ECA2'| 
EXTRACTHESID = '25279D8AC802714B00A6F148D807C818'| 
EXTRACTHESID = '12A9CD0026A07F51BF068BFCA2595840'| 
EXTRACTHESID = '0D94C25173784412DB2E72428D4AFF25'| 
EXTRACTHESID = '1540B093DDDFE4876F4154ED70CC5669'| 
EXTRACTHESID = '235FC3332A56E0A2CD938062E33A33E4'| 
EXTRACTHESID = '2F616CA89D38FD4A000DD70F1EA40A07'| 
EXTRACTHESID = '08235D34E68C3B5273E96DB723058EC9'| 
EXTRACTHESID = '1CF796A3599AF5636EA9E606A9F97082'| 
EXTRACTHESID = '3508EAEB42EF43EAC093553CB1D95664'| 
EXTRACTHESID = '2D60DAF195129696CA0BCFAF9B661191'| 
EXTRACTHESID = '10AC2D67784E86ED41B913BC55EBCAF0'| 
EXTRACTHESID = '132BADA97BD3F9BE4906DEDDB8E7F5D8'| 
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EXTRACTHESID = '216E32BD8CBFD7A301D241C237BB82F5'| 
EXTRACTHESID = '1BB2D3EF40F19D8ED476764DB7FE8C4E'| 
EXTRACTHESID = '32FA34123C03A490D2C809BF210C7742'| 
EXTRACTHESID = '06C9D05F31DF31B907FA7599F945E429'| 
EXTRACTHESID = 
'13F141E3DDB753F3E72C49F7F7FA0005')HESIDPRESENTNE
W = 1. 
EXECUTE.  
 
 
ERCP Syntax 4 – Admission method type 
This syntax was used to update a new variable called ADMISSMETHTYPE that defines how 
the patient was admitted to hospital for the spell. First of all, the syntax creates a variable 
called ADMISSMETHTYPE and sets to 0; it then updates this variable dependant on what 
code is present in ADMIMETH.  If ADMIMETH is equal to 11, 12, 13 then it is an ELECTIVE 
spell and ADMISSMETHTYPE is then updated to code 1.  If ADMIMETH is equal to 21, 22, 23, 
24, 28 then it is an EMERGENCY spell and ADMISSMETHTYPE is then updated to code 4. A 
new variable is now created called ADMMETHTYPE which will take the Admission type and 
the Patient Classification field which looks how the patient was managed into account.  The 
syntax commands if ADMIMETHTYPE is equal to 1 and CLASS PAT is equal to 1 then update 
ADMMETHTYPE to 1, this means that this is an ELECTIVE ORDINARY admission. The syntax 
commands if ADMIMETHTYPE is equal to 81 then update ADMMETHTYPE to 1; this means 
that this is an ELECTIVE ORDINARY admission. The syntax commands if ADMIMETHTYPE is 
equal to 1 and CLASS PAT is equal to 2 then update ADMMETHTYPE to 2; this means that 
this is an ELECTIVE DAYCASE admission. The syntax commands if ADMIMETHTYPE is equal 
to 1 and CLASS PAT is equal to 3 and 4 then update ADMMETHTYPE to 3; this means that 
this is an ELECTIVE REGULAR ATTENDER admission. The syntax commands if 
ADMIMETHTYPE is equal to 4 then update ADMMETHTYPE to 4; this means that this is an 
EMERGENCY admission.    
ADMISSMETHTYPE field was then deleted from dataset after this syntax was run as no 
longer required for analysis and ADMISSMETHTYPE retained. 
 
 
COMPUTE ADMISSMETHTYPE = 0. 
EXECUTE. 
IF (ADMIMETH = 11| 
ADMIMETH = 12| 
ADMIMETH = 13)ADMISSMETHTYPE = 1. 
EXECUTE. 
IF (ADMIMETH = 21| 
ADMIMETH = 22| 
ADMIMETH = 23| 
ADMIMETH = 24| 
ADMIMETH = 28)ADMISSMETHTYPE = 4. 
EXECUTE. 
 
COMPUTE ADMMETHTYPE = 0. 
EXECUTE. 
IF (ADMISSMETHTYPE= 1 & 
CLASSPAT = 1) ADMMETHTYPE = 1. 
EXECUTE. 
IF (ADMIMETH = 81)ADMMETHTYPE = 1. 
EXECUTE. 
IF (ADMISSMETHTYPE= 1 & 
CLASSPAT = 2) ADMMETHTYPE = 2. 
EXECUTE. 
IF (ADMISSMETHTYPE= 1 & 
CLASSPAT = 3) ADMMETHTYPE = 3. 
EXECUTE. 
IF (ADMISSMETHTYPE= 1 & 
CLASSPAT = 4) ADMMETHTYPE = 3. 
EXECUTE. 
IF (ADMISSMETHTYPE= 4) ADMMETHTYPE = 4. 
EXECUTE. 
260 
 
ERCP Syntax 5 – ERCP occurring before admission date 
COMPUTE ERCPDATEB4ADMDATE = 0. 
EXECUTE. 
IF (ERCPDATE1 < ADMIDATE2)ERCPDATEB4ADMDATE = 1. 
EXECUTE. 
 
 
ERCP Syntax 6 – Dataset month of ERCP 
COMPUTE MOE = 0. 
EXECUTE. 
IF (MONTHOFERCP = 4)MOE = 1. 
EXECUTE. 
IF (MONTHOFERCP = 5)MOE = 2. 
EXECUTE. 
IF (MONTHOFERCP = 6)MOE = 3. 
EXECUTE. 
IF (MONTHOFERCP = 7)MOE = 4. 
EXECUTE. 
IF (MONTHOFERCP = 8)MOE = 5. 
EXECUTE. 
IF (MONTHOFERCP = 9)MOE = 6. 
EXECUTE.
 
IF (MONTHOFERCP = 10)MOE = 7. 
EXECUTE. 
IF (MONTHOFERCP = 11)MOE = 8. 
EXECUTE. 
IF (MONTHOFERCP = 12)MOE = 9. 
EXECUTE. 
IF (MONTHOFERCP = 1)MOE = 10. 
EXECUTE. 
IF (MONTHOFERCP = 2)MOE = 11. 
EXECUTE. 
IF (MONTHOFERCP = 3)MOE = 12. 
EXECUTE. 
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ERCP Syntax 7 – Assign 2 year dataset month  
COMPUTE MONTHNUM = 0. 
EXECUTE. 
IF (MONTHOFERCP = 1 & DATAYEAR = 200607)MONTHNUM = 1. 
EXECUTE. 
IF (MONTHOFERCP = 2 & DATAYEAR = 200607)MONTHNUM = 2. 
EXECUTE. 
IF (MONTHOFERCP = 3 & DATAYEAR = 200607)MONTHNUM = 3. 
EXECUTE. 
IF (MONTHOFERCP = 4 & DATAYEAR = 200607)MONTHNUM = 4. 
EXECUTE. 
IF (MONTHOFERCP = 5 & DATAYEAR = 200607)MONTHNUM = 5. 
EXECUTE. 
IF (MONTHOFERCP = 6 & DATAYEAR = 200607)MONTHNUM = 6. 
EXECUTE. 
IF (MONTHOFERCP = 7 & DATAYEAR = 200607)MONTHNUM = 7. 
EXECUTE. 
IF (MONTHOFERCP = 8 & DATAYEAR = 200607)MONTHNUM = 8. 
EXECUTE. 
IF (MONTHOFERCP = 9 & DATAYEAR = 200607)MONTHNUM = 9. 
EXECUTE. 
IF (MONTHOFERCP = 10 & DATAYEAR = 200607)MONTHNUM = 10. 
EXECUTE. 
IF (MONTHOFERCP = 11 & DATAYEAR = 200607)MONTHNUM = 11. 
EXECUTE. 
IF (MONTHOFERCP = 12 & DATAYEAR = 200607)MONTHNUM = 12. 
EXECUTE. 
IF (MONTHOFERCP = 1 & DATAYEAR = 200708)MONTHNUM = 13. 
EXECUTE. 
IF (MONTHOFERCP = 2 & DATAYEAR = 200708)MONTHNUM = 14. 
EXECUTE. 
IF (MONTHOFERCP = 3 & DATAYEAR = 200708)MONTHNUM = 15. 
EXECUTE. 
IF (MONTHOFERCP = 4 & DATAYEAR = 200708)MONTHNUM = 16. 
EXECUTE. 
IF (MONTHOFERCP = 5 & DATAYEAR = 200708)MONTHNUM = 17. 
EXECUTE. 
IF (MONTHOFERCP = 6 & DATAYEAR = 200708)MONTHNUM = 18. 
EXECUTE. 
IF (MONTHOFERCP = 7 & DATAYEAR = 200708)MONTHNUM = 19. 
EXECUTE. 
IF (MONTHOFERCP = 8 & DATAYEAR = 200708)MONTHNUM = 20. 
EXECUTE. 
IF (MONTHOFERCP = 9 & DATAYEAR = 200708)MONTHNUM = 21. 
EXECUTE. 
IF (MONTHOFERCP = 10 & DATAYEAR = 200708)MONTHNUM = 22. 
EXECUTE. 
IF (MONTHOFERCP = 11 & DATAYEAR = 200708)MONTHNUM = 23. 
EXECUTE. 
IF (MONTHOFERCP = 12 & DATAYEAR = 200708)MONTHNUM = 24. 
EXECUTE. 
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ERCP Syntax 8 – Speciality type 
COMPUTE SPECIALTYTYPE = 0. 
EXECUTE. 
IF (MAINSPEF = 300| 
MAINSPEF = 301| 
MAINSPEF = 302| 
MAINSPEF = 303| 
MAINSPEF = 305| 
MAINSPEF = 313| 
MAINSPEF = 314| 
MAINSPEF = 315| 
MAINSPEF = 320| 
MAINSPEF = 330| 
MAINSPEF = 340| 
MAINSPEF = 350| 
MAINSPEF = 352| 
MAINSPEF = 360| 
MAINSPEF = 361| 
MAINSPEF = 370| 
MAINSPEF = 400| 
MAINSPEF = 410| 
MAINSPEF = 430| 
MAINSPEF = 823)SPECIALTYTYPE = 2. 
EXECUTE. 
 
 
 
 
 
 
 
 
IF (MAINSPEF = 100| 
MAINSPEF = 101| 
MAINSPEF = 110| 
MAINSPEF = 120| 
MAINSPEF = 130| 
MAINSPEF = 140| 
MAINSPEF = 145| 
MAINSPEF = 150| 
MAINSPEF = 160| 
MAINSPEF = 170| 
MAINSPEF = 180| 
MAINSPEF = 190| 
MAINSPEF = 192)SPECIALTYTYPE = 1. 
EXECUTE. 
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ERCP Syntax 9 – Age bands  
COMPUTE AGEBAND = 0. 
EXECUTE. 
IF (ENDAGE < 21) AGEBAND = 16. 
EXECUTE. 
IF (ENDAGE < 26 & ENDAGE >20) AGEBAND = 
21. 
EXECUTE. 
IF (ENDAGE < 31 & ENDAGE >25) AGEBAND = 
26. 
EXECUTE. 
IF (ENDAGE < 36 & ENDAGE >30) AGEBAND = 
31. 
EXECUTE. 
IF (ENDAGE < 41 & ENDAGE >35) AGEBAND = 
36. 
EXECUTE. 
IF (ENDAGE < 46 & ENDAGE >40) AGEBAND = 
41. 
EXECUTE. 
IF (ENDAGE < 51 & ENDAGE >45) AGEBAND = 
46. 
EXECUTE. 
IF (ENDAGE < 56 & ENDAGE >50) AGEBAND = 
51. 
EXECUTE. 
IF (ENDAGE < 61 & ENDAGE >55) AGEBAND = 
56. 
EXECUTE. 
IF (ENDAGE < 66 & ENDAGE >60) AGEBAND = 
61. 
EXECUTE. 
IF (ENDAGE < 71 & ENDAGE >65) AGEBAND = 
66. 
EXECUTE. 
IF (ENDAGE < 76 & ENDAGE >70) AGEBAND = 
71. 
EXECUTE. 
IF (ENDAGE < 81 & ENDAGE >75) AGEBAND = 
76. 
EXECUTE. 
IF (ENDAGE < 86 & ENDAGE >80) AGEBAND = 
81. 
EXECUTE. 
IF (ENDAGE > 85) AGEBAND = 86. 
EXECUTE. 
ERCP Syntax 10 – Age groups 
COMPUTE AGEGROUP = 0. 
EXECUTE. 
IF (ENDAGE < 55) AGEGROUP = 1. 
EXECUTE. 
IF (ENDAGE > 54 & ENDAGE < 65) AGEGROUP = 2. 
EXECUTE. 
IF (ENDAGE > 64 & ENDAGE <75) AGEGROUP = 3. 
EXECUTE. 
IF (ENDAGE >74 & ENDAGE <85) AGEGROUP = 4. 
EXECUTE. 
IF (ENDAGE >84) AGEGROUP = 5. 
EXECUTE. 
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ERCP Syntax 11 – Death marker 
COMPUTE DEATHMARKERALL = 0. 
EXECUTE. 
IF (DIEDCATEGORY > 0)DEATHMARKERALL = 1. 
EXECUTE. 
 
ERCP Syntax 12 – Died in hospital 
COMPUTE DIEDINHOSPITAL = 0. 
EXECUTE. 
IF (DISMETH = 4)DIEDINHOSPITAL = 1. 
EXECUTE. 
 
ERCP Syntax 13 – Death categories  
(Alive, death within 7 days, death within 8 to 30 days, death beyond 30 days)  
COMPUTE DIEDCATEGORY = 0. 
EXECUTE. 
IF (DODMINUSERCPDATE > 30)DIEDCATEGORY = 3. 
EXECUTE. 
IF (DODMINUSERCPDATE > 7 & DODMINUSERCPDATE < 31)DIEDCATEGORY = 2. 
EXECUTE. 
IF (DODMINUSERCPDATE < 8)DIEDCATEGORY = 1. 
EXECUTE. 
 
ERCP Syntax 14 – Mortality markers (7 and 30 day) 
COMPUTE DEATH7 = 0. 
EXECUTE. 
IF (DODMINUSERCPDATE1 < 8)DEATH7 = 1. 
EXECUTE. 
COMPUTE DEATH30 = 0. 
EXECUTE. 
IF (DODMINUSERCPDATE1 < 31)DEATH30 = 1. 
EXECUTE. 
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ERCP Syntax 15 – Comorbidity  
COMPUTE ALLCOMORB1 = 
0. 
EXECUTE. 
IF (DIAG01 = 'C000'| 
DIAG01 = 'C001'| 
DIAG01 = 'C002'| 
DIAG01 = 'C003'| 
DIAG01 = 'C004'| 
DIAG01 = 'C005'| 
DIAG01 = 'C006'| 
DIAG01 = 'C008'| 
DIAG01 = 'C009'| 
DIAG01 = 'C01X'| 
DIAG01 = 'C020'| 
DIAG01 = 'C021'| 
DIAG01 = 'C022'| 
DIAG01 = 'C023'| 
DIAG01 = 'C024'| 
DIAG01 = 'C028'| 
DIAG01 = 'C029'| 
DIAG01 = 'C030'| 
DIAG01 = 'C031'| 
DIAG01 = 'C039'| 
DIAG01 = 'C040'| 
DIAG01 = 'C041'| 
DIAG01 = 'C048'| 
DIAG01 = 'C049'| 
DIAG01 = 'C050'| 
DIAG01 = 'C051'| 
DIAG01 = 'C052'| 
DIAG01 = 'C058'| 
DIAG01 = 'C059'| 
DIAG01 = 'C060'| 
DIAG01 = 'C061'| 
DIAG01 = 'C062'| 
DIAG01 = 'C068'| 
DIAG01 = 'C069'| 
DIAG01 = 'C07X'| 
DIAG01 = 'C080'| 
DIAG01 = 'C081'| 
DIAG01 = 'C088'| 
DIAG01 = 'C089'| 
DIAG01 = 'C090'| 
DIAG01 = 'C091'| 
DIAG01 = 'C098'| 
DIAG01 = 'C099'| 
DIAG01 = 'C100'| 
DIAG01 = 'C101'| 
DIAG01 = 'C102'| 
DIAG01 = 'C103'| 
DIAG01 = 'C104'| 
DIAG01 = 'C108'| 
DIAG01 = 'C109'| 
DIAG01 = 'C110'| 
DIAG01 = 'C111'| 
DIAG01 = 'C112'| 
DIAG01 = 'C113'| 
DIAG01 = 'C118'| 
DIAG01 = 'C119'| 
DIAG01 = 'C12X'| 
DIAG01 = 'C130'| 
DIAG01 = 'C131'| 
DIAG01 = 'C132'| 
DIAG01 = 'C138'| 
DIAG01 = 'C139'| 
DIAG01 = 'C140'| 
DIAG01 = 'C142'| 
DIAG01 = 'C148'| 
DIAG01 = 'C150'| 
DIAG01 = 'C151'| 
DIAG01 = 'C152'| 
DIAG01 = 'C153'| 
DIAG01 = 'C154'| 
DIAG01 = 'C155'| 
DIAG01 = 'C158'| 
DIAG01 = 'C159'| 
DIAG01 = 'C160'| 
DIAG01 = 'C161'| 
DIAG01 = 'C162'| 
DIAG01 = 'C163'| 
DIAG01 = 'C164'| 
DIAG01 = 'C165'| 
DIAG01 = 'C166'| 
DIAG01 = 'C168'| 
DIAG01 = 'C169'| 
DIAG01 = 'C170'| 
DIAG01 = 'C171'| 
DIAG01 = 'C172'| 
DIAG01 = 'C173'| 
DIAG01 = 'C178'| 
DIAG01 = 'C179'| 
DIAG01 = 'C180'| 
DIAG01 = 'C181'| 
DIAG01 = 'C182'| 
DIAG01 = 'C183'| 
DIAG01 = 'C184'| 
DIAG01 = 'C185'| 
DIAG01 = 'C186'| 
DIAG01 = 'C187'| 
DIAG01 = 'C188'| 
DIAG01 = 'C189'| 
DIAG01 = 'C19X'| 
DIAG01 = 'C20X'| 
DIAG01 = 'C210'| 
DIAG01 = 'C211'| 
DIAG01 = 'C212'| 
DIAG01 = 'C218'| 
DIAG01 = 'C220'| 
DIAG01 = 'C221'| 
DIAG01 = 'C222'| 
DIAG01 = 'C223'| 
DIAG01 = 'C224'| 
DIAG01 = 'C227'| 
DIAG01 = 'C229'| 
DIAG01 = 'C23X'| 
DIAG01 = 'C240'| 
DIAG01 = 'C241'| 
DIAG01 = 'C248'| 
DIAG01 = 'C249'| 
DIAG01 = 'C250'| 
DIAG01 = 'C251'| 
DIAG01 = 'C252'| 
DIAG01 = 'C253'| 
DIAG01 = 'C254'| 
DIAG01 = 'C257'| 
DIAG01 = 'C258'| 
DIAG01 = 'C259'| 
DIAG01 = 'C260'| 
DIAG01 = 'C261'| 
DIAG01 = 'C268'| 
DIAG01 = 'C269'| 
DIAG01 = 'C300'| 
DIAG01 = 'C301'| 
DIAG01 = 'C310'| 
DIAG01 = 'C311'| 
DIAG01 = 'C312'| 
DIAG01 = 'C313'| 
DIAG01 = 'C318'| 
DIAG01 = 'C319'| 
DIAG01 = 'C320'| 
DIAG01 = 'C321'| 
DIAG01 = 'C322'| 
DIAG01 = 'C323'| 
DIAG01 = 'C328'| 
DIAG01 = 'C329'| 
DIAG01 = 'C33X'| 
DIAG01 = 'C340'| 
DIAG01 = 'C341'| 
DIAG01 = 'C342'| 
DIAG01 = 'C343'| 
DIAG01 = 'C348'| 
DIAG01 = 'C349'| 
DIAG01 = 'C37X'| 
DIAG01 = 'C380'| 
DIAG01 = 'C381'| 
DIAG01 = 'C382'| 
DIAG01 = 'C383'| 
DIAG01 = 'C384'| 
DIAG01 = 'C388'| 
DIAG01 = 'C390'| 
DIAG01 = 'C398'| 
DIAG01 = 'C399'| 
DIAG01 = 'C400'| 
DIAG01 = 'C401'| 
DIAG01 = 'C402'| 
DIAG01 = 'C403'| 
DIAG01 = 'C408'| 
DIAG01 = 'C409'| 
DIAG01 = 'C410'| 
DIAG01 = 'C411'| 
DIAG01 = 'C412'| 
DIAG01 = 'C413'| 
DIAG01 = 'C414'| 
DIAG01 = 'C418'| 
DIAG01 = 'C419'| 
DIAG01 = 'C430'| 
DIAG01 = 'C431'| 
DIAG01 = 'C432'| 
DIAG01 = 'C433'| 
DIAG01 = 'C434'| 
DIAG01 = 'C435'| 
DIAG01 = 'C436'| 
DIAG01 = 'C437'| 
DIAG01 = 'C438'| 
DIAG01 = 'C439'| 
DIAG01 = 'C450'| 
DIAG01 = 'C451'| 
DIAG01 = 'C452'| 
DIAG01 = 'C457'| 
DIAG01 = 'C459'| 
DIAG01 = 'C460'| 
DIAG01 = 'C461'| 
DIAG01 = 'C462'| 
DIAG01 = 'C463'| 
DIAG01 = 'C467'| 
DIAG01 = 'C468'| 
DIAG01 = 'C469'| 
DIAG01 = 'C470'| 
DIAG01 = 'C471'| 
DIAG01 = 'C472'| 
DIAG01 = 'C473'| 
DIAG01 = 'C474'| 
DIAG01 = 'C475'| 
DIAG01 = 'C476'| 
DIAG01 = 'C478'| 
DIAG01 = 'C479'| 
DIAG01 = 'C480'| 
DIAG01 = 'C481'| 
DIAG01 = 'C482'| 
DIAG01 = 'C488'| 
DIAG01 = 'C490'| 
DIAG01 = 'C491'| 
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DIAG01 = 'C492'| 
DIAG01 = 'C493'| 
DIAG01 = 'C494'| 
DIAG01 = 'C495'| 
DIAG01 = 'C496'| 
DIAG01 = 'C498'| 
DIAG01 = 'C499'| 
DIAG01 = 'C500'| 
DIAG01 = 'C501'| 
DIAG01 = 'C502'| 
DIAG01 = 'C503'| 
DIAG01 = 'C504'| 
DIAG01 = 'C505'| 
DIAG01 = 'C506'| 
DIAG01 = 'C508'| 
DIAG01 = 'C509'| 
DIAG01 = 'C510'| 
DIAG01 = 'C511'| 
DIAG01 = 'C512'| 
DIAG01 = 'C518'| 
DIAG01 = 'C519'| 
DIAG01 = 'C52X'| 
DIAG01 = 'C530'| 
DIAG01 = 'C531'| 
DIAG01 = 'C538'| 
DIAG01 = 'C539'| 
DIAG01 = 'C540'| 
DIAG01 = 'C541'| 
DIAG01 = 'C542'| 
DIAG01 = 'C543'| 
DIAG01 = 'C548'| 
DIAG01 = 'C549'| 
DIAG01 = 'C55X'| 
DIAG01 = 'C56X'| 
DIAG01 = 'C570'| 
DIAG01 = 'C571'| 
DIAG01 = 'C572'| 
DIAG01 = 'C573'| 
DIAG01 = 'C574'| 
DIAG01 = 'C577'| 
DIAG01 = 'C578'| 
DIAG01 = 'C579'| 
DIAG01 = 'C58X'| 
DIAG01 = 'C600'| 
DIAG01 = 'C601'| 
DIAG01 = 'C602'| 
DIAG01 = 'C608'| 
DIAG01 = 'C609'| 
DIAG01 = 'C61X'| 
DIAG01 = 'C620'| 
DIAG01 = 'C621'| 
DIAG01 = 'C629'| 
DIAG01 = 'C630'| 
DIAG01 = 'C631'| 
DIAG01 = 'C632'| 
DIAG01 = 'C637'| 
DIAG01 = 'C638'| 
DIAG01 = 'C639'| 
DIAG01 = 'C64X'| 
DIAG01 = 'C65X'| 
DIAG01 = 'C66X'| 
DIAG01 = 'C670'| 
DIAG01 = 'C671'| 
DIAG01 = 'C672'| 
DIAG01 = 'C673'| 
DIAG01 = 'C674'| 
DIAG01 = 'C675'| 
DIAG01 = 'C676'| 
DIAG01 = 'C677'| 
DIAG01 = 'C678'| 
DIAG01 = 'C679'| 
DIAG01 = 'C680'| 
DIAG01 = 'C681'| 
DIAG01 = 'C688'| 
DIAG01 = 'C689'| 
DIAG01 = 'C690'| 
DIAG01 = 'C691'| 
DIAG01 = 'C692'| 
DIAG01 = 'C693'| 
DIAG01 = 'C694'| 
DIAG01 = 'C695'| 
DIAG01 = 'C696'| 
DIAG01 = 'C698'| 
DIAG01 = 'C699'| 
DIAG01 = 'C700'| 
DIAG01 = 'C701'| 
DIAG01 = 'C709'| 
DIAG01 = 'C710'| 
DIAG01 = 'C711'| 
DIAG01 = 'C712'| 
DIAG01 = 'C713'| 
DIAG01 = 'C714'| 
DIAG01 = 'C715'| 
DIAG01 = 'C716'| 
DIAG01 = 'C717'| 
DIAG01 = 'C718'| 
DIAG01 = 'C719'| 
DIAG01 = 'C720'| 
DIAG01 = 'C721'| 
DIAG01 = 'C722'| 
DIAG01 = 'C723'| 
DIAG01 = 'C724'| 
DIAG01 = 'C725'| 
DIAG01 = 'C728'| 
DIAG01 = 'C729'| 
DIAG01 = 'C73X'| 
DIAG01 = 'C740'| 
DIAG01 = 'C741'| 
DIAG01 = 'C749'| 
DIAG01 = 'C750'| 
DIAG01 = 'C751'| 
DIAG01 = 'C752'| 
DIAG01 = 'C753'| 
DIAG01 = 'C754'| 
DIAG01 = 'C755'| 
DIAG01 = 'C758'| 
DIAG01 = 'C759'| 
DIAG01 = 'C760'| 
DIAG01 = 'C761'| 
DIAG01 = 'C762'| 
DIAG01 = 'C763'| 
DIAG01 = 'C764'| 
DIAG01 = 'C765'| 
DIAG01 = 'C767'| 
DIAG01 = 'C768'| 
DIAG01 = 'C770'| 
DIAG01 = 'C771'| 
DIAG01 = 'C772'| 
DIAG01 = 'C773'| 
DIAG01 = 'C774'| 
DIAG01 = 'C775'| 
DIAG01 = 'C778'| 
DIAG01 = 'C779'| 
DIAG01 = 'C780'| 
DIAG01 = 'C781'| 
DIAG01 = 'C782'| 
DIAG01 = 'C783'| 
DIAG01 = 'C784'| 
DIAG01 = 'C785'| 
DIAG01 = 'C786'| 
DIAG01 = 'C787'| 
DIAG01 = 'C788'| 
DIAG01 = 'C790'| 
DIAG01 = 'C791'| 
DIAG01 = 'C792'| 
DIAG01 = 'C793'| 
DIAG01 = 'C794'| 
DIAG01 = 'C795'| 
DIAG01 = 'C796'| 
DIAG01 = 'C797'| 
DIAG01 = 'C798'| 
DIAG01 = 'C80X'| 
DIAG01 = 'C810'| 
DIAG01 = 'C811'| 
DIAG01 = 'C812'| 
DIAG01 = 'C813'| 
DIAG01 = 'C817'| 
DIAG01 = 'C819'| 
DIAG01 = 'C820'| 
DIAG01 = 'C821'| 
DIAG01 = 'C822'| 
DIAG01 = 'C827'| 
DIAG01 = 'C829'| 
DIAG01 = 'C830'| 
DIAG01 = 'C831'| 
DIAG01 = 'C832'| 
DIAG01 = 'C833'| 
DIAG01 = 'C834'| 
DIAG01 = 'C835'| 
DIAG01 = 'C836'| 
DIAG01 = 'C837'| 
DIAG01 = 'C838'| 
DIAG01 = 'C839'| 
DIAG01 = 'C840'| 
DIAG01 = 'C841'| 
DIAG01 = 'C842'| 
DIAG01 = 'C843'| 
DIAG01 = 'C844'| 
DIAG01 = 'C845'| 
DIAG01 = 'C850'| 
DIAG01 = 'C851'| 
DIAG01 = 'C857'| 
DIAG01 = 'C859'| 
DIAG01 = 'C883'| 
DIAG01 = 'C887'| 
DIAG01 = 'C889'| 
DIAG01 = 'C900'| 
DIAG01 = 'C901'| 
DIAG01 = 'C902'| 
DIAG01 = 'C910'| 
DIAG01 = 'C911'| 
DIAG01 = 'C912'| 
DIAG01 = 'C913'| 
DIAG01 = 'C914'| 
DIAG01 = 'C915'| 
DIAG01 = 'C917'| 
DIAG01 = 'C919'| 
DIAG01 = 'C920'| 
DIAG01 = 'C921'| 
DIAG01 = 'C922'| 
DIAG01 = 'C923'| 
DIAG01 = 'C924'| 
DIAG01 = 'C925'| 
DIAG01 = 'C927'| 
DIAG01 = 'C929'| 
DIAG01 = 'C930'| 
DIAG01 = 'C931'| 
DIAG01 = 'C932'| 
DIAG01 = 'C937'| 
DIAG01 = 'C939'| 
DIAG01 = 'C940'| 
DIAG01 = 'C941'| 
DIAG01 = 'C942'| 
DIAG01 = 'C943'| 
DIAG01 = 'C947'| 
DIAG01 = 'C950'| 
DIAG01 = 'C951'| 
DIAG01 = 'C952'| 
DIAG01 = 'C957'| 
DIAG01 = 'C959'| 
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DIAG01 = 'C960'| 
DIAG01 = 'C961'| 
DIAG01 = 'C962'| 
DIAG01 = 'C963'| 
DIAG01 = 'C967'| 
DIAG01 = 'C969'| 
DIAG01 = 'C97X'| 
DIAG01 = 'I210'| 
DIAG01 = 'I211'| 
DIAG01 = 'I212'| 
DIAG01 = 'I213'| 
DIAG01 = 'I214'| 
DIAG01 = 'I219'| 
DIAG01 = 'I220'| 
DIAG01 = 'I221'| 
DIAG01 = 'I228'| 
DIAG01 = 'I229'| 
DIAG01 = 'I252'| 
DIAG01 = 'I500'| 
DIAG01 = 'I710'| 
DIAG01 = 'I711'| 
DIAG01 = 'I712'| 
DIAG01 = 'I713'| 
DIAG01 = 'I714'| 
DIAG01 = 'I715'| 
DIAG01 = 'I716'| 
DIAG01 = 'I718'| 
DIAG01 = 'I719'| 
DIAG01 = 'I738'| 
DIAG01 = 'I739'| 
DIAG01 = 'I600'| 
DIAG01 = 'I601'| 
DIAG01 = 'I602'| 
DIAG01 = 'I603'| 
DIAG01 = 'I604'| 
DIAG01 = 'I605'| 
DIAG01 = 'I606'| 
DIAG01 = 'I607'| 
DIAG01 = 'I608'| 
DIAG01 = 'I609'| 
DIAG01 = 'I610'| 
DIAG01 = 'I611'| 
DIAG01 = 'I612'| 
DIAG01 = 'I613'| 
DIAG01 = 'I614'| 
DIAG01 = 'I615'| 
DIAG01 = 'I616'| 
DIAG01 = 'I618'| 
DIAG01 = 'I619'| 
DIAG01 = 'I620'| 
DIAG01 = 'I621'| 
DIAG01 = 'I629'| 
DIAG01 = 'I630'| 
DIAG01 = 'I631'| 
DIAG01 = 'I632'| 
DIAG01 = 'I633'| 
DIAG01 = 'I634'| 
DIAG01 = 'I635'| 
DIAG01 = 'I636'| 
DIAG01 = 'I638'| 
DIAG01 = 'I639'| 
DIAG01 = 'I64X'| 
DIAG01 = 'I650'| 
DIAG01 = 'I651'| 
DIAG01 = 'I652'| 
DIAG01 = 'I653'| 
DIAG01 = 'I658'| 
DIAG01 = 'I659'| 
DIAG01 = 'I660'| 
DIAG01 = 'I661'| 
DIAG01 = 'I662'| 
DIAG01 = 'I663'| 
DIAG01 = 'I664'| 
DIAG01 = 'I668'| 
DIAG01 = 'I669'| 
DIAG01 = 'I670'| 
DIAG01 = 'I671'| 
DIAG01 = 'I672'| 
DIAG01 = 'I673'| 
DIAG01 = 'I674'| 
DIAG01 = 'I675'| 
DIAG01 = 'I676'| 
DIAG01 = 'I677'| 
DIAG01 = 'I678'| 
DIAG01 = 'I679'| 
DIAG01 = 'I680'| 
DIAG01 = 'I681'| 
DIAG01 = 'I682'| 
DIAG01 = 'I688'| 
DIAG01 = 'I690'| 
DIAG01 = 'I691'| 
DIAG01 = 'I692'| 
DIAG01 = 'I693'| 
DIAG01 = 'I694'| 
DIAG01 = 'I698'| 
DIAG01 = 'F000'| 
DIAG01 = 'F001'| 
DIAG01 = 'F002'| 
DIAG01 = 'F009'| 
DIAG01 = 'F010'| 
DIAG01 = 'F011'| 
DIAG01 = 'F012'| 
DIAG01 = 'F013'| 
DIAG01 = 'F018'| 
DIAG01 = 'F019'| 
DIAG01 = 'F020'| 
DIAG01 = 'F021'| 
DIAG01 = 'F022'| 
DIAG01 = 'F023'| 
DIAG01 = 'F024'| 
DIAG01 = 'F028'| 
DIAG01 = 'F03X'| 
DIAG01 = 'F051'| 
DIAG01 = 'J40X'| 
DIAG01 = 'J410'| 
DIAG01 = 'J411'| 
DIAG01 = 'J418'| 
DIAG01 = 'J42X'| 
DIAG01 = 'J430'| 
DIAG01 = 'J431'| 
DIAG01 = 'J432'| 
DIAG01 = 'J438'| 
DIAG01 = 'J439'| 
DIAG01 = 'J440'| 
DIAG01 = 'J441'| 
DIAG01 = 'J448'| 
DIAG01 = 'J449'| 
DIAG01 = 'J450'| 
DIAG01 = 'J451'| 
DIAG01 = 'J458'| 
DIAG01 = 'J459'| 
DIAG01 = 'J46X'| 
DIAG01 = 'J47X'| 
DIAG01 = 'J60X'| 
DIAG01 = 'J61X'| 
DIAG01 = 'J620'| 
DIAG01 = 'J628'| 
DIAG01 = 'J630'| 
DIAG01 = 'J631'| 
DIAG01 = 'J632'| 
DIAG01 = 'J633'| 
DIAG01 = 'J634'| 
DIAG01 = 'J635'| 
DIAG01 = 'J638'| 
DIAG01 = 'J64X'| 
DIAG01 = 'J65X'| 
DIAG01 = 'J660'| 
DIAG01 = 'J661'| 
DIAG01 = 'J662'| 
DIAG01 = 'J668'| 
DIAG01 = 'J670'| 
DIAG01 = 'J671'| 
DIAG01 = 'J672'| 
DIAG01 = 'J673'| 
DIAG01 = 'J674'| 
DIAG01 = 'J675'| 
DIAG01 = 'J676'| 
DIAG01 = 'J677'| 
DIAG01 = 'J678'| 
DIAG01 = 'J679'| 
DIAG01 = 'M050'| 
DIAG01 = 'M051'| 
DIAG01 = 'M052'| 
DIAG01 = 'M059'| 
DIAG01 = 'M060'| 
DIAG01 = 'M063'| 
DIAG01 = 'M069'| 
DIAG01 = 'M300'| 
DIAG01 = 'M301'| 
DIAG01 = 'M302'| 
DIAG01 = 'M303'| 
DIAG01 = 'M308'| 
DIAG01 = 'M310'| 
DIAG01 = 'M311'| 
DIAG01 = 'M312'| 
DIAG01 = 'M313'| 
DIAG01 = 'M314'| 
DIAG01 = 'M315'| 
DIAG01 = 'M316'| 
DIAG01 = 'M318'| 
DIAG01 = 'M319'| 
DIAG01 = 'M320'| 
DIAG01 = 'M321'| 
DIAG01 = 'M328'| 
DIAG01 = 'M329'| 
DIAG01 = 'M332'| 
DIAG01 = 'M339'| 
DIAG01 = 'M340'| 
DIAG01 = 'M341'| 
DIAG01 = 'M342'| 
DIAG01 = 'M348'| 
DIAG01 = 'M349'| 
DIAG01 = 'M350'| 
DIAG01 = 'M351'| 
DIAG01 = 'M352'| 
DIAG01 = 'M353'| 
DIAG01 = 'M354'| 
DIAG01 = 'M355'| 
DIAG01 = 'M356'| 
DIAG01 = 'M357'| 
DIAG01 = 'K250'| 
DIAG01 = 'K251'| 
DIAG01 = 'K252'| 
DIAG01 = 'K253'| 
DIAG01 = 'K254'| 
DIAG01 = 'K255'| 
DIAG01 = 'K256'| 
DIAG01 = 'K257'| 
DIAG01 = 'K259'| 
DIAG01 = 'K260'| 
DIAG01 = 'K261'| 
DIAG01 = 'K262'| 
DIAG01 = 'K263'| 
DIAG01 = 'K264'| 
DIAG01 = 'K265'| 
DIAG01 = 'K266'| 
DIAG01 = 'K267'| 
DIAG01 = 'K269'| 
DIAG01 = 'K270'| 
DIAG01 = 'K271'| 
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DIAG01 = 'K272'| 
DIAG01 = 'K273'| 
DIAG01 = 'K274'| 
DIAG01 = 'K275'| 
DIAG01 = 'K276'| 
DIAG01 = 'K277'| 
DIAG01 = 'K279'| 
DIAG01 = 'K280'| 
DIAG01 = 'K281'| 
DIAG01 = 'K282'| 
DIAG01 = 'K283'| 
DIAG01 = 'K284'| 
DIAG01 = 'K285'| 
DIAG01 = 'K286'| 
DIAG01 = 'K287'| 
DIAG01 = 'K289'| 
DIAG01 = 'K701'| 
DIAG01 = 'K702'| 
DIAG01 = 'K703'| 
DIAG01 = 'K704'| 
DIAG01 = 'K709'| 
DIAG01 = 'K710'| 
DIAG01 = 'K711'| 
DIAG01 = 'K712'| 
DIAG01 = 'K713'| 
DIAG01 = 'K714'| 
DIAG01 = 'K715'| 
DIAG01 = 'K716'| 
DIAG01 = 'K717'| 
DIAG01 = 'K718'| 
DIAG01 = 'K719'| 
DIAG01 = 'K721'| 
DIAG01 = 'K729'| 
DIAG01 = 'K730'| 
DIAG01 = 'K731'| 
DIAG01 = 'K732'| 
DIAG01 = 'K738'| 
DIAG01 = 'K739'| 
DIAG01 = 'K740'| 
DIAG01 = 'K741'| 
DIAG01 = 'K742'| 
DIAG01 = 'K743'| 
DIAG01 = 'K744'| 
DIAG01 = 'K745'| 
DIAG01 = 'K746'| 
DIAG01 = 'K753'| 
DIAG01 = 'K754'| 
DIAG01 = 'K758'| 
DIAG01 = 'K764'| 
DIAG01 = 'K765'| 
DIAG01 = 'K766'| 
DIAG01 = 'K767'| 
DIAG01 = 'K768'| 
DIAG01 = 'E102'| 
DIAG01 = 'E103'| 
DIAG01 = 'E104'| 
DIAG01 = 'E105'| 
DIAG01 = 'E106'| 
DIAG01 = 'E107'| 
DIAG01 = 'E108'| 
DIAG01 = 'E109'| 
DIAG01 = 'E112'| 
DIAG01 = 'E113'| 
DIAG01 = 'E114'| 
DIAG01 = 'E115'| 
DIAG01 = 'E116'| 
DIAG01 = 'E117'| 
DIAG01 = 'E118'| 
DIAG01 = 'E119'| 
DIAG01 = 'E132'| 
DIAG01 = 'E133'| 
DIAG01 = 'E134'| 
DIAG01 = 'E135'| 
DIAG01 = 'E136'| 
DIAG01 = 'E137'| 
DIAG01 = 'E138'| 
DIAG01 = 'E139'| 
DIAG01 = 'E142'| 
DIAG01 = 'E143'| 
DIAG01 = 'E144'| 
DIAG01 = 'E145'| 
DIAG01 = 'E146'| 
DIAG01 = 'E147'| 
DIAG01 = 'E148'| 
DIAG01 = 'E149'| 
DIAG01 = 'G810'| 
DIAG01 = 'G811'| 
DIAG01 = 'G819'| 
DIAG01 = 'G820'| 
DIAG01 = 'G821'| 
DIAG01 = 'G822'| 
DIAG01 = 'N001'| 
DIAG01 = 'N002'| 
DIAG01 = 'N003'| 
DIAG01 = 'N004'| 
DIAG01 = 'N005'| 
DIAG01 = 'N007'| 
DIAG01 = 'N010'| 
DIAG01 = 'N011'| 
DIAG01 = 'N012'| 
DIAG01 = 'N013'| 
DIAG01 = 'N014'| 
DIAG01 = 'N015'| 
DIAG01 = 'N016'| 
DIAG01 = 'N017'| 
DIAG01 = 'N018'| 
DIAG01 = 'N019'| 
DIAG01 = 'N020'| 
DIAG01 = 'N021'| 
DIAG01 = 'N022'| 
DIAG01 = 'N023'| 
DIAG01 = 'N024'| 
DIAG01 = 'N025'| 
DIAG01 = 'N026'| 
DIAG01 = 'N027'| 
DIAG01 = 'N030'| 
DIAG01 = 'N031'| 
DIAG01 = 'N032'| 
DIAG01 = 'N033'| 
DIAG01 = 'N034'| 
DIAG01 = 'N035'| 
DIAG01 = 'N036'| 
DIAG01 = 'N037'| 
DIAG01 = 'N038'| 
DIAG01 = 'N039'| 
DIAG01 = 'N040'| 
DIAG01 = 'N041'| 
DIAG01 = 'N042'| 
DIAG01 = 'N043'| 
DIAG01 = 'N044'| 
DIAG01 = 'N045'| 
DIAG01 = 'N046'| 
DIAG01 = 'N047'| 
DIAG01 = 'N048'| 
DIAG01 = 'N049'| 
DIAG01 = 'N050'| 
DIAG01 = 'N051'| 
DIAG01 = 'N052'| 
DIAG01 = 'N053'| 
DIAG01 = 'N054'| 
DIAG01 = 'N055'| 
DIAG01 = 'N056'| 
DIAG01 = 'N057'| 
DIAG01 = 'N071'| 
DIAG01 = 'N072'| 
DIAG01 = 'N073'| 
DIAG01 = 'N074'| 
DIAG01 = 'N075'| 
DIAG01 = 'N180'| 
DIAG01 = 'N188'| 
DIAG01 = 'N189'| 
DIAG01 = 'N19X'| 
DIAG01 = 'N250'| 
DIAG01 = 'Z992'| 
DIAG01 = 'B200'| 
DIAG01 = 'B201'| 
DIAG01 = 'B202'| 
DIAG01 = 'B203'| 
DIAG01 = 'B204'| 
DIAG01 = 'B205'| 
DIAG01 = 'B206'| 
DIAG01 = 'B207'| 
DIAG01 = 'B208'| 
DIAG01 = 'B209'| 
DIAG01 = 'B210'| 
DIAG01 = 'B211'| 
DIAG01 = 'B212'| 
DIAG01 = 'B213'| 
DIAG01 = 'B217'| 
DIAG01 = 'B218'| 
DIAG01 = 'B219'| 
DIAG01 = 'B220'| 
DIAG01 = 'B221'| 
DIAG01 = 'B222'| 
DIAG01 = 'B227'| 
DIAG01 = 'B230'| 
DIAG01 = 'B231'| 
DIAG01 = 'B232'| 
DIAG01 = 'B238'| 
DIAG01 = 
'B24X')ALLCOMORB1 = 1. 
EXECUTE. 
 
COMPUTE ALLCOMORB2 = 
0. 
EXECUTE. 
IF (DIAG02 = 'C000'| 
DIAG02 = 'C001'| 
DIAG02 = 'C002'| 
DIAG02 = 'C003'| 
DIAG02 = 'C004'| 
DIAG02 = 'C005'| 
DIAG02 = 'C006'| 
DIAG02 = 'C008'| 
DIAG02 = 'C009'| 
DIAG02 = 'C01X'| 
DIAG02 = 'C020'| 
DIAG02 = 'C021'| 
DIAG02 = 'C022'| 
DIAG02 = 'C023'| 
DIAG02 = 'C024'| 
DIAG02 = 'C028'| 
DIAG02 = 'C029'| 
DIAG02 = 'C030'| 
DIAG02 = 'C031'| 
DIAG02 = 'C039'| 
DIAG02 = 'C040'| 
DIAG02 = 'C041'| 
DIAG02 = 'C048'| 
DIAG02 = 'C049'| 
DIAG02 = 'C050'| 
DIAG02 = 'C051'| 
DIAG02 = 'C052'| 
DIAG02 = 'C058'| 
DIAG02 = 'C059'| 
DIAG02 = 'C060'| 
DIAG02 = 'C061'| 
DIAG02 = 'C062'| 
DIAG02 = 'C068'| 
DIAG02 = 'C069'| 
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DIAG02 = 'C07X'| 
DIAG02 = 'C080'| 
DIAG02 = 'C081'| 
DIAG02 = 'C088'| 
DIAG02 = 'C089'| 
DIAG02 = 'C090'| 
DIAG02 = 'C091'| 
DIAG02 = 'C098'| 
DIAG02 = 'C099'| 
DIAG02 = 'C100'| 
DIAG02 = 'C101'| 
DIAG02 = 'C102'| 
DIAG02 = 'C103'| 
DIAG02 = 'C104'| 
DIAG02 = 'C108'| 
DIAG02 = 'C109'| 
DIAG02 = 'C110'| 
DIAG02 = 'C111'| 
DIAG02 = 'C112'| 
DIAG02 = 'C113'| 
DIAG02 = 'C118'| 
DIAG02 = 'C119'| 
DIAG02 = 'C12X'| 
DIAG02 = 'C130'| 
DIAG02 = 'C131'| 
DIAG02 = 'C132'| 
DIAG02 = 'C138'| 
DIAG02 = 'C139'| 
DIAG02 = 'C140'| 
DIAG02 = 'C142'| 
DIAG02 = 'C148'| 
DIAG02 = 'C150'| 
DIAG02 = 'C151'| 
DIAG02 = 'C152'| 
DIAG02 = 'C153'| 
DIAG02 = 'C154'| 
DIAG02 = 'C155'| 
DIAG02 = 'C158'| 
DIAG02 = 'C159'| 
DIAG02 = 'C160'| 
DIAG02 = 'C161'| 
DIAG02 = 'C162'| 
DIAG02 = 'C163'| 
DIAG02 = 'C164'| 
DIAG02 = 'C165'| 
DIAG02 = 'C166'| 
DIAG02 = 'C168'| 
DIAG02 = 'C169'| 
DIAG02 = 'C170'| 
DIAG02 = 'C171'| 
DIAG02 = 'C172'| 
DIAG02 = 'C173'| 
DIAG02 = 'C178'| 
DIAG02 = 'C179'| 
DIAG02 = 'C180'| 
DIAG02 = 'C181'| 
DIAG02 = 'C182'| 
DIAG02 = 'C183'| 
DIAG02 = 'C184'| 
DIAG02 = 'C185'| 
DIAG02 = 'C186'| 
DIAG02 = 'C187'| 
DIAG02 = 'C188'| 
DIAG02 = 'C189'| 
DIAG02 = 'C19X'| 
DIAG02 = 'C20X'| 
DIAG02 = 'C210'| 
DIAG02 = 'C211'| 
DIAG02 = 'C212'| 
DIAG02 = 'C218'| 
DIAG02 = 'C220'| 
DIAG02 = 'C221'| 
DIAG02 = 'C222'| 
DIAG02 = 'C223'| 
DIAG02 = 'C224'| 
DIAG02 = 'C227'| 
DIAG02 = 'C229'| 
DIAG02 = 'C23X'| 
DIAG02 = 'C240'| 
DIAG02 = 'C241'| 
DIAG02 = 'C248'| 
DIAG02 = 'C249'| 
DIAG02 = 'C250'| 
DIAG02 = 'C251'| 
DIAG02 = 'C252'| 
DIAG02 = 'C253'| 
DIAG02 = 'C254'| 
DIAG02 = 'C257'| 
DIAG02 = 'C258'| 
DIAG02 = 'C259'| 
DIAG02 = 'C260'| 
DIAG02 = 'C261'| 
DIAG02 = 'C268'| 
DIAG02 = 'C269'| 
DIAG02 = 'C300'| 
DIAG02 = 'C301'| 
DIAG02 = 'C310'| 
DIAG02 = 'C311'| 
DIAG02 = 'C312'| 
DIAG02 = 'C313'| 
DIAG02 = 'C318'| 
DIAG02 = 'C319'| 
DIAG02 = 'C320'| 
DIAG02 = 'C321'| 
DIAG02 = 'C322'| 
DIAG02 = 'C323'| 
DIAG02 = 'C328'| 
DIAG02 = 'C329'| 
DIAG02 = 'C33X'| 
DIAG02 = 'C340'| 
DIAG02 = 'C341'| 
DIAG02 = 'C342'| 
DIAG02 = 'C343'| 
DIAG02 = 'C348'| 
DIAG02 = 'C349'| 
DIAG02 = 'C37X'| 
DIAG02 = 'C380'| 
DIAG02 = 'C381'| 
DIAG02 = 'C382'| 
DIAG02 = 'C383'| 
DIAG02 = 'C384'| 
DIAG02 = 'C388'| 
DIAG02 = 'C390'| 
DIAG02 = 'C398'| 
DIAG02 = 'C399'| 
DIAG02 = 'C400'| 
DIAG02 = 'C401'| 
DIAG02 = 'C402'| 
DIAG02 = 'C403'| 
DIAG02 = 'C408'| 
DIAG02 = 'C409'| 
DIAG02 = 'C410'| 
DIAG02 = 'C411'| 
DIAG02 = 'C412'| 
DIAG02 = 'C413'| 
DIAG02 = 'C414'| 
DIAG02 = 'C418'| 
DIAG02 = 'C419'| 
DIAG02 = 'C430'| 
DIAG02 = 'C431'| 
DIAG02 = 'C432'| 
DIAG02 = 'C433'| 
DIAG02 = 'C434'| 
DIAG02 = 'C435'| 
DIAG02 = 'C436'| 
DIAG02 = 'C437'| 
DIAG02 = 'C438'| 
DIAG02 = 'C439'| 
DIAG02 = 'C450'| 
DIAG02 = 'C451'| 
DIAG02 = 'C452'| 
DIAG02 = 'C457'| 
DIAG02 = 'C459'| 
DIAG02 = 'C460'| 
DIAG02 = 'C461'| 
DIAG02 = 'C462'| 
DIAG02 = 'C463'| 
DIAG02 = 'C467'| 
DIAG02 = 'C468'| 
DIAG02 = 'C469'| 
DIAG02 = 'C470'| 
DIAG02 = 'C471'| 
DIAG02 = 'C472'| 
DIAG02 = 'C473'| 
DIAG02 = 'C474'| 
DIAG02 = 'C475'| 
DIAG02 = 'C476'| 
DIAG02 = 'C478'| 
DIAG02 = 'C479'| 
DIAG02 = 'C480'| 
DIAG02 = 'C481'| 
DIAG02 = 'C482'| 
DIAG02 = 'C488'| 
DIAG02 = 'C490'| 
DIAG02 = 'C491'| 
DIAG02 = 'C492'| 
DIAG02 = 'C493'| 
DIAG02 = 'C494'| 
DIAG02 = 'C495'| 
DIAG02 = 'C496'| 
DIAG02 = 'C498'| 
DIAG02 = 'C499'| 
DIAG02 = 'C500'| 
DIAG02 = 'C501'| 
DIAG02 = 'C502'| 
DIAG02 = 'C503'| 
DIAG02 = 'C504'| 
DIAG02 = 'C505'| 
DIAG02 = 'C506'| 
DIAG02 = 'C508'| 
DIAG02 = 'C509'| 
DIAG02 = 'C510'| 
DIAG02 = 'C511'| 
DIAG02 = 'C512'| 
DIAG02 = 'C518'| 
DIAG02 = 'C519'| 
DIAG02 = 'C52X'| 
DIAG02 = 'C530'| 
DIAG02 = 'C531'| 
DIAG02 = 'C538'| 
DIAG02 = 'C539'| 
DIAG02 = 'C540'| 
DIAG02 = 'C541'| 
DIAG02 = 'C542'| 
DIAG02 = 'C543'| 
DIAG02 = 'C548'| 
DIAG02 = 'C549'| 
DIAG02 = 'C55X'| 
DIAG02 = 'C56X'| 
DIAG02 = 'C570'| 
DIAG02 = 'C571'| 
DIAG02 = 'C572'| 
DIAG02 = 'C573'| 
DIAG02 = 'C574'| 
DIAG02 = 'C577'| 
DIAG02 = 'C578'| 
DIAG02 = 'C579'| 
DIAG02 = 'C58X'| 
DIAG02 = 'C600'| 
DIAG02 = 'C601'| 
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DIAG02 = 'C602'| 
DIAG02 = 'C608'| 
DIAG02 = 'C609'| 
DIAG02 = 'C61X'| 
DIAG02 = 'C620'| 
DIAG02 = 'C621'| 
DIAG02 = 'C629'| 
DIAG02 = 'C630'| 
DIAG02 = 'C631'| 
DIAG02 = 'C632'| 
DIAG02 = 'C637'| 
DIAG02 = 'C638'| 
DIAG02 = 'C639'| 
DIAG02 = 'C64X'| 
DIAG02 = 'C65X'| 
DIAG02 = 'C66X'| 
DIAG02 = 'C670'| 
DIAG02 = 'C671'| 
DIAG02 = 'C672'| 
DIAG02 = 'C673'| 
DIAG02 = 'C674'| 
DIAG02 = 'C675'| 
DIAG02 = 'C676'| 
DIAG02 = 'C677'| 
DIAG02 = 'C678'| 
DIAG02 = 'C679'| 
DIAG02 = 'C680'| 
DIAG02 = 'C681'| 
DIAG02 = 'C688'| 
DIAG02 = 'C689'| 
DIAG02 = 'C690'| 
DIAG02 = 'C691'| 
DIAG02 = 'C692'| 
DIAG02 = 'C693'| 
DIAG02 = 'C694'| 
DIAG02 = 'C695'| 
DIAG02 = 'C696'| 
DIAG02 = 'C698'| 
DIAG02 = 'C699'| 
DIAG02 = 'C700'| 
DIAG02 = 'C701'| 
DIAG02 = 'C709'| 
DIAG02 = 'C710'| 
DIAG02 = 'C711'| 
DIAG02 = 'C712'| 
DIAG02 = 'C713'| 
DIAG02 = 'C714'| 
DIAG02 = 'C715'| 
DIAG02 = 'C716'| 
DIAG02 = 'C717'| 
DIAG02 = 'C718'| 
DIAG02 = 'C719'| 
DIAG02 = 'C720'| 
DIAG02 = 'C721'| 
DIAG02 = 'C722'| 
DIAG02 = 'C723'| 
DIAG02 = 'C724'| 
DIAG02 = 'C725'| 
DIAG02 = 'C728'| 
DIAG02 = 'C729'| 
DIAG02 = 'C73X'| 
DIAG02 = 'C740'| 
DIAG02 = 'C741'| 
DIAG02 = 'C749'| 
DIAG02 = 'C750'| 
DIAG02 = 'C751'| 
DIAG02 = 'C752'| 
DIAG02 = 'C753'| 
DIAG02 = 'C754'| 
DIAG02 = 'C755'| 
DIAG02 = 'C758'| 
DIAG02 = 'C759'| 
DIAG02 = 'C760'| 
DIAG02 = 'C761'| 
DIAG02 = 'C762'| 
DIAG02 = 'C763'| 
DIAG02 = 'C764'| 
DIAG02 = 'C765'| 
DIAG02 = 'C767'| 
DIAG02 = 'C768'| 
DIAG02 = 'C770'| 
DIAG02 = 'C771'| 
DIAG02 = 'C772'| 
DIAG02 = 'C773'| 
DIAG02 = 'C774'| 
DIAG02 = 'C775'| 
DIAG02 = 'C778'| 
DIAG02 = 'C779'| 
DIAG02 = 'C780'| 
DIAG02 = 'C781'| 
DIAG02 = 'C782'| 
DIAG02 = 'C783'| 
DIAG02 = 'C784'| 
DIAG02 = 'C785'| 
DIAG02 = 'C786'| 
DIAG02 = 'C787'| 
DIAG02 = 'C788'| 
DIAG02 = 'C790'| 
DIAG02 = 'C791'| 
DIAG02 = 'C792'| 
DIAG02 = 'C793'| 
DIAG02 = 'C794'| 
DIAG02 = 'C795'| 
DIAG02 = 'C796'| 
DIAG02 = 'C797'| 
DIAG02 = 'C798'| 
DIAG02 = 'C80X'| 
DIAG02 = 'C810'| 
DIAG02 = 'C811'| 
DIAG02 = 'C812'| 
DIAG02 = 'C813'| 
DIAG02 = 'C817'| 
DIAG02 = 'C819'| 
DIAG02 = 'C820'| 
DIAG02 = 'C821'| 
DIAG02 = 'C822'| 
DIAG02 = 'C827'| 
DIAG02 = 'C829'| 
DIAG02 = 'C830'| 
DIAG02 = 'C831'| 
DIAG02 = 'C832'| 
DIAG02 = 'C833'| 
DIAG02 = 'C834'| 
DIAG02 = 'C835'| 
DIAG02 = 'C836'| 
DIAG02 = 'C837'| 
DIAG02 = 'C838'| 
DIAG02 = 'C839'| 
DIAG02 = 'C840'| 
DIAG02 = 'C841'| 
DIAG02 = 'C842'| 
DIAG02 = 'C843'| 
DIAG02 = 'C844'| 
DIAG02 = 'C845'| 
DIAG02 = 'C850'| 
DIAG02 = 'C851'| 
DIAG02 = 'C857'| 
DIAG02 = 'C859'| 
DIAG02 = 'C883'| 
DIAG02 = 'C887'| 
DIAG02 = 'C889'| 
DIAG02 = 'C900'| 
DIAG02 = 'C901'| 
DIAG02 = 'C902'| 
DIAG02 = 'C910'| 
DIAG02 = 'C911'| 
DIAG02 = 'C912'| 
DIAG02 = 'C913'| 
DIAG02 = 'C914'| 
DIAG02 = 'C915'| 
DIAG02 = 'C917'| 
DIAG02 = 'C919'| 
DIAG02 = 'C920'| 
DIAG02 = 'C921'| 
DIAG02 = 'C922'| 
DIAG02 = 'C923'| 
DIAG02 = 'C924'| 
DIAG02 = 'C925'| 
DIAG02 = 'C927'| 
DIAG02 = 'C929'| 
DIAG02 = 'C930'| 
DIAG02 = 'C931'| 
DIAG02 = 'C932'| 
DIAG02 = 'C937'| 
DIAG02 = 'C939'| 
DIAG02 = 'C940'| 
DIAG02 = 'C941'| 
DIAG02 = 'C942'| 
DIAG02 = 'C943'| 
DIAG02 = 'C947'| 
DIAG02 = 'C950'| 
DIAG02 = 'C951'| 
DIAG02 = 'C952'| 
DIAG02 = 'C957'| 
DIAG02 = 'C959'| 
DIAG02 = 'C960'| 
DIAG02 = 'C961'| 
DIAG02 = 'C962'| 
DIAG02 = 'C963'| 
DIAG02 = 'C967'| 
DIAG02 = 'C969'| 
DIAG02 = 'C97X'| 
DIAG02 = 'I210'| 
DIAG02 = 'I211'| 
DIAG02 = 'I212'| 
DIAG02 = 'I213'| 
DIAG02 = 'I214'| 
DIAG02 = 'I219'| 
DIAG02 = 'I220'| 
DIAG02 = 'I221'| 
DIAG02 = 'I228'| 
DIAG02 = 'I229'| 
DIAG02 = 'I252'| 
DIAG02 = 'I500'| 
DIAG02 = 'I710'| 
DIAG02 = 'I711'| 
DIAG02 = 'I712'| 
DIAG02 = 'I713'| 
DIAG02 = 'I714'| 
DIAG02 = 'I715'| 
DIAG02 = 'I716'| 
DIAG02 = 'I718'| 
DIAG02 = 'I719'| 
DIAG02 = 'I738'| 
DIAG02 = 'I739'| 
DIAG02 = 'I600'| 
DIAG02 = 'I601'| 
DIAG02 = 'I602'| 
DIAG02 = 'I603'| 
DIAG02 = 'I604'| 
DIAG02 = 'I605'| 
DIAG02 = 'I606'| 
DIAG02 = 'I607'| 
DIAG02 = 'I608'| 
DIAG02 = 'I609'| 
DIAG02 = 'I610'| 
DIAG02 = 'I611'| 
DIAG02 = 'I612'| 
DIAG02 = 'I613'| 
DIAG02 = 'I614'| 
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DIAG02 = 'I615'| 
DIAG02 = 'I616'| 
DIAG02 = 'I618'| 
DIAG02 = 'I619'| 
DIAG02 = 'I620'| 
DIAG02 = 'I621'| 
DIAG02 = 'I629'| 
DIAG02 = 'I630'| 
DIAG02 = 'I631'| 
DIAG02 = 'I632'| 
DIAG02 = 'I633'| 
DIAG02 = 'I634'| 
DIAG02 = 'I635'| 
DIAG02 = 'I636'| 
DIAG02 = 'I638'| 
DIAG02 = 'I639'| 
DIAG02 = 'I64X'| 
DIAG02 = 'I650'| 
DIAG02 = 'I651'| 
DIAG02 = 'I652'| 
DIAG02 = 'I653'| 
DIAG02 = 'I658'| 
DIAG02 = 'I659'| 
DIAG02 = 'I660'| 
DIAG02 = 'I661'| 
DIAG02 = 'I662'| 
DIAG02 = 'I663'| 
DIAG02 = 'I664'| 
DIAG02 = 'I668'| 
DIAG02 = 'I669'| 
DIAG02 = 'I670'| 
DIAG02 = 'I671'| 
DIAG02 = 'I672'| 
DIAG02 = 'I673'| 
DIAG02 = 'I674'| 
DIAG02 = 'I675'| 
DIAG02 = 'I676'| 
DIAG02 = 'I677'| 
DIAG02 = 'I678'| 
DIAG02 = 'I679'| 
DIAG02 = 'I680'| 
DIAG02 = 'I681'| 
DIAG02 = 'I682'| 
DIAG02 = 'I688'| 
DIAG02 = 'I690'| 
DIAG02 = 'I691'| 
DIAG02 = 'I692'| 
DIAG02 = 'I693'| 
DIAG02 = 'I694'| 
DIAG02 = 'I698'| 
DIAG02 = 'F000'| 
DIAG02 = 'F001'| 
DIAG02 = 'F002'| 
DIAG02 = 'F009'| 
DIAG02 = 'F010'| 
DIAG02 = 'F011'| 
DIAG02 = 'F012'| 
DIAG02 = 'F013'| 
DIAG02 = 'F018'| 
DIAG02 = 'F019'| 
DIAG02 = 'F020'| 
DIAG02 = 'F021'| 
DIAG02 = 'F022'| 
DIAG02 = 'F023'| 
DIAG02 = 'F024'| 
DIAG02 = 'F028'| 
DIAG02 = 'F03X'| 
DIAG02 = 'F051'| 
DIAG02 = 'J40X'| 
DIAG02 = 'J410'| 
DIAG02 = 'J411'| 
DIAG02 = 'J418'| 
DIAG02 = 'J42X'| 
DIAG02 = 'J430'| 
DIAG02 = 'J431'| 
DIAG02 = 'J432'| 
DIAG02 = 'J438'| 
DIAG02 = 'J439'| 
DIAG02 = 'J440'| 
DIAG02 = 'J441'| 
DIAG02 = 'J448'| 
DIAG02 = 'J449'| 
DIAG02 = 'J450'| 
DIAG02 = 'J451'| 
DIAG02 = 'J458'| 
DIAG02 = 'J459'| 
DIAG02 = 'J46X'| 
DIAG02 = 'J47X'| 
DIAG02 = 'J60X'| 
DIAG02 = 'J61X'| 
DIAG02 = 'J620'| 
DIAG02 = 'J628'| 
DIAG02 = 'J630'| 
DIAG02 = 'J631'| 
DIAG02 = 'J632'| 
DIAG02 = 'J633'| 
DIAG02 = 'J634'| 
DIAG02 = 'J635'| 
DIAG02 = 'J638'| 
DIAG02 = 'J64X'| 
DIAG02 = 'J65X'| 
DIAG02 = 'J660'| 
DIAG02 = 'J661'| 
DIAG02 = 'J662'| 
DIAG02 = 'J668'| 
DIAG02 = 'J670'| 
DIAG02 = 'J671'| 
DIAG02 = 'J672'| 
DIAG02 = 'J673'| 
DIAG02 = 'J674'| 
DIAG02 = 'J675'| 
DIAG02 = 'J676'| 
DIAG02 = 'J677'| 
DIAG02 = 'J678'| 
DIAG02 = 'J679'| 
DIAG02 = 'M050'| 
DIAG02 = 'M051'| 
DIAG02 = 'M052'| 
DIAG02 = 'M059'| 
DIAG02 = 'M060'| 
DIAG02 = 'M063'| 
DIAG02 = 'M069'| 
DIAG02 = 'M300'| 
DIAG02 = 'M301'| 
DIAG02 = 'M302'| 
DIAG02 = 'M303'| 
DIAG02 = 'M308'| 
DIAG02 = 'M310'| 
DIAG02 = 'M311'| 
DIAG02 = 'M312'| 
DIAG02 = 'M313'| 
DIAG02 = 'M314'| 
DIAG02 = 'M315'| 
DIAG02 = 'M316'| 
DIAG02 = 'M318'| 
DIAG02 = 'M319'| 
DIAG02 = 'M320'| 
DIAG02 = 'M321'| 
DIAG02 = 'M328'| 
DIAG02 = 'M329'| 
DIAG02 = 'M332'| 
DIAG02 = 'M339'| 
DIAG02 = 'M340'| 
DIAG02 = 'M341'| 
DIAG02 = 'M342'| 
DIAG02 = 'M348'| 
DIAG02 = 'M349'| 
DIAG02 = 'M350'| 
DIAG02 = 'M351'| 
DIAG02 = 'M352'| 
DIAG02 = 'M353'| 
DIAG02 = 'M354'| 
DIAG02 = 'M355'| 
DIAG02 = 'M356'| 
DIAG02 = 'M357'| 
DIAG02 = 'K250'| 
DIAG02 = 'K251'| 
DIAG02 = 'K252'| 
DIAG02 = 'K253'| 
DIAG02 = 'K254'| 
DIAG02 = 'K255'| 
DIAG02 = 'K256'| 
DIAG02 = 'K257'| 
DIAG02 = 'K259'| 
DIAG02 = 'K260'| 
DIAG02 = 'K261'| 
DIAG02 = 'K262'| 
DIAG02 = 'K263'| 
DIAG02 = 'K264'| 
DIAG02 = 'K265'| 
DIAG02 = 'K266'| 
DIAG02 = 'K267'| 
DIAG02 = 'K269'| 
DIAG02 = 'K270'| 
DIAG02 = 'K271'| 
DIAG02 = 'K272'| 
DIAG02 = 'K273'| 
DIAG02 = 'K274'| 
DIAG02 = 'K275'| 
DIAG02 = 'K276'| 
DIAG02 = 'K277'| 
DIAG02 = 'K279'| 
DIAG02 = 'K280'| 
DIAG02 = 'K281'| 
DIAG02 = 'K282'| 
DIAG02 = 'K283'| 
DIAG02 = 'K284'| 
DIAG02 = 'K285'| 
DIAG02 = 'K286'| 
DIAG02 = 'K287'| 
DIAG02 = 'K289'| 
DIAG02 = 'K701'| 
DIAG02 = 'K702'| 
DIAG02 = 'K703'| 
DIAG02 = 'K704'| 
DIAG02 = 'K709'| 
DIAG02 = 'K710'| 
DIAG02 = 'K711'| 
DIAG02 = 'K712'| 
DIAG02 = 'K713'| 
DIAG02 = 'K714'| 
DIAG02 = 'K715'| 
DIAG02 = 'K716'| 
DIAG02 = 'K717'| 
DIAG02 = 'K718'| 
DIAG02 = 'K719'| 
DIAG02 = 'K721'| 
DIAG02 = 'K729'| 
DIAG02 = 'K730'| 
DIAG02 = 'K731'| 
DIAG02 = 'K732'| 
DIAG02 = 'K738'| 
DIAG02 = 'K739'| 
DIAG02 = 'K740'| 
DIAG02 = 'K741'| 
DIAG02 = 'K742'| 
DIAG02 = 'K743'| 
DIAG02 = 'K744'| 
DIAG02 = 'K745'| 
DIAG02 = 'K746'| 
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DIAG02 = 'K753'| 
DIAG02 = 'K754'| 
DIAG02 = 'K758'| 
DIAG02 = 'K764'| 
DIAG02 = 'K765'| 
DIAG02 = 'K766'| 
DIAG02 = 'K767'| 
DIAG02 = 'K768'| 
DIAG02 = 'E102'| 
DIAG02 = 'E103'| 
DIAG02 = 'E104'| 
DIAG02 = 'E105'| 
DIAG02 = 'E106'| 
DIAG02 = 'E107'| 
DIAG02 = 'E108'| 
DIAG02 = 'E109'| 
DIAG02 = 'E112'| 
DIAG02 = 'E113'| 
DIAG02 = 'E114'| 
DIAG02 = 'E115'| 
DIAG02 = 'E116'| 
DIAG02 = 'E117'| 
DIAG02 = 'E118'| 
DIAG02 = 'E119'| 
DIAG02 = 'E132'| 
DIAG02 = 'E133'| 
DIAG02 = 'E134'| 
DIAG02 = 'E135'| 
DIAG02 = 'E136'| 
DIAG02 = 'E137'| 
DIAG02 = 'E138'| 
DIAG02 = 'E139'| 
DIAG02 = 'E142'| 
DIAG02 = 'E143'| 
DIAG02 = 'E144'| 
DIAG02 = 'E145'| 
DIAG02 = 'E146'| 
DIAG02 = 'E147'| 
DIAG02 = 'E148'| 
DIAG02 = 'E149'| 
DIAG02 = 'G810'| 
DIAG02 = 'G811'| 
DIAG02 = 'G819'| 
DIAG02 = 'G820'| 
DIAG02 = 'G821'| 
DIAG02 = 'G822'| 
DIAG02 = 'N001'| 
DIAG02 = 'N002'| 
DIAG02 = 'N003'| 
DIAG02 = 'N004'| 
DIAG02 = 'N005'| 
DIAG02 = 'N007'| 
DIAG02 = 'N010'| 
DIAG02 = 'N011'| 
DIAG02 = 'N012'| 
DIAG02 = 'N013'| 
DIAG02 = 'N014'| 
DIAG02 = 'N015'| 
DIAG02 = 'N016'| 
DIAG02 = 'N017'| 
DIAG02 = 'N018'| 
DIAG02 = 'N019'| 
DIAG02 = 'N020'| 
DIAG02 = 'N021'| 
DIAG02 = 'N022'| 
DIAG02 = 'N023'| 
DIAG02 = 'N024'| 
DIAG02 = 'N025'| 
DIAG02 = 'N026'| 
DIAG02 = 'N027'| 
DIAG02 = 'N030'| 
DIAG02 = 'N031'| 
DIAG02 = 'N032'| 
DIAG02 = 'N033'| 
DIAG02 = 'N034'| 
DIAG02 = 'N035'| 
DIAG02 = 'N036'| 
DIAG02 = 'N037'| 
DIAG02 = 'N038'| 
DIAG02 = 'N039'| 
DIAG02 = 'N040'| 
DIAG02 = 'N041'| 
DIAG02 = 'N042'| 
DIAG02 = 'N043'| 
DIAG02 = 'N044'| 
DIAG02 = 'N045'| 
DIAG02 = 'N046'| 
DIAG02 = 'N047'| 
DIAG02 = 'N048'| 
DIAG02 = 'N049'| 
DIAG02 = 'N050'| 
DIAG02 = 'N051'| 
DIAG02 = 'N052'| 
DIAG02 = 'N053'| 
DIAG02 = 'N054'| 
DIAG02 = 'N055'| 
DIAG02 = 'N056'| 
DIAG02 = 'N057'| 
DIAG02 = 'N071'| 
DIAG02 = 'N072'| 
DIAG02 = 'N073'| 
DIAG02 = 'N074'| 
DIAG02 = 'N075'| 
DIAG02 = 'N180'| 
DIAG02 = 'N188'| 
DIAG02 = 'N189'| 
DIAG02 = 'N19X'| 
DIAG02 = 'N250'| 
DIAG02 = 'Z992'| 
DIAG02 = 'B200'| 
DIAG02 = 'B201'| 
DIAG02 = 'B202'| 
DIAG02 = 'B203'| 
DIAG02 = 'B204'| 
DIAG02 = 'B205'| 
DIAG02 = 'B206'| 
DIAG02 = 'B207'| 
DIAG02 = 'B208'| 
DIAG02 = 'B209'| 
DIAG02 = 'B210'| 
DIAG02 = 'B211'| 
DIAG02 = 'B212'| 
DIAG02 = 'B213'| 
DIAG02 = 'B217'| 
DIAG02 = 'B218'| 
DIAG02 = 'B219'| 
DIAG02 = 'B220'| 
DIAG02 = 'B221'| 
DIAG02 = 'B222'| 
DIAG02 = 'B227'| 
DIAG02 = 'B230'| 
DIAG02 = 'B231'| 
DIAG02 = 'B232'| 
DIAG02 = 'B238'| 
DIAG02 = 
'B24X')ALLCOMORB2 = 1. 
EXECUTE. 
 
 
 
And then repeat for DIAG03 to DIAG17. 
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ERCP Syntax 16 – Cancer marker (Based on Dr Foster list)
COMPUTE CANCER1 = 0. 
EXECUTE. 
IF (DIAG01 = 'C000'| 
DIAG01 = 'C001'| 
DIAG01 = 'C002'| 
DIAG01 = 'C003'| 
DIAG01 = 'C004'| 
DIAG01 = 'C005'| 
DIAG01 = 'C006'| 
DIAG01 = 'C008'| 
DIAG01 = 'C009'| 
DIAG01 = 'C01X'| 
DIAG01 = 'C020'| 
DIAG01 = 'C021'| 
DIAG01 = 'C022'| 
DIAG01 = 'C023'| 
DIAG01 = 'C024'| 
DIAG01 = 'C028'| 
DIAG01 = 'C029'| 
DIAG01 = 'C030'| 
DIAG01 = 'C031'| 
DIAG01 = 'C039'| 
DIAG01 = 'C040'| 
DIAG01 = 'C041'| 
DIAG01 = 'C048'| 
DIAG01 = 'C049'| 
DIAG01 = 'C050'| 
DIAG01 = 'C051'| 
DIAG01 = 'C052'| 
DIAG01 = 'C058'| 
DIAG01 = 'C059'| 
DIAG01 = 'C060'| 
DIAG01 = 'C061'| 
DIAG01 = 'C062'| 
DIAG01 = 'C068'| 
DIAG01 = 'C069'| 
DIAG01 = 'C07X'| 
DIAG01 = 'C080'| 
DIAG01 = 'C081'| 
DIAG01 = 'C088'| 
DIAG01 = 'C089'| 
DIAG01 = 'C090'| 
DIAG01 = 'C091'| 
DIAG01 = 'C098'| 
DIAG01 = 'C099'| 
DIAG01 = 'C100'| 
DIAG01 = 'C101'| 
DIAG01 = 'C102'| 
DIAG01 = 'C103'| 
DIAG01 = 'C104'| 
DIAG01 = 'C108'| 
DIAG01 = 'C109'| 
DIAG01 = 'C110'| 
DIAG01 = 'C111'| 
DIAG01 = 'C112'| 
DIAG01 = 'C113'| 
DIAG01 = 'C118'| 
DIAG01 = 'C119'| 
DIAG01 = 'C12X'| 
DIAG01 = 'C130'| 
DIAG01 = 'C131'| 
DIAG01 = 'C132'| 
DIAG01 = 'C138'| 
DIAG01 = 'C139'| 
DIAG01 = 'C140'| 
DIAG01 = 'C142'| 
DIAG01 = 'C148'| 
DIAG01 = 'C150'| 
DIAG01 = 'C151'| 
DIAG01 = 'C152'| 
DIAG01 = 'C153'| 
DIAG01 = 'C154'| 
DIAG01 = 'C155'| 
DIAG01 = 'C158'| 
DIAG01 = 'C159'| 
DIAG01 = 'C160'| 
DIAG01 = 'C161'| 
DIAG01 = 'C162'| 
DIAG01 = 'C163'| 
DIAG01 = 'C164'| 
DIAG01 = 'C165'| 
DIAG01 = 'C166'| 
DIAG01 = 'C168'| 
DIAG01 = 'C169'| 
DIAG01 = 'C170'| 
DIAG01 = 'C171'| 
DIAG01 = 'C172'| 
DIAG01 = 'C173'| 
DIAG01 = 'C178'| 
DIAG01 = 'C179'| 
DIAG01 = 'C180'| 
DIAG01 = 'C181'| 
DIAG01 = 'C182'| 
DIAG01 = 'C183'| 
DIAG01 = 'C184'| 
DIAG01 = 'C185'| 
DIAG01 = 'C186'| 
DIAG01 = 'C187'| 
DIAG01 = 'C188'| 
DIAG01 = 'C189'| 
DIAG01 = 'C19X'| 
DIAG01 = 'C20X'| 
DIAG01 = 'C210'| 
DIAG01 = 'C211'| 
DIAG01 = 'C212'| 
DIAG01 = 'C218'| 
DIAG01 = 'C220'| 
DIAG01 = 'C221'| 
DIAG01 = 'C222'| 
DIAG01 = 'C223'| 
DIAG01 = 'C224'| 
DIAG01 = 'C227'| 
DIAG01 = 'C229'| 
DIAG01 = 'C23X'| 
DIAG01 = 'C240'| 
DIAG01 = 'C241'| 
DIAG01 = 'C248'| 
DIAG01 = 'C249'| 
DIAG01 = 'C250'| 
DIAG01 = 'C251'| 
DIAG01 = 'C252'| 
DIAG01 = 'C253'| 
DIAG01 = 'C254'| 
DIAG01 = 'C257'| 
DIAG01 = 'C258'| 
DIAG01 = 'C259'| 
DIAG01 = 'C260'| 
DIAG01 = 'C261'| 
DIAG01 = 'C268'| 
DIAG01 = 'C269'| 
DIAG01 = 'C300'| 
DIAG01 = 'C301'| 
DIAG01 = 'C310'| 
DIAG01 = 'C311'| 
DIAG01 = 'C312'| 
DIAG01 = 'C313'| 
DIAG01 = 'C318'| 
DIAG01 = 'C319'| 
DIAG01 = 'C320'| 
DIAG01 = 'C321'| 
DIAG01 = 'C322'| 
DIAG01 = 'C323'| 
DIAG01 = 'C328'| 
DIAG01 = 'C329'| 
DIAG01 = 'C33X'| 
DIAG01 = 'C340'| 
DIAG01 = 'C341'| 
DIAG01 = 'C342'| 
DIAG01 = 'C343'| 
DIAG01 = 'C348'| 
DIAG01 = 'C349'| 
DIAG01 = 'C37X'| 
DIAG01 = 'C380'| 
DIAG01 = 'C381'| 
DIAG01 = 'C382'| 
DIAG01 = 'C383'| 
DIAG01 = 'C384'| 
DIAG01 = 'C388'| 
DIAG01 = 'C390'| 
DIAG01 = 'C398'| 
DIAG01 = 'C399'| 
DIAG01 = 'C400'| 
DIAG01 = 'C401'| 
DIAG01 = 'C402'| 
DIAG01 = 'C403'| 
DIAG01 = 'C408'| 
DIAG01 = 'C409'| 
DIAG01 = 'C410'| 
DIAG01 = 'C411'| 
DIAG01 = 'C412'| 
DIAG01 = 'C413'| 
DIAG01 = 'C414'| 
DIAG01 = 'C418'| 
DIAG01 = 'C419'| 
DIAG01 = 'C430'| 
DIAG01 = 'C431'| 
DIAG01 = 'C432'| 
DIAG01 = 'C433'| 
DIAG01 = 'C434'| 
DIAG01 = 'C435'| 
DIAG01 = 'C436'| 
DIAG01 = 'C437'| 
DIAG01 = 'C438'| 
DIAG01 = 'C439'| 
DIAG01 = 'C450'| 
DIAG01 = 'C451'| 
DIAG01 = 'C452'| 
DIAG01 = 'C457'| 
DIAG01 = 'C459'| 
DIAG01 = 'C460'| 
DIAG01 = 'C461'| 
DIAG01 = 'C462'| 
DIAG01 = 'C463'| 
DIAG01 = 'C467'| 
DIAG01 = 'C468'| 
DIAG01 = 'C469'| 
DIAG01 = 'C470'| 
DIAG01 = 'C471'| 
DIAG01 = 'C472'| 
DIAG01 = 'C473'| 
DIAG01 = 'C474'| 
DIAG01 = 'C475'| 
DIAG01 = 'C476'| 
DIAG01 = 'C478'| 
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DIAG01 = 'C479'| 
DIAG01 = 'C480'| 
DIAG01 = 'C481'| 
DIAG01 = 'C482'| 
DIAG01 = 'C488'| 
DIAG01 = 'C490'| 
DIAG01 = 'C491'| 
DIAG01 = 'C492'| 
DIAG01 = 'C493'| 
DIAG01 = 'C494'| 
DIAG01 = 'C495'| 
DIAG01 = 'C496'| 
DIAG01 = 'C498'| 
DIAG01 = 'C499'| 
DIAG01 = 'C500'| 
DIAG01 = 'C501'| 
DIAG01 = 'C502'| 
DIAG01 = 'C503'| 
DIAG01 = 'C504'| 
DIAG01 = 'C505'| 
DIAG01 = 'C506'| 
DIAG01 = 'C508'| 
DIAG01 = 'C509'| 
DIAG01 = 'C510'| 
DIAG01 = 'C511'| 
DIAG01 = 'C512'| 
DIAG01 = 'C518'| 
DIAG01 = 'C519'| 
DIAG01 = 'C52X'| 
DIAG01 = 'C530'| 
DIAG01 = 'C531'| 
DIAG01 = 'C538'| 
DIAG01 = 'C539'| 
DIAG01 = 'C540'| 
DIAG01 = 'C541'| 
DIAG01 = 'C542'| 
DIAG01 = 'C543'| 
DIAG01 = 'C548'| 
DIAG01 = 'C549'| 
DIAG01 = 'C55X'| 
DIAG01 = 'C56X'| 
DIAG01 = 'C570'| 
DIAG01 = 'C571'| 
DIAG01 = 'C572'| 
DIAG01 = 'C573'| 
DIAG01 = 'C574'| 
DIAG01 = 'C577'| 
DIAG01 = 'C578'| 
DIAG01 = 'C579'| 
DIAG01 = 'C58X'| 
DIAG01 = 'C600'| 
DIAG01 = 'C601'| 
DIAG01 = 'C602'| 
DIAG01 = 'C608'| 
DIAG01 = 'C609'| 
DIAG01 = 'C61X'| 
DIAG01 = 'C620'| 
DIAG01 = 'C621'| 
DIAG01 = 'C629'| 
DIAG01 = 'C630'| 
DIAG01 = 'C631'| 
DIAG01 = 'C632'| 
DIAG01 = 'C637'| 
DIAG01 = 'C638'| 
DIAG01 = 'C639'| 
DIAG01 = 'C64X'| 
DIAG01 = 'C65X'| 
DIAG01 = 'C66X'| 
DIAG01 = 'C670'| 
DIAG01 = 'C671'| 
DIAG01 = 'C672'| 
DIAG01 = 'C673'| 
DIAG01 = 'C674'| 
DIAG01 = 'C675'| 
DIAG01 = 'C676'| 
DIAG01 = 'C677'| 
DIAG01 = 'C678'| 
DIAG01 = 'C679'| 
DIAG01 = 'C680'| 
DIAG01 = 'C681'| 
DIAG01 = 'C688'| 
DIAG01 = 'C689'| 
DIAG01 = 'C690'| 
DIAG01 = 'C691'| 
DIAG01 = 'C692'| 
DIAG01 = 'C693'| 
DIAG01 = 'C694'| 
DIAG01 = 'C695'| 
DIAG01 = 'C696'| 
DIAG01 = 'C698'| 
DIAG01 = 'C699'| 
DIAG01 = 'C700'| 
DIAG01 = 'C701'| 
DIAG01 = 'C709'| 
DIAG01 = 'C710'| 
DIAG01 = 'C711'| 
DIAG01 = 'C712'| 
DIAG01 = 'C713'| 
DIAG01 = 'C714'| 
DIAG01 = 'C715'| 
DIAG01 = 'C716'| 
DIAG01 = 'C717'| 
DIAG01 = 'C718'| 
DIAG01 = 'C719'| 
DIAG01 = 'C720'| 
DIAG01 = 'C721'| 
DIAG01 = 'C722'| 
DIAG01 = 'C723'| 
DIAG01 = 'C724'| 
DIAG01 = 'C725'| 
DIAG01 = 'C728'| 
DIAG01 = 'C729'| 
DIAG01 = 'C73X'| 
DIAG01 = 'C740'| 
DIAG01 = 'C741'| 
DIAG01 = 'C749'| 
DIAG01 = 'C750'| 
DIAG01 = 'C751'| 
DIAG01 = 'C752'| 
DIAG01 = 'C753'| 
DIAG01 = 'C754'| 
DIAG01 = 'C755'| 
DIAG01 = 'C758'| 
DIAG01 = 'C759'| 
DIAG01 = 'C760'| 
DIAG01 = 'C761'| 
DIAG01 = 'C762'| 
DIAG01 = 'C763'| 
DIAG01 = 'C764'| 
DIAG01 = 'C765'| 
DIAG01 = 'C767'| 
DIAG01 = 'C768'| 
DIAG01 = 'C770'| 
DIAG01 = 'C771'| 
DIAG01 = 'C772'| 
DIAG01 = 'C773'| 
DIAG01 = 'C774'| 
DIAG01 = 'C775'| 
DIAG01 = 'C778'| 
DIAG01 = 'C779'| 
DIAG01 = 'C780'| 
DIAG01 = 'C781'| 
DIAG01 = 'C782'| 
DIAG01 = 'C783'| 
DIAG01 = 'C784'| 
DIAG01 = 'C785'| 
DIAG01 = 'C786'| 
DIAG01 = 'C787'| 
DIAG01 = 'C788'| 
DIAG01 = 'C790'| 
DIAG01 = 'C791'| 
DIAG01 = 'C792'| 
DIAG01 = 'C793'| 
DIAG01 = 'C794'| 
DIAG01 = 'C795'| 
DIAG01 = 'C796'| 
DIAG01 = 'C797'| 
DIAG01 = 'C798'| 
DIAG01 = 'C80X'| 
DIAG01 = 'C810'| 
DIAG01 = 'C811'| 
DIAG01 = 'C812'| 
DIAG01 = 'C813'| 
DIAG01 = 'C817'| 
DIAG01 = 'C819'| 
DIAG01 = 'C820'| 
DIAG01 = 'C821'| 
DIAG01 = 'C822'| 
DIAG01 = 'C827'| 
DIAG01 = 'C829'| 
DIAG01 = 'C830'| 
DIAG01 = 'C831'| 
DIAG01 = 'C832'| 
DIAG01 = 'C833'| 
DIAG01 = 'C834'| 
DIAG01 = 'C835'| 
DIAG01 = 'C836'| 
DIAG01 = 'C837'| 
DIAG01 = 'C838'| 
DIAG01 = 'C839'| 
DIAG01 = 'C840'| 
DIAG01 = 'C841'| 
DIAG01 = 'C842'| 
DIAG01 = 'C843'| 
DIAG01 = 'C844'| 
DIAG01 = 'C845'| 
DIAG01 = 'C850'| 
DIAG01 = 'C851'| 
DIAG01 = 'C857'| 
DIAG01 = 'C859'| 
DIAG01 = 'C883'| 
DIAG01 = 'C887'| 
DIAG01 = 'C889'| 
DIAG01 = 'C900'| 
DIAG01 = 'C901'| 
DIAG01 = 'C902'| 
DIAG01 = 'C910'| 
DIAG01 = 'C911'| 
DIAG01 = 'C912'| 
DIAG01 = 'C913'| 
DIAG01 = 'C914'| 
DIAG01 = 'C915'| 
DIAG01 = 'C917'| 
DIAG01 = 'C919'| 
DIAG01 = 'C920'| 
DIAG01 = 'C921'| 
DIAG01 = 'C922'| 
DIAG01 = 'C923'| 
DIAG01 = 'C924'| 
DIAG01 = 'C925'| 
DIAG01 = 'C927'| 
DIAG01 = 'C929'| 
DIAG01 = 'C930'| 
DIAG01 = 'C931'| 
DIAG01 = 'C932'| 
DIAG01 = 'C937'| 
DIAG01 = 'C939'| 
DIAG01 = 'C940'| 
DIAG01 = 'C941'| 
DIAG01 = 'C942'| 
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DIAG01 = 'C943'| 
DIAG01 = 'C947'| 
DIAG01 = 'C950'| 
DIAG01 = 'C951'| 
DIAG01 = 'C952'| 
DIAG01 = 'C957'| 
DIAG01 = 'C959'| 
DIAG01 = 'C960'| 
DIAG01 = 'C961'| 
DIAG01 = 'C962'| 
DIAG01 = 'C963'| 
DIAG01 = 'C967'| 
DIAG01 = 'C969'| 
DIAG01 = 'C97X')CANCER1 
= 1. 
EXECUTE. 
 
COMPUTE CANCER2 = 0. 
EXECUTE. 
 
IF (DIAG02 = 
'C000'|DIAG02 = 
'C001'|DIAG02 = 
'C002'|DIAG02 = 
'C003'|DIAG02 = 
'C004'|DIAG02 = 
'C005'|DIAG02 = 
'C006'|DIAG02 = 
'C008'|DIAG02 = 
'C009'|DIAG02 = 
'C01X'|DIAG02 = 
'C020'|DIAG02 = 
'C021'|DIAG02 = 
'C022'|DIAG02 = 
'C023'|DIAG02 = 
'C024'|DIAG02 = 
'C028'|DIAG02 = 
'C029'|DIAG02 = 
'C030'|DIAG02 = 
'C031'|DIAG02 = 
'C039'|DIAG02 = 
'C040'|DIAG02 = 
'C041'|DIAG02 = 
'C048'|DIAG02 = 
'C049'|DIAG02 = 
'C050'|DIAG02 = 
'C051'|DIAG02 = 
'C052'|DIAG02 = 
'C058'|DIAG02 = 
'C059'|DIAG02 = 
'C060'|DIAG02 = 
'C061'|DIAG02 = 
'C062'|DIAG02 = 
'C068'|DIAG02 = 
'C069'|DIAG02 = 
'C07X'|DIAG02 = 
'C080'|DIAG02 = 
'C081'|DIAG02 = 
'C088'|DIAG02 = 
'C089'|DIAG02 = 
'C090'|DIAG02 = 
'C091'|DIAG02 = 
'C098'|DIAG02 = 
'C099'|DIAG02 = 
'C100'|DIAG02 = 
'C101'|DIAG02 = 
'C102'|DIAG02 = 
'C103'|DIAG02 = 
'C104'|DIAG02 = 
'C108'|DIAG02 = 
'C109'|DIAG02 = 
'C110'|DIAG02 = 
'C111'|DIAG02 = 
'C112'|DIAG02 = 
'C113'|DIAG02 = 
'C118'|DIAG02 = 
'C119'|DIAG02 = 
'C12X'|DIAG02 = 
'C130'|DIAG02 = 
'C131'|DIAG02 = 
'C132'|DIAG02 = 
'C138'|DIAG02 = 
'C139'|DIAG02 = 
'C140'|DIAG02 = 
'C142'|DIAG02 = 
'C148'|DIAG02 = 
'C150'|DIAG02 = 
'C151'|DIAG02 = 
'C152'|DIAG02 = 
'C153'|DIAG02 = 
'C154'|DIAG02 = 
'C155'|DIAG02 = 
'C158'|DIAG02 = 
'C159'|DIAG02 = 
'C160'|DIAG02 = 
'C161'|DIAG02 = 
'C162'|DIAG02 = 
'C163'|DIAG02 = 
'C164'|DIAG02 = 
'C165'|DIAG02 = 
'C166'|DIAG02 = 
'C168'|DIAG02 = 
'C169'|DIAG02 = 
'C170'|DIAG02 = 
'C171'|DIAG02 = 
'C172'|DIAG02 = 
'C173'|DIAG02 = 
'C178'|DIAG02 = 
'C179'|DIAG02 = 
'C180'|DIAG02 = 
'C181'|DIAG02 = 
'C182'|DIAG02 = 
'C183'|DIAG02 = 
'C184'|DIAG02 = 
'C185'|DIAG02 = 
'C186'|DIAG02 = 
'C187'|DIAG02 = 
'C188'|DIAG02 = 
'C189'|DIAG02 = 
'C19X'|DIAG02 = 
'C20X'|DIAG02 = 
'C210'|DIAG02 = 
'C211'|DIAG02 = 
'C212'|DIAG02 = 
'C218'|DIAG02 = 
'C220'|DIAG02 = 
'C221'|DIAG02 = 
'C222'|DIAG02 = 
'C223'|DIAG02 = 
'C224'|DIAG02 = 
'C227'|DIAG02 = 
'C229'|DIAG02 = 
'C23X'|DIAG02 = 
'C240'|DIAG02 = 
'C241'|DIAG02 = 
'C248'|DIAG02 = 
'C249'|DIAG02 = 
'C250'|DIAG02 = 
'C251'|DIAG02 = 
'C252'|DIAG02 = 
'C253'|DIAG02 = 
'C254'|DIAG02 = 
'C257'|DIAG02 = 
'C258'|DIAG02 = 
'C259'|DIAG02 = 
'C260'|DIAG02 = 
'C261'|DIAG02 = 
'C268'|DIAG02 = 
'C269'|DIAG02 = 
'C300'|DIAG02 = 
'C301'|DIAG02 = 
'C310'|DIAG02 = 
'C311'|DIAG02 = 
'C312'|DIAG02 = 
'C313'|DIAG02 = 
'C318'|DIAG02 = 
'C319'|DIAG02 = 
'C320'|DIAG02 = 
'C321'|DIAG02 = 
'C322'|DIAG02 = 
'C323'|DIAG02 = 
'C328'|DIAG02 = 
'C329'|DIAG02 = 
'C33X'|DIAG02 = 
'C340'|DIAG02 = 
'C341'|DIAG02 = 
'C342'|DIAG02 = 
'C343'|DIAG02 = 
'C348'|DIAG02 = 
'C349'|DIAG02 = 
'C37X'|DIAG02 = 
'C380'|DIAG02 = 
'C381'|DIAG02 = 
'C382'|DIAG02 = 
'C383'|DIAG02 = 
'C384'|DIAG02 = 
'C388'|DIAG02 = 
'C390'|DIAG02 = 
'C398'|DIAG02 = 
'C399'|DIAG02 = 
'C400'|DIAG02 = 
'C401'|DIAG02 = 
'C402'|DIAG02 = 
'C403'|DIAG02 = 
'C408'|DIAG02 = 
'C409'|DIAG02 = 
'C410'|DIAG02 = 
'C411'|DIAG02 = 
'C412'|DIAG02 = 
'C413'|DIAG02 = 
'C414'|DIAG02 = 
'C418'|DIAG02 = 
'C419'|DIAG02 = 
'C430'|DIAG02 = 
'C431'|DIAG02 = 
'C432'|DIAG02 = 
'C433'|DIAG02 = 
'C434'|DIAG02 = 
'C435'|DIAG02 = 
'C436'|DIAG02 = 
'C437'|DIAG02 = 
'C438'|DIAG02 = 
'C439'|DIAG02 = 
'C450'|DIAG02 = 
'C451'|DIAG02 = 
'C452'|DIAG02 = 
'C457'|DIAG02 = 
'C459'|DIAG02 = 
'C460'|DIAG02 = 
'C461'|DIAG02 = 
'C462'|DIAG02 = 
'C463'|DIAG02 = 
'C467'|DIAG02 = 
'C468'|DIAG02 = 
'C469'|DIAG02 = 
'C470'|DIAG02 = 
'C471'|DIAG02 = 
'C472'|DIAG02 = 
'C473'|DIAG02 = 
'C474'|DIAG02 = 
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'C475'|DIAG02 = 
'C476'|DIAG02 = 
'C478'|DIAG02 = 
'C479'|DIAG02 = 
'C480'|DIAG02 = 
'C481'|DIAG02 = 
'C482'|DIAG02 = 
'C488'|DIAG02 = 
'C490'|DIAG02 = 
'C491'|DIAG02 = 
'C492'|DIAG02 = 
'C493'|DIAG02 = 
'C494'|DIAG02 = 
'C495'|DIAG02 = 
'C496'|DIAG02 = 
'C498'|DIAG02 = 
'C499'|DIAG02 = 
'C500'|DIAG02 = 
'C501'|DIAG02 = 
'C502'|DIAG02 = 
'C503'|DIAG02 = 
'C504'|DIAG02 = 
'C505'|DIAG02 = 
'C506'|DIAG02 = 
'C508'|DIAG02 = 
'C509'|DIAG02 = 
'C510'|DIAG02 = 
'C511'|DIAG02 = 
'C512'|DIAG02 = 
'C518'|DIAG02 = 
'C519'|DIAG02 = 
'C52X'|DIAG02 = 
'C530'|DIAG02 = 
'C531'|DIAG02 = 
'C538'|DIAG02 = 
'C539'|DIAG02 = 
'C540'|DIAG02 = 
'C541'|DIAG02 = 
'C542'|DIAG02 = 
'C543'|DIAG02 = 
'C548'|DIAG02 = 
'C549'|DIAG02 = 
'C55X'|DIAG02 = 
'C56X'|DIAG02 = 
'C570'|DIAG02 = 
'C571'|DIAG02 = 
'C572'|DIAG02 = 
'C573'|DIAG02 = 
'C574'|DIAG02 = 
'C577'|DIAG02 = 
'C578'|DIAG02 = 
'C579'|DIAG02 = 
'C58X'|DIAG02 = 
'C600'|DIAG02 = 
'C601'|DIAG02 = 
'C602'|DIAG02 = 
'C608'|DIAG02 = 
'C609'|DIAG02 = 
'C61X'|DIAG02 = 
'C620'|DIAG02 = 
'C621'|DIAG02 = 
'C629'|DIAG02 = 
'C630'|DIAG02 = 
'C631'|DIAG02 = 
'C632'|DIAG02 = 
'C637'|DIAG02 = 
'C638'|DIAG02 = 
'C639'|DIAG02 = 
'C64X'|DIAG02 = 
'C65X'|DIAG02 = 
'C66X'|DIAG02 = 
'C670'|DIAG02 = 
'C671'|DIAG02 = 
'C672'|DIAG02 = 
'C673'|DIAG02 = 
'C674'|DIAG02 = 
'C675'|DIAG02 = 
'C676'|DIAG02 = 
'C677'|DIAG02 = 
'C678'|DIAG02 = 
'C679'|DIAG02 = 
'C680'|DIAG02 = 
'C681'|DIAG02 = 
'C688'|DIAG02 = 
'C689'|DIAG02 = 
'C690'|DIAG02 = 
'C691'|DIAG02 = 
'C692'|DIAG02 = 
'C693'|DIAG02 = 
'C694'|DIAG02 = 
'C695'|DIAG02 = 
'C696'|DIAG02 = 
'C698'|DIAG02 = 
'C699'|DIAG02 = 
'C700'|DIAG02 = 
'C701'|DIAG02 = 
'C709'|DIAG02 = 
'C710'|DIAG02 = 
'C711'|DIAG02 = 
'C712'|DIAG02 = 
'C713'|DIAG02 = 
'C714'|DIAG02 = 
'C715'|DIAG02 = 
'C716'|DIAG02 = 
'C717'|DIAG02 = 
'C718'|DIAG02 = 
'C719'|DIAG02 = 
'C720'|DIAG02 = 
'C721'|DIAG02 = 
'C722'|DIAG02 = 
'C723'|DIAG02 = 
'C724'|DIAG02 = 
'C725'|DIAG02 = 
'C728'|DIAG02 = 
'C729'|DIAG02 = 
'C73X'|DIAG02 = 
'C740'|DIAG02 = 
'C741'|DIAG02 = 
'C749'|DIAG02 = 
'C750'|DIAG02 = 
'C751'|DIAG02 = 
'C752'|DIAG02 = 
'C753'|DIAG02 = 
'C754'|DIAG02 = 
'C755'|DIAG02 = 
'C758'|DIAG02 = 
'C759'|DIAG02 = 
'C760'|DIAG02 = 
'C761'|DIAG02 = 
'C762'|DIAG02 = 
'C763'|DIAG02 = 
'C764'|DIAG02 = 
'C765'|DIAG02 = 
'C767'|DIAG02 = 
'C768'|DIAG02 = 
'C770'|DIAG02 = 
'C771'|DIAG02 = 
'C772'|DIAG02 = 
'C773'|DIAG02 = 
'C774'|DIAG02 = 
'C775'|DIAG02 = 
'C778'|DIAG02 = 
'C779'|DIAG02 = 
'C780'|DIAG02 = 
'C781'|DIAG02 = 
'C782'|DIAG02 = 
'C783'|DIAG02 = 
'C784'|DIAG02 = 
'C785'|DIAG02 = 
'C786'|DIAG02 = 
'C787'|DIAG02 = 
'C788'|DIAG02 = 
'C790'|DIAG02 = 
'C791'|DIAG02 = 
'C792'|DIAG02 = 
'C793'|DIAG02 = 
'C794'|DIAG02 = 
'C795'|DIAG02 = 
'C796'|DIAG02 = 
'C797'|DIAG02 = 
'C798'|DIAG02 = 
'C80X'|DIAG02 = 
'C810'|DIAG02 = 
'C811'|DIAG02 = 
'C812'|DIAG02 = 
'C813'|DIAG02 = 
'C817'|DIAG02 = 
'C819'|DIAG02 = 
'C820'|DIAG02 = 
'C821'|DIAG02 = 
'C822'|DIAG02 = 
'C827'|DIAG02 = 
'C829'|DIAG02 = 
'C830'|DIAG02 = 
'C831'|DIAG02 = 
'C832'|DIAG02 = 
'C833'|DIAG02 = 
'C834'|DIAG02 = 
'C835'|DIAG02 = 
'C836'|DIAG02 = 
'C837'|DIAG02 = 
'C838'|DIAG02 = 
'C839'|DIAG02 = 
'C840'|DIAG02 = 
'C841'|DIAG02 = 
'C842'|DIAG02 = 
'C843'|DIAG02 = 
'C844'|DIAG02 = 
'C845'|DIAG02 = 
'C850'|DIAG02 = 
'C851'|DIAG02 = 
'C857'|DIAG02 = 
'C859'|DIAG02 = 
'C883'|DIAG02 = 
'C887'|DIAG02 = 
'C889'|DIAG02 = 
'C900'|DIAG02 = 
'C901'|DIAG02 = 
'C902'|DIAG02 = 
'C910'|DIAG02 = 
'C911'|DIAG02 = 
'C912'|DIAG02 = 
'C913'|DIAG02 = 
'C914'|DIAG02 = 
'C915'|DIAG02 = 
'C917'|DIAG02 = 
'C919'|DIAG02 = 
'C920'|DIAG02 = 
'C921'|DIAG02 = 
'C922'|DIAG02 = 
'C923'|DIAG02 = 
'C924'|DIAG02 = 
'C925'|DIAG02 = 
'C927'|DIAG02 = 
'C929'|DIAG02 = 
'C930'|DIAG02 = 
'C931'|DIAG02 = 
'C932'|DIAG02 = 
'C937'|DIAG02 = 
'C939'|DIAG02 = 
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'C940'|DIAG02 = 
'C941'|DIAG02 = 
'C942'|DIAG02 = 
'C943'|DIAG02 = 
'C947'|DIAG02 = 
'C950'|DIAG02 = 
'C951'|DIAG02 = 
'C952'|DIAG02 = 
'C957'|DIAG02 = 
'C959'|DIAG02 = 
'C960'|DIAG02 = 
'C961'|DIAG02 = 
'C962'|DIAG02 = 
'C963'|DIAG02 = 
'C967'|DIAG02 = 
'C969'|DIAG02 = 
'C97X')CANCER2 = 1. 
EXECUTE. 
And then repeat for 
DIAG03 to DIAG17
ERCP Syntax 17 – Non cancer comorbidity 
COMPUTE 
NONCANCERCOMORB1 = 
0. 
EXECUTE. 
IF (DIAG01 = 'I210'| 
DIAG01 = 'I211'| 
DIAG01 = 'I212'| 
DIAG01 = 'I213'| 
DIAG01 = 'I214'| 
DIAG01 = 'I219'| 
DIAG01 = 'I220'| 
DIAG01 = 'I221'| 
DIAG01 = 'I228'| 
DIAG01 = 'I229'| 
DIAG01 = 'I252'| 
DIAG01 = 'I500'| 
DIAG01 = 'I710'| 
DIAG01 = 'I711'| 
DIAG01 = 'I712'| 
DIAG01 = 'I713'| 
DIAG01 = 'I714'| 
DIAG01 = 'I715'| 
DIAG01 = 'I716'| 
DIAG01 = 'I718'| 
DIAG01 = 'I719'| 
DIAG01 = 'I738'| 
DIAG01 = 'I739'| 
DIAG01 = 'I600'| 
DIAG01 = 'I601'| 
DIAG01 = 'I602'| 
DIAG01 = 'I603'| 
DIAG01 = 'I604'| 
DIAG01 = 'I605'| 
DIAG01 = 'I606'| 
DIAG01 = 'I607'| 
DIAG01 = 'I608'| 
DIAG01 = 'I609'| 
DIAG01 = 'I610'| 
DIAG01 = 'I611'| 
DIAG01 = 'I612'| 
DIAG01 = 'I613'| 
DIAG01 = 'I614'| 
DIAG01 = 'I615'| 
DIAG01 = 'I616'| 
DIAG01 = 'I618'| 
DIAG01 = 'I619'| 
DIAG01 = 'I620'| 
DIAG01 = 'I621'| 
DIAG01 = 'I629'| 
DIAG01 = 'I630'| 
DIAG01 = 'I631'| 
DIAG01 = 'I632'| 
DIAG01 = 'I633'| 
DIAG01 = 'I634'| 
DIAG01 = 'I635'| 
DIAG01 = 'I636'| 
DIAG01 = 'I638'| 
DIAG01 = 'I639'| 
DIAG01 = 'I64X'| 
DIAG01 = 'I650'| 
DIAG01 = 'I651'| 
DIAG01 = 'I652'| 
DIAG01 = 'I653'| 
DIAG01 = 'I658'| 
DIAG01 = 'I659'| 
DIAG01 = 'I660'| 
DIAG01 = 'I661'| 
DIAG01 = 'I662'| 
DIAG01 = 'I663'| 
DIAG01 = 'I664'| 
DIAG01 = 'I668'| 
DIAG01 = 'I669'| 
DIAG01 = 'I670'| 
DIAG01 = 'I671'| 
DIAG01 = 'I672'| 
DIAG01 = 'I673'| 
DIAG01 = 'I674'| 
DIAG01 = 'I675'| 
DIAG01 = 'I676'| 
DIAG01 = 'I677'| 
DIAG01 = 'I678'| 
DIAG01 = 'I679'| 
DIAG01 = 'I680'| 
DIAG01 = 'I681'| 
DIAG01 = 'I682'| 
DIAG01 = 'I688'| 
DIAG01 = 'I690'| 
DIAG01 = 'I691'| 
DIAG01 = 'I692'| 
DIAG01 = 'I693'| 
DIAG01 = 'I694'| 
DIAG01 = 'I698'| 
DIAG01 = 'F000'| 
DIAG01 = 'F001'| 
DIAG01 = 'F002'| 
DIAG01 = 'F009'| 
DIAG01 = 'F010'| 
DIAG01 = 'F011'| 
DIAG01 = 'F012'| 
DIAG01 = 'F013'| 
DIAG01 = 'F018'| 
DIAG01 = 'F019'| 
DIAG01 = 'F020'| 
DIAG01 = 'F021'| 
DIAG01 = 'F022'| 
DIAG01 = 'F023'| 
DIAG01 = 'F024'| 
DIAG01 = 'F028'| 
DIAG01 = 'F03X'| 
DIAG01 = 'F051'| 
DIAG01 = 'J40X'| 
DIAG01 = 'J410'| 
DIAG01 = 'J411'| 
DIAG01 = 'J418'| 
DIAG01 = 'J42X'| 
DIAG01 = 'J430'| 
DIAG01 = 'J431'| 
DIAG01 = 'J432'| 
DIAG01 = 'J438'| 
DIAG01 = 'J439'| 
DIAG01 = 'J440'| 
DIAG01 = 'J441'| 
DIAG01 = 'J448'| 
DIAG01 = 'J449'| 
DIAG01 = 'J450'| 
DIAG01 = 'J451'| 
DIAG01 = 'J458'| 
DIAG01 = 'J459'| 
DIAG01 = 'J46X'| 
DIAG01 = 'J47X'| 
DIAG01 = 'J60X'| 
DIAG01 = 'J61X'| 
DIAG01 = 'J620'| 
DIAG01 = 'J628'| 
DIAG01 = 'J630'| 
DIAG01 = 'J631'| 
DIAG01 = 'J632'| 
DIAG01 = 'J633'| 
DIAG01 = 'J634'| 
DIAG01 = 'J635'| 
DIAG01 = 'J638'| 
DIAG01 = 'J64X'| 
DIAG01 = 'J65X'| 
DIAG01 = 'J660'| 
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DIAG01 = 'J661'| 
DIAG01 = 'J662'| 
DIAG01 = 'J668'| 
DIAG01 = 'J670'| 
DIAG01 = 'J671'| 
DIAG01 = 'J672'| 
DIAG01 = 'J673'| 
DIAG01 = 'J674'| 
DIAG01 = 'J675'| 
DIAG01 = 'J676'| 
DIAG01 = 'J677'| 
DIAG01 = 'J678'| 
DIAG01 = 'J679'| 
DIAG01 = 'M050'| 
DIAG01 = 'M051'| 
DIAG01 = 'M052'| 
DIAG01 = 'M059'| 
DIAG01 = 'M060'| 
DIAG01 = 'M063'| 
DIAG01 = 'M069'| 
DIAG01 = 'M300'| 
DIAG01 = 'M301'| 
DIAG01 = 'M302'| 
DIAG01 = 'M303'| 
DIAG01 = 'M308'| 
DIAG01 = 'M310'| 
DIAG01 = 'M311'| 
DIAG01 = 'M312'| 
DIAG01 = 'M313'| 
DIAG01 = 'M314'| 
DIAG01 = 'M315'| 
DIAG01 = 'M316'| 
DIAG01 = 'M318'| 
DIAG01 = 'M319'| 
DIAG01 = 'M320'| 
DIAG01 = 'M321'| 
DIAG01 = 'M328'| 
DIAG01 = 'M329'| 
DIAG01 = 'M332'| 
DIAG01 = 'M339'| 
DIAG01 = 'M340'| 
DIAG01 = 'M341'| 
DIAG01 = 'M342'| 
DIAG01 = 'M348'| 
DIAG01 = 'M349'| 
DIAG01 = 'M350'| 
DIAG01 = 'M351'| 
DIAG01 = 'M352'| 
DIAG01 = 'M353'| 
DIAG01 = 'M354'| 
DIAG01 = 'M355'| 
DIAG01 = 'M356'| 
DIAG01 = 'M357'| 
DIAG01 = 'K250'| 
DIAG01 = 'K251'| 
DIAG01 = 'K252'| 
DIAG01 = 'K253'| 
DIAG01 = 'K254'| 
DIAG01 = 'K255'| 
DIAG01 = 'K256'| 
DIAG01 = 'K257'| 
DIAG01 = 'K259'| 
DIAG01 = 'K260'| 
DIAG01 = 'K261'| 
DIAG01 = 'K262'| 
DIAG01 = 'K263'| 
DIAG01 = 'K264'| 
DIAG01 = 'K265'| 
DIAG01 = 'K266'| 
DIAG01 = 'K267'| 
DIAG01 = 'K269'| 
DIAG01 = 'K270'| 
DIAG01 = 'K271'| 
DIAG01 = 'K272'| 
DIAG01 = 'K273'| 
DIAG01 = 'K274'| 
DIAG01 = 'K275'| 
DIAG01 = 'K276'| 
DIAG01 = 'K277'| 
DIAG01 = 'K279'| 
DIAG01 = 'K280'| 
DIAG01 = 'K281'| 
DIAG01 = 'K282'| 
DIAG01 = 'K283'| 
DIAG01 = 'K284'| 
DIAG01 = 'K285'| 
DIAG01 = 'K286'| 
DIAG01 = 'K287'| 
DIAG01 = 'K289'| 
DIAG01 = 'K701'| 
DIAG01 = 'K702'| 
DIAG01 = 'K703'| 
DIAG01 = 'K704'| 
DIAG01 = 'K709'| 
DIAG01 = 'K710'| 
DIAG01 = 'K711'| 
DIAG01 = 'K712'| 
DIAG01 = 'K713'| 
DIAG01 = 'K714'| 
DIAG01 = 'K715'| 
DIAG01 = 'K716'| 
DIAG01 = 'K717'| 
DIAG01 = 'K718'| 
DIAG01 = 'K719'| 
DIAG01 = 'K721'| 
DIAG01 = 'K729'| 
DIAG01 = 'K730'| 
DIAG01 = 'K731'| 
DIAG01 = 'K732'| 
DIAG01 = 'K738'| 
DIAG01 = 'K739'| 
DIAG01 = 'K740'| 
DIAG01 = 'K741'| 
DIAG01 = 'K742'| 
DIAG01 = 'K743'| 
DIAG01 = 'K744'| 
DIAG01 = 'K745'| 
DIAG01 = 'K746'| 
DIAG01 = 'K753'| 
DIAG01 = 'K754'| 
DIAG01 = 'K758'| 
DIAG01 = 'K764'| 
DIAG01 = 'K765'| 
DIAG01 = 'K766'| 
DIAG01 = 'K767'| 
DIAG01 = 'K768'| 
DIAG01 = 'E102'| 
DIAG01 = 'E103'| 
DIAG01 = 'E104'| 
DIAG01 = 'E105'| 
DIAG01 = 'E106'| 
DIAG01 = 'E107'| 
DIAG01 = 'E108'| 
DIAG01 = 'E109'| 
DIAG01 = 'E112'| 
DIAG01 = 'E113'| 
DIAG01 = 'E114'| 
DIAG01 = 'E115'| 
DIAG01 = 'E116'| 
DIAG01 = 'E117'| 
DIAG01 = 'E118'| 
DIAG01 = 'E119'| 
DIAG01 = 'E132'| 
DIAG01 = 'E133'| 
DIAG01 = 'E134'| 
DIAG01 = 'E135'| 
DIAG01 = 'E136'| 
DIAG01 = 'E137'| 
DIAG01 = 'E138'| 
DIAG01 = 'E139'| 
DIAG01 = 'E142'| 
DIAG01 = 'E143'| 
DIAG01 = 'E144'| 
DIAG01 = 'E145'| 
DIAG01 = 'E146'| 
DIAG01 = 'E147'| 
DIAG01 = 'E148'| 
DIAG01 = 'E149'| 
DIAG01 = 'G810'| 
DIAG01 = 'G811'| 
DIAG01 = 'G819'| 
DIAG01 = 'G820'| 
DIAG01 = 'G821'| 
DIAG01 = 'G822'| 
DIAG01 = 'N001'| 
DIAG01 = 'N002'| 
DIAG01 = 'N003'| 
DIAG01 = 'N004'| 
DIAG01 = 'N005'| 
DIAG01 = 'N007'| 
DIAG01 = 'N010'| 
DIAG01 = 'N011'| 
DIAG01 = 'N012'| 
DIAG01 = 'N013'| 
DIAG01 = 'N014'| 
DIAG01 = 'N015'| 
DIAG01 = 'N016'| 
DIAG01 = 'N017'| 
DIAG01 = 'N018'| 
DIAG01 = 'N019'| 
DIAG01 = 'N020'| 
DIAG01 = 'N021'| 
DIAG01 = 'N022'| 
DIAG01 = 'N023'| 
DIAG01 = 'N024'| 
DIAG01 = 'N025'| 
DIAG01 = 'N026'| 
DIAG01 = 'N027'| 
DIAG01 = 'N030'| 
DIAG01 = 'N031'| 
DIAG01 = 'N032'| 
DIAG01 = 'N033'| 
DIAG01 = 'N034'| 
DIAG01 = 'N035'| 
DIAG01 = 'N036'| 
DIAG01 = 'N037'| 
DIAG01 = 'N038'| 
DIAG01 = 'N039'| 
DIAG01 = 'N040'| 
DIAG01 = 'N041'| 
DIAG01 = 'N042'| 
DIAG01 = 'N043'| 
DIAG01 = 'N044'| 
DIAG01 = 'N045'| 
DIAG01 = 'N046'| 
DIAG01 = 'N047'| 
DIAG01 = 'N048'| 
DIAG01 = 'N049'| 
DIAG01 = 'N050'| 
DIAG01 = 'N051'| 
DIAG01 = 'N052'| 
DIAG01 = 'N053'| 
DIAG01 = 'N054'| 
DIAG01 = 'N055'| 
DIAG01 = 'N056'| 
DIAG01 = 'N057'| 
DIAG01 = 'N071'| 
DIAG01 = 'N072'| 
DIAG01 = 'N073'| 
DIAG01 = 'N074'| 
DIAG01 = 'N075'| 
DIAG01 = 'N180'| 
DIAG01 = 'N188'| 
DIAG01 = 'N189'| 
DIAG01 = 'N19X'| 
DIAG01 = 'N250'| 
DIAG01 = 'Z992'| 
DIAG01 = 'B200'| 
DIAG01 = 'B201'| 
DIAG01 = 'B202'| 
DIAG01 = 'B203'| 
DIAG01 = 'B204'| 
DIAG01 = 'B205'| 
DIAG01 = 'B206'| 
DIAG01 = 'B207'| 
DIAG01 = 'B208'| 
DIAG01 = 'B209'| 
DIAG01 = 'B210'| 
DIAG01 = 'B211'| 
DIAG01 = 'B212'| 
DIAG01 = 'B213'| 
DIAG01 = 'B217'| 
DIAG01 = 'B218'| 
DIAG01 = 'B219'| 
DIAG01 = 'B220'| 
DIAG01 = 'B221'| 
DIAG01 = 'B222'| 
DIAG01 = 'B227'| 
DIAG01 = 'B230'| 
DIAG01 = 'B231'| 
DIAG01 = 'B232'| 
DIAG01 = 'B238'| 
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DIAG01 = 
'B24X')NONCANCERCOM
ORB1 = 1. 
EXECUTE. 
 
COMPUTE 
NONCANCERCOMORB2 = 
0. 
EXECUTE. 
IF (DIAG02 = 'I210'| 
DIAG02 = 'I211'| 
DIAG02 = 'I212'| 
DIAG02 = 'I213'| 
DIAG02 = 'I214'| 
DIAG02 = 'I219'| 
DIAG02 = 'I220'| 
DIAG02 = 'I221'| 
DIAG02 = 'I228'| 
DIAG02 = 'I229'| 
DIAG02 = 'I252'| 
DIAG02 = 'I500'| 
DIAG02 = 'I710'| 
DIAG02 = 'I711'| 
DIAG02 = 'I712'| 
DIAG02 = 'I713'| 
DIAG02 = 'I714'| 
DIAG02 = 'I715'| 
DIAG02 = 'I716'| 
DIAG02 = 'I718'| 
DIAG02 = 'I719'| 
DIAG02 = 'I738'| 
DIAG02 = 'I739'| 
DIAG02 = 'I600'| 
DIAG02 = 'I601'| 
DIAG02 = 'I602'| 
DIAG02 = 'I603'| 
DIAG02 = 'I604'| 
DIAG02 = 'I605'| 
DIAG02 = 'I606'| 
DIAG02 = 'I607'| 
DIAG02 = 'I608'| 
DIAG02 = 'I609'| 
DIAG02 = 'I610'| 
DIAG02 = 'I611'| 
DIAG02 = 'I612'| 
DIAG02 = 'I613'| 
DIAG02 = 'I614'| 
DIAG02 = 'I615'| 
DIAG02 = 'I616'| 
DIAG02 = 'I618'| 
DIAG02 = 'I619'| 
DIAG02 = 'I620'| 
DIAG02 = 'I621'| 
DIAG02 = 'I629'| 
DIAG02 = 'I630'| 
DIAG02 = 'I631'| 
DIAG02 = 'I632'| 
DIAG02 = 'I633'| 
DIAG02 = 'I634'| 
DIAG02 = 'I635'| 
DIAG02 = 'I636'| 
DIAG02 = 'I638'| 
DIAG02 = 'I639'| 
DIAG02 = 'I64X'| 
DIAG02 = 'I650'| 
DIAG02 = 'I651'| 
DIAG02 = 'I652'| 
DIAG02 = 'I653'| 
DIAG02 = 'I658'| 
DIAG02 = 'I659'| 
DIAG02 = 'I660'| 
DIAG02 = 'I661'| 
DIAG02 = 'I662'| 
DIAG02 = 'I663'| 
DIAG02 = 'I664'| 
DIAG02 = 'I668'| 
DIAG02 = 'I669'| 
DIAG02 = 'I670'| 
DIAG02 = 'I671'| 
DIAG02 = 'I672'| 
DIAG02 = 'I673'| 
DIAG02 = 'I674'| 
DIAG02 = 'I675'| 
DIAG02 = 'I676'| 
DIAG02 = 'I677'| 
DIAG02 = 'I678'| 
DIAG02 = 'I679'| 
DIAG02 = 'I680'| 
DIAG02 = 'I681'| 
DIAG02 = 'I682'| 
DIAG02 = 'I688'| 
DIAG02 = 'I690'| 
DIAG02 = 'I691'| 
DIAG02 = 'I692'| 
DIAG02 = 'I693'| 
DIAG02 = 'I694'| 
DIAG02 = 'I698'| 
DIAG02 = 'F000'| 
DIAG02 = 'F001'| 
DIAG02 = 'F002'| 
DIAG02 = 'F009'| 
DIAG02 = 'F010'| 
DIAG02 = 'F011'| 
DIAG02 = 'F012'| 
DIAG02 = 'F013'| 
DIAG02 = 'F018'| 
DIAG02 = 'F019'| 
DIAG02 = 'F020'| 
DIAG02 = 'F021'| 
DIAG02 = 'F022'| 
DIAG02 = 'F023'| 
DIAG02 = 'F024'| 
DIAG02 = 'F028'| 
DIAG02 = 'F03X'| 
DIAG02 = 'F051'| 
DIAG02 = 'J40X'| 
DIAG02 = 'J410'| 
DIAG02 = 'J411'| 
DIAG02 = 'J418'| 
DIAG02 = 'J42X'| 
DIAG02 = 'J430'| 
DIAG02 = 'J431'| 
DIAG02 = 'J432'| 
DIAG02 = 'J438'| 
DIAG02 = 'J439'| 
DIAG02 = 'J440'| 
DIAG02 = 'J441'| 
DIAG02 = 'J448'| 
DIAG02 = 'J449'| 
DIAG02 = 'J450'| 
DIAG02 = 'J451'| 
DIAG02 = 'J458'| 
DIAG02 = 'J459'| 
DIAG02 = 'J46X'| 
DIAG02 = 'J47X'| 
DIAG02 = 'J60X'| 
DIAG02 = 'J61X'| 
DIAG02 = 'J620'| 
DIAG02 = 'J628'| 
DIAG02 = 'J630'| 
DIAG02 = 'J631'| 
DIAG02 = 'J632'| 
DIAG02 = 'J633'| 
DIAG02 = 'J634'| 
DIAG02 = 'J635'| 
DIAG02 = 'J638'| 
DIAG02 = 'J64X'| 
DIAG02 = 'J65X'| 
DIAG02 = 'J660'| 
DIAG02 = 'J661'| 
DIAG02 = 'J662'| 
DIAG02 = 'J668'| 
DIAG02 = 'J670'| 
DIAG02 = 'J671'| 
DIAG02 = 'J672'| 
DIAG02 = 'J673'| 
DIAG02 = 'J674'| 
DIAG02 = 'J675'| 
DIAG02 = 'J676'| 
DIAG02 = 'J677'| 
DIAG02 = 'J678'| 
DIAG02 = 'J679'| 
DIAG02 = 'M050'| 
DIAG02 = 'M051'| 
DIAG02 = 'M052'| 
DIAG02 = 'M059'| 
DIAG02 = 'M060'| 
DIAG02 = 'M063'| 
DIAG02 = 'M069'| 
DIAG02 = 'M300'| 
DIAG02 = 'M301'| 
DIAG02 = 'M302'| 
DIAG02 = 'M303'| 
DIAG02 = 'M308'| 
DIAG02 = 'M310'| 
DIAG02 = 'M311'| 
DIAG02 = 'M312'| 
DIAG02 = 'M313'| 
DIAG02 = 'M314'| 
DIAG02 = 'M315'| 
DIAG02 = 'M316'| 
DIAG02 = 'M318'| 
DIAG02 = 'M319'| 
DIAG02 = 'M320'| 
DIAG02 = 'M321'| 
DIAG02 = 'M328'| 
DIAG02 = 'M329'| 
DIAG02 = 'M332'| 
DIAG02 = 'M339'| 
DIAG02 = 'M340'| 
DIAG02 = 'M341'| 
DIAG02 = 'M342'| 
DIAG02 = 'M348'| 
DIAG02 = 'M349'| 
DIAG02 = 'M350'| 
DIAG02 = 'M351'| 
DIAG02 = 'M352'| 
DIAG02 = 'M353'| 
DIAG02 = 'M354'| 
DIAG02 = 'M355'| 
DIAG02 = 'M356'| 
DIAG02 = 'M357'| 
DIAG02 = 'K250'| 
DIAG02 = 'K251'| 
DIAG02 = 'K252'| 
DIAG02 = 'K253'| 
DIAG02 = 'K254'| 
DIAG02 = 'K255'| 
DIAG02 = 'K256'| 
DIAG02 = 'K257'| 
DIAG02 = 'K259'| 
DIAG02 = 'K260'| 
DIAG02 = 'K261'| 
DIAG02 = 'K262'| 
DIAG02 = 'K263'| 
DIAG02 = 'K264'| 
DIAG02 = 'K265'| 
DIAG02 = 'K266'| 
DIAG02 = 'K267'| 
DIAG02 = 'K269'| 
DIAG02 = 'K270'| 
DIAG02 = 'K271'| 
DIAG02 = 'K272'| 
DIAG02 = 'K273'| 
DIAG02 = 'K274'| 
DIAG02 = 'K275'| 
DIAG02 = 'K276'| 
DIAG02 = 'K277'| 
DIAG02 = 'K279'| 
DIAG02 = 'K280'| 
DIAG02 = 'K281'| 
DIAG02 = 'K282'| 
DIAG02 = 'K283'| 
DIAG02 = 'K284'| 
DIAG02 = 'K285'| 
DIAG02 = 'K286'| 
DIAG02 = 'K287'| 
DIAG02 = 'K289'| 
DIAG02 = 'K701'| 
DIAG02 = 'K702'| 
DIAG02 = 'K703'| 
DIAG02 = 'K704'| 
DIAG02 = 'K709'| 
DIAG02 = 'K710'| 
DIAG02 = 'K711'| 
DIAG02 = 'K712'| 
DIAG02 = 'K713'| 
DIAG02 = 'K714'| 
DIAG02 = 'K715'| 
DIAG02 = 'K716'| 
DIAG02 = 'K717'| 
DIAG02 = 'K718'| 
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DIAG02 = 'K719'| 
DIAG02 = 'K721'| 
DIAG02 = 'K729'| 
DIAG02 = 'K730'| 
DIAG02 = 'K731'| 
DIAG02 = 'K732'| 
DIAG02 = 'K738'| 
DIAG02 = 'K739'| 
DIAG02 = 'K740'| 
DIAG02 = 'K741'| 
DIAG02 = 'K742'| 
DIAG02 = 'K743'| 
DIAG02 = 'K744'| 
DIAG02 = 'K745'| 
DIAG02 = 'K746'| 
DIAG02 = 'K753'| 
DIAG02 = 'K754'| 
DIAG02 = 'K758'| 
DIAG02 = 'K764'| 
DIAG02 = 'K765'| 
DIAG02 = 'K766'| 
DIAG02 = 'K767'| 
DIAG02 = 'K768'| 
DIAG02 = 'E102'| 
DIAG02 = 'E103'| 
DIAG02 = 'E104'| 
DIAG02 = 'E105'| 
DIAG02 = 'E106'| 
DIAG02 = 'E107'| 
DIAG02 = 'E108'| 
DIAG02 = 'E109'| 
DIAG02 = 'E112'| 
DIAG02 = 'E113'| 
DIAG02 = 'E114'| 
DIAG02 = 'E115'| 
DIAG02 = 'E116'| 
DIAG02 = 'E117'| 
DIAG02 = 'E118'| 
DIAG02 = 'E119'| 
DIAG02 = 'E132'| 
DIAG02 = 'E133'| 
DIAG02 = 'E134'| 
DIAG02 = 'E135'| 
DIAG02 = 'E136'| 
DIAG02 = 'E137'| 
DIAG02 = 'E138'| 
DIAG02 = 'E139'| 
DIAG02 = 'E142'| 
DIAG02 = 'E143'| 
DIAG02 = 'E144'| 
DIAG02 = 'E145'| 
DIAG02 = 'E146'| 
DIAG02 = 'E147'| 
DIAG02 = 'E148'| 
DIAG02 = 'E149'| 
DIAG02 = 'G810'| 
DIAG02 = 'G811'| 
DIAG02 = 'G819'| 
DIAG02 = 'G820'| 
DIAG02 = 'G821'| 
DIAG02 = 'G822'| 
DIAG02 = 'N001'| 
DIAG02 = 'N002'| 
DIAG02 = 'N003'| 
DIAG02 = 'N004'| 
DIAG02 = 'N005'| 
DIAG02 = 'N007'| 
DIAG02 = 'N010'| 
DIAG02 = 'N011'| 
DIAG02 = 'N012'| 
DIAG02 = 'N013'| 
DIAG02 = 'N014'| 
DIAG02 = 'N015'| 
DIAG02 = 'N016'| 
DIAG02 = 'N017'| 
DIAG02 = 'N018'| 
DIAG02 = 'N019'| 
DIAG02 = 'N020'| 
DIAG02 = 'N021'| 
DIAG02 = 'N022'| 
DIAG02 = 'N023'| 
DIAG02 = 'N024'| 
DIAG02 = 'N025'| 
DIAG02 = 'N026'| 
DIAG02 = 'N027'| 
DIAG02 = 'N030'| 
DIAG02 = 'N031'| 
DIAG02 = 'N032'| 
DIAG02 = 'N033'| 
DIAG02 = 'N034'| 
DIAG02 = 'N035'| 
DIAG02 = 'N036'| 
DIAG02 = 'N037'| 
DIAG02 = 'N038'| 
DIAG02 = 'N039'| 
DIAG02 = 'N040'| 
DIAG02 = 'N041'| 
DIAG02 = 'N042'| 
DIAG02 = 'N043'| 
DIAG02 = 'N044'| 
DIAG02 = 'N045'| 
DIAG02 = 'N046'| 
DIAG02 = 'N047'| 
DIAG02 = 'N048'| 
DIAG02 = 'N049'| 
DIAG02 = 'N050'| 
DIAG02 = 'N051'| 
DIAG02 = 'N052'| 
DIAG02 = 'N053'| 
DIAG02 = 'N054'| 
DIAG02 = 'N055'| 
DIAG02 = 'N056'| 
DIAG02 = 'N057'| 
DIAG02 = 'N071'| 
DIAG02 = 'N072'| 
DIAG02 = 'N073'| 
DIAG02 = 'N074'| 
DIAG02 = 'N075'| 
DIAG02 = 'N180'| 
DIAG02 = 'N188'| 
DIAG02 = 'N189'| 
DIAG02 = 'N19X'| 
DIAG02 = 'N250'| 
DIAG02 = 'Z992'| 
DIAG02 = 'B200'| 
DIAG02 = 'B201'| 
DIAG02 = 'B202'| 
DIAG02 = 'B203'| 
DIAG02 = 'B204'| 
DIAG02 = 'B205'| 
DIAG02 = 'B206'| 
DIAG02 = 'B207'| 
DIAG02 = 'B208'| 
DIAG02 = 'B209'| 
DIAG02 = 'B210'| 
DIAG02 = 'B211'| 
DIAG02 = 'B212'| 
DIAG02 = 'B213'| 
DIAG02 = 'B217'| 
DIAG02 = 'B218'| 
DIAG02 = 'B219'| 
DIAG02 = 'B220'| 
DIAG02 = 'B221'| 
DIAG02 = 'B222'| 
DIAG02 = 'B227'| 
DIAG02 = 'B230'| 
DIAG02 = 'B231'| 
DIAG02 = 'B232'| 
DIAG02 = 'B238'| 
DIAG02 = 
'B24X')NONCANCERCOM
ORB2 = 1. 
EXECUTE. 
 
   
 
 
 
And then repeat for DIAG03 to DIAG17  
 
ERCP Syntax 18 – Gallstones 
COMPUTE GS1 = 0. 
EXECUTE. 
IF (DIAG01 = 'K800'| 
DIAG01 = 'K801'| 
DIAG01 = 'K802'| 
DIAG01 = 'K803'| 
DIAG01 = 'K804'| 
DIAG01 = 'K805'| 
DIAG01 = 'K808'| 
DIAG01 = 'K563')GS1 = 1. 
EXECUTE. 
COMPUTE GS2 = 0. 
EXECUTE. 
IF (DIAG02 = 'K800'| 
DIAG02 = 'K801'| 
DIAG02 = 'K802'| 
DIAG02 = 'K803'| 
DIAG02 = 'K804'| 
DIAG02 = 'K805'| 
DIAG02 = 'K808'| 
DIAG02 = 'K563')GS2 = 1. 
EXECUTE. 
COMPUTE GS3 = 0. 
EXECUTE. 
IF (DIAG03 = 'K800'| 
DIAG03 = 'K801'| 
DIAG03 = 'K802'| 
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DIAG03 = 'K803'| 
DIAG03 = 'K804'| 
DIAG03 = 'K805'| 
DIAG03 = 'K808'| 
DIAG03 = 'K563')GS3 = 1. 
EXECUTE. 
COMPUTE GS4 = 0. 
EXECUTE. 
IF (DIAG04 = 'K800'| 
DIAG04 = 'K801'| 
DIAG04 = 'K802'| 
DIAG04 = 'K803'| 
DIAG04 = 'K804'| 
DIAG04 = 'K805'| 
DIAG04 = 'K808'| 
DIAG04 = 'K563')GS4 = 1. 
EXECUTE. 
COMPUTE GS5 = 0. 
EXECUTE. 
IF (DIAG05 = 'K800'| 
DIAG05 = 'K801'| 
DIAG05 = 'K802'| 
DIAG05 = 'K803'| 
DIAG05 = 'K804'| 
DIAG05 = 'K805'| 
DIAG05 = 'K808'| 
DIAG05 = 'K563')GS5 = 1. 
EXECUTE. 
COMPUTE GS6 = 0. 
EXECUTE. 
IF (DIAG06 = 'K800'| 
DIAG06 = 'K801'| 
DIAG06 = 'K802'| 
DIAG06 = 'K803'| 
DIAG06 = 'K804'| 
DIAG06 = 'K805'| 
DIAG06 = 'K808'| 
DIAG06 = 'K563')GS6 = 1. 
EXECUTE. 
COMPUTE GS7 = 0. 
EXECUTE. 
IF (DIAG07 = 'K800'| 
DIAG07 = 'K801'| 
DIAG07 = 'K802'| 
DIAG07 = 'K803'| 
DIAG07 = 'K804'| 
DIAG07 = 'K805'| 
DIAG07 = 'K808'| 
DIAG07 = 'K563')GS7 = 1. 
EXECUTE. 
COMPUTE GS8 = 0. 
EXECUTE. 
IF (DIAG08 = 'K800'| 
DIAG08 = 'K801'| 
DIAG08 = 'K802'| 
DIAG08 = 'K803'| 
DIAG08 = 'K804'| 
DIAG08 = 'K805'| 
DIAG08 = 'K808'| 
DIAG08 = 'K563')GS8 = 1. 
EXECUTE. 
COMPUTE GS9 = 0. 
EXECUTE. 
IF (DIAG09 = 'K800'| 
DIAG09 = 'K801'| 
DIAG09 = 'K802'| 
DIAG09 = 'K803'| 
DIAG09 = 'K804'| 
DIAG09 = 'K805'| 
DIAG09 = 'K808'| 
DIAG09 = 'K563')GS9 = 1. 
EXECUTE. 
COMPUTE GS10 = 0. 
EXECUTE. 
IF (DIAG10 = 'K800'| 
DIAG10 = 'K801'| 
DIAG10 = 'K802'| 
DIAG10 = 'K803'| 
DIAG10 = 'K804'| 
DIAG10 = 'K805'| 
DIAG10 = 'K808'| 
DIAG10 = 'K563')GS10 = 1. 
EXECUTE. 
COMPUTE GS11 = 0. 
EXECUTE. 
IF (DIAG11 = 'K800'| 
DIAG11 = 'K801'| 
DIAG11 = 'K802'| 
DIAG11 = 'K803'| 
DIAG11 = 'K804'| 
DIAG11 = 'K805'| 
DIAG11 = 'K808'| 
DIAG11 = 'K563')GS11 = 1. 
EXECUTE. 
COMPUTE GS12 = 0. 
EXECUTE. 
IF (DIAG12 = 'K800'| 
DIAG12 = 'K801'| 
DIAG12 = 'K802'| 
DIAG12 = 'K803'| 
DIAG12 = 'K804'| 
DIAG12 = 'K805'| 
DIAG12 = 'K808'| 
DIAG12 = 'K563')GS12 = 1. 
EXECUTE. 
COMPUTE GS13 = 0. 
EXECUTE. 
IF (DIAG13 = 'K800'| 
DIAG13 = 'K801'| 
DIAG13 = 'K802'| 
DIAG13 = 'K803'| 
DIAG13 = 'K804'| 
DIAG13 = 'K805'| 
DIAG13 = 'K808'| 
DIAG13 = 'K563')GS13 = 1. 
EXECUTE. 
COMPUTE GS14 = 0. 
EXECUTE. 
IF (DIAG14 = 'K800'| 
DIAG14 = 'K801'| 
DIAG14 = 'K802'| 
DIAG14 = 'K803'| 
DIAG14 = 'K804'| 
DIAG14 = 'K805'| 
DIAG14 = 'K808'| 
DIAG14 = 'K563')GS14 = 1. 
EXECUTE. 
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ERCP Syntax 19 – Acute pancreatitis 
COMPUTE PANC1 = 0. 
EXECUTE. 
IF (DIAG01 = 'K85X')PANC1 = 
1. 
EXECUTE. 
COMPUTE PANC2 = 0. 
EXECUTE. 
IF (DIAG02 = 'K85X')PANC2 = 
1. 
EXECUTE. 
COMPUTE PANC3 = 0. 
EXECUTE. 
IF (DIAG03 = 'K85X')PANC3 = 
1. 
EXECUTE. 
COMPUTE PANC4 = 0. 
EXECUTE. 
IF (DIAG04 = 'K85X')PANC4 = 
1. 
EXECUTE. 
COMPUTE PANC5 = 0. 
EXECUTE. 
IF (DIAG05 = 'K85X')PANC5 = 
1. 
EXECUTE. 
COMPUTE PANC6 = 0. 
EXECUTE. 
IF (DIAG06 = 'K85X')PANC6 = 
1. 
EXECUTE. 
COMPUTE PANC7 = 0. 
EXECUTE. 
IF (DIAG07 = 'K85X')PANC7 = 
1. 
EXECUTE. 
COMPUTE PANC8 = 0. 
EXECUTE. 
IF (DIAG08 = 'K85X')PANC8 = 
1. 
EXECUTE. 
COMPUTE PANC9 = 0. 
EXECUTE. 
IF (DIAG09 = 'K85X')PANC9 = 
1. 
EXECUTE. 
COMPUTE PANC10 = 0. 
EXECUTE. 
IF (DIAG10 = 'K85X')PANC10 
= 1. 
EXECUTE. 
COMPUTE PANC11 = 0. 
EXECUTE. 
IF (DIAG11 = 'K85X')PANC11 
= 1. 
EXECUTE. 
COMPUTE PANC12 = 0. 
EXECUTE. 
IF (DIAG12 = 'K85X')PANC12 
= 1. 
EXECUTE. 
COMPUTE PANC13 = 0. 
EXECUTE. 
IF (DIAG13 = 'K85X')PANC13 
= 1. 
EXECUTE. 
COMPUTE PANC14 = 0. 
EXECUTE. 
IF (DIAG14 = 'K85X')PANC14 
= 1. 
EXECUTE. 
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ERCP Syntax 20 – Hepato-pancreatico-biliary cancer diagnosis
COMPUTE HPBCA1 = 0. 
EXECUTE. 
IF (DIAG01 = 'C220'| 
DIAG01 = 'C221'| 
DIAG01 = 'C222'| 
DIAG01 = 'C223'| 
DIAG01 = 'C224'| 
DIAG01 = 'C227'| 
DIAG01 = 'C229'| 
DIAG01 = 'C23X'| 
DIAG01 = 'C240'| 
DIAG01 = 'C241'| 
DIAG01 = 'C248'| 
DIAG01 = 'C249'| 
DIAG01 = 'C250'| 
DIAG01 = 'C251'| 
DIAG01 = 'C252'| 
DIAG01 = 'C253'| 
DIAG01 = 'C254'| 
DIAG01 = 'C257'| 
DIAG01 = 'C258'| 
DIAG01 = 'C259'| 
DIAG01 = 'C787'| 
DIAG01 = 
'D376')HPBCA1 = 1. 
EXECUTE. 
 
COMPUTE HPBCA2 = 0. 
EXECUTE. 
IF (DIAG02 = 'C220'| 
DIAG02 = 'C221'| 
DIAG02 = 'C222'| 
DIAG02 = 'C223'| 
DIAG02 = 'C224'| 
DIAG02 = 'C227'| 
DIAG02 = 'C229'| 
DIAG02 = 'C23X'| 
DIAG02 = 'C240'| 
DIAG02 = 'C241'| 
DIAG02 = 'C248'| 
DIAG02 = 'C249'| 
DIAG02 = 'C250'| 
DIAG02 = 'C251'| 
DIAG02 = 'C252'| 
DIAG02 = 'C253'| 
DIAG02 = 'C254'| 
DIAG02 = 'C257'| 
DIAG02 = 'C258'| 
DIAG02 = 'C259'| 
DIAG02 = 'C787'| 
DIAG02 = 
'C376')HPBCA2 = 1. 
EXECUTE. 
 
COMPUTE HPBCA3 = 0. 
EXECUTE. 
IF (DIAG03 = 'C220'| 
DIAG03 = 'C221'| 
DIAG03 = 'C222'| 
DIAG03 = 'C223'| 
DIAG03 = 'C224'| 
DIAG03 = 'C227'| 
DIAG03 = 'C229'| 
DIAG03 = 'C23X'| 
DIAG03 = 'C240'| 
DIAG03 = 'C241'| 
DIAG03 = 'C248'| 
DIAG03 = 'C249'| 
DIAG03 = 'C250'| 
DIAG03 = 'C251'| 
DIAG03 = 'C252'| 
DIAG03 = 'C253'| 
DIAG03 = 'C254'| 
DIAG03 = 'C257'| 
DIAG03 = 'C258'| 
DIAG03 = 'C259'| 
DIAG03 = 'C787'| 
DIAG03 = 
'C376')HPBCA3 = 1. 
EXECUTE. 
 
COMPUTE HPBCA4 = 0. 
EXECUTE. 
IF (DIAG04 = 'C220'| 
DIAG04 = 'C221'| 
DIAG04 = 'C222'| 
DIAG04 = 'C223'| 
DIAG04 = 'C224'| 
DIAG04 = 'C227'| 
DIAG04 = 'C229'| 
DIAG04 = 'C23X'| 
DIAG04 = 'C240'| 
DIAG04 = 'C241'| 
DIAG04 = 'C248'| 
DIAG04 = 'C249'| 
DIAG04 = 'C250'| 
DIAG04 = 'C251'| 
DIAG04 = 'C252'| 
DIAG04 = 'C253'| 
DIAG04 = 'C254'| 
DIAG04 = 'C257'| 
DIAG04 = 'C258'| 
DIAG04 = 'C259'| 
DIAG04 = 'C787'| 
DIAG04 = 
'C376')HPBCA4 = 1. 
EXECUTE. 
 
COMPUTE HPBCA5 = 0. 
EXECUTE. 
IF (DIAG05 = 'C220'| 
DIAG05 = 'C221'| 
DIAG05 = 'C222'| 
DIAG05 = 'C223'| 
DIAG05 = 'C224'| 
DIAG05 = 'C227'| 
DIAG05 = 'C229'| 
DIAG05 = 'C23X'| 
DIAG05 = 'C240'| 
DIAG05 = 'C241'| 
DIAG05 = 'C248'| 
DIAG05 = 'C249'| 
DIAG05 = 'C250'| 
DIAG05 = 'C251'| 
DIAG05 = 'C252'| 
DIAG05 = 'C253'| 
DIAG05 = 'C254'| 
DIAG05 = 'C257'| 
DIAG05 = 'C258'| 
DIAG05 = 'C259'| 
DIAG05 = 'C787'| 
DIAG05 = 
'C376')HPBCA5 = 1. 
EXECUTE. 
 
COMPUTE HPBCA6 = 0. 
EXECUTE. 
IF (DIAG06 = 'C220'| 
DIAG06 = 'C221'| 
DIAG06 = 'C222'| 
DIAG06 = 'C223'| 
DIAG06 = 'C224'| 
DIAG06 = 'C227'| 
DIAG06 = 'C229'| 
DIAG06 = 'C23X'| 
DIAG06 = 'C240'| 
DIAG06 = 'C241'| 
DIAG06 = 'C248'| 
DIAG06 = 'C249'| 
DIAG06 = 'C250'| 
DIAG06 = 'C251'| 
DIAG06 = 'C252'| 
DIAG06 = 'C253'| 
DIAG06 = 'C254'| 
DIAG06 = 'C257'| 
DIAG06 = 'C258'| 
DIAG06 = 'C259'| 
DIAG06 = 'C787'| 
DIAG06 = 
'C376')HPBCA6 = 1. 
EXECUTE. 
 
COMPUTE HPBCA7 = 0. 
EXECUTE. 
IF (DIAG07 = 'C220'| 
DIAG07 = 'C221'| 
DIAG07 = 'C222'| 
DIAG07 = 'C223'| 
DIAG07 = 'C224'| 
DIAG07 = 'C227'| 
DIAG07 = 'C229'| 
DIAG07 = 'C23X'| 
DIAG07 = 'C240'| 
DIAG07 = 'C241'| 
DIAG07 = 'C248'| 
DIAG07 = 'C249'| 
DIAG07 = 'C250'| 
DIAG07 = 'C251'| 
DIAG07 = 'C252'| 
DIAG07 = 'C253'| 
DIAG07 = 'C254'| 
DIAG07 = 'C257'| 
DIAG07 = 'C258'| 
DIAG07 = 'C259'| 
DIAG07 = 'C787'| 
DIAG07 = 
'C376')HPBCA7 = 1. 
EXECUTE. 
 
COMPUTE HPBCA8 = 0. 
EXECUTE. 
IF (DIAG08 = 'C220'| 
DIAG08 = 'C221'| 
DIAG08 = 'C222'| 
DIAG08 = 'C223'| 
DIAG08 = 'C224'| 
DIAG08 = 'C227'| 
DIAG08 = 'C229'| 
DIAG08 = 'C23X'| 
DIAG08 = 'C240'| 
DIAG08 = 'C241'| 
DIAG08 = 'C248'| 
DIAG08 = 'C249'| 
DIAG08 = 'C250'| 
DIAG08 = 'C251'| 
DIAG08 = 'C252'| 
DIAG08 = 'C253'| 
DIAG08 = 'C254'| 
DIAG08 = 'C257'| 
DIAG08 = 'C258'| 
DIAG08 = 'C259'| 
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DIAG08 = 'C787'| 
DIAG08 = 
'C376')HPBCA8 = 1. 
EXECUTE. 
 
COMPUTE HPBCA9 = 0. 
EXECUTE. 
IF (DIAG09 = 'C220'| 
DIAG09 = 'C221'| 
DIAG09 = 'C222'| 
DIAG09 = 'C223'| 
DIAG09 = 'C224'| 
DIAG09 = 'C227'| 
DIAG09 = 'C229'| 
DIAG09 = 'C23X'| 
DIAG09 = 'C240'| 
DIAG09 = 'C241'| 
DIAG09 = 'C248'| 
DIAG09 = 'C249'| 
DIAG09 = 'C250'| 
DIAG09 = 'C251'| 
DIAG09 = 'C252'| 
DIAG09 = 'C253'| 
DIAG09 = 'C254'| 
DIAG09 = 'C257'| 
DIAG09 = 'C258'| 
DIAG09 = 'C259'| 
DIAG09 = 'C787'| 
DIAG09 = 
'C376')HPBCA9 = 1. 
EXECUTE. 
 
COMPUTE HPBCA10 = 
0. 
EXECUTE. 
IF (DIAG10 = 'C220'| 
DIAG10 = 'C221'| 
DIAG10 = 'C222'| 
DIAG10 = 'C223'| 
DIAG10 = 'C224'| 
DIAG10 = 'C227'| 
DIAG10 = 'C229'| 
DIAG10 = 'C23X'| 
DIAG10 = 'C240'| 
DIAG10 = 'C241'| 
DIAG10 = 'C248'| 
DIAG10 = 'C249'| 
DIAG10 = 'C250'| 
DIAG10 = 'C251'| 
DIAG10 = 'C252'| 
DIAG10 = 'C253'| 
DIAG10 = 'C254'| 
DIAG10 = 'C257'| 
DIAG10 = 'C258'| 
DIAG10 = 'C259'| 
DIAG10 = 'C787'| 
DIAG10 = 
'C376')HPBCA10 = 1. 
EXECUTE. 
 
COMPUTE HPBCA11 = 
0. 
EXECUTE. 
IF (DIAG11 = 'C220'| 
DIAG11 = 'C221'| 
DIAG11 = 'C222'| 
DIAG11 = 'C223'| 
DIAG11 = 'C224'| 
DIAG11 = 'C227'| 
DIAG11 = 'C229'| 
DIAG11 = 'C23X'| 
DIAG11 = 'C240'| 
DIAG11 = 'C241'| 
DIAG11 = 'C248'| 
DIAG11 = 'C249'| 
DIAG11 = 'C250'| 
DIAG11 = 'C251'| 
DIAG11 = 'C252'| 
DIAG11 = 'C253'| 
DIAG11 = 'C254'| 
DIAG11 = 'C257'| 
DIAG11 = 'C258'| 
DIAG11 = 'C259'| 
DIAG11 = 'C787'| 
DIAG11 = 
'C376')HPBCA11 = 1. 
EXECUTE. 
 
COMPUTE HPBCA12 = 
0. 
EXECUTE. 
IF (DIAG12 = 'C220'| 
DIAG12 = 'C221'| 
DIAG12 = 'C222'| 
DIAG12 = 'C223'| 
DIAG12 = 'C224'| 
DIAG12 = 'C227'| 
DIAG12 = 'C229'| 
DIAG12 = 'C23X'| 
DIAG12 = 'C240'| 
DIAG12 = 'C241'| 
DIAG12 = 'C248'| 
DIAG12 = 'C249'| 
DIAG12 = 'C250'| 
DIAG12 = 'C251'| 
DIAG12 = 'C252'| 
DIAG12 = 'C253'| 
DIAG12 = 'C254'| 
DIAG12 = 'C257'| 
DIAG12 = 'C258'| 
DIAG12 = 'C259'| 
DIAG12 = 'C787'| 
DIAG12 = 
'C376')HPBCA12 = 1. 
EXECUTE. 
 
COMPUTE HPBCA13 = 
0. 
EXECUTE. 
IF (DIAG13 = 'C220'| 
DIAG13 = 'C221'| 
DIAG13 = 'C222'| 
DIAG13 = 'C223'| 
DIAG13 = 'C224'| 
DIAG13 = 'C227'| 
DIAG13 = 'C229'| 
DIAG13 = 'C23X'| 
DIAG13 = 'C240'| 
DIAG13 = 'C241'| 
DIAG13 = 'C248'| 
DIAG13 = 'C249'| 
DIAG13 = 'C250'| 
DIAG13 = 'C251'| 
DIAG13 = 'C252'| 
DIAG13 = 'C253'| 
DIAG13 = 'C254'| 
DIAG13 = 'C257'| 
DIAG13 = 'C258'| 
DIAG13 = 'C259'| 
DIAG13 = 'C787'| 
DIAG13 = 
'C376')HPBCA13 = 1. 
EXECUTE. 
 
COMPUTE HPBCA14 = 
0. 
EXECUTE. 
IF (DIAG14 = 'C220'| 
DIAG14 = 'C221'| 
DIAG14 = 'C222'| 
DIAG14 = 'C223'| 
DIAG14 = 'C224'| 
DIAG14 = 'C227'| 
DIAG14 = 'C229'| 
DIAG14 = 'C23X'| 
DIAG14 = 'C240'| 
DIAG14 = 'C241'| 
DIAG14 = 'C248'| 
DIAG14 = 'C249'| 
DIAG14 = 'C250'| 
DIAG14 = 'C251'| 
DIAG14 = 'C252'| 
DIAG14 = 'C253'| 
DIAG14 = 'C254'| 
DIAG14 = 'C257'| 
DIAG14 = 'C258'| 
DIAG14 = 'C259'| 
DIAG14 = 'C787'| 
DIAG14 = 
'C376')HPBCA14 = 1. 
EXECUTE.
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ERCP Syntax 21 – Marker to indicate Trust contributed to BSG audit
COMPUTE BSGPARTICIPANT 
= 0. 
EXECUTE. 
IF (PROCODE = 'RAL'| 
PROCODE = 'RBL'| 
PROCODE = 'RBN'| 
PROCODE = 'RDD'| 
PROCODE = 'RDE'| 
PROCODE = 'REM'| 
PROCODE = 'RF4'| 
PROCODE = 'RFS'| 
PROCODE = 'RFW'| 
PROCODE = 'RG2'| 
PROCODE = 'RG3'| 
PROCODE = 'RJ1'| 
PROCODE = 'RJ2'| 
PROCODE = 'RJ5'| 
PROCODE = 'RJC'| 
PROCODE = 'RJN'| 
PROCODE = 'RKB'| 
PROCODE = 'RL4'| 
PROCODE = 'RLQ'| 
PROCODE = 'RLT'| 
PROCODE = 'RM2'| 
PROCODE = 'RM3'| 
PROCODE = 'RMC'| 
PROCODE = 'RMP'| 
PROCODE = 'RN7'| 
PROCODE = 'RNA'| 
PROCODE = 'RNJ'| 
PROCODE = 'RP5'| 
PROCODE = 'RQ6'| 
PROCODE = 'RQ8'| 
PROCODE = 'RQM'| 
PROCODE = 'RR1'| 
PROCODE = 'RRK'| 
PROCODE = 'RTG'| 
PROCODE = 'RV8'| 
PROCODE = 'RVV'| 
PROCODE = 'RVY'| 
PROCODE = 'RW3'| 
PROCODE = 'RW6'| 
PROCODE = 'RWE'| 
PROCODE = 'RWF'| 
PROCODE = 'RWG'| 
PROCODE = 'RWH'| 
PROCODE = 'RWJ'| 
PROCODE = 'RWP'| 
PROCODE = 'RX1'| 
PROCODE = 'RXC'| 
PROCODE = 'RXH'| 
PROCODE = 'RXK'| 
PROCODE = 'RXN'| 
PROCODE = 'RXR'| 
PROCODE = 'RXW'| 
PROCODE = 
'RYJ')BSGPARTICIPANT = 1. 
EXECUTE. 
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ERCP Syntax 22 – Number of cases contributed to the BSG audit
 
COMPUTE BSGTOTAL = 0. 
EXECUTE. 
IF (PROCODE = 'RAL')BSGTOTAL = 100. 
EXECUTE. 
IF (PROCODE = 'RBL')BSGTOTAL = 99. 
EXECUTE. 
IF (PROCODE = 'RBN')BSGTOTAL = 54. 
EXECUTE. 
IF (PROCODE = 'RDD')BSGTOTAL = 147. 
EXECUTE. 
IF (PROCODE = 'RDE')BSGTOTAL = 54. 
EXECUTE. 
IF (PROCODE = 'REM')BSGTOTAL = 12. 
EXECUTE. 
IF (PROCODE = 'RF4')BSGTOTAL = 83. 
EXECUTE. 
IF (PROCODE = 'RFS')BSGTOTAL = 74. 
EXECUTE. 
IF (PROCODE = 'RFW')BSGTOTAL = 39. 
EXECUTE. 
IF (PROCODE = 'RG2')BSGTOTAL = 82. 
EXECUTE. 
IF (PROCODE = 'RG3')BSGTOTAL = 97. 
EXECUTE. 
IF (PROCODE = 'RJ1')BSGTOTAL = 249. 
EXECUTE. 
IF (PROCODE = 'RJ2')BSGTOTAL = 54. 
EXECUTE. 
IF (PROCODE = 'RJC')BSGTOTAL = 59. 
EXECUTE. 
IF (PROCODE = 'RJN')BSGTOTAL = 36. 
EXECUTE. 
IF (PROCODE = 'RKB')BSGTOTAL = 152. 
EXECUTE. 
IF (PROCODE = 'RL4')BSGTOTAL = 81. 
EXECUTE. 
IF (PROCODE = 'RLQ')BSGTOTAL = 30. 
EXECUTE. 
IF (PROCODE = 'RLT')BSGTOTAL = 31. 
EXECUTE. 
IF (PROCODE = 'RM2')BSGTOTAL = 186. 
EXECUTE. 
IF (PROCODE = 'RM3')BSGTOTAL = 57. 
EXECUTE. 
IF (PROCODE = 'RMC')BSGTOTAL = 37. 
EXECUTE. 
IF (PROCODE = 'RMP')BSGTOTAL = 55. 
EXECUTE. 
IF (PROCODE = 'RN7')BSGTOTAL =127. 
EXECUTE. 
IF (PROCODE = 'RNA')BSGTOTAL = 235. 
EXECUTE. 
IF (PROCODE = 'RNJ')BSGTOTAL = 79. 
EXECUTE. 
IF (PROCODE = 'RP5')BSGTOTAL = 93. 
EXECUTE. 
IF (PROCODE = 'RQ6')BSGTOTAL = 292. 
EXECUTE. 
IF (PROCODE = 'RQ8')BSGTOTAL = 74. 
EXECUTE. 
IF (PROCODE = 'RQM')BSGTOTAL = 216. 
EXECUTE. 
IF (PROCODE = 'RR1')BSGTOTAL = 103. 
EXECUTE. 
IF (PROCODE = 'RRK')BSGTOTAL = 137. 
EXECUTE. 
IF (PROCODE = 'RTG')BSGTOTAL = 38. 
EXECUTE. 
IF (PROCODE = 'RV8')BSGTOTAL = 93. 
EXECUTE. 
IF (PROCODE = 'RVV')BSGTOTAL = 170. 
EXECUTE. 
IF (PROCODE = 'RVY')BSGTOTAL = 24. 
EXECUTE. 
IF (PROCODE = 'RW3')BSGTOTAL = 65. 
EXECUTE. 
IF (PROCODE = 'RW6')BSGTOTAL = 137. 
EXECUTE. 
IF (PROCODE = 'RWE')BSGTOTAL = 84. 
EXECUTE. 
IF (PROCODE = 'RWF')BSGTOTAL = 24. 
EXECUTE. 
IF (PROCODE = 'RWG')BSGTOTAL = 73. 
EXECUTE. 
IF (PROCODE = 'RWH')BSGTOTAL = 126. 
EXECUTE. 
IF (PROCODE = 'RWJ')BSGTOTAL = 145. 
EXECUTE. 
IF (PROCODE = 'RWP')BSGTOTAL = 49. 
EXECUTE. 
IF (PROCODE = 'RX1')BSGTOTAL = 242. 
EXECUTE. 
IF (PROCODE = 'RXC')BSGTOTAL = 77. 
EXECUTE. 
IF (PROCODE = 'RXH')BSGTOTAL = 77. 
EXECUTE. 
IF (PROCODE = 'RXK')BSGTOTAL = 52. 
EXECUTE. 
IF (PROCODE = 'RXN')BSGTOTAL = 44. 
EXECUTE. 
IF (PROCODE = 'RXR')BSGTOTAL = 98. 
EXECUTE. 
IF (PROCODE = 'RXW')BSGTOTAL = 105. 
EXECUTE. 
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IF (PROCODE = 'RYJ')BSGTOTAL = 115. EXECUTE
 
ERCP Syntax 23 – YZ code marker
COMPUTE YZCODES = 0. 
EXECUTE. 
IF (OPERNT7 = 'Y141'| 
OPERNT7 = 'Y142'| 
OPERNT7 = 'Y143'| 
OPERNT7 = 'Y144'| 
OPERNT7 = 'Y148'| 
OPERNT7 = 'Y149'| 
OPERNT7 = 'Y151'| 
OPERNT7 = 'Y152'| 
OPERNT7 = 'Y153'| 
OPERNT7 = 'Y154'| 
OPERNT7 = 'Y156'| 
OPERNT7 = 'Y157'| 
OPERNT7 = 'Y158'| 
OPERNT7 = 'Y159'| 
OPERNT7 = 'Y203'| 
OPERNT7 = 'Y204'| 
OPERNT7 = 'Y211'| 
OPERNT7 = 'Y511'| 
OPERNT7 = 'Y512'| 
OPERNT7 = 'Z300'| 
OPERNT7 = 'Z301'| 
OPERNT7 = 'Z302'| 
OPERNT7 = 'Z303'| 
OPERNT7 = 'Z304'| 
OPERNT7 = 'Z305'| 
OPERNT7 = 'Z306'| 
OPERNT7 = 'Z307'| 
OPERNT7 = 'Z308'| 
OPERNT7 = 'Z309'| 
OPERNT7 = 'Z311'| 
OPERNT7 = 'Z312'| 
OPERNT6 = 'Y141'| 
OPERNT6 = 'Y142'| 
OPERNT6 = 'Y143'| 
OPERNT6 = 'Y144'| 
OPERNT6 = 'Y148'| 
OPERNT6 = 'Y149'| 
OPERNT6 = 'Y151'| 
OPERNT6 = 'Y152'| 
OPERNT6 = 'Y153'| 
OPERNT6 = 'Y154'| 
OPERNT6 = 'Y156'| 
OPERNT6 = 'Y157'| 
OPERNT6 = 'Y158'| 
OPERNT6 = 'Y159'| 
OPERNT6 = 'Y203'| 
OPERNT6 = 'Y204'| 
OPERNT6 = 'Y211'| 
OPERNT6 = 'Y511'| 
OPERNT6 = 'Y512'| 
OPERNT6 = 'Z300'| 
OPERNT6 = 'Z301'| 
OPERNT6 = 'Z302'| 
OPERNT6 = 'Z303'| 
OPERNT6 = 'Z304'| 
OPERNT6 = 'Z305'| 
OPERNT6 = 'Z306'| 
OPERNT6 = 'Z307'| 
OPERNT6 = 'Z308'| 
OPERNT6 = 'Z309'| 
OPERNT6 = 'Z311'| 
OPERNT6 = 'Z312'| 
OPERNT5 = 'Y141'| 
OPERNT5 = 'Y142'| 
OPERNT5 = 'Y143'| 
OPERNT5 = 'Y144'| 
OPERNT5 = 'Y148'| 
OPERNT5 = 'Y149'| 
OPERNT5 = 'Y151'| 
OPERNT5 = 'Y152'| 
OPERNT5 = 'Y153'| 
OPERNT5 = 'Y154'| 
OPERNT5 = 'Y156'| 
OPERNT5 = 'Y157'| 
OPERNT5 = 'Y158'| 
OPERNT5 = 'Y159'| 
OPERNT5 = 'Y203'| 
OPERNT5 = 'Y204'| 
OPERNT5 = 'Y211'| 
OPERNT5 = 'Y511'| 
OPERNT5 = 'Y512'| 
OPERNT5 = 'Z300'| 
OPERNT5 = 'Z301'| 
OPERNT5 = 'Z302'| 
OPERNT5 = 'Z303'| 
OPERNT5 = 'Z304'| 
OPERNT5 = 'Z305'| 
OPERNT5 = 'Z306'| 
OPERNT5 = 'Z307'| 
OPERNT5 = 'Z308'| 
OPERNT5 = 'Z309'| 
OPERNT5 = 'Z311'| 
OPERNT5 = 'Z312'| 
OPERNT4 = 'Y141'| 
OPERNT4 = 'Y142'| 
OPERNT4 = 'Y143'| 
OPERNT4 = 'Y144'| 
OPERNT4 = 'Y148'| 
OPERNT4 = 'Y149'| 
OPERNT4 = 'Y151'| 
OPERNT4 = 'Y152'| 
OPERNT4 = 'Y153'| 
OPERNT4 = 'Y154'| 
OPERNT4 = 'Y156'| 
OPERNT4 = 'Y157'| 
OPERNT4 = 'Y158'| 
OPERNT4 = 'Y159'| 
OPERNT4 = 'Y203'| 
OPERNT4 = 'Y204'| 
OPERNT4 = 'Y211'| 
OPERNT4 = 'Y511'| 
OPERNT4 = 'Y512'| 
OPERNT4 = 'Z300'| 
OPERNT4 = 'Z301'| 
OPERNT4 = 'Z302'| 
OPERNT4 = 'Z303'| 
OPERNT4 = 'Z304'| 
OPERNT4 = 'Z305'| 
OPERNT4 = 'Z306'| 
OPERNT4 = 'Z307'| 
OPERNT4 = 'Z308'| 
OPERNT4 = 'Z309'| 
OPERNT4 = 'Z311'| 
OPERNT4 = 'Z312'| 
OPERNT3 = 'Y141'| 
OPERNT3 = 'Y142'| 
OPERNT3 = 'Y143'| 
OPERNT3 = 'Y144'| 
OPERNT3 = 'Y148'| 
OPERNT3 = 'Y149'| 
OPERNT3 = 'Y151'| 
OPERNT3 = 'Y152'| 
288 
 
OPERNT3 = 'Y153'| 
OPERNT3 = 'Y154'| 
OPERNT3 = 'Y156'| 
OPERNT3 = 'Y157'| 
OPERNT3 = 'Y158'| 
OPERNT3 = 'Y159'| 
OPERNT3 = 'Y203'| 
OPERNT3 = 'Y204'| 
OPERNT3 = 'Y211'| 
OPERNT3 = 'Y511'| 
OPERNT3 = 'Y512'| 
OPERNT3 = 'Z300'| 
OPERNT3 = 'Z301'| 
OPERNT3 = 'Z302'| 
OPERNT3 = 'Z303'| 
OPERNT3 = 'Z304'| 
OPERNT3 = 'Z305'| 
OPERNT3 = 'Z306'| 
OPERNT3 = 'Z307'| 
OPERNT3 = 'Z308'| 
OPERNT3 = 'Z309'| 
OPERNT3 = 'Z311'| 
OPERNT3 = 'Z312'| 
OPERNT2 = 'Y141'| 
OPERNT2 = 'Y142'| 
OPERNT2 = 'Y143'| 
OPERNT2 = 'Y144'| 
OPERNT2 = 'Y148'| 
OPERNT2 = 'Y149'| 
OPERNT2 = 'Y151'| 
OPERNT2 = 'Y152'| 
OPERNT2 = 'Y153'| 
OPERNT2 = 'Y154'| 
OPERNT2 = 'Y156'| 
OPERNT2 = 'Y157'| 
OPERNT2 = 'Y158'| 
OPERNT2 = 'Y159'| 
OPERNT2 = 'Y203'| 
OPERNT2 = 'Y204'| 
OPERNT2 = 'Y211'| 
OPERNT2 = 'Y511'| 
OPERNT2 = 'Y512'| 
OPERNT2 = 'Z300'| 
OPERNT2 = 'Z301'| 
OPERNT2 = 'Z302'| 
OPERNT2 = 'Z303'| 
OPERNT2 = 'Z304'| 
OPERNT2 = 'Z305'| 
OPERNT2 = 'Z306'| 
OPERNT2 = 'Z307'| 
OPERNT2 = 'Z308'| 
OPERNT2 = 'Z309'| 
OPERNT2 = 'Z311'| 
OPERNT2 = 'Z312'| 
OPERNT1 = 'Y141'| 
OPERNT1 = 'Y142'| 
OPERNT1 = 'Y143'| 
OPERNT1 = 'Y144'| 
OPERNT1 = 'Y148'| 
OPERNT1 = 'Y149'| 
OPERNT1 = 'Y151'| 
OPERNT1 = 'Y152'| 
OPERNT1 = 'Y153'| 
OPERNT1 = 'Y154'| 
OPERNT1 = 'Y156'| 
OPERNT1 = 'Y157'| 
OPERNT1 = 'Y158'| 
OPERNT1 = 'Y159'| 
OPERNT1 = 'Y203'| 
OPERNT1 = 'Y204'| 
OPERNT1 = 'Y211'| 
OPERNT1 = 'Y511'| 
OPERNT1 = 'Y512'| 
OPERNT1 = 'Z300'| 
OPERNT1 = 'Z301'| 
OPERNT1 = 'Z302'| 
OPERNT1 = 'Z303'| 
OPERNT1 = 'Z304'| 
OPERNT1 = 'Z305'| 
OPERNT1 = 'Z306'| 
OPERNT1 = 'Z307'| 
OPERNT1 = 'Z308'| 
OPERNT1 = 'Z309'| 
OPERNT1 = 'Z311'| 
OPERNT1 = 'Z312')YZCODES 
= 1. 
EXECUTE
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PEG Syntax 1 Extracting PEG episodes 
 ‘Select cases if’: OPERTN1 = 'G341' | OPERTN1 = 'G342' | OPERTN1 = 'G343' | 
OPERTN1 = 'G344' | OPERTN1 = 'G345' | OPERTN1 = 'G348' | OPERTN1 = 'G349' | 
OPERTN1 = 'G361' | OPERTN1 = 'G363' | OPERTN1 = 'G368' | OPERTN1 = 'G369' | 
OPERTN1 = 'G445' | OPERTN1 = 'G448' 
PEG Syntax 2 – G445 code present
COMPUTE PEGINSERT1 = 0. 
EXECUTE. 
IF (OPERTN1 = 'G445')PEGINSERT1 = 1. 
EXECUTE.  
COMPUTE PEGINSERT2 = 0. 
EXECUTE. 
IF (OPERTN2 = 'G445')PEGINSERT2 = 1. 
EXECUTE.  
COMPUTE PEGINSERT3 = 0. 
EXECUTE. 
IF (OPERTN3 = 'G445')PEGINSERT3 = 1. 
EXECUTE.  
COMPUTE PEGINSERT4 = 0. 
EXECUTE. 
IF (OPERTN4 = 'G445')PEGINSERT4 = 1. 
EXECUTE.  
COMPUTE PEGINSERT5 = 0. 
EXECUTE. 
IF (OPERTN5 = 'G445')PEGINSERT5 = 1. 
EXECUTE.  
COMPUTE PEGINSERT6 = 0. 
EXECUTE. 
IF (OPERTN6 = 'G445')PEGINSERT6 = 1. 
EXECUTE.  
COMPUTE PEGINSERT7 = 0. 
EXECUTE. 
IF (OPERTN7 = 'G445')PEGINSERT7 = 1. 
EXECUTE. 
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PEG Syntax 3 – Assign PEG procedure code position
  
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN1= 'G341'|  
OPERTN1= 'G342'|   
OPERTN1= 'G343'|                
OPERTN1= 'G344'|                
OPERTN1= 'G345'|                
OPERTN1= 'G348'|                
OPERTN1= 'G349'|                
OPERTN1= 'G361'|                
OPERTN1= 'G363'|                
OPERTN1= 'G368'|                
OPERTN1= 'G369'|                
OPERTN1= 'G445'| 
OPERTN1= 'G448')PEG = 1.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN2= 'G341'|  
OPERTN2= 'G342'|   
OPERTN2= 'G343'|                
OPERTN2= 'G344'|                
OPERTN2= 'G345'|                
OPERTN2= 'G348'|                
OPERTN2= 'G349'|                
OPERTN2= 'G361'|                
OPERTN2= 'G363'|                
OPERTN2= 'G368'|                
OPERTN2= 'G369'|                
OPERTN2= 'G445'| 
OPERTN2= 'G448')PEG = 2.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN3= 'G341'|  
OPERTN3= 'G342'|   
OPERTN3= 'G343'|                
OPERTN3= 'G344'|                
OPERTN3= 'G345'|                
OPERTN3= 'G348'|                
OPERTN3= 'G349'|                
OPERTN3= 'G361'|                
OPERTN3= 'G363'|                
OPERTN3= 'G368'|                
OPERTN3= 'G369'|                
OPERTN3= 'G445'| 
OPERTN3= 'G448')PEG = 3.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN4= 'G341'|  
OPERTN4= 'G342'|   
OPERTN4= 'G343'|                
OPERTN4= 'G344'|                
OPERTN4= 'G345'|                
OPERTN4= 'G348'|                
OPERTN4= 'G349'|                
OPERTN4= 'G361'|                
OPERTN4= 'G363'|                
OPERTN4= 'G368'|                
OPERTN4= 'G369'|                
OPERTN4= 'G445'| 
OPERTN4= 'G448')PEG = 4.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN5= 'G341'|  
OPERTN5= 'G342'|   
OPERTN5= 'G343'|                
OPERTN5= 'G344'|                
OPERTN5= 'G345'|                
OPERTN5= 'G348'|                
OPERTN5= 'G349'|                
OPERTN5= 'G361'|                
OPERTN5= 'G363'|                
OPERTN5= 'G368'|                
OPERTN5= 'G369'|                
OPERTN5= 'G445'| 
OPERTN5= 'G448')PEG = 5.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN6= 'G341'|  
OPERTN6= 'G342'|   
OPERTN6= 'G343'|                
OPERTN6= 'G344'|                
OPERTN6= 'G345'|                
OPERTN6= 'G348'|                
OPERTN6= 'G349'|                
OPERTN6= 'G361'|                
OPERTN6= 'G363'|                
OPERTN6= 'G368'|                
OPERTN6= 'G369'|                
OPERTN6= 'G445'| 
OPERTN6= 'G448')PEG = 6.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN7= 'G341'|  
OPERTN7= 'G342'|   
OPERTN7= 'G343'|                
OPERTN7= 'G344'|                
OPERTN7= 'G345'|                
OPERTN7= 'G348'|                
OPERTN7= 'G349'|                
OPERTN7= 'G361'|                
OPERTN7= 'G363'|                
OPERTN7= 'G368'|                
OPERTN7= 'G369'|                
OPERTN7= 'G445'| 
OPERTN7= 'G448')PEG = 7.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN8= 'G341'|  
OPERTN8= 'G342'|   
OPERTN8= 'G343'|                
OPERTN8= 'G344'|                
OPERTN8= 'G345'|                
OPERTN8= 'G348'|                
OPERTN8= 'G349'|                
OPERTN8= 'G361'|                
OPERTN8= 'G363'|                
OPERTN8= 'G368'|                
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OPERTN8= 'G369'|                
OPERTN8= 'G445'| 
OPERTN8= 'G448')PEG = 8.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN9= 'G341'|  
OPERTN9= 'G342'|   
OPERTN9= 'G343'|                
OPERTN9= 'G344'|                
OPERTN9= 'G345'|                
OPERTN9= 'G348'|                
OPERTN9= 'G349'|                
OPERTN9= 'G361'|                
OPERTN9= 'G363'|                
OPERTN9= 'G368'|                
OPERTN9= 'G369'|                
OPERTN9= 'G445'| 
OPERTN9= 'G448')PEG = 9.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN10= 'G341'|  
OPERTN10= 'G342'|   
OPERTN10= 'G343'|                
OPERTN10= 'G344'|                
OPERTN10= 'G345'|                
OPERTN10= 'G348'|                
OPERTN10= 'G349'|                
OPERTN10= 'G361'|                
OPERTN10= 'G363'|                
OPERTN10= 'G368'|                
OPERTN10= 'G369'|                
OPERTN10= 'G445'| 
OPERTN10= 'G448')PEG = 
10.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN11= 'G341'|  
OPERTN11= 'G342'|   
OPERTN11= 'G343'|                
OPERTN11= 'G344'|                
OPERTN11= 'G345'|                
OPERTN11= 'G348'|                
OPERTN11= 'G349'|                
OPERTN11= 'G361'|                
OPERTN11= 'G363'|                
OPERTN11= 'G368'|                
OPERTN11= 'G369'|                
OPERTN11= 'G445'| 
OPERTN11= 'G448')PEG = 
11.  
EXECUTE.   
 
COMPUTE PEG = 0. 
EXECUTE. 
IF (OPERTN12= 'G341'|  
OPERTN12= 'G342'|   
OPERTN12= 'G343'|                
OPERTN12= 'G344'|                
OPERTN12= 'G345'|                
OPERTN12= 'G348'|                
OPERTN12= 'G349'|                
OPERTN12= 'G361'|                
OPERTN12= 'G363'|                
OPERTN12= 'G368'|                
OPERTN12= 'G369'|                
OPERTN12= 'G445'| 
OPERTN12= 'G448')PEG = 
12.  
EXECUTE.  
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PEG Syntax 4 – PEG procedure date before admission date 
COMPUTE PEGDATEB4ADMISSION = 0. 
EXECUTE. 
 
IF (PEGDATE1 < ADMIDATE1)PEGDATEB4ADMISSION = 1. 
EXECUTE. 
PEG Syntax 5 – Date of death before PEG procedure date 
COMPUTE DEATHDATEB4PEG = 0. 
EXECUTE. 
 
IF (DEATHDATE < PEGDATE1)DEATHDATEB4PEG = 1. 
EXECUTE.
 
PEG Syntax 6 – Non-stroke, non-cancer comorbidity code present
 
COMPUTE 
NONSTROKENONCANCERCOM
ORB1 = 0. 
EXECUTE. 
IF (DIAG01 = 'I210'| 
DIAG01 = 'I211'| 
DIAG01 = 'I212'| 
DIAG01 = 'I213'| 
DIAG01 = 'I214'| 
DIAG01 = 'I219'| 
DIAG01 = 'I220'| 
DIAG01 = 'I221'| 
DIAG01 = 'I228'| 
DIAG01 = 'I229'| 
DIAG01 = 'I252'| 
DIAG01 = 'I500'| 
DIAG01 = 'I710'| 
DIAG01 = 'I711'| 
DIAG01 = 'I712'| 
DIAG01 = 'I713'| 
DIAG01 = 'I714'| 
DIAG01 = 'I715'| 
DIAG01 = 'I716'| 
DIAG01 = 'I718'| 
DIAG01 = 'I719'| 
DIAG01 = 'I738'| 
DIAG01 = 'I739'| 
DIAG01 = 'F000'| 
DIAG01 = 'F001'| 
DIAG01 = 'F002'| 
DIAG01 = 'F009'| 
DIAG01 = 'F010'| 
DIAG01 = 'F011'| 
DIAG01 = 'F012'| 
DIAG01 = 'F013'| 
DIAG01 = 'F018'| 
DIAG01 = 'F019'| 
DIAG01 = 'F020'| 
DIAG01 = 'F021'| 
DIAG01 = 'F022'| 
DIAG01 = 'F023'| 
DIAG01 = 'F024'| 
DIAG01 = 'F028'| 
DIAG01 = 'F03X'| 
DIAG01 = 'F051'| 
DIAG01 = 'J40X'| 
DIAG01 = 'J410'| 
DIAG01 = 'J411'| 
DIAG01 = 'J418'| 
DIAG01 = 'J42X'| 
DIAG01 = 'J430'| 
DIAG01 = 'J431'| 
DIAG01 = 'J432'| 
DIAG01 = 'J438'| 
DIAG01 = 'J439'| 
DIAG01 = 'J440'| 
DIAG01 = 'J441'| 
DIAG01 = 'J448'| 
DIAG01 = 'J449'| 
DIAG01 = 'J450'| 
DIAG01 = 'J451'| 
DIAG01 = 'J458'| 
DIAG01 = 'J459'| 
DIAG01 = 'J46X'| 
DIAG01 = 'J47X'| 
DIAG01 = 'J60X'| 
DIAG01 = 'J61X'| 
DIAG01 = 'J620'| 
DIAG01 = 'J628'| 
DIAG01 = 'J630'| 
DIAG01 = 'J631'| 
DIAG01 = 'J632'| 
DIAG01 = 'J633'| 
DIAG01 = 'J634'| 
DIAG01 = 'J635'| 
DIAG01 = 'J638'| 
DIAG01 = 'J64X'| 
DIAG01 = 'J65X'| 
DIAG01 = 'J660'| 
DIAG01 = 'J661'| 
DIAG01 = 'J662'| 
DIAG01 = 'J668'| 
DIAG01 = 'J670'| 
DIAG01 = 'J671'| 
DIAG01 = 'J672'| 
DIAG01 = 'J673'| 
DIAG01 = 'J674'| 
DIAG01 = 'J675'| 
DIAG01 = 'J676'| 
DIAG01 = 'J677'| 
DIAG01 = 'J678'| 
DIAG01 = 'J679'| 
DIAG01 = 'M050'| 
DIAG01 = 'M051'| 
DIAG01 = 'M052'| 
DIAG01 = 'M059'| 
DIAG01 = 'M060'| 
DIAG01 = 'M063'| 
DIAG01 = 'M069'| 
DIAG01 = 'M300'| 
DIAG01 = 'M301'| 
DIAG01 = 'M302'| 
DIAG01 = 'M303'| 
DIAG01 = 'M308'| 
DIAG01 = 'M310'| 
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DIAG01 = 'M311'| 
DIAG01 = 'M312'| 
DIAG01 = 'M313'| 
DIAG01 = 'M314'| 
DIAG01 = 'M315'| 
DIAG01 = 'M316'| 
DIAG01 = 'M318'| 
DIAG01 = 'M319'| 
DIAG01 = 'M320'| 
DIAG01 = 'M321'| 
DIAG01 = 'M328'| 
DIAG01 = 'M329'| 
DIAG01 = 'M332'| 
DIAG01 = 'M339'| 
DIAG01 = 'M340'| 
DIAG01 = 'M341'| 
DIAG01 = 'M342'| 
DIAG01 = 'M348'| 
DIAG01 = 'M349'| 
DIAG01 = 'M350'| 
DIAG01 = 'M351'| 
DIAG01 = 'M352'| 
DIAG01 = 'M353'| 
DIAG01 = 'M354'| 
DIAG01 = 'M355'| 
DIAG01 = 'M356'| 
DIAG01 = 'M357'| 
DIAG01 = 'K250'| 
DIAG01 = 'K251'| 
DIAG01 = 'K252'| 
DIAG01 = 'K253'| 
DIAG01 = 'K254'| 
DIAG01 = 'K255'| 
DIAG01 = 'K256'| 
DIAG01 = 'K257'| 
DIAG01 = 'K259'| 
DIAG01 = 'K260'| 
DIAG01 = 'K261'| 
DIAG01 = 'K262'| 
DIAG01 = 'K263'| 
DIAG01 = 'K264'| 
DIAG01 = 'K265'| 
DIAG01 = 'K266'| 
DIAG01 = 'K267'| 
DIAG01 = 'K269'| 
DIAG01 = 'K270'| 
DIAG01 = 'K271'| 
DIAG01 = 'K272'| 
DIAG01 = 'K273'| 
DIAG01 = 'K274'| 
DIAG01 = 'K275'| 
DIAG01 = 'K276'| 
DIAG01 = 'K277'| 
DIAG01 = 'K279'| 
DIAG01 = 'K280'| 
DIAG01 = 'K281'| 
DIAG01 = 'K282'| 
DIAG01 = 'K283'| 
DIAG01 = 'K284'| 
DIAG01 = 'K285'| 
DIAG01 = 'K286'| 
DIAG01 = 'K287'| 
DIAG01 = 'K289'| 
DIAG01 = 'K701'| 
DIAG01 = 'K702'| 
DIAG01 = 'K703'| 
DIAG01 = 'K704'| 
DIAG01 = 'K709'| 
DIAG01 = 'K710'| 
DIAG01 = 'K711'| 
DIAG01 = 'K712'| 
DIAG01 = 'K713'| 
DIAG01 = 'K714'| 
DIAG01 = 'K715'| 
DIAG01 = 'K716'| 
DIAG01 = 'K717'| 
DIAG01 = 'K718'| 
DIAG01 = 'K719'| 
DIAG01 = 'K721'| 
DIAG01 = 'K729'| 
DIAG01 = 'K730'| 
DIAG01 = 'K731'| 
DIAG01 = 'K732'| 
DIAG01 = 'K738'| 
DIAG01 = 'K739'| 
DIAG01 = 'K740'| 
DIAG01 = 'K741'| 
DIAG01 = 'K742'| 
DIAG01 = 'K743'| 
DIAG01 = 'K744'| 
DIAG01 = 'K745'| 
DIAG01 = 'K746'| 
DIAG01 = 'K753'| 
DIAG01 = 'K754'| 
DIAG01 = 'K758'| 
DIAG01 = 'K764'| 
DIAG01 = 'K765'| 
DIAG01 = 'K766'| 
DIAG01 = 'K767'| 
DIAG01 = 'K768'| 
DIAG01 = 'E102'| 
DIAG01 = 'E103'| 
DIAG01 = 'E104'| 
DIAG01 = 'E105'| 
DIAG01 = 'E106'| 
DIAG01 = 'E107'| 
DIAG01 = 'E108'| 
DIAG01 = 'E109'| 
DIAG01 = 'E112'| 
DIAG01 = 'E113'| 
DIAG01 = 'E114'| 
DIAG01 = 'E115'| 
DIAG01 = 'E116'| 
DIAG01 = 'E117'| 
DIAG01 = 'E118'| 
DIAG01 = 'E119'| 
DIAG01 = 'E132'| 
DIAG01 = 'E133'| 
DIAG01 = 'E134'| 
DIAG01 = 'E135'| 
DIAG01 = 'E136'| 
DIAG01 = 'E137'| 
DIAG01 = 'E138'| 
DIAG01 = 'E139'| 
DIAG01 = 'E142'| 
DIAG01 = 'E143'| 
DIAG01 = 'E144'| 
DIAG01 = 'E145'| 
DIAG01 = 'E146'| 
DIAG01 = 'E147'| 
DIAG01 = 'E148'| 
DIAG01 = 'E149'| 
DIAG01 = 'N001'| 
DIAG01 = 'N002'| 
DIAG01 = 'N003'| 
DIAG01 = 'N004'| 
DIAG01 = 'N005'| 
DIAG01 = 'N007'| 
DIAG01 = 'N010'| 
DIAG01 = 'N011'| 
DIAG01 = 'N012'| 
DIAG01 = 'N013'| 
DIAG01 = 'N014'| 
DIAG01 = 'N015'| 
DIAG01 = 'N016'| 
DIAG01 = 'N017'| 
DIAG01 = 'N018'| 
DIAG01 = 'N019'| 
DIAG01 = 'N020'| 
DIAG01 = 'N021'| 
DIAG01 = 'N022'| 
DIAG01 = 'N023'| 
DIAG01 = 'N024'| 
DIAG01 = 'N025'| 
DIAG01 = 'N026'| 
DIAG01 = 'N027'| 
DIAG01 = 'N030'| 
DIAG01 = 'N031'| 
DIAG01 = 'N032'| 
DIAG01 = 'N033'| 
DIAG01 = 'N034'| 
DIAG01 = 'N035'| 
DIAG01 = 'N036'| 
DIAG01 = 'N037'| 
DIAG01 = 'N038'| 
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DIAG01 = 'N039'| 
DIAG01 = 'N040'| 
DIAG01 = 'N041'| 
DIAG01 = 'N042'| 
DIAG01 = 'N043'| 
DIAG01 = 'N044'| 
DIAG01 = 'N045'| 
DIAG01 = 'N046'| 
DIAG01 = 'N047'| 
DIAG01 = 'N048'| 
DIAG01 = 'N049'| 
DIAG01 = 'N050'| 
DIAG01 = 'N051'| 
DIAG01 = 'N052'| 
DIAG01 = 'N053'| 
DIAG01 = 'N054'| 
DIAG01 = 'N055'| 
DIAG01 = 'N056'| 
DIAG01 = 'N057'| 
DIAG01 = 'N071'| 
DIAG01 = 'N072'| 
DIAG01 = 'N073'| 
DIAG01 = 'N074'| 
DIAG01 = 'N075'| 
DIAG01 = 'N180'| 
DIAG01 = 'N188'| 
DIAG01 = 'N189'| 
DIAG01 = 'N19X'| 
DIAG01 = 'N250'| 
DIAG01 = 'Z992'| 
DIAG01 = 'B200'| 
DIAG01 = 'B201'| 
DIAG01 = 'B202'| 
DIAG01 = 'B203'| 
DIAG01 = 'B204'| 
DIAG01 = 'B205'| 
DIAG01 = 'B206'| 
DIAG01 = 'B207'| 
DIAG01 = 'B208'| 
DIAG01 = 'B209'| 
DIAG01 = 'B210'| 
DIAG01 = 'B211'| 
DIAG01 = 'B212'| 
DIAG01 = 'B213'| 
DIAG01 = 'B217'| 
DIAG01 = 'B218'| 
DIAG01 = 'B219'| 
DIAG01 = 'B220'| 
DIAG01 = 'B221'| 
DIAG01 = 'B222'| 
DIAG01 = 'B227'| 
DIAG01 = 'B230'| 
DIAG01 = 'B231'| 
DIAG01 = 'B232'| 
DIAG01 = 'B238'| 
DIAG01 = 
'B24X')NONSTROKENONCANC
ERCOMORB1 = 1. 
EXECUTE. 
 
COMPUTE 
NONSTROKENONCANCERCOM
ORB2 = 0. 
EXECUTE. 
IF (DIAG02 = 'I210'| 
DIAG02 = 'I211'| 
DIAG02 = 'I212'| 
DIAG02 = 'I213'| 
DIAG02 = 'I214'| 
DIAG02 = 'I219'| 
DIAG02 = 'I220'| 
DIAG02 = 'I221'| 
DIAG02 = 'I228'| 
DIAG02 = 'I229'| 
DIAG02 = 'I252'| 
DIAG02 = 'I500'| 
DIAG02 = 'I710'| 
DIAG02 = 'I711'| 
DIAG02 = 'I712'| 
DIAG02 = 'I713'| 
DIAG02 = 'I714'| 
DIAG02 = 'I715'| 
DIAG02 = 'I716'| 
DIAG02 = 'I718'| 
DIAG02 = 'I719'| 
DIAG02 = 'I738'| 
DIAG02 = 'I739'| 
DIAG02 = 'F000'| 
DIAG02 = 'F001'| 
DIAG02 = 'F002'| 
DIAG02 = 'F009'| 
DIAG02 = 'F010'| 
DIAG02 = 'F011'| 
DIAG02 = 'F012'| 
DIAG02 = 'F013'| 
DIAG02 = 'F018'| 
DIAG02 = 'F019'| 
DIAG02 = 'F020'| 
DIAG02 = 'F021'| 
DIAG02 = 'F022'| 
DIAG02 = 'F023'| 
DIAG02 = 'F024'| 
DIAG02 = 'F028'| 
DIAG02 = 'F03X'| 
DIAG02 = 'F051'| 
DIAG02 = 'J40X'| 
DIAG02 = 'J410'| 
DIAG02 = 'J411'| 
DIAG02 = 'J418'| 
DIAG02 = 'J42X'| 
DIAG02 = 'J430'| 
DIAG02 = 'J431'| 
DIAG02 = 'J432'| 
DIAG02 = 'J438'| 
DIAG02 = 'J439'| 
DIAG02 = 'J440'| 
DIAG02 = 'J441'| 
DIAG02 = 'J448'| 
DIAG02 = 'J449'| 
DIAG02 = 'J450'| 
DIAG02 = 'J451'| 
DIAG02 = 'J458'| 
DIAG02 = 'J459'| 
DIAG02 = 'J46X'| 
DIAG02 = 'J47X'| 
DIAG02 = 'J60X'| 
DIAG02 = 'J61X'| 
DIAG02 = 'J620'| 
DIAG02 = 'J628'| 
DIAG02 = 'J630'| 
DIAG02 = 'J631'| 
DIAG02 = 'J632'| 
DIAG02 = 'J633'| 
DIAG02 = 'J634'| 
DIAG02 = 'J635'| 
DIAG02 = 'J638'| 
DIAG02 = 'J64X'| 
DIAG02 = 'J65X'| 
DIAG02 = 'J660'| 
DIAG02 = 'J661'| 
DIAG02 = 'J662'| 
DIAG02 = 'J668'| 
DIAG02 = 'J670'| 
DIAG02 = 'J671'| 
DIAG02 = 'J672'| 
DIAG02 = 'J673'| 
DIAG02 = 'J674'| 
DIAG02 = 'J675'| 
DIAG02 = 'J676'| 
DIAG02 = 'J677'| 
DIAG02 = 'J678'| 
DIAG02 = 'J679'| 
DIAG02 = 'M050'| 
DIAG02 = 'M051'| 
DIAG02 = 'M052'| 
DIAG02 = 'M059'| 
DIAG02 = 'M060'| 
DIAG02 = 'M063'| 
DIAG02 = 'M069'| 
DIAG02 = 'M300'| 
DIAG02 = 'M301'| 
DIAG02 = 'M302'| 
DIAG02 = 'M303'| 
DIAG02 = 'M308'| 
DIAG02 = 'M310'| 
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DIAG02 = 'M311'| 
DIAG02 = 'M312'| 
DIAG02 = 'M313'| 
DIAG02 = 'M314'| 
DIAG02 = 'M315'| 
DIAG02 = 'M316'| 
DIAG02 = 'M318'| 
DIAG02 = 'M319'| 
DIAG02 = 'M320'| 
DIAG02 = 'M321'| 
DIAG02 = 'M328'| 
DIAG02 = 'M329'| 
DIAG02 = 'M332'| 
DIAG02 = 'M339'| 
DIAG02 = 'M340'| 
DIAG02 = 'M341'| 
DIAG02 = 'M342'| 
DIAG02 = 'M348'| 
DIAG02 = 'M349'| 
DIAG02 = 'M350'| 
DIAG02 = 'M351'| 
DIAG02 = 'M352'| 
DIAG02 = 'M353'| 
DIAG02 = 'M354'| 
DIAG02 = 'M355'| 
DIAG02 = 'M356'| 
DIAG02 = 'M357'| 
DIAG02 = 'K250'| 
DIAG02 = 'K251'| 
DIAG02 = 'K252'| 
DIAG02 = 'K253'| 
DIAG02 = 'K254'| 
DIAG02 = 'K255'| 
DIAG02 = 'K256'| 
DIAG02 = 'K257'| 
DIAG02 = 'K259'| 
DIAG02 = 'K260'| 
DIAG02 = 'K261'| 
DIAG02 = 'K262'| 
DIAG02 = 'K263'| 
DIAG02 = 'K264'| 
DIAG02 = 'K265'| 
DIAG02 = 'K266'| 
DIAG02 = 'K267'| 
DIAG02 = 'K269'| 
DIAG02 = 'K270'| 
DIAG02 = 'K271'| 
DIAG02 = 'K272'| 
DIAG02 = 'K273'| 
DIAG02 = 'K274'| 
DIAG02 = 'K275'| 
DIAG02 = 'K276'| 
DIAG02 = 'K277'| 
DIAG02 = 'K279'| 
DIAG02 = 'K280'| 
DIAG02 = 'K281'| 
DIAG02 = 'K282'| 
DIAG02 = 'K283'| 
DIAG02 = 'K284'| 
DIAG02 = 'K285'| 
DIAG02 = 'K286'| 
DIAG02 = 'K287'| 
DIAG02 = 'K289'| 
DIAG02 = 'K701'| 
DIAG02 = 'K702'| 
DIAG02 = 'K703'| 
DIAG02 = 'K704'| 
DIAG02 = 'K709'| 
DIAG02 = 'K710'| 
DIAG02 = 'K711'| 
DIAG02 = 'K712'| 
DIAG02 = 'K713'| 
DIAG02 = 'K714'| 
DIAG02 = 'K715'| 
DIAG02 = 'K716'| 
DIAG02 = 'K717'| 
DIAG02 = 'K718'| 
DIAG02 = 'K719'| 
DIAG02 = 'K721'| 
DIAG02 = 'K729'| 
DIAG02 = 'K730'| 
DIAG02 = 'K731'| 
DIAG02 = 'K732'| 
DIAG02 = 'K738'| 
DIAG02 = 'K739'| 
DIAG02 = 'K740'| 
DIAG02 = 'K741'| 
DIAG02 = 'K742'| 
DIAG02 = 'K743'| 
DIAG02 = 'K744'| 
DIAG02 = 'K745'| 
DIAG02 = 'K746'| 
DIAG02 = 'K753'| 
DIAG02 = 'K754'| 
DIAG02 = 'K758'| 
DIAG02 = 'K764'| 
DIAG02 = 'K765'| 
DIAG02 = 'K766'| 
DIAG02 = 'K767'| 
DIAG02 = 'K768'| 
DIAG02 = 'E102'| 
DIAG02 = 'E103'| 
DIAG02 = 'E104'| 
DIAG02 = 'E105'| 
DIAG02 = 'E106'| 
DIAG02 = 'E107'| 
DIAG02 = 'E108'| 
DIAG02 = 'E109'| 
DIAG02 = 'E112'| 
DIAG02 = 'E113'| 
DIAG02 = 'E114'| 
DIAG02 = 'E115'| 
DIAG02 = 'E116'| 
DIAG02 = 'E117'| 
DIAG02 = 'E118'| 
DIAG02 = 'E119'| 
DIAG02 = 'E132'| 
DIAG02 = 'E133'| 
DIAG02 = 'E134'| 
DIAG02 = 'E135'| 
DIAG02 = 'E136'| 
DIAG02 = 'E137'| 
DIAG02 = 'E138'| 
DIAG02 = 'E139'| 
DIAG02 = 'E142'| 
DIAG02 = 'E143'| 
DIAG02 = 'E144'| 
DIAG02 = 'E145'| 
DIAG02 = 'E146'| 
DIAG02 = 'E147'| 
DIAG02 = 'E148'| 
DIAG02 = 'E149'| 
DIAG02 = 'N001'| 
DIAG02 = 'N002'| 
DIAG02 = 'N003'| 
DIAG02 = 'N004'| 
DIAG02 = 'N005'| 
DIAG02 = 'N007'| 
DIAG02 = 'N010'| 
DIAG02 = 'N011'| 
DIAG02 = 'N012'| 
DIAG02 = 'N013'| 
DIAG02 = 'N014'| 
DIAG02 = 'N015'| 
DIAG02 = 'N016'| 
DIAG02 = 'N017'| 
DIAG02 = 'N018'| 
DIAG02 = 'N019'| 
DIAG02 = 'N020'| 
DIAG02 = 'N021'| 
DIAG02 = 'N022'| 
DIAG02 = 'N023'| 
DIAG02 = 'N024'| 
DIAG02 = 'N025'| 
DIAG02 = 'N026'| 
DIAG02 = 'N027'| 
DIAG02 = 'N030'| 
DIAG02 = 'N031'| 
DIAG02 = 'N032'| 
DIAG02 = 'N033'| 
DIAG02 = 'N034'| 
DIAG02 = 'N035'| 
DIAG02 = 'N036'| 
DIAG02 = 'N037'| 
DIAG02 = 'N038'| 
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DIAG02 = 'N039'| 
DIAG02 = 'N040'| 
DIAG02 = 'N041'| 
DIAG02 = 'N042'| 
DIAG02 = 'N043'| 
DIAG02 = 'N044'| 
DIAG02 = 'N045'| 
DIAG02 = 'N046'| 
DIAG02 = 'N047'| 
DIAG02 = 'N048'| 
DIAG02 = 'N049'| 
DIAG02 = 'N050'| 
DIAG02 = 'N051'| 
DIAG02 = 'N052'| 
DIAG02 = 'N053'| 
DIAG02 = 'N054'| 
DIAG02 = 'N055'| 
DIAG02 = 'N056'| 
DIAG02 = 'N057'| 
DIAG02 = 'N071'| 
DIAG02 = 'N072'| 
DIAG02 = 'N073'| 
DIAG02 = 'N074'| 
DIAG02 = 'N075'| 
DIAG02 = 'N180'| 
DIAG02 = 'N188'| 
DIAG02 = 'N189'| 
DIAG02 = 'N19X'| 
DIAG02 = 'N250'| 
DIAG02 = 'Z992'| 
DIAG02 = 'B200'| 
DIAG02 = 'B201'| 
DIAG02 = 'B202'| 
DIAG02 = 'B203'| 
DIAG02 = 'B204'| 
DIAG02 = 'B205'| 
DIAG02 = 'B206'| 
DIAG02 = 'B207'| 
DIAG02 = 'B208'| 
DIAG02 = 'B209'| 
DIAG02 = 'B210'| 
DIAG02 = 'B211'| 
DIAG02 = 'B212'| 
DIAG02 = 'B213'| 
DIAG02 = 'B217'| 
DIAG02 = 'B218'| 
DIAG02 = 'B219'| 
DIAG02 = 'B220'| 
DIAG02 = 'B221'| 
DIAG02 = 'B222'| 
DIAG02 = 'B227'| 
DIAG02 = 'B230'| 
DIAG02 = 'B231'| 
DIAG02 = 'B232'| 
DIAG02 = 'B238'| 
DIAG02 = 
'B24X')NONSTROKENONCANC
ERCOMORB2 = 1. 
EXECUTE 
 Then repeat as above 
for ICD-10 code positions 
3 through 20
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PEG Syntax 7 – Stroke code present
COMPUTE STROKE1 = 0. 
EXECUTE. 
IF(DIAG01 = 'G450'| 
DIAG01 = 'G451'| 
DIAG01 = 'G452'| 
DIAG01 = 'G454'| 
DIAG01 = 'G458'| 
DIAG01 = 'G459'| 
DIAG01 = 'G460'| 
DIAG01 = 'G461'| 
DIAG01 = 'G462'| 
DIAG01 = 'G463'| 
DIAG01 = 'G464'| 
DIAG01 = 'G465'| 
DIAG01 = 'G466'| 
DIAG01 = 'G467'| 
DIAG01 = 'G468'| 
DIAG01 = 'I600'| 
DIAG01 = 'I601'| 
DIAG01 = 'I602'| 
DIAG01 = 'I603'| 
DIAG01 = 'I604'| 
DIAG01 = 'I605'| 
DIAG01 = 'I606'| 
DIAG01 = 'I607'| 
DIAG01 = 'I608'| 
DIAG01 = 'I609'| 
DIAG01 = 'I610'| 
DIAG01 = 'I611'| 
DIAG01 = 'I612'| 
DIAG01 = 'I613'| 
DIAG01 = 'I614'| 
DIAG01 = 'I615'| 
DIAG01 = 'I616'| 
DIAG01 = 'I618'| 
DIAG01 = 'I619'| 
DIAG01 = 'I620'| 
DIAG01 = 'I621'| 
DIAG01 = 'I629'| 
DIAG01 = 'I630'| 
DIAG01 = 'I631'| 
DIAG01 = 'I632'| 
DIAG01 = 'I633'| 
DIAG01 = 'I634'| 
DIAG01 = 'I635'| 
DIAG01 = 'I636'| 
DIAG01 = 'I638'| 
DIAG01 = 'I639'| 
DIAG01 = 'I64X'| 
DIAG01 = 'I650'| 
DIAG01 = 'I651'| 
DIAG01 = 'I652'| 
DIAG01 = 'I653'| 
DIAG01 = 'I658'| 
DIAG01 = 'I659'| 
DIAG01 = 'I660'| 
DIAG01 = 'I661'| 
DIAG01 = 'I662'| 
DIAG01 = 'I663'| 
DIAG01 = 'I664'| 
DIAG01 = 'I668'| 
DIAG01 = 'I669'| 
DIAG01 = 'I670'| 
DIAG01 = 'I671'| 
DIAG01 = 'I672'| 
DIAG01 = 'I673'| 
DIAG01 = 'I674'| 
DIAG01 = 'I675'| 
DIAG01 = 'I676'| 
DIAG01 = 'I677'| 
DIAG01 = 'I678'| 
DIAG01 = 'I679'| 
DIAG01 = 'I681'| 
DIAG01 = 'I682'| 
DIAG01 = 'I688'| 
DIAG01 = 'I690'| 
DIAG01 = 'I691'| 
DIAG01 = 'I692'| 
DIAG01 = 'I693'| 
DIAG01 = 'I694'| 
DIAG01 = 'I698'| 
DIAG01 = 'G820'| 
DIAG01 = 'G821'| 
DIAG01 = 'G822'| 
DIAG01 = 'G810'| 
DIAG01 = 'G811'| 
DIAG01 = 'G819'| 
DIAG01 = 'G041')STROKE1 = 
1. 
EXECUTE. 
 
COMPUTE STROKE2 = 0. 
EXECUTE. 
IF(DIAG02 = 'G450'| 
DIAG02 = 'G451'| 
DIAG02 = 'G452'| 
DIAG02 = 'G454'| 
DIAG02 = 'G458'| 
DIAG02 = 'G459'| 
DIAG02 = 'G460'| 
DIAG02 = 'G461'| 
DIAG02 = 'G462'| 
DIAG02 = 'G463'| 
DIAG02 = 'G464'| 
DIAG02 = 'G465'| 
DIAG02 = 'G466'| 
DIAG02 = 'G467'| 
DIAG02 = 'G468'| 
DIAG02 = 'I600'| 
DIAG02 = 'I601'| 
DIAG02 = 'I602'| 
DIAG02 = 'I603'| 
DIAG02 = 'I604'| 
DIAG02 = 'I605'| 
DIAG02 = 'I606'| 
DIAG02 = 'I607'| 
DIAG02 = 'I608'| 
DIAG02 = 'I609'| 
DIAG02 = 'I610'| 
DIAG02 = 'I611'| 
DIAG02 = 'I612'| 
DIAG02 = 'I613'| 
DIAG02 = 'I614'| 
DIAG02 = 'I615'| 
DIAG02 = 'I616'| 
DIAG02 = 'I618'| 
DIAG02 = 'I619'| 
DIAG02 = 'I620'| 
DIAG02 = 'I621'| 
DIAG02 = 'I629'| 
DIAG02 = 'I630'| 
DIAG02 = 'I631'| 
DIAG02 = 'I632'| 
DIAG02 = 'I633'| 
DIAG02 = 'I634'| 
DIAG02 = 'I635'| 
DIAG02 = 'I636'| 
DIAG02 = 'I638'| 
DIAG02 = 'I639'| 
DIAG02 = 'I64X'| 
DIAG02 = 'I650'| 
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DIAG02 = 'I651'| 
DIAG02 = 'I652'| 
DIAG02 = 'I653'| 
DIAG02 = 'I658'| 
DIAG02 = 'I659'| 
DIAG02 = 'I660'| 
DIAG02 = 'I661'| 
DIAG02 = 'I662'| 
DIAG02 = 'I663'| 
DIAG02 = 'I664'| 
DIAG02 = 'I668'| 
DIAG02 = 'I669'| 
DIAG02 = 'I670'| 
DIAG02 = 'I671'| 
DIAG02 = 'I672'| 
DIAG02 = 'I673'| 
DIAG02 = 'I674'| 
DIAG02 = 'I675'| 
DIAG02 = 'I676'| 
DIAG02 = 'I677'| 
DIAG02 = 'I678'| 
DIAG02 = 'I679'| 
DIAG02 = 'I681'| 
DIAG02 = 'I682'| 
DIAG02 = 'I688'| 
DIAG02 = 'I690'| 
DIAG02 = 'I691'| 
DIAG02 = 'I692'| 
DIAG02 = 'I693'| 
DIAG02 = 'I694'| 
DIAG02 = 'I698'| 
DIAG02 = 'G820'| 
DIAG02 = 'G821'| 
DIAG02 = 'G822'| 
DIAG02 = 'G810'| 
DIAG02 = 'G811'| 
DIAG02 = 'G819'| 
DIAG02 = 'G041')STROKE2 = 
1. 
EXECUTE
.
 
Then repeat as above for ICD-10 code positions 3 through 20 
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PEG Syntax 8 – Dementia code present
COMPUTE DEMENTIA1 = 0. 
EXECUTE. 
IF(DIAG01 = 'F000'| 
DIAG01 = 'F001'| 
DIAG01 = 'F009'| 
DIAG01 = 'F011'| 
DIAG01 = 'F019'| 
DIAG01 = 'F020'| 
DIAG01 = 'F022'| 
DIAG01 = 'F023'| 
DIAG01 = 'F024'| 
DIAG01 = 'F028'| 
DIAG01 = 'F03X'| 
DIAG01 = 'F051'| 
DIAG01 = 'G300'| 
DIAG01 = 'G301'| 
DIAG01 = 'G309')DEMENTIA1 = 
1. 
EXECUTE.  
COMPUTE DEMENTIA2 = 0. 
EXECUTE. 
IF(DIAG02 = 'F000'| 
DIAG02 = 'F001'| 
DIAG02 = 'F009'| 
DIAG02 = 'F011'| 
DIAG02 = 'F019'| 
DIAG02 = 'F020'| 
DIAG02 = 'F022'| 
DIAG02 = 'F023'| 
DIAG02 = 'F024'| 
DIAG02 = 'F028'| 
DIAG02 = 'F03X'| 
DIAG02 = 'F051'| 
DIAG02 = 'G300'| 
DIAG02 = 'G301'| 
DIAG02 = 'G309')DEMENTIA2 = 
1. 
EXECUTE.  
COMPUTE DEMENTIA3 = 0. 
EXECUTE. 
IF(DIAG03 = 'F000'| 
DIAG03 = 'F001'| 
DIAG03 = 'F009'| 
DIAG03 = 'F011'| 
DIAG03 = 'F019'| 
DIAG03 = 'F020'| 
DIAG03 = 'F022'| 
DIAG03 = 'F023'| 
DIAG03 = 'F024'| 
DIAG03 = 'F028'| 
DIAG03 = 'F03X'| 
DIAG03 = 'F051'| 
DIAG03 = 'G300'| 
DIAG03 = 'G301'| 
DIAG03 = 'G309')DEMENTIA3 = 
1. 
EXECUTE.  
COMPUTE DEMENTIA4 = 0. 
EXECUTE. 
IF(DIAG04 = 'F000'| 
DIAG04 = 'F001'| 
DIAG04 = 'F009'| 
DIAG04 = 'F011'| 
DIAG04 = 'F019'| 
DIAG04 = 'F020'| 
DIAG04 = 'F022'| 
DIAG04 = 'F023'| 
DIAG04 = 'F024'| 
DIAG04 = 'F028'| 
DIAG04 = 'F03X'| 
DIAG04 = 'F051'| 
DIAG04 = 'G300'| 
DIAG04 = 'G301'| 
DIAG04 = 'G309')DEMENTIA4 = 
1. 
EXECUTE.  
 
COMPUTE DEMENTIA5 = 0. 
EXECUTE. 
IF(DIAG05 = 'F000'| 
DIAG05 = 'F001'| 
DIAG05 = 'F009'| 
DIAG05 = 'F011'| 
DIAG05 = 'F019'| 
DIAG05 = 'F020'| 
DIAG05 = 'F022'| 
DIAG05 = 'F023'| 
DIAG05 = 'F024'| 
DIAG05 = 'F028'| 
DIAG05 = 'F03X'| 
DIAG05 = 'F051'| 
DIAG05 = 'G300'| 
DIAG05 = 'G301'| 
DIAG05 = 'G309')DEMENTIA5 = 
1. 
EXECUTE.  
 
COMPUTE DEMENTIA6 = 0. 
EXECUTE. 
IF(DIAG06 = 'F000'| 
DIAG06 = 'F001'| 
DIAG06 = 'F009'| 
DIAG06 = 'F011'| 
DIAG06 = 'F019'| 
DIAG06 = 'F020'| 
DIAG06 = 'F022'| 
DIAG06 = 'F023'| 
DIAG06 = 'F024'| 
DIAG06 = 'F028'| 
DIAG06 = 'F03X'| 
DIAG06 = 'F051'| 
DIAG06 = 'G300'| 
DIAG06 = 'G301'| 
DIAG06 = 'G309')DEMENTIA6 = 
1. 
EXECUTE.  
 
COMPUTE DEMENTIA7 = 0. 
EXECUTE. 
IF(DIAG07 = 'F000'| 
DIAG07 = 'F001'| 
DIAG07 = 'F009'| 
DIAG07 = 'F011'| 
DIAG07 = 'F019'| 
DIAG07 = 'F020'| 
DIAG07 = 'F022'| 
DIAG07 = 'F023'| 
DIAG07 = 'F024'| 
DIAG07 = 'F028'| 
DIAG07 = 'F03X'| 
DIAG07 = 'F051'| 
DIAG07 = 'G300'| 
DIAG07 = 'G301'| 
DIAG07 = 'G309')DEMENTIA7 = 
1. 
EXECUTE.  
 
COMPUTE DEMENTIA8 = 0. 
EXECUTE. 
IF(DIAG08 = 'F000'| 
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DIAG08 = 'F001'| 
DIAG08 = 'F009'| 
DIAG08 = 'F011'| 
DIAG08 = 'F019'| 
DIAG08 = 'F020'| 
DIAG08 = 'F022'| 
DIAG08 = 'F023'| 
DIAG08 = 'F024'| 
DIAG08 = 'F028'| 
DIAG08 = 'F03X'| 
DIAG08 = 'F051'| 
DIAG08 = 'G300'| 
DIAG08 = 'G301'| 
DIAG08 = 'G309')DEMENTIA8 = 
1. 
EXECUTE.  
 
COMPUTE DEMENTIA9 = 0. 
EXECUTE. 
IF(DIAG09 = 'F000'| 
DIAG09 = 'F001'| 
DIAG09 = 'F009'| 
DIAG09 = 'F011'| 
DIAG09 = 'F019'| 
DIAG09 = 'F020'| 
DIAG09 = 'F022'| 
DIAG09 = 'F023'| 
DIAG09 = 'F024'| 
DIAG09 = 'F028'| 
DIAG09 = 'F03X'| 
DIAG09 = 'F051'| 
DIAG09 = 'G300'| 
DIAG09 = 'G301'| 
DIAG09 = 'G309')DEMENTIA9 = 
1. 
EXECUTE.  
 
COMPUTE DEMENTIA10 = 0. 
EXECUTE. 
IF(DIAG10 = 'F000'| 
DIAG10 = 'F001'| 
DIAG10 = 'F009'| 
DIAG10 = 'F011'| 
DIAG10 = 'F019'| 
DIAG10 = 'F020'| 
DIAG10 = 'F022'| 
DIAG10 = 'F023'| 
DIAG10 = 'F024'| 
DIAG10 = 'F028'| 
DIAG10 = 'F03X'| 
DIAG10 = 'F051'| 
DIAG10 = 'G300'| 
DIAG10 = 'G301'| 
DIAG10 = 'G309')DEMENTIA10 
= 1. 
EXECUTE.  
 
COMPUTE DEMENTIA11 = 0. 
EXECUTE. 
IF(DIAG11 = 'F000'| 
DIAG11 = 'F001'| 
DIAG11 = 'F009'| 
DIAG11 = 'F011'| 
DIAG11 = 'F019'| 
DIAG11 = 'F020'| 
DIAG11 = 'F022'| 
DIAG11 = 'F023'| 
DIAG11 = 'F024'| 
DIAG11 = 'F028'| 
DIAG11 = 'F03X'| 
DIAG11 = 'F051'| 
DIAG11 = 'G300'| 
DIAG11 = 'G301'| 
DIAG11 = 'G309')DEMENTIA11 
= 1. 
EXECUTE.  
 
 
COMPUTE DEMENTIA12 = 0. 
EXECUTE. 
IF(DIAG12 = 'F000'| 
DIAG12 = 'F001'| 
DIAG12 = 'F009'| 
DIAG12 = 'F011'| 
DIAG12 = 'F019'| 
DIAG12 = 'F020'| 
DIAG12 = 'F022'| 
DIAG12 = 'F023'| 
DIAG12 = 'F024'| 
DIAG12 = 'F028'| 
DIAG12 = 'F03X'| 
DIAG12 = 'F051'| 
DIAG12 = 'G300'| 
DIAG12 = 'G301'| 
DIAG12 = 'G309')DEMENTIA12 
= 1. 
EXECUTE.  
 
COMPUTE DEMENTIA13 = 0. 
EXECUTE. 
IF(DIAG13 = 'F000'| 
DIAG13 = 'F001'| 
DIAG13 = 'F009'| 
DIAG13 = 'F011'| 
DIAG13 = 'F019'| 
DIAG13 = 'F020'| 
DIAG13 = 'F022'| 
DIAG13 = 'F023'| 
DIAG13 = 'F024'| 
DIAG13 = 'F028'| 
DIAG13 = 'F03X'| 
DIAG13 = 'F051'| 
DIAG13 = 'G300'| 
DIAG13 = 'G301'| 
DIAG13 = 'G309')DEMENTIA13 
= 1. 
EXECUTE.  
 
COMPUTE DEMENTIA14 = 0. 
EXECUTE. 
IF(DIAG14 = 'F000'| 
DIAG14 = 'F001'| 
DIAG14 = 'F009'| 
DIAG14 = 'F011'| 
DIAG14 = 'F019'| 
DIAG14 = 'F020'| 
DIAG14 = 'F022'| 
DIAG14 = 'F023'| 
DIAG14 = 'F024'| 
DIAG14 = 'F028'| 
DIAG14 = 'F03X'| 
DIAG14 = 'F051'| 
DIAG14 = 'G300'| 
DIAG14 = 'G301'| 
DIAG14 = 'G309')DEMENTIA14 
= 1. 
EXECUTE.
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PEG Syntax 9 – Motor Neurone disease marker 
COMPUTE MND1 = 0. 
EXECUTE. 
IF(DIAG01 = 'G122')MND1 = 
1. 
EXECUTE. 
 
COMPUTE MND2 = 0. 
EXECUTE. 
IF(DIAG02 = 'G122')MND2 = 
1. 
EXECUTE. 
 
COMPUTE MND3 = 0. 
EXECUTE. 
IF(DIAG03 = 'G122')MND3 = 
1. 
EXECUTE. 
 
COMPUTE MND4 = 0. 
EXECUTE. 
IF(DIAG04 = 'G122')MND4 = 
1. 
EXECUTE. 
 
COMPUTE MND5 = 0. 
EXECUTE. 
IF(DIAG05 = 'G122')MND5 = 
1. 
EXECUTE. 
 
COMPUTE MND6 = 0. 
EXECUTE. 
IF(DIAG06 = 'G122')MND6 = 
1. 
EXECUTE. 
 
COMPUTE MND7 = 0. 
EXECUTE. 
IF(DIAG07 = 'G122')MND7 = 
1. 
EXECUTE. 
 
COMPUTE MND8 = 0. 
EXECUTE. 
IF(DIAG08 = 'G122')MND8 = 
1. 
EXECUTE. 
 
COMPUTE MND9 = 0. 
EXECUTE. 
IF(DIAG09 = 'G122')MND9 = 
1. 
EXECUTE. 
 
COMPUTE MND10 = 0. 
EXECUTE. 
IF(DIAG10 = 'G122')MND10 
= 1. 
EXECUTE. 
COMPUTE MND11 = 0. 
EXECUTE. 
IF(DIAG11 = 'G122')MND11 
= 1. 
EXECUTE. 
 
COMPUTE MND12 = 0. 
EXECUTE. 
IF(DIAG12 = 'G122')MND12 
= 1. 
EXECUTE. 
 
COMPUTE MND13 = 0. 
EXECUTE. 
IF(DIAG13 = 'G122')MND13 
= 1. 
EXECUTE. 
 
COMPUTE MND14 = 0. 
EXECUTE. 
IF(DIAG14 = 'G122')MND14 
= 1. 
EXECUTE.
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PEG Syntax 10– Multiple sclerosis code present
 
COMPUTE MS1 = 0. 
EXECUTE. 
IF(DIAG01 = 'G35X')MS1 = 
1. 
EXECUTE. 
 
COMPUTE MS2 = 0. 
EXECUTE. 
IF(DIAG02 = 'G35X')MS2 = 
1. 
EXECUTE. 
 
COMPUTE MS3 = 0. 
EXECUTE. 
IF(DIAG03 = 'G35X')MS3 = 
1. 
EXECUTE. 
 
COMPUTE MS4 = 0. 
EXECUTE. 
IF(DIAG04 = 'G35X')MS4 = 
1. 
EXECUTE. 
 
COMPUTE MS5 = 0. 
EXECUTE. 
IF(DIAG05 = 'G35X')MS5 = 
1. 
EXECUTE. 
COMPUTE MS6 = 0. 
EXECUTE. 
IF(DIAG06 = 'G35X')MS6 = 
1. 
EXECUTE. 
 
COMPUTE MS7 = 0. 
EXECUTE. 
IF(DIAG07 = 'G35X')MS7 = 
1. 
EXECUTE. 
 
COMPUTE MS8 = 0. 
EXECUTE. 
IF(DIAG08 = 'G35X')MS8 = 
1. 
EXECUTE. 
 
COMPUTE MS9 = 0. 
EXECUTE. 
IF(DIAG09 = 'G35X')MS9 = 
1. 
EXECUTE. 
 
COMPUTE MS10 = 0. 
EXECUTE. 
IF(DIAG10 = 'G35X')MS10 = 
1. 
EXECUTE. 
 
COMPUTE MS11 = 0. 
EXECUTE. 
IF(DIAG11 = 'G35X')MS11 = 
1. 
EXECUTE. 
 
COMPUTE MS12 = 0. 
EXECUTE. 
IF(DIAG12 = 'G35X')MS12 = 
1. 
EXECUTE. 
 
COMPUTE MS13 = 0. 
EXECUTE. 
IF(DIAG13 = 'G35X')MS13 = 
1. 
EXECUTE. 
 
COMPUTE MS14 = 0. 
EXECUTE. 
IF(DIAG14 = 'G35X')MS14 = 
1. 
EXECUTE. 
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PEG Syntax 11 –Parkinson’s disease 
COMPUTE PARKINSONS1 = 
0. 
EXECUTE. 
IF(DIAG01 = 
'G20X')PARKINSONS1 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS2 = 
0. 
EXECUTE. 
IF(DIAG02 = 
'G20X')PARKINSONS2 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS3 = 
0. 
EXECUTE. 
IF(DIAG03 = 
'G20X')PARKINSONS3 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS4 = 
0. 
EXECUTE. 
IF(DIAG04 = 
'G20X')PARKINSONS4 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS5 = 
0. 
EXECUTE. 
IF(DIAG05 = 
'G20X')PARKINSONS5 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS6 = 
0. 
EXECUTE. 
IF(DIAG06 = 
'G20X')PARKINSONS6 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS7 = 
0. 
EXECUTE. 
IF(DIAG07 = 
'G20X')PARKINSONS7 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS8 = 
0. 
EXECUTE. 
IF(DIAG08 = 
'G20X')PARKINSONS8 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS9 = 
0. 
EXECUTE. 
IF(DIAG09 = 
'G20X')PARKINSONS9 = 1. 
EXECUTE. 
COMPUTE PARKINSONS10 = 
0. 
EXECUTE. 
IF(DIAG10 = 
'G20X')PARKINSONS10 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS11 = 
0. 
EXECUTE. 
IF(DIAG11 = 
'G20X')PARKINSONS11 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS12 = 
0. 
EXECUTE. 
IF(DIAG12 = 
'G20X')PARKINSONS12 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS13 = 
0. 
EXECUTE. 
IF(DIAG13 = 
'G20X')PARKINSONS13 = 1. 
EXECUTE. 
 
COMPUTE PARKINSONS14 = 
0. 
EXECUTE. 
IF(DIAG14 = 
'G20X')PARKINSONS14 = 1. 
EXECUTE. 
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Stroke Syntax 1 – Stroke code
 
COMPUTE STROKE1 = 0. 
EXECUTE. 
 
IF(DIAG01 = 'G450'| 
DIAG01 = 'G451'| 
DIAG01 = 'G460'| 
DIAG01 = 'G461'| 
DIAG01 = 'G462'| 
DIAG01 = 'G463'| 
DIAG01 = 'G464'| 
DIAG01 = 'G465'| 
DIAG01 = 'G467'| 
DIAG01 = 'G468'| 
DIAG01 = 'G810'| 
DIAG01 = 'G811'| 
DIAG01 = 'G819'| 
DIAG01 = 'I610'| 
DIAG01 = 'I611'| 
DIAG01 = 'I612'| 
DIAG01 = 'I613'| 
DIAG01 = 'I614'| 
DIAG01 = 'I615'| 
DIAG01 = 'I616'| 
DIAG01 = 'I618'| 
DIAG01 = 'I619'| 
DIAG01 = 'I629'| 
DIAG01 = 'I630'| 
DIAG01 = 'I631'| 
DIAG01 = 'I632'| 
DIAG01 = 'I633'| 
DIAG01 = 'I634'| 
DIAG01 = 'I635'| 
DIAG01 = 'I636'| 
DIAG01 = 'I638'| 
DIAG01 = 'I639'| 
DIAG01 = 'I64X'| 
DIAG01 = 'I650'| 
DIAG01 = 'I651'| 
DIAG01 = 'I652'| 
DIAG01 = 'I653'| 
DIAG01 = 'I658'| 
DIAG01 = 'I659'| 
DIAG01 = 'I660'| 
DIAG01 = 'I661'| 
DIAG01 = 'I662'| 
DIAG01 = 'I663'| 
DIAG01 = 'I664'| 
DIAG01 = 'I668'| 
DIAG01 = 'I669'| 
DIAG01 = 'I670'| 
DIAG01 = 'I672'| 
DIAG01 = 'I678'| 
DIAG01 = 'I679'| 
DIAG01 = 'I688'| 
DIAG01 = 'I691'| 
DIAG01 = 'I692'| 
DIAG01 = 'I693'| 
DIAG01 = 'I694')STROKE1 = 
1. 
EXECUTE. 
 
COMPUTE STROKE2 = 0. 
EXECUTE. 
 
IF(DIAG02 = 'G450'| 
DIAG02 = 'G451'| 
DIAG02 = 'G460'| 
DIAG02 = 'G461'| 
DIAG02 = 'G462'| 
DIAG02 = 'G463'| 
DIAG02 = 'G464'| 
DIAG02 = 'G465'| 
DIAG02 = 'G467'| 
DIAG02 = 'G468'| 
DIAG02 = 'G810'| 
DIAG02 = 'G811'| 
DIAG02 = 'G819'| 
DIAG02 = 'I610'| 
DIAG02 = 'I611'| 
DIAG02 = 'I612'| 
DIAG02 = 'I613'| 
DIAG02 = 'I614'| 
DIAG02 = 'I615'| 
DIAG02 = 'I616'| 
DIAG02 = 'I618'| 
DIAG02 = 'I619'| 
DIAG02 = 'I629'| 
DIAG02 = 'I630'| 
DIAG02 = 'I631'| 
DIAG02 = 'I632'| 
DIAG02 = 'I633'| 
DIAG02 = 'I634'| 
DIAG02 = 'I635'| 
DIAG02 = 'I636'| 
DIAG02 = 'I638'| 
DIAG02 = 'I639'| 
DIAG02 = 'I64X'| 
DIAG02 = 'I650'| 
DIAG02 = 'I651'| 
DIAG02 = 'I652'| 
DIAG02 = 'I653'| 
DIAG02 = 'I658'| 
DIAG02 = 'I659'| 
DIAG02 = 'I660'| 
DIAG02 = 'I661'| 
DIAG02 = 'I662'| 
DIAG02 = 'I663'| 
DIAG02 = 'I664'| 
DIAG02 = 'I668'| 
DIAG02 = 'I669'| 
DIAG02 = 'I670'| 
DIAG02 = 'I672'| 
DIAG02 = 'I678'| 
DIAG02 = 'I679'| 
DIAG02 = 'I688'| 
DIAG02 = 'I691'| 
DIAG02 = 'I692'| 
DIAG02 = 'I693'| 
DIAG02 = 'I694')STROKE2 = 
1. 
EXECUTE. 
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Stroke Syntax 2 – Admission method type 
This syntax was used to update a new variable called ADMISSMETHTYPE that defines how 
the patient was admitted to hospital for the spell. First of all, the syntax creates a variable 
called ADMISSMETHTYPE and sets to 0; it then updates this variable dependant on what 
code is present in ADMIMETH.  If ADMIMETH is equal to 11, 12, 13 then it is an ELECTIVE 
spell and ADMISSMETHTYPE is then updated to code 1.  If ADMIMETH is equal to 21, 22, 23, 
24, 28 then it is an EMERGENCY spell and ADMISSMETHTYPE is then updated to code 4. A 
new variable is now created called ADMMETHTYPE which will take the Admission type and 
the Patient Classification field which looks how the patient was managed into account.  The 
syntax commands if ADMIMETHTYPE is equal to 1 and CLASS PAT is equal to 1 then update 
ADMMETHTYPE to 1, this means that this is an ELECTIVEORDINARY admission.   The syntax 
commands if ADMIMETHTYPE is equal to 81 then update ADMMETHTYPE to 1, this means 
that this is an ELECTIVEORDINARY admission. The syntax commands if ADMIMETHTYPE is 
equal to 1 and CLASS PAT is equal to 2 then update ADMMETHTYPE to 2; this means that 
this is an ELECTIVEDAYCASE admission. The syntax commands if ADMIMETHTYPE is equal to 
1 and CLASS PAT is equal to 3 and 4 then update ADMMETHTYPE to 3; this means that this 
is an ELECTIVEREGULAR ATTENDER admission. The syntax commands if ADMIMETHTYPE is 
equal to 4 then update ADMMETHTYPE to 4; this means that this is an EMERGENCY 
admission. 
 
ADMISSMETHTYPE field was then deleted from dataset after this syntax was run as no 
longer required for analysis and ADMISSMETHTYPE retained 
 
 
COMPUTE ADMISSMETHTYPE = 0 . 
EXECUTE . 
 
IF (ADMIMETH = 11| 
ADMIMETH = 12| 
ADMIMETH = 13)ADMISSMETHTYPE = 1. 
EXECUTE . 
 
IF (ADMIMETH = 21| 
ADMIMETH = 22| 
ADMIMETH = 23| 
ADMIMETH = 24| 
ADMIMETH = 28)ADMISSMETHTYPE = 4. 
EXECUTE . 
COMPUTE ADMMETHTYPE = 0 . 
EXECUTE . 
 
IF (ADMISSMETHTYPE= 1 & 
CLASSPAT = 1) ADMMETHTYPE = 1 . 
EXECUTE . 
 
IF (ADMIMETH = 81) ADMMETHTYPE = 1 . 
EXECUTE . 
 
IF (ADMISSMETHTYPE= 1 & 
CLASSPAT = 2) ADMMETHTYPE = 2 . 
EXECUTE . 
 
IF (ADMISSMETHTYPE= 1 & 
CLASSPAT = 3) ADMMETHTYPE = 3 . 
EXECUTE . 
 
IF (ADMISSMETHTYPE= 1 & 
CLASSPAT = 4) ADMMETHTYPE = 3 . 
EXECUTE . 
 
IF (ADMISSMETHTYPE= 4) ADMMETHTYPE = 4 
. 
EXECUTE . 
306 
 
Stroke Syntax 3 – Age Band marker 
COMPUTE AGEBAND  = 0 . 
EXECUTE . 
 
 
IF (ENDAGE < 21) AGEBAND 
= 16 . 
EXECUTE . 
 
IF (ENDAGE < 26 & ENDAGE 
>20) AGEBAND = 21 . 
EXECUTE . 
 
IF (ENDAGE < 31 & ENDAGE 
>25) AGEBAND = 26 . 
EXECUTE . 
 
IF (ENDAGE < 36 & ENDAGE 
>30) AGEBAND = 31 . 
EXECUTE . 
 
IF (ENDAGE < 41 & ENDAGE 
>35) AGEBAND = 36 . 
EXECUTE . 
 
 
IF (ENDAGE < 46 & ENDAGE 
>40) AGEBAND = 41 . 
EXECUTE . 
 
IF (ENDAGE < 51 & ENDAGE 
>45) AGEBAND = 46 . 
EXECUTE . 
 
IF (ENDAGE < 56 & ENDAGE 
>50) AGEBAND = 51 . 
EXECUTE . 
 
IF (ENDAGE < 61 & ENDAGE 
>55) AGEBAND = 56 . 
EXECUTE . 
 
IF (ENDAGE < 66 & ENDAGE 
>60) AGEBAND = 61 . 
EXECUTE . 
 
IF (ENDAGE < 71 & ENDAGE 
>65) AGEBAND = 66 . 
EXECUTE . 
 
IF (ENDAGE < 76 & ENDAGE 
>70) AGEBAND = 71 . 
EXECUTE . 
 
IF (ENDAGE < 81 & ENDAGE 
>75) AGEBAND = 76 . 
EXECUTE . 
 
IF (ENDAGE < 86 & ENDAGE 
>80) AGEBAND = 81 . 
EXECUTE . 
 
IF (ENDAGE > 85) AGEBAND 
= 86 . 
EXECUTE . 
 
Stroke Syntax 4 – Age group markers 
COMPUTE AGEGROUP = 0. 
EXECUTE. 
 
IF (ENDAGE < 55)AGEGROUP = 1. 
EXECUTE. 
IF (ENDAGE > 54 & ENDAGE < 65)AGEGROUP = 2. 
EXECUTE. 
IF (ENDAGE > 64 & ENDAGE <75)AGEGROUP = 3. 
EXECUTE. 
IF (ENDAGE >74 & ENDAGE <85)AGEGROUP = 4. 
EXECUTE. 
IF (ENDAGE >84)AGEGROUP = 5. 
EXECUTE. 
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Stroke Syntax 5 – Emergency admission marker 
COMPUTE EMERGENCYMARKER = 0. 
EXECUTE. 
 
IF (ADMIMETH = 21| 
ADMIMETH = 22| 
ADMIMETH = 23| 
ADMIMETH = 24| 
ADMIMETH = 28)EMERGENCYMARKER = 1. 
EXECUTE. 
 
Stroke Syntax 6 – Died in admission spell 
COMPUTE DIEDINSPELL = 0. 
EXECUTE. 
 
IF (DISMETH = 4| 
DISDEST = 79)DIEDINSPELL = 1. 
EXECUTE. 
 
Stroke Syntax 7 – Death marker (all) 
COMPUTE DEATHMARKERALL = 0. 
EXECUTE. 
 
IF (DIEDINSPELL = 1| 
DODMINUSADMDATE < 50000)DEATHMARKERALL = 1. 
EXECUTE. 
 
Stroke Syntax 8 – Death within 7 days of admission 
 COMPUTE DIED7DAYS = 0. 
EXECUTE. 
 
IF (DODMINUSADMDATE < 8)DIED7DAYS = 1. 
EXECUTE. 
 
This syntax can be amended to create markers for death within any number of days of stroke 
admission. 
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Stroke Syntax 9 – Discharge Type
COMPUTE DISCHARGE = 3. 
EXECUTE. 
 
IF (DISDEST = 79)DISCHARGE = 4. 
EXECUTE. 
 
IF (DISDEST = 54| 
DISDEST = 65| 
DISDEST = 85| 
DISDEST = 87| 
DISDEST = 88)DISCHARGE = 2. 
EXECUTE. 
 
IF (DISDEST = 19)DISCHARGE = 1. 
EXECUTE. 
 
Stroke Syntax 10 – Transfer from another provider as emergency  
COMPUTE 
TRANSFINASEMERGENCYO
THERPROV = 0. 
EXECUTE. 
 
IF (ADMIMETH = 
28)TRANSFINASEMERGENC
YOTHERPROV = 1. 
EXECUTE.
  
Stroke Syntax 11 – London SHA
COMPUTE LONDONSHA = 0. 
EXECUTE. 
 
IF (PROCODE = 'RAL'| 
PROCODE = 'RJ1'| 
PROCODE = 'RJ7'| 
PROCODE = 'RJZ'| 
PROCODE = 'RNJ'| 
PROCODE = 'RVR'| 
PROCODE = 'RYJ'| 
PROCODE = 'RAP'| 
PROCODE = 'RF4'| 
PROCODE = 'RGC'| 
PROCODE = 'RAS'| 
PROCODE = 'RAX'| 
PROCODE = 'RC3'| 
PROCODE = 'RFW'| 
PROCODE = 'RG2'| 
PROCODE = 'RG3'| 
PROCODE = 'RGZ'| 
PROCODE = 'RJ2'| 
PROCODE = 'RJ6'| 
PROCODE = 'RKE'| 
PROCODE = 'RNH'| 
PROCODE = 'RQM'| 
PROCODE = 'RQX'| 
PROCODE = 'RRV'| 
PROCODE = 'RV8'| 
PROCODE = 'RVL')LONDONSHA = 1. 
EXECUTE
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Stroke Syntax 12 – Male gender marker for calculations 
COMPUTE MALE = 0. 
EXECUTE. 
 
IF (SEX = 1)MALE = 1. 
EXECUTE. 
 
Stroke Syntax 13 – Over 75 years old marker for calculations 
COMPUTE OVER75 = 0. 
EXECUTE. 
 
IF (ENDAGE > 75)OVER75 = 1. 
EXECUTE. 
 
Stroke Syntax 14 – PEG procedure code position marker 
COMPUTE PEGPRC1 = 0. 
EXECUTE. 
 
IF (OPERTN1 = 'G341'|  
OPERTN1 = 'G342' |   
OPERTN1 = 'G343' |                
OPERTN1 = 'G344' |                
OPERTN1 = 'G345' |                
OPERTN1 = 'G348' |                
OPERTN1 = 'G349' |                
OPERTN1 = 'G361' |                
OPERTN1 = 'G363' |                
OPERTN1 = 'G368' |                
OPERTN1 = 'G369' |                
OPERTN1 = 
'G445')PEGPRC1 = 1.  
EXECUTE.      
 
COMPUTE PEGPRC2 = 0. 
EXECUTE. 
 
IF (OPERTN2 = 'G341'|  
OPERTN2 = 'G342' |   
OPERTN2 = 'G343' |                
OPERTN2 = 'G344' |                
OPERTN2 = 'G345' |                
OPERTN2 = 'G348' |                
OPERTN2 = 'G349' |                
OPERTN2 = 'G361' |                
OPERTN2 = 'G363' |                
OPERTN2 = 'G368' |                
OPERTN2 = 'G369' |                
OPERTN2 = 
'G445')PEGPRC2 = 1.  
EXECUTE.     
 
COMPUTE PEGPRC3 = 0. 
EXECUTE. 
 
IF (OPERTN3 = 'G341'|  
OPERTN3 = 'G342' |   
OPERTN3 = 'G343' |                
OPERTN3 = 'G344' |                
OPERTN3 = 'G345' |                
OPERTN3 = 'G348' |                
OPERTN3 = 'G349' |                
OPERTN3 = 'G361' |                
OPERTN3 = 'G363' |                
OPERTN3 = 'G368' |                
OPERTN3 = 'G369' |                
OPERTN3 = 
'G445')PEGPRC3 = 1.  
EXECUTE.     
 
COMPUTE PEGPRC4 = 0. 
EXECUTE. 
 
IF (OPERTN4 = 'G341'|  
OPERTN4 = 'G342' |   
OPERTN4 = 'G343' |                
OPERTN4 = 'G344' |                
OPERTN4 = 'G345' |                
OPERTN4 = 'G348' |                
OPERTN4 = 'G349' |                
OPERTN4 = 'G361' |                
OPERTN4 = 'G363' |                
OPERTN4 = 'G368' |                
OPERTN4 = 'G369' |                
OPERTN4 = 
'G445')PEGPRC4 = 1.  
EXECUTE.     
 
COMPUTE PEGPRC5 = 0. 
EXECUTE. 
 
IF (OPERTN5 = 'G341'|  
OPERTN5 = 'G342' |   
OPERTN5 = 'G343' |                
OPERTN5 = 'G344' |                
OPERTN5 = 'G345' |                
OPERTN5 = 'G348' |                
OPERTN5 = 'G349' |                
OPERTN5 = 'G361' |                
OPERTN5 = 'G363' |                
OPERTN5 = 'G368' |                
OPERTN5 = 'G369' |                
OPERTN5 = 
'G445')PEGPRC5 = 1.  
EXECUTE.     
 
COMPUTE PEGPRC6 = 0. 
EXECUTE. 
 
IF (OPERTN6 = 'G341'|  
OPERTN6 = 'G342' |   
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OPERTN6 = 'G343' |                
OPERTN6 = 'G344' |                
OPERTN6 = 'G345' |                
OPERTN6 = 'G348' |                
OPERTN6 = 'G349' |                
OPERTN6 = 'G361' |                
OPERTN6 = 'G363' |                
OPERTN6 = 'G368' |                
OPERTN6 = 'G369' |                
OPERTN6 = 
'G445')PEGPRC6 = 1.  
EXECUTE.     
 
COMPUTE PEGPRC7 = 0. 
EXECUTE. 
 
IF (OPERTN7 = 'G341'|  
OPERTN7 = 'G342' |   
OPERTN7 = 'G343' |                
OPERTN7 = 'G344' |                
OPERTN7 = 'G345' |                
OPERTN7 = 'G348' |                
OPERTN7 = 'G349' |                
OPERTN7 = 'G361' |                
OPERTN7 = 'G363' |                
OPERTN7 = 'G368' |                
OPERTN7 = 'G369' |                
OPERTN7 = 
'G445')PEGPRC7 = 1.  
EXECUTE.     
 
COMPUTE PEGPRC8 = 0. 
EXECUTE. 
 
IF (OPERTN8 = 'G341'|  
OPERTN8 = 'G342' |   
OPERTN8 = 'G343' |                
OPERTN8 = 'G344' |                
OPERTN8 = 'G345' |                
OPERTN8 = 'G348' |                
OPERTN8 = 'G349' |                
OPERTN8 = 'G361' |                
OPERTN8 = 'G363' |                
OPERTN8 = 'G368' |                
OPERTN8 = 'G369' |                
OPERTN8 = 
'G445')PEGPRC8 = 1.  
EXECUTE.   
 
COMPUTE PEGPRC9 = 0 . 
EXECUTE. 
 
IF (OPERTN9 = 'G341'|  
OPERTN9 = 'G342' |   
OPERTN9 = 'G343' |                
OPERTN9 = 'G344' |                
OPERTN9 = 'G345' |                
OPERTN9 = 'G348' |                
OPERTN9 = 'G349' |                
OPERTN9 = 'G361' |                
OPERTN9 = 'G363' |                
OPERTN9 = 'G368' |                
OPERTN9 = 'G369' |                
OPERTN9 = 
'G445')PEGPRC9 = 1.  
EXECUTE.   
 
COMPUTE PEGPRC10 = 0 . 
EXECUTE. 
 
IF (OPERTN10 = 'G341'|  
OPERTN10 = 'G342' |   
OPERTN10 = 'G343' |                
OPERTN10 = 'G344' |                
OPERTN10 = 'G345' |                
OPERTN10 = 'G348' |                
OPERTN10 = 'G349' |                
OPERTN10 = 'G361' |                
OPERTN10 = 'G363' |                
OPERTN10 = 'G368' |                
OPERTN10 = 'G369' |                
OPERTN10 = 
'G445')PEGPRC10 = 1.  
EXECUTE.   
 
COMPUTE PEGPRC11 = 0 . 
EXECUTE. 
 
IF (OPERTN11 = 'G341'|  
OPERTN11 = 'G342' |   
OPERTN11 = 'G343' |                
OPERTN11 = 'G344' |                
OPERTN11 = 'G345' |                
OPERTN11 = 'G348' |                
OPERTN11 = 'G349' |                
OPERTN11 = 'G361' |                
OPERTN11 = 'G363' |                
OPERTN11 = 'G368' |                
OPERTN11 = 'G369' |                
OPERTN11 = 
'G445')PEGPRC11 = 1.  
EXECUTE.   
 
COMPUTE PEGPRC12 = 0 . 
EXECUTE. 
 
IF (OPERTN12 = 'G341'|  
OPERTN12 = 'G342' |   
OPERTN12 = 'G343' |                
OPERTN12 = 'G344' |                
OPERTN12 = 'G345' |                
OPERTN12 = 'G348' |                
OPERTN12 = 'G349' |                
OPERTN12 = 'G361' |                
OPERTN12 = 'G363' |                
OPERTN12 = 'G368' |                
OPERTN12 = 'G369' |                
OPERTN12 = 
'G445')PEGPRC12 = 1.  
EXECUTE.   
 
COMPUTE PEGPRC13 = 0 . 
EXECUTE. 
 
IF (OPERTN13 = 'G341'|  
OPERTN13 = 'G342' |   
OPERTN13 = 'G343' |                
OPERTN13 = 'G344' |                
OPERTN13 = 'G345' |                
OPERTN13 = 'G348' |                
OPERTN13 = 'G349' |                
OPERTN13 = 'G361' |                
OPERTN13 = 'G363' |                
OPERTN13 = 'G368' |                
OPERTN13 = 'G369' |                
OPERTN13 = 
'G445')PEGPRC13 = 1.  
EXECUTE.   
 
COMPUTE PEGPRC14 = 0. 
EXECUTE. 
 
IF (OPERTN14 = 'G341'|  
OPERTN14 = 'G342' |   
OPERTN14 = 'G343' |                
OPERTN14 = 'G344' |                
OPERTN14 = 'G345' |                
OPERTN14 = 'G348' |                
OPERTN14 = 'G349' |                
OPERTN14 = 'G361' |                
OPERTN14 = 'G363' |                
OPERTN14 = 'G368' |                
OPERTN14 = 'G369' |                
OPERTN14 = 
'G445')PEGPRC14 = 1.  
EXECUTE.  
 
COMPUTE PEGPRESENT = 
0. 
EXECUTE. 
 
IF (PEGPRC1 = 1| 
PEGPRC2 = 1| 
PEGPRC3 = 1| 
PEGPRC4 = 1| 
PEGPRC5 = 1| 
PEGPRC6 = 1| 
PEGPRC7 = 1| 
PEGPRC8 = 1| 
PEGPRC9 = 1| 
PEGPRC10 = 1| 
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PEGPRC11 = 1| 
PEGPRC12 = 1| 
PEGPRC13 = 1| 
PEGPRC14 = 1)PEGPRESENT 
= 1. 
EXECUTE 
 
 
 
 
 
Stroke Syntax 15 – Comorbidity Score 
COMPUTE COMORBIDITY1 = 0. 
EXECUTE. 
 
IF (DIAG01 = 'E101'|DIAG01 = 'E105'|DIAG01 = 'E109'|DIAG01 = 'E111'|DIAG01 = 'E115'|DIAG01 = 
'E119'|DIAG01 = 'E131'|DIAG01 = 'E135'|DIAG01 = 'E139'|DIAG01 = 'E141'|DIAG01 = 'E145'|DIAG01 = 
'E149'|DIAG01 = 'F000'|DIAG01 = 'F001'|DIAG01 = 'F002'|DIAG01 = 'F009'|DIAG01 = 'F010'|DIAG01 = 
'F011'|DIAG01 = 'F012'|DIAG01 = 'F013'|DIAG01 = 'F018'|DIAG01 = 'F019'|DIAG01 = 'F020'|DIAG01 = 
'F021'|DIAG01 = 'F022'|DIAG01 = 'F023'|DIAG01 = 'F024'|DIAG01 = 'F028'|DIAG01 = 'F051'|DIAG01 = 
'G452'|DIAG01 = 'G454'|DIAG01 = 'G458'|DIAG01 = 'G459'|DIAG01 = 'G466'|DIAG01 = 'I210'|DIAG01 = 
'I211'|DIAG01 = 'I212'|DIAG01 = 'I213'|DIAG01 = 'I214'|DIAG01 = 'I219'|DIAG01 = 'I220'|DIAG01 = 
'I221'|DIAG01 = 'I228'|DIAG01 = 'I229'|DIAG01 = 'I252'|DIAG01 = 'I500'|DIAG01 = 'I501'|DIAG01 = 
'I509'|DIAG01 = 'I601'|DIAG01 = 'I602'|DIAG01 = 'I603'|DIAG01 = 'I604'|DIAG01 = 'I605'|DIAG01 = 
'I606'|DIAG01 = 'I607'|DIAG01 = 'I608'|DIAG01 = 'I609'|DIAG01 = 'I620'|DIAG01 = 'I621'|DIAG01 = 
'I671'|DIAG01 = 'I674'|DIAG01 = 'I675'|DIAG01 = 'I676'|DIAG01 = 'I677'|DIAG01 = 'I681'|DIAG01 = 
'I682'|DIAG01 = 'I690'|DIAG01 = 'I710'|DIAG01 = 'I711'|DIAG01 = 'I712'|DIAG01 = 'I713'|DIAG01 = 
'I714'|DIAG01 = 'I715'|DIAG01 = 'I716'|DIAG01 = 'I718'|DIAG01 = 'I719'|DIAG01 = 'I739'|DIAG01 = 
'I790'|DIAG01 = 'J40X'|DIAG01 = 'J410'|DIAG01 = 'J411'|DIAG01 = 'J418'|DIAG01 = 'J42X'|DIAG01 = 
'J430'|DIAG01 = 'J431'|DIAG01 = 'J432'|DIAG01 = 'J438'|DIAG01 = 'J439'|DIAG01 = 'J440'|DIAG01 = 
'J441'|DIAG01 = 'J448'|DIAG01 = 'J449'|DIAG01 = 'J450'|DIAG01 = 'J451'|DIAG01 = 'J458'|DIAG01 = 
'J459'|DIAG01 = 'J46X'|DIAG01 = 'J47X'|DIAG01 = 'J60X'|DIAG01 = 'J61X'|DIAG01 = 'J620'|DIAG01 = 
'J628'|DIAG01 = 'J630'|DIAG01 = 'J631'|DIAG01 = 'J632'|DIAG01 = 'J633'|DIAG01 = 'J634'|DIAG01 = 
'J635'|DIAG01 = 'J638'|DIAG01 = 'J64X'|DIAG01 = 'J65X'|DIAG01 = 'J660'|DIAG01 = 'J661'|DIAG01 = 
'J662'|DIAG01 = 'J668'|DIAG01 = 'K250'|DIAG01 = 'K251'|DIAG01 = 'K252'|DIAG01 = 'K253'|DIAG01 = 
'K254'|DIAG01 = 'K255'|DIAG01 = 'K256'|DIAG01 = 'K257'|DIAG01 = 'K259'|DIAG01 = 'K260'|DIAG01 = 
'K261'|DIAG01 = 'K262'|DIAG01 = 'K263'|DIAG01 = 'K264'|DIAG01 = 'K265'|DIAG01 = 'K266'|DIAG01 = 
'K267'|DIAG01 = 'K269'|DIAG01 = 'K270'|DIAG01 = 'K271'|DIAG01 = 'K272'|DIAG01 = 'K273'|DIAG01 = 
'K274'|DIAG01 = 'K275'|DIAG01 = 'K276'|DIAG01 = 'K277'|DIAG01 = 'K279'|DIAG01 = 'K280'|DIAG01 = 
'K281'|DIAG01 = 'K282'|DIAG01 = 'K283'|DIAG01 = 'K284'|DIAG01 = 'K285'|DIAG01 = 'K286'|DIAG01 = 
'K287'|DIAG01 = 'K289'|DIAG01 = 'K702'|DIAG01 = 'K703'|DIAG01 = 'K717'|DIAG01 = 'K731'|DIAG01 = 
'K732'|DIAG01 = 'K738'|DIAG01 = 'K739'|DIAG01 = 'K740'|DIAG01 = 'K742'|DIAG01 = 'K743'|DIAG01 = 
'K744'|DIAG01 = 'K745'|DIAG01 = 'K746'|DIAG01 = 'M050'|DIAG01 = 'M051'|DIAG01 = 'M052'|DIAG01 = 
'M053'|DIAG01 = 'M058'|DIAG01 = 'M059'|DIAG01 = 'M060'|DIAG01 = 'M063'|DIAG01 = 'M069'|DIAG01 = 
'M320'|DIAG01 = 'M321'|DIAG01 = 'M328'|DIAG01 = 'M329'|DIAG01 = 'M332'|DIAG01 = 'M340'|DIAG01 = 
'M341'|DIAG01 = 'M342'|DIAG01 = 'M348'|DIAG01 = 'M349'|DIAG01 = 'M353'|DIAG01 = 'R02X'|DIAG01 = 
'Z958'|DIAG01 = 'Z959')COMORBIDITY1 = 1. 
EXECUTE. 
 
IF (DIAG01 = 'C000'|DIAG01 = 'C001'|DIAG01 = 'C002'|DIAG01 = 'C003'|DIAG01 = 'C004'|DIAG01 = 
'C005'|DIAG01 = 'C006'|DIAG01 = 'C008'|DIAG01 = 'C009'|DIAG01 = 'C01X'|DIAG01 = 'C020'|DIAG01 = 
'C021'|DIAG01 = 'C022'|DIAG01 = 'C023'|DIAG01 = 'C024'|DIAG01 = 'C028'|DIAG01 = 'C029'|DIAG01 = 
'C030'|DIAG01 = 'C031'|DIAG01 = 'C039'|DIAG01 = 'C040'|DIAG01 = 'C041'|DIAG01 = 'C048'|DIAG01 = 
'C049'|DIAG01 = 'C050'|DIAG01 = 'C051'|DIAG01 = 'C052'|DIAG01 = 'C058'|DIAG01 = 'C059'|DIAG01 = 
'C060'|DIAG01 = 'C061'|DIAG01 = 'C062'|DIAG01 = 'C068'|DIAG01 = 'C069'|DIAG01 = 'C07X'|DIAG01 = 
'C080'|DIAG01 = 'C081'|DIAG01 = 'C088'|DIAG01 = 'C089'|DIAG01 = 'C090'|DIAG01 = 'C091'|DIAG01 = 
'C098'|DIAG01 = 'C099'|DIAG01 = 'C100'|DIAG01 = 'C101'|DIAG01 = 'C102'|DIAG01 = 'C103'|DIAG01 = 
'C104'|DIAG01 = 'C108'|DIAG01 = 'C109'|DIAG01 = 'C110'|DIAG01 = 'C111'|DIAG01 = 'C112'|DIAG01 = 
'C113'|DIAG01 = 'C118'|DIAG01 = 'C119'|DIAG01 = 'C12X'|DIAG01 = 'C130'|DIAG01 = 'C131'|DIAG01 = 
'C132'|DIAG01 = 'C138'|DIAG01 = 'C139'|DIAG01 = 'C140'|DIAG01 = 'C142'|DIAG01 = 'C148'|DIAG01 = 
'C150'|DIAG01 = 'C151'|DIAG01 = 'C152'|DIAG01 = 'C153'|DIAG01 = 'C154'|DIAG01 = 'C155'|DIAG01 = 
'C158'|DIAG01 = 'C159'|DIAG01 = 'C160'|DIAG01 = 'C161'|DIAG01 = 'C162'|DIAG01 = 'C163'|DIAG01 = 
'C164'|DIAG01 = 'C165'|DIAG01 = 'C166'|DIAG01 = 'C168'|DIAG01 = 'C169'|DIAG01 = 'C170'|DIAG01 = 
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'C171'|DIAG01 = 'C172'|DIAG01 = 'C173'|DIAG01 = 'C178'|DIAG01 = 'C179'|DIAG01 = 'C180'|DIAG01 = 
'C181'|DIAG01 = 'C182'|DIAG01 = 'C183'|DIAG01 = 'C184'|DIAG01 = 'C185'|DIAG01 = 'C186'|DIAG01 = 
'C187'|DIAG01 = 'C188'|DIAG01 = 'C189'|DIAG01 = 'C19X'|DIAG01 = 'C20X'|DIAG01 = 'C210'|DIAG01 = 
'C211'|DIAG01 = 'C212'|DIAG01 = 'C218'|DIAG01 = 'C220'|DIAG01 = 'C221'|DIAG01 = 'C222'|DIAG01 = 
'C223'|DIAG01 = 'C224'|DIAG01 = 'C227'|DIAG01 = 'C229'|DIAG01 = 'C23X'|DIAG01 = 'C240'|DIAG01 = 
'C241'|DIAG01 = 'C248'|DIAG01 = 'C249'|DIAG01 = 'C250'|DIAG01 = 'C251'|DIAG01 = 'C252'|DIAG01 = 
'C253'|DIAG01 = 'C254'|DIAG01 = 'C257'|DIAG01 = 'C258'|DIAG01 = 'C259'|DIAG01 = 'C260'|DIAG01 = 
'C261'|DIAG01 = 'C268'|DIAG01 = 'C269'|DIAG01 = 'C300'|DIAG01 = 'C301'|DIAG01 = 'C310'|DIAG01 = 
'C311'|DIAG01 = 'C312'|DIAG01 = 'C313'|DIAG01 = 'C318'|DIAG01 = 'C319'|DIAG01 = 'C320'|DIAG01 = 
'C321'|DIAG01 = 'C322'|DIAG01 = 'C323'|DIAG01 = 'C328'|DIAG01 = 'C329'|DIAG01 = 'C33X'|DIAG01 = 
'C340'|DIAG01 = 'C341'|DIAG01 = 'C342'|DIAG01 = 'C343'|DIAG01 = 'C348'|DIAG01 = 'C349'|DIAG01 = 
'C37X'|DIAG01 = 'C380'|DIAG01 = 'C381'|DIAG01 = 'C382'|DIAG01 = 'C383'|DIAG01 = 'C384'|DIAG01 = 
'C388'|DIAG01 = 'C390'|DIAG01 = 'C398'|DIAG01 = 'C399'|DIAG01 = 'C400'|DIAG01 = 'C401'|DIAG01 = 
'C402'|DIAG01 = 'C403'|DIAG01 = 'C408'|DIAG01 = 'C409'|DIAG01 = 'C410'|DIAG01 = 'C411'|DIAG01 = 
'C412'|DIAG01 = 'C413'|DIAG01 = 'C414'|DIAG01 = 'C418'|DIAG01 = 'C419'|DIAG01 = 'C430'|DIAG01 = 
'C431'|DIAG01 = 'C432'|DIAG01 = 'C433'|DIAG01 = 'C434'|DIAG01 = 'C435'|DIAG01 = 'C436'|DIAG01 = 
'C437'|DIAG01 = 'C438'|DIAG01 = 'C439'|DIAG01 = 'C450'|DIAG01 = 'C451'|DIAG01 = 'C452'|DIAG01 = 
'C457'|DIAG01 = 'C459'|DIAG01 = 'C460'|DIAG01 = 'C461'|DIAG01 = 'C462'|DIAG01 = 'C463'|DIAG01 = 
'C467'|DIAG01 = 'C468'|DIAG01 = 'C469'|DIAG01 = 'C470'|DIAG01 = 'C471'|DIAG01 = 'C472'|DIAG01 = 
'C473'|DIAG01 = 'C474'|DIAG01 = 'C475'|DIAG01 = 'C476'|DIAG01 = 'C478'|DIAG01 = 'C479'|DIAG01 = 
'C480'|DIAG01 = 'C481'|DIAG01 = 'C482'|DIAG01 = 'C488'|DIAG01 = 'C490'|DIAG01 = 'C491'|DIAG01 = 
'C492'|DIAG01 = 'C493'|DIAG01 = 'C494'|DIAG01 = 'C495'|DIAG01 = 'C496'|DIAG01 = 'C498'|DIAG01 = 
'C499'|DIAG01 = 'C500'|DIAG01 = 'C501'|DIAG01 = 'C502'|DIAG01 = 'C503'|DIAG01 = 'C504'|DIAG01 = 
'C505'|DIAG01 = 'C506'|DIAG01 = 'C508'|DIAG01 = 'C509'|DIAG01 = 'C510'|DIAG01 = 'C511'|DIAG01 = 
'C512'|DIAG01 = 'C518'|DIAG01 = 'C519'|DIAG01 = 'C52X'|DIAG01 = 'C530'|DIAG01 = 'C531'|DIAG01 = 
'C538'|DIAG01 = 'C539'|DIAG01 = 'C540'|DIAG01 = 'C541'|DIAG01 = 'C542'|DIAG01 = 'C543'|DIAG01 = 
'C548'|DIAG01 = 'C549'|DIAG01 = 'C55X'|DIAG01 = 'C56X'|DIAG01 = 'C570'|DIAG01 = 'C571'|DIAG01 = 
'C572'|DIAG01 = 'C573'|DIAG01 = 'C574'|DIAG01 = 'C577'|DIAG01 = 'C578'|DIAG01 = 'C579'|DIAG01 = 
'C58X'|DIAG01 = 'C600'|DIAG01 = 'C601'|DIAG01 = 'C602'|DIAG01 = 'C608'|DIAG01 = 'C609'|DIAG01 = 
'C61X'|DIAG01 = 'C620'|DIAG01 = 'C621'|DIAG01 = 'C629'|DIAG01 = 'C630'|DIAG01 = 'C631'|DIAG01 = 
'C632'|DIAG01 = 'C637'|DIAG01 = 'C638'|DIAG01 = 'C639'|DIAG01 = 'C64X'|DIAG01 = 'C65X'|DIAG01 = 
'C66X'|DIAG01 = 'C670'|DIAG01 = 'C671'|DIAG01 = 'C672'|DIAG01 = 'C673'|DIAG01 = 'C674'|DIAG01 = 
'C675'|DIAG01 = 'C676'|DIAG01 = 'C677'|DIAG01 = 'C678'|DIAG01 = 'C679'|DIAG01 = 'C680'|DIAG01 = 
'C681'|DIAG01 = 'C688'|DIAG01 = 'C689'|DIAG01 = 'C690'|DIAG01 = 'C691'|DIAG01 = 'C692'|DIAG01 = 
'C693'|DIAG01 = 'C694'|DIAG01 = 'C695'|DIAG01 = 'C696'|DIAG01 = 'C698'|DIAG01 = 'C699'|DIAG01 = 
'C700'|DIAG01 = 'C701'|DIAG01 = 'C709'|DIAG01 = 'C710'|DIAG01 = 'C711'|DIAG01 = 'C712'|DIAG01 = 
'C713'|DIAG01 = 'C714'|DIAG01 = 'C715'|DIAG01 = 'C716'|DIAG01 = 'C717'|DIAG01 = 'C718'|DIAG01 = 
'C719'|DIAG01 = 'C720'|DIAG01 = 'C721'|DIAG01 = 'C722'|DIAG01 = 'C723'|DIAG01 = 'C724'|DIAG01 = 
'C725'|DIAG01 = 'C728'|DIAG01 = 'C729'|DIAG01 = 'C73X'|DIAG01 = 'C740'|DIAG01 = 'C741'|DIAG01 = 
'C749'|DIAG01 = 'C750'|DIAG01 = 'C751'|DIAG01 = 'C752'|DIAG01 = 'C753'|DIAG01 = 'C754'|DIAG01 = 
'C755'|DIAG01 = 'C758'|DIAG01 = 'C759'|DIAG01 = 'C760'|DIAG01 = 'C761'|DIAG01 = 'C762'|DIAG01 = 
'C763'|DIAG01 = 'C764'|DIAG01 = 'C765'|DIAG01 = 'C767'|DIAG01 = 'C768'|DIAG01 = 'C810'|DIAG01 = 
'C811'|DIAG01 = 'C812'|DIAG01 = 'C813'|DIAG01 = 'C817'|DIAG01 = 'C819'|DIAG01 = 'C820'|DIAG01 = 
'C821'|DIAG01 = 'C822'|DIAG01 = 'C827'|DIAG01 = 'C829'|DIAG01 = 'C830'|DIAG01 = 'C831'|DIAG01 = 
'C832'|DIAG01 = 'C833'|DIAG01 = 'C834'|DIAG01 = 'C835'|DIAG01 = 'C836'|DIAG01 = 'C837'|DIAG01 = 
'C838'|DIAG01 = 'C839'|DIAG01 = 'C840'|DIAG01 = 'C841'|DIAG01 = 'C842'|DIAG01 = 'C843'|DIAG01 = 
'C844'|DIAG01 = 'C845'|DIAG01 = 'C850'|DIAG01 = 'C851'|DIAG01 = 'C857'|DIAG01 = 'C859'|DIAG01 = 
'C883'|DIAG01 = 'C887'|DIAG01 = 'C889'|DIAG01 = 'C900'|DIAG01 = 'C901'|DIAG01 = 'C910'|DIAG01 = 
'C911'|DIAG01 = 'C912'|DIAG01 = 'C913'|DIAG01 = 'C914'|DIAG01 = 'C915'|DIAG01 = 'C917'|DIAG01 = 
'C919'|DIAG01 = 'C920'|DIAG01 = 'C921'|DIAG01 = 'C922'|DIAG01 = 'C923'|DIAG01 = 'C924'|DIAG01 = 
'C925'|DIAG01 = 'C927'|DIAG01 = 'C929'|DIAG01 = 'C930'|DIAG01 = 'C931'|DIAG01 = 'C932'|DIAG01 = 
'C937'|DIAG01 = 'C939'|DIAG01 = 'C940'|DIAG01 = 'C941'|DIAG01 = 'C942'|DIAG01 = 'C943'|DIAG01 = 
'C945'|DIAG01 = 'C947'|DIAG01 = 'C950'|DIAG01 = 'C951'|DIAG01 = 'C952'|DIAG01 = 'C957'|DIAG01 = 
'C959'|DIAG01 = 'C960'|DIAG01 = 'C961'|DIAG01 = 'C962'|DIAG01 = 'C963'|DIAG01 = 'C967'|DIAG01 = 
'C969'|DIAG01 = 'E102'|DIAG01 = 'E103'|DIAG01 = 'E104'|DIAG01 = 'E112'|DIAG01 = 'E113'|DIAG01 = 
'E114'|DIAG01 = 'E132'|DIAG01 = 'E133'|DIAG01 = 'E134'|DIAG01 = 'E142'|DIAG01 = 'E143'|DIAG01 = 
'E144'|DIAG01 = 'G041'|DIAG01 = 'G820'|DIAG01 = 'G821'|DIAG01 = 'G822'|DIAG01 = 'N010'|DIAG01 = 
'N011'|DIAG01 = 'N012'|DIAG01 = 'N013'|DIAG01 = 'N014'|DIAG01 = 'N015'|DIAG01 = 'N016'|DIAG01 = 
'N017'|DIAG01 = 'N018'|DIAG01 = 'N019'|DIAG01 = 'N031'|DIAG01 = 'N032'|DIAG01 = 'N033'|DIAG01 = 
'N034'|DIAG01 = 'N035'|DIAG01 = 'N036'|DIAG01 = 'N037'|DIAG01 = 'N038'|DIAG01 = 'N039'|DIAG01 = 
'N052'|DIAG01 = 'N053'|DIAG01 = 'N054'|DIAG01 = 'N055'|DIAG01 = 'N056'|DIAG01 = 'N072'|DIAG01 = 
'N073'|DIAG01 = 'N074'|DIAG01 = 'N180'|DIAG01 = 'N188'|DIAG01 = 'N189'|DIAG01 = 'N19X'|DIAG01 = 
'N250'|DIAG01 = 'N251'|DIAG01 = 'N258'|DIAG01 = 'N259')COMORBIDITY1 = 2. 
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EXECUTE. 
 
IF (DIAG01 = 'C770'|DIAG01 = 'C771'|DIAG01 = 'C772'|DIAG01 = 'C773'|DIAG01 = 'C774'|DIAG01 = 
'C775'|DIAG01 = 'C778'|DIAG01 = 'C779'|DIAG01 = 'C780'|DIAG01 = 'C781'|DIAG01 = 'C782'|DIAG01 = 
'C783'|DIAG01 = 'C784'|DIAG01 = 'C785'|DIAG01 = 'C786'|DIAG01 = 'C787'|DIAG01 = 'C788'|DIAG01 = 
'C790'|DIAG01 = 'C791'|DIAG01 = 'C792'|DIAG01 = 'C793'|DIAG01 = 'C794'|DIAG01 = 'C795'|DIAG01 = 
'C796'|DIAG01 = 'C797'|DIAG01 = 'C798'|DIAG01 = 'C80X'|DIAG01 = 'K721'|DIAG01 = 'K729'|DIAG01 = 
'K766'|DIAG01 = 'K767')COMORBIDITY1 = 3. 
EXECUTE. 
 
IF (DIAG01 = 'B200'|DIAG01 = 'B201'|DIAG01 = 'B202'|DIAG01 = 'B203'|DIAG01 = 'B204'|DIAG01 = 
'B205'|DIAG01 = 'B206'|DIAG01 = 'B207'|DIAG01 = 'B208'|DIAG01 = 'B209'|DIAG01 = 'B210'|DIAG01 = 
'B211'|DIAG01 = 'B212'|DIAG01 = 'B213'|DIAG01 = 'B217'|DIAG01 = 'B218'|DIAG01 = 'B219'|DIAG01 = 
'B220'|DIAG01 = 'B221'|DIAG01 = 'B222'|DIAG01 = 'B227'|DIAG01 = 'B230'|DIAG01 = 'B231'|DIAG01 = 
'B232'|DIAG01 = 'B238'|DIAG01 = 'B24X') COMORBIDITY1 = 6. 
EXECUTE. 
 
COMPUTE COMORBIDITY2 = 0. 
EXECUTE. 
 
IF (DIAG02 = 'E101'|DIAG02 = 'E105'|DIAG02 = 'E109'|DIAG02 = 'E111'|DIAG02 = 'E115'|DIAG02 = 
'E119'|DIAG02 = 'E131'|DIAG02 = 'E135'|DIAG02 = 'E139'|DIAG02 = 'E141'|DIAG02 = 'E145'|DIAG02 = 
'E149'|DIAG02 = 'F000'|DIAG02 = 'F001'|DIAG02 = 'F002'|DIAG02 = 'F009'|DIAG02 = 'F010'|DIAG02 = 
'F011'|DIAG02 = 'F012'|DIAG02 = 'F013'|DIAG02 = 'F018'|DIAG02 = 'F019'|DIAG02 = 'F020'|DIAG02 = 
'F021'|DIAG02 = 'F022'|DIAG02 = 'F023'|DIAG02 = 'F024'|DIAG02 = 'F028'|DIAG02 = 'F051'|DIAG02 = 
'G452'|DIAG02 = 'G454'|DIAG02 = 'G458'|DIAG02 = 'G459'|DIAG02 = 'G466'|DIAG02 = 'I210'|DIAG02 = 
'I211'|DIAG02 = 'I212'|DIAG02 = 'I213'|DIAG02 = 'I214'|DIAG02 = 'I219'|DIAG02 = 'I220'|DIAG02 = 
'I221'|DIAG02 = 'I228'|DIAG02 = 'I229'|DIAG02 = 'I252'|DIAG02 = 'I500'|DIAG02 = 'I501'|DIAG02 = 
'I509'|DIAG02 = 'I601'|DIAG02 = 'I602'|DIAG02 = 'I603'|DIAG02 = 'I604'|DIAG02 = 'I605'|DIAG02 = 
'I606'|DIAG02 = 'I607'|DIAG02 = 'I608'|DIAG02 = 'I609'|DIAG02 = 'I620'|DIAG02 = 'I621'|DIAG02 = 
'I671'|DIAG02 = 'I674'|DIAG02 = 'I675'|DIAG02 = 'I676'|DIAG02 = 'I677'|DIAG02 = 'I681'|DIAG02 = 
'I682'|DIAG02 = 'I690'|DIAG02 = 'I710'|DIAG02 = 'I711'|DIAG02 = 'I712'|DIAG02 = 'I713'|DIAG02 = 
'I714'|DIAG02 = 'I715'|DIAG02 = 'I716'|DIAG02 = 'I718'|DIAG02 = 'I719'|DIAG02 = 'I739'|DIAG02 = 
'I790'|DIAG02 = 'J40X'|DIAG02 = 'J410'|DIAG02 = 'J411'|DIAG02 = 'J418'|DIAG02 = 'J42X'|DIAG02 = 
'J430'|DIAG02 = 'J431'|DIAG02 = 'J432'|DIAG02 = 'J438'|DIAG02 = 'J439'|DIAG02 = 'J440'|DIAG02 = 
'J441'|DIAG02 = 'J448'|DIAG02 = 'J449'|DIAG02 = 'J450'|DIAG02 = 'J451'|DIAG02 = 'J458'|DIAG02 = 
'J459'|DIAG02 = 'J46X'|DIAG02 = 'J47X'|DIAG02 = 'J60X'|DIAG02 = 'J61X'|DIAG02 = 'J620'|DIAG02 = 
'J628'|DIAG02 = 'J630'|DIAG02 = 'J631'|DIAG02 = 'J632'|DIAG02 = 'J633'|DIAG02 = 'J634'|DIAG02 = 
'J635'|DIAG02 = 'J638'|DIAG02 = 'J64X'|DIAG02 = 'J65X'|DIAG02 = 'J660'|DIAG02 = 'J661'|DIAG02 = 
'J662'|DIAG02 = 'J668'|DIAG02 = 'K250'|DIAG02 = 'K251'|DIAG02 = 'K252'|DIAG02 = 'K253'|DIAG02 = 
'K254'|DIAG02 = 'K255'|DIAG02 = 'K256'|DIAG02 = 'K257'|DIAG02 = 'K259'|DIAG02 = 'K260'|DIAG02 = 
'K261'|DIAG02 = 'K262'|DIAG02 = 'K263'|DIAG02 = 'K264'|DIAG02 = 'K265'|DIAG02 = 'K266'|DIAG02 = 
'K267'|DIAG02 = 'K269'|DIAG02 = 'K270'|DIAG02 = 'K271'|DIAG02 = 'K272'|DIAG02 = 'K273'|DIAG02 = 
'K274'|DIAG02 = 'K275'|DIAG02 = 'K276'|DIAG02 = 'K277'|DIAG02 = 'K279'|DIAG02 = 'K280'|DIAG02 = 
'K281'|DIAG02 = 'K282'|DIAG02 = 'K283'|DIAG02 = 'K284'|DIAG02 = 'K285'|DIAG02 = 'K286'|DIAG02 = 
'K287'|DIAG02 = 'K289'|DIAG02 = 'K702'|DIAG02 = 'K703'|DIAG02 = 'K717'|DIAG02 = 'K731'|DIAG02 = 
'K732'|DIAG02 = 'K738'|DIAG02 = 'K739'|DIAG02 = 'K740'|DIAG02 = 'K742'|DIAG02 = 'K743'|DIAG02 = 
'K744'|DIAG02 = 'K745'|DIAG02 = 'K746'|DIAG02 = 'M050'|DIAG02 = 'M051'|DIAG02 = 'M052'|DIAG02 = 
'M053'|DIAG02 = 'M058'|DIAG02 = 'M059'|DIAG02 = 'M060'|DIAG02 = 'M063'|DIAG02 = 'M069'|DIAG02 = 
'M320'|DIAG02 = 'M321'|DIAG02 = 'M328'|DIAG02 = 'M329'|DIAG02 = 'M332'|DIAG02 = 'M340'|DIAG02 = 
'M341'|DIAG02 = 'M342'|DIAG02 = 'M348'|DIAG02 = 'M349'|DIAG02 = 'M353'|DIAG02 = 'R02X'|DIAG02 = 
'Z958'|DIAG02 = 'Z959')COMORBIDITY2 = 1. 
EXECUTE. 
 
IF (DIAG02 = 'C000'|DIAG02 = 'C001'|DIAG02 = 'C002'|DIAG02 = 'C003'|DIAG02 = 'C004'|DIAG02 = 
'C005'|DIAG02 = 'C006'|DIAG02 = 'C008'|DIAG02 = 'C009'|DIAG02 = 'C01X'|DIAG02 = 'C020'|DIAG02 = 
'C021'|DIAG02 = 'C022'|DIAG02 = 'C023'|DIAG02 = 'C024'|DIAG02 = 'C028'|DIAG02 = 'C029'|DIAG02 = 
'C030'|DIAG02 = 'C031'|DIAG02 = 'C039'|DIAG02 = 'C040'|DIAG02 = 'C041'|DIAG02 = 'C048'|DIAG02 = 
'C049'|DIAG02 = 'C050'|DIAG02 = 'C051'|DIAG02 = 'C052'|DIAG02 = 'C058'|DIAG02 = 'C059'|DIAG02 = 
'C060'|DIAG02 = 'C061'|DIAG02 = 'C062'|DIAG02 = 'C068'|DIAG02 = 'C069'|DIAG02 = 'C07X'|DIAG02 = 
'C080'|DIAG02 = 'C081'|DIAG02 = 'C088'|DIAG02 = 'C089'|DIAG02 = 'C090'|DIAG02 = 'C091'|DIAG02 = 
'C098'|DIAG02 = 'C099'|DIAG02 = 'C100'|DIAG02 = 'C101'|DIAG02 = 'C102'|DIAG02 = 'C103'|DIAG02 = 
'C104'|DIAG02 = 'C108'|DIAG02 = 'C109'|DIAG02 = 'C110'|DIAG02 = 'C111'|DIAG02 = 'C112'|DIAG02 = 
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'C113'|DIAG02 = 'C118'|DIAG02 = 'C119'|DIAG02 = 'C12X'|DIAG02 = 'C130'|DIAG02 = 'C131'|DIAG02 = 
'C132'|DIAG02 = 'C138'|DIAG02 = 'C139'|DIAG02 = 'C140'|DIAG02 = 'C142'|DIAG02 = 'C148'|DIAG02 = 
'C150'|DIAG02 = 'C151'|DIAG02 = 'C152'|DIAG02 = 'C153'|DIAG02 = 'C154'|DIAG02 = 'C155'|DIAG02 = 
'C158'|DIAG02 = 'C159'|DIAG02 = 'C160'|DIAG02 = 'C161'|DIAG02 = 'C162'|DIAG02 = 'C163'|DIAG02 = 
'C164'|DIAG02 = 'C165'|DIAG02 = 'C166'|DIAG02 = 'C168'|DIAG02 = 'C169'|DIAG02 = 'C170'|DIAG02 = 
'C171'|DIAG02 = 'C172'|DIAG02 = 'C173'|DIAG02 = 'C178'|DIAG02 = 'C179'|DIAG02 = 'C180'|DIAG02 = 
'C181'|DIAG02 = 'C182'|DIAG02 = 'C183'|DIAG02 = 'C184'|DIAG02 = 'C185'|DIAG02 = 'C186'|DIAG02 = 
'C187'|DIAG02 = 'C188'|DIAG02 = 'C189'|DIAG02 = 'C19X'|DIAG02 = 'C20X'|DIAG02 = 'C210'|DIAG02 = 
'C211'|DIAG02 = 'C212'|DIAG02 = 'C218'|DIAG02 = 'C220'|DIAG02 = 'C221'|DIAG02 = 'C222'|DIAG02 = 
'C223'|DIAG02 = 'C224'|DIAG02 = 'C227'|DIAG02 = 'C229'|DIAG02 = 'C23X'|DIAG02 = 'C240'|DIAG02 = 
'C241'|DIAG02 = 'C248'|DIAG02 = 'C249'|DIAG02 = 'C250'|DIAG02 = 'C251'|DIAG02 = 'C252'|DIAG02 = 
'C253'|DIAG02 = 'C254'|DIAG02 = 'C257'|DIAG02 = 'C258'|DIAG02 = 'C259'|DIAG02 = 'C260'|DIAG02 = 
'C261'|DIAG02 = 'C268'|DIAG02 = 'C269'|DIAG02 = 'C300'|DIAG02 = 'C301'|DIAG02 = 'C310'|DIAG02 = 
'C311'|DIAG02 = 'C312'|DIAG02 = 'C313'|DIAG02 = 'C318'|DIAG02 = 'C319'|DIAG02 = 'C320'|DIAG02 = 
'C321'|DIAG02 = 'C322'|DIAG02 = 'C323'|DIAG02 = 'C328'|DIAG02 = 'C329'|DIAG02 = 'C33X'|DIAG02 = 
'C340'|DIAG02 = 'C341'|DIAG02 = 'C342'|DIAG02 = 'C343'|DIAG02 = 'C348'|DIAG02 = 'C349'|DIAG02 = 
'C37X'|DIAG02 = 'C380'|DIAG02 = 'C381'|DIAG02 = 'C382'|DIAG02 = 'C383'|DIAG02 = 'C384'|DIAG02 = 
'C388'|DIAG02 = 'C390'|DIAG02 = 'C398'|DIAG02 = 'C399'|DIAG02 = 'C400'|DIAG02 = 'C401'|DIAG02 = 
'C402'|DIAG02 = 'C403'|DIAG02 = 'C408'|DIAG02 = 'C409'|DIAG02 = 'C410'|DIAG02 = 'C411'|DIAG02 = 
'C412'|DIAG02 = 'C413'|DIAG02 = 'C414'|DIAG02 = 'C418'|DIAG02 = 'C419'|DIAG02 = 'C430'|DIAG02 = 
'C431'|DIAG02 = 'C432'|DIAG02 = 'C433'|DIAG02 = 'C434'|DIAG02 = 'C435'|DIAG02 = 'C436'|DIAG02 = 
'C437'|DIAG02 = 'C438'|DIAG02 = 'C439'|DIAG02 = 'C450'|DIAG02 = 'C451'|DIAG02 = 'C452'|DIAG02 = 
'C457'|DIAG02 = 'C459'|DIAG02 = 'C460'|DIAG02 = 'C461'|DIAG02 = 'C462'|DIAG02 = 'C463'|DIAG02 = 
'C467'|DIAG02 = 'C468'|DIAG02 = 'C469'|DIAG02 = 'C470'|DIAG02 = 'C471'|DIAG02 = 'C472'|DIAG02 = 
'C473'|DIAG02 = 'C474'|DIAG02 = 'C475'|DIAG02 = 'C476'|DIAG02 = 'C478'|DIAG02 = 'C479'|DIAG02 = 
'C480'|DIAG02 = 'C481'|DIAG02 = 'C482'|DIAG02 = 'C488'|DIAG02 = 'C490'|DIAG02 = 'C491'|DIAG02 = 
'C492'|DIAG02 = 'C493'|DIAG02 = 'C494'|DIAG02 = 'C495'|DIAG02 = 'C496'|DIAG02 = 'C498'|DIAG02 = 
'C499'|DIAG02 = 'C500'|DIAG02 = 'C501'|DIAG02 = 'C502'|DIAG02 = 'C503'|DIAG02 = 'C504'|DIAG02 = 
'C505'|DIAG02 = 'C506'|DIAG02 = 'C508'|DIAG02 = 'C509'|DIAG02 = 'C510'|DIAG02 = 'C511'|DIAG02 = 
'C512'|DIAG02 = 'C518'|DIAG02 = 'C519'|DIAG02 = 'C52X'|DIAG02 = 'C530'|DIAG02 = 'C531'|DIAG02 = 
'C538'|DIAG02 = 'C539'|DIAG02 = 'C540'|DIAG02 = 'C541'|DIAG02 = 'C542'|DIAG02 = 'C543'|DIAG02 = 
'C548'|DIAG02 = 'C549'|DIAG02 = 'C55X'|DIAG02 = 'C56X'|DIAG02 = 'C570'|DIAG02 = 'C571'|DIAG02 = 
'C572'|DIAG02 = 'C573'|DIAG02 = 'C574'|DIAG02 = 'C577'|DIAG02 = 'C578'|DIAG02 = 'C579'|DIAG02 = 
'C58X'|DIAG02 = 'C600'|DIAG02 = 'C601'|DIAG02 = 'C602'|DIAG02 = 'C608'|DIAG02 = 'C609'|DIAG02 = 
'C61X'|DIAG02 = 'C620'|DIAG02 = 'C621'|DIAG02 = 'C629'|DIAG02 = 'C630'|DIAG02 = 'C631'|DIAG02 = 
'C632'|DIAG02 = 'C637'|DIAG02 = 'C638'|DIAG02 = 'C639'|DIAG02 = 'C64X'|DIAG02 = 'C65X'|DIAG02 = 
'C66X'|DIAG02 = 'C670'|DIAG02 = 'C671'|DIAG02 = 'C672'|DIAG02 = 'C673'|DIAG02 = 'C674'|DIAG02 = 
'C675'|DIAG02 = 'C676'|DIAG02 = 'C677'|DIAG02 = 'C678'|DIAG02 = 'C679'|DIAG02 = 'C680'|DIAG02 = 
'C681'|DIAG02 = 'C688'|DIAG02 = 'C689'|DIAG02 = 'C690'|DIAG02 = 'C691'|DIAG02 = 'C692'|DIAG02 = 
'C693'|DIAG02 = 'C694'|DIAG02 = 'C695'|DIAG02 = 'C696'|DIAG02 = 'C698'|DIAG02 = 'C699'|DIAG02 = 
'C700'|DIAG02 = 'C701'|DIAG02 = 'C709'|DIAG02 = 'C710'|DIAG02 = 'C711'|DIAG02 = 'C712'|DIAG02 = 
'C713'|DIAG02 = 'C714'|DIAG02 = 'C715'|DIAG02 = 'C716'|DIAG02 = 'C717'|DIAG02 = 'C718'|DIAG02 = 
'C719'|DIAG02 = 'C720'|DIAG02 = 'C721'|DIAG02 = 'C722'|DIAG02 = 'C723'|DIAG02 = 'C724'|DIAG02 = 
'C725'|DIAG02 = 'C728'|DIAG02 = 'C729'|DIAG02 = 'C73X'|DIAG02 = 'C740'|DIAG02 = 'C741'|DIAG02 = 
'C749'|DIAG02 = 'C750'|DIAG02 = 'C751'|DIAG02 = 'C752'|DIAG02 = 'C753'|DIAG02 = 'C754'|DIAG02 = 
'C755'|DIAG02 = 'C758'|DIAG02 = 'C759'|DIAG02 = 'C760'|DIAG02 = 'C761'|DIAG02 = 'C762'|DIAG02 = 
'C763'|DIAG02 = 'C764'|DIAG02 = 'C765'|DIAG02 = 'C767'|DIAG02 = 'C768'|DIAG02 = 'C810'|DIAG02 = 
'C811'|DIAG02 = 'C812'|DIAG02 = 'C813'|DIAG02 = 'C817'|DIAG02 = 'C819'|DIAG02 = 'C820'|DIAG02 = 
'C821'|DIAG02 = 'C822'|DIAG02 = 'C827'|DIAG02 = 'C829'|DIAG02 = 'C830'|DIAG02 = 'C831'|DIAG02 = 
'C832'|DIAG02 = 'C833'|DIAG02 = 'C834'|DIAG02 = 'C835'|DIAG02 = 'C836'|DIAG02 = 'C837'|DIAG02 = 
'C838'|DIAG02 = 'C839'|DIAG02 = 'C840'|DIAG02 = 'C841'|DIAG02 = 'C842'|DIAG02 = 'C843'|DIAG02 = 
'C844'|DIAG02 = 'C845'|DIAG02 = 'C850'|DIAG02 = 'C851'|DIAG02 = 'C857'|DIAG02 = 'C859'|DIAG02 = 
'C883'|DIAG02 = 'C887'|DIAG02 = 'C889'|DIAG02 = 'C900'|DIAG02 = 'C901'|DIAG02 = 'C910'|DIAG02 = 
'C911'|DIAG02 = 'C912'|DIAG02 = 'C913'|DIAG02 = 'C914'|DIAG02 = 'C915'|DIAG02 = 'C917'|DIAG02 = 
'C919'|DIAG02 = 'C920'|DIAG02 = 'C921'|DIAG02 = 'C922'|DIAG02 = 'C923'|DIAG02 = 'C924'|DIAG02 = 
'C925'|DIAG02 = 'C927'|DIAG02 = 'C929'|DIAG02 = 'C930'|DIAG02 = 'C931'|DIAG02 = 'C932'|DIAG02 = 
'C937'|DIAG02 = 'C939'|DIAG02 = 'C940'|DIAG02 = 'C941'|DIAG02 = 'C942'|DIAG02 = 'C943'|DIAG02 = 
'C945'|DIAG02 = 'C947'|DIAG02 = 'C950'|DIAG02 = 'C951'|DIAG02 = 'C952'|DIAG02 = 'C957'|DIAG02 = 
'C959'|DIAG02 = 'C960'|DIAG02 = 'C961'|DIAG02 = 'C962'|DIAG02 = 'C963'|DIAG02 = 'C967'|DIAG02 = 
'C969'|DIAG02 = 'E102'|DIAG02 = 'E103'|DIAG02 = 'E104'|DIAG02 = 'E112'|DIAG02 = 'E113'|DIAG02 = 
'E114'|DIAG02 = 'E132'|DIAG02 = 'E133'|DIAG02 = 'E134'|DIAG02 = 'E142'|DIAG02 = 'E143'|DIAG02 = 
'E144'|DIAG02 = 'G041'|DIAG02 = 'G820'|DIAG02 = 'G821'|DIAG02 = 'G822'|DIAG02 = 'N010'|DIAG02 = 
'N011'|DIAG02 = 'N012'|DIAG02 = 'N013'|DIAG02 = 'N014'|DIAG02 = 'N015'|DIAG02 = 'N016'|DIAG02 = 
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'N017'|DIAG02 = 'N018'|DIAG02 = 'N019'|DIAG02 = 'N031'|DIAG02 = 'N032'|DIAG02 = 'N033'|DIAG02 = 
'N034'|DIAG02 = 'N035'|DIAG02 = 'N036'|DIAG02 = 'N037'|DIAG02 = 'N038'|DIAG02 = 'N039'|DIAG02 = 
'N052'|DIAG02 = 'N053'|DIAG02 = 'N054'|DIAG02 = 'N055'|DIAG02 = 'N056'|DIAG02 = 'N072'|DIAG02 = 
'N073'|DIAG02 = 'N074'|DIAG02 = 'N180'|DIAG02 = 'N188'|DIAG02 = 'N189'|DIAG02 = 'N19X'|DIAG02 = 
'N250'|DIAG02 = 'N251'|DIAG02 = 'N258'|DIAG02 = 'N259')COMORBIDITY2 = 2. 
EXECUTE. 
 
IF (DIAG02 = 'C770'|DIAG02 = 'C771'|DIAG02 = 'C772'|DIAG02 = 'C773'|DIAG02 = 'C774'|DIAG02 = 
'C775'|DIAG02 = 'C778'|DIAG02 = 'C779'|DIAG02 = 'C780'|DIAG02 = 'C781'|DIAG02 = 'C782'|DIAG02 = 
'C783'|DIAG02 = 'C784'|DIAG02 = 'C785'|DIAG02 = 'C786'|DIAG02 = 'C787'|DIAG02 = 'C788'|DIAG02 = 
'C790'|DIAG02 = 'C791'|DIAG02 = 'C792'|DIAG02 = 'C793'|DIAG02 = 'C794'|DIAG02 = 'C795'|DIAG02 = 
'C796'|DIAG02 = 'C797'|DIAG02 = 'C798'|DIAG02 = 'C80X'|DIAG02 = 'K721'|DIAG02 = 'K729'|DIAG02 = 
'K766'|DIAG02 = 'K767')COMORBIDITY2 = 3. 
EXECUTE. 
 
IF (DIAG02 = 'B200'|DIAG02 = 'B201'|DIAG02 = 'B202'|DIAG02 = 'B203'|DIAG02 = 'B204'|DIAG02 = 
'B205'|DIAG02 = 'B206'|DIAG02 = 'B207'|DIAG02 = 'B208'|DIAG02 = 'B209'|DIAG02 = 'B210'|DIAG02 = 
'B211'|DIAG02 = 'B212'|DIAG02 = 'B213'|DIAG02 = 'B217'|DIAG02 = 'B218'|DIAG02 = 'B219'|DIAG02 = 
'B220'|DIAG02 = 'B221'|DIAG02 = 'B222'|DIAG02 = 'B227'|DIAG02 = 'B230'|DIAG02 = 'B231'|DIAG02 = 
'B232'|DIAG02 = 'B238'|DIAG02 = 'B24X') COMORBIDITY2 = 6. 
EXECUTE. 
Then repeat as above for ICD-10 code positions 3 through 20 
Stroke Syntax 16 – Speciality type marker 
COMPUTE SPECTYPE = 0. 
EXECUTE. 
 
IF (MAINSPEF = 300| 
MAINSPEF = 301| 
MAINSPEF = 302| 
MAINSPEF = 303| 
MAINSPEF = 305| 
MAINSPEF = 313| 
MAINSPEF = 314| 
MAINSPEF = 315| 
MAINSPEF = 320| 
MAINSPEF = 330| 
MAINSPEF = 340| 
MAINSPEF = 350| 
MAINSPEF = 352| 
MAINSPEF = 360| 
MAINSPEF = 361| 
MAINSPEF = 370| 
MAINSPEF = 400| 
MAINSPEF = 410| 
MAINSPEF = 430| 
MAINSPEF = 823)SPECTYPE = 1. 
EXECUTE. 
 
 
 
 
 
 
 
 
 
IF (MAINSPEF = 100| 
MAINSPEF = 101| 
MAINSPEF = 110| 
MAINSPEF = 120| 
MAINSPEF = 130| 
MAINSPEF = 140| 
MAINSPEF = 145| 
MAINSPEF = 150| 
MAINSPEF = 160| 
MAINSPEF = 170| 
MAINSPEF = 180| 
MAINSPEF = 190| 
MAINSPEF = 192)SPECTYPE = 2. 
EXECUTE
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Stroke Syntax 17 – Comorbidity group marker 
COMPUTE COMORBIDGRP = 0. 
EXECUTE . 
 
IF (COMORBIDTOTAL = 0)COMORBIDGRP = 1. 
EXECUTE. 
 
IF (COMORBIDTOTAL = 1)COMORBIDGRP = 2. 
EXECUTE . 
 
IF (COMORBIDTOTAL > 1)COMORBIDGRP = 3. 
EXECUTE. 
 
Stroke Syntax 18 – PEG procedure performed in first stroke admission
COMPUTE PEGINFIRSTSTROKEADM = 2. 
EXECUTE. 
 
IF (SPELLOS = PEGDATEMINUSADMDATE| 
SPELLOS > PEGDATEMINUSADMDATE)PEGINFIRSTSTROKEADM = 1. 
EXECUTE. 
Stroke Syntax 19 – Death status 30 days after PEG procedure 
COMPUTE ALIVEDEAD30DAYAFTERPEG = 3. 
EXECUTE. 
 
IF (NOOFDAYSFROMPEGDATETODEATHDATE < 31)ALIVEDEAD30DAYAFTERPEG = 1. 
EXECUTE. 
 
IF (NOOFDAYSFROMPEGDATETODEATHDATE > 30)ALIVEDEAD30DAYAFTERPEG = 2. 
EXECUTE. 
 
This can be modified to create markers for death within any number of days of PEG procedure 
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Stroke Syntax 20 – Small volume Trust marker 
   
COMPUTE 
SMALLVOLTRUST = 0. 
EXECUTE. 
 
IF (PROCODE='RAS'| 
PROCODE='RBD'| 
PROCODE='RJN'| 
PROCODE='RLQ'| 
PROCODE='RM2'| 
PROCODE='RNJ'| 
PROCODE='RRV'| 
PROCODE='RWJ'| 
PROCODE='RA7'| 
PROCODE='RM4'| 
PROCODE='RTP'| 
PROCODE='RWH'| 
PROCODE='RBA'| 
PROCODE='RCC'| 
PROCODE='RCF'| 
PROCODE='RJ6'| 
PROCODE='RJE'| 
PROCODE='RLN'| 
PROCODE='RN5'| 
PROCODE='RQM'| 
PROCODE='RA4'| 
PROCODE='RBZ'| 
PROCODE='RDU'| 
PROCODE='RDZ'| 
PROCODE='RE9'| 
PROCODE='RN3'| 
PROCODE='RNH'| 
PROCODE='RNZ'| 
PROCODE='RPA'| 
PROCODE='RPL'| 
PROCODE='RQQ'| 
PROCODE='RTE')SMALLVOL
TRUST = 1. 
EXECUTE
 
 
Stroke Syntax 21 – Discharge to Nursing Home 
COMPUTE DISCHNURSINGHOME = 0. 
EXECUTE . 
IF (DISDEST = 54| 
DISDEST = 65| 
DISDEST = 85| 
DISDEST = 87| 
DISDEST = 88)DISCHNURSINGHOME = 1. 
EXECUTE. 
 
Stroke Syntax 22 – Emergency readmission following stroke admission 
COMPUTE EMERGREADMIT7DAYSOF1STSTROKE = 0. 
EXECUTE. 
 
IF (DAYSBETDISCHOF1STSTROKEANDADMOFNXTEMERGADM < 
8)EMERGREADMIT7DAYSOF1STSTROKE = 1. 
EXECUTE. 
 
COMPUTE EMERGREADMIT30DAYSOF1STSTROKE = 0. 
EXECUTE. 
 
IF (DAYSBETDISCHOF1STSTROKEANDADMOFNXTEMERGADM < 
31)EMERGREADMIT30DAYSOF1STSTROKE = 1. 
EXECUTE. 
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Stroke Syntax 23 – Assign 2 year dataset month tag
COMPUTE MONTHTAG = 0. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 4)MONTHTAG = 13. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 5)MONTHTAG = 14. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 6)MONTHTAG = 15. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 7)MONTHTAG = 16. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 8)MONTHTAG = 17. 
EXECUTE. 
IF (MONTHFINANCIAL = 9)MONTHTAG = 18. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 10)MONTHTAG = 19. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 11)MONTHTAG = 20. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 12)MONTHTAG = 21. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 1)MONTHTAG = 22. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 2)MONTHTAG = 23. 
EXECUTE. 
 
IF (MONTHFINANCIAL = 3)MONTHTAG = 24. 
EXECUTE 
 
 
 
 
Stroke Syntax 24 – Stroke marker 
COMPUTE MARKER = 0. 
EXECUTE. 
 
IF (STROKE > 0)MARKER = 1. 
EXECUTE. 
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Stroke Syntax 25 – PEG volume Tertiles
COMPUTE LOWPEGVOLTRUST 
= 0. 
EXECUTE. 
 
IF(PROCODE='RCF'| 
PROCODE='RA3'| 
PROCODE='5QT'| 
PROCODE='RGZ'| 
PROCODE='RE9'| 
PROCODE='RNH'| 
PROCODE='RCC'| 
PROCODE='RR7'| 
PROCODE='RQQ'| 
PROCODE='RQX'| 
PROCODE='RKE'| 
PROCODE='RA4'| 
PROCODE='RFW'| 
PROCODE='RBZ'| 
PROCODE='RNZ'| 
PROCODE='RJF'| 
PROCODE='RVY'| 
PROCODE='RPL'| 
PROCODE='RC1'| 
PROCODE='RN7'| 
PROCODE='RJ2'| 
PROCODE='RGP'| 
PROCODE='RN3'| 
PROCODE='RCD'| 
PROCODE='RGR'| 
PROCODE='RG2'| 
PROCODE='RN5'| 
PROCODE='RC3'| 
PROCODE='RAX'| 
PROCODE='RBT'| 
PROCODE='RLT'| 
PROCODE='RRF'| 
PROCODE='RDU'| 
PROCODE='RQW'| 
PROCODE='RJ6'| 
PROCODE='RGC'| 
PROCODE='RK5'| 
PROCODE='RJD'| 
PROCODE='RFF'| 
PROCODE='RTK'| 
PROCODE='RDZ'| 
PROCODE='RBA'| 
PROCODE='RXL'| 
PROCODE='RJC'| 
PROCODE='RD8'| 
PROCODE='RTF')LOWPEGVOLT
RUST = 1. 
EXECUTE. 
 
COMPUTE MEDPEGVOLTRUST 
= 0. 
EXECUTE. 
 
IF(PROCODE='RN1'| 
PROCODE='RAL'| 
PROCODE='RA7'| 
PROCODE='RGN'| 
PROCODE='RM4'| 
PROCODE='RVW'| 
PROCODE='RBK'| 
PROCODE='RA9'| 
PROCODE='RBL'| 
PROCODE='RPA'| 
PROCODE='RWG'| 
PROCODE='RJL'| 
PROCODE='RNL'| 
PROCODE='RWW'| 
PROCODE='RG3'| 
PROCODE='RMP'| 
PROCODE='RD7'| 
PROCODE='RF4'| 
PROCODE='RCX'| 
PROCODE='RTX'| 
PROCODE='RFR'| 
PROCODE='RQM'| 
PROCODE='RWF'| 
PROCODE='RXQ'| 
PROCODE='RC9'| 
PROCODE='RXP'| 
PROCODE='RPR'| 
PROCODE='RHM'| 
PROCODE='RDE'| 
PROCODE='RD1'| 
PROCODE='RGQ'| 
PROCODE='RCB'| 
PROCODE='RQ8'| 
PROCODE='RJR'| 
PROCODE='RNA'| 
PROCODE='RLN'| 
PROCODE='RJ7'| 
PROCODE='RNS'| 
PROCODE='RNQ'| 
PROCODE='RL4'| 
PROCODE='RWP'| 
PROCODE='RD3'| 
PROCODE='RVL'| 
PROCODE='RMC'| 
PROCODE='RAP'| 
PROCODE='RVV')MEDPEGVOL
TRUST = 1. 
EXECUTE. 
 
COMPUTE HIGHPEGVOLTRUST 
= 0. 
EXECUTE. 
 
IF(PROCODE='RWD'| 
PROCODE='RXK'| 
PROCODE='RK9'| 
PROCODE='RFS'| 
PROCODE='RA2'| 
PROCODE='RAJ'| 
PROCODE='RW3'| 
PROCODE='RXH'| 
PROCODE='RHU'| 
PROCODE='RR1'| 
PROCODE='RH8'| 
PROCODE='RXC'| 
PROCODE='RKB'| 
PROCODE='RVR'| 
PROCODE='RQ6'| 
PROCODE='RJZ'| 
PROCODE='RTR'| 
PROCODE='RAE'| 
PROCODE='RYJ'| 
PROCODE='RRK'| 
PROCODE='RWY'| 
PROCODE='RGT'| 
PROCODE='REF'| 
PROCODE='RV8'| 
PROCODE='RTE'| 
PROCODE='RHW'| 
PROCODE='RM1'| 
PROCODE='RJE'| 
PROCODE='RXF'| 
PROCODE='RXR'| 
PROCODE='RXW'| 
PROCODE='RM3'| 
PROCODE='RTG'| 
PROCODE='RP5'| 
PROCODE='RVJ'| 
PROCODE='RXN'| 
PROCODE='RR8'| 
PROCODE='RX1'| 
PROCODE='RWE'| 
PROCODE='RTH'| 
PROCODE='RTD'| 
PROCODE='RHQ'| 
PROCODE='REM'| 
PROCODE='RWA'| 
PROCODE='RW6')HIGHPEGVO
LTRUST = 1. 
EXECUTE.
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Stroke Syntax 26 – Stroke volume 
TertilesCOMPUTE 
LOWSTROKEVOLUME = 0. 
EXECUTE. 
IF(PROCODE='RQM'| 
PROCODE='RQX'| 
PROCODE='RM4'| 
PROCODE='RD8'| 
PROCODE='RN5'| 
PROCODE='RJF'| 
PROCODE='RNH'| 
PROCODE='RQQ'| 
PROCODE='RJC'| 
PROCODE='RBZ'| 
PROCODE='RKE'| 
PROCODE='RC1'| 
PROCODE='RGZ'| 
PROCODE='RN1'| 
PROCODE='RC3'| 
PROCODE='RCC'| 
PROCODE='RJR'| 
PROCODE='RA4'| 
PROCODE='RCD'| 
PROCODE='RE9'| 
PROCODE='RAL'| 
PROCODE='RNZ'| 
PROCODE='RLT'| 
PROCODE='RA3'| 
PROCODE='RNS'| 
PROCODE='RV8'| 
PROCODE='RAP'| 
PROCODE='RA2'| 
PROCODE='RGR'| 
PROCODE='5QT'| 
PROCODE='RN3'| 
PROCODE='RR7'| 
PROCODE='RG2'| 
PROCODE='RQW'| 
PROCODE='RDU'| 
PROCODE='RPR'| 
PROCODE='RBT'| 
PROCODE='RFW'| 
PROCODE='RCF'| 
PROCODE='RJ2'| 
PROCODE='RBK'| 
PROCODE='RJZ'| 
PROCODE='RMP'| 
PROCODE='RW3'| 
PROCODE='RG3'| 
PROCODE='RGP'| 
PROCODE='RTK')LOWSTRO
KEVOLUME = 1. 
EXECUTE. 
 
COMPUTE 
MEDSTROKEVOLUME = 0. 
EXECUTE. 
IF(PROCODE='RVY'| 
PROCODE='RJ6'| 
PROCODE='RJD'| 
PROCODE='RD3'| 
PROCODE='RCX'| 
PROCODE='RM3'| 
PROCODE='RFS'| 
PROCODE='RJ7'| 
PROCODE='RA7'| 
PROCODE='RPA'| 
PROCODE='RBA'| 
PROCODE='RFF'| 
PROCODE='RC9'| 
PROCODE='RA9'| 
PROCODE='RD7'| 
PROCODE='RN7'| 
PROCODE='RNQ'| 
PROCODE='RGC'| 
PROCODE='RGN'| 
PROCODE='RK5'| 
PROCODE='RQ8'| 
PROCODE='RFR'| 
PROCODE='RAE'| 
PROCODE='RXQ'| 
PROCODE='RL4'| 
PROCODE='RGQ'| 
PROCODE='REM'| 
PROCODE='RPL'| 
PROCODE='RAX'| 
PROCODE='RJE'| 
PROCODE='RDZ'| 
PROCODE='RRK'| 
PROCODE='RNA'| 
PROCODE='RMC'| 
PROCODE='RVW'| 
PROCODE='RTD'| 
PROCODE='RWW'| 
PROCODE='RHW'| 
PROCODE='RGT'| 
PROCODE='RTX'| 
PROCODE='RAJ'| 
PROCODE='RNL'| 
PROCODE='RQ6'| 
PROCODE='RXH')MEDSTRO
KEVOLUME = 1. 
EXECUTE. 
 
COMPUTE 
HIGHSTROKEVOLUME = 0. 
EXECUTE. 
 
IF(PROCODE='RK9'| 
PROCODE='RH8'| 
PROCODE='RDE'| 
PROCODE='RRF'| 
PROCODE='RVJ'| 
PROCODE='RXN'| 
PROCODE='RCB'| 
PROCODE='RWY'| 
PROCODE='RWG'| 
PROCODE='RWP'| 
PROCODE='RLN'| 
PROCODE='RTH'| 
PROCODE='RD1'| 
PROCODE='RJL'| 
PROCODE='RVL'| 
PROCODE='RKB'| 
PROCODE='RHM'| 
PROCODE='RVR'| 
PROCODE='RP5'| 
PROCODE='RTG'| 
PROCODE='RYJ'| 
PROCODE='RXW'| 
PROCODE='REF'| 
PROCODE='RWF'| 
PROCODE='RXL'| 
PROCODE='RBL'| 
PROCODE='RXR'| 
PROCODE='RTR'| 
PROCODE='RXK'| 
PROCODE='RTE'| 
PROCODE='RTF'| 
PROCODE='RXC'| 
PROCODE='RHU'| 
PROCODE='RXP'| 
PROCODE='RXF'| 
PROCODE='RX1'| 
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PROCODE='RWA'| 
PROCODE='RM1'| 
PROCODE='RF4'| 
PROCODE='RWD'| 
PROCODE='RR8'| 
PROCODE='RVV'| 
PROCODE='RHQ'| 
PROCODE='RR1'| 
PROCODE='RWE'| 
PROCODE='RW6')HIGHSTR
OKEVOLUME = 1. 
EXECUTE. 
 
 
 
Stroke Syntax 27 – SINAP score 
TertileCOMPUTE 
SINAPTERTILE = 0. 
EXECUTE. 
IF(PROCODE='RQQ'| 
PROCODE='RWP'| 
PROCODE='RBT'| 
PROCODE='REF'| 
PROCODE='RXN'| 
PROCODE='RA3'| 
PROCODE='RTH'| 
PROCODE='RN3'| 
PROCODE='RLN'| 
PROCODE='RD7'| 
PROCODE='RNQ'| 
PROCODE='RM1'| 
PROCODE='RG3'| 
PROCODE='RXF'| 
PROCODE='RHU'| 
PROCODE='RW3'| 
PROCODE='RXW'| 
PROCODE='RTX'| 
PROCODE='RC1'| 
PROCODE='RJL'| 
PROCODE='RXR'| 
PROCODE='RXL'| 
PROCODE='RBZ'| 
PROCODE='RGQ'| 
PROCODE='RK9'| 
PROCODE='RWF'| 
PROCODE='RJC'| 
PROCODE='RXP'| 
PROCODE='RPL'| 
PROCODE='RJD'| 
PROCODE='RQW'| 
PROCODE='RWD'| 
PROCODE='RWY'| 
PROCODE='RAE'| 
PROCODE='RR8'| 
PROCODE='5QT'| 
PROCODE='RC9'| 
PROCODE='RXQ'| 
PROCODE='RN7'| 
PROCODE='RR7'| 
PROCODE='RK5'| 
PROCODE='RPA'| 
PROCODE='RE9'| 
PROCODE='RJF'| 
PROCODE='RJ6'| 
PROCODE='RRK')SINAPTERT
ILE = 1. 
EXECUTE. 
 
IF(PROCODE='RGP'| 
PROCODE='RGR'| 
PROCODE='RQ8'| 
PROCODE='RVR'| 
PROCODE='RDU'| 
PROCODE='RNS'| 
PROCODE='RFS'| 
PROCODE='RX1'| 
PROCODE='RXK'| 
PROCODE='RBK'| 
PROCODE='RWE'| 
PROCODE='RDE'| 
PROCODE='RLT'| 
PROCODE='RCB'| 
PROCODE='RC3'| 
PROCODE='RD1'| 
PROCODE='RR1'| 
PROCODE='RCC'| 
PROCODE='RJE'| 
PROCODE='RTD'| 
PROCODE='RPR'| 
PROCODE='RL4'| 
PROCODE='RXC'| 
PROCODE='RD3'| 
PROCODE='RFF'| 
PROCODE='RVJ'| 
PROCODE='RP5'| 
PROCODE='RCX'| 
PROCODE='RNL'| 
PROCODE='RVY'| 
PROCODE='RM4'| 
PROCODE='RBA'| 
PROCODE='RTK'| 
PROCODE='RTR'| 
PROCODE='RMP'| 
PROCODE='RTE'| 
PROCODE='RHM'| 
PROCODE='RGN'| 
PROCODE='RWW'| 
PROCODE='RHQ'| 
PROCODE='RVL'| 
PROCODE='RA7'| 
PROCODE='RNA'| 
PROCODE='RNZ'| 
PROCODE='RAP')SINAPTER
TILE = 2. 
EXECUTE. 
 
IF(PROCODE='RJR'| 
PROCODE='RFW'| 
PROCODE='RV8'| 
PROCODE='RXH'| 
PROCODE='RCF'| 
PROCODE='RKB'| 
PROCODE='RFR'| 
PROCODE='RGT'| 
PROCODE='RF4'| 
PROCODE='RGC'| 
PROCODE='RRF'| 
PROCODE='RWG'| 
PROCODE='RHW'| 
PROCODE='RW6'| 
PROCODE='RVV'| 
PROCODE='RD8'| 
PROCODE='RTG'| 
PROCODE='RN5'| 
PROCODE='RJ2'| 
PROCODE='RH8'| 
PROCODE='REM'| 
PROCODE='RQ6'| 
PROCODE='RVW'| 
PROCODE='RQX'| 
PROCODE='RA2'| 
PROCODE='RBL'| 
PROCODE='RA9'| 
PROCODE='RNH'| 
PROCODE='RTF'| 
PROCODE='RWA'| 
PROCODE='RN1'| 
PROCODE='RKE'| 
PROCODE='RAJ'| 
PROCODE='RM3'| 
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PROCODE='RJ7'| 
PROCODE='RCD'| 
PROCODE='RDZ'| 
PROCODE='RMC'| 
PROCODE='RQM'| 
PROCODE='RAL'| 
PROCODE='RJZ')SINAPTERTI
LE = 3. 
EXECUTE. 
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7.2. Codes for NHS Acute Trusts 
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Trust 
Code Trust Name 
5QT Isle Of Wight 
RA2 Royal Surrey County Hospital NHS Trust 
RA3 Weston Area Health NHS Trust 
RA4 Yeovil District Hospital NHS Foundation Trust 
RA7 University Hospitals Of Bristol NHS Foundation Trust 
RA9 South Devon Healthcare NHS Foundation Trust 
RAE Bradford Teaching Hospitals NHS Foundation Trust 
RAJ Southend University Hospital NHS Foundation Trust 
RAL Royal Free Hampstead NHS Trust 
RAP North Middlesex University Hospital NHS Trust 
RAS The Hillingdon Hospital NHS Trust 
RAX Kingston Hospital NHS Trust 
RBA Taunton And Somerset NHS Foundation Trust 
RBD Dorset County Hospital NHS Foundation Trust 
RBK Walsall Hospitals NHS Trust 
RBL Wirral University Teaching Hospital NHS Foundation Trust 
RBN St Helens And Knowsley Hospitals NHS Trust 
RBT Mid Cheshire Hospitals NHS Foundation Trust 
RBZ Northern Devon Healthcare NHS Trust 
RC1 Bedford Hospital NHS Trust 
RC3 Ealing Hospital NHS Trust 
RC9 Luton And Dunstable Hospital NHS Foundation Trust 
RCB York Hospitals NHS Foundation Trust 
RCC Scarborough And North East Yorkshire Health Care NHS Trust 
RCD Harrogate And District NHS Foundation Trust 
RCF Airedale NHS Trust 
RCX The Queen Elizabeth Hospital King's Lynn NHS Trust 
RD1 Royal United Hospital Bath NHS Trust 
RD3 Poole Hospital NHS Foundation Trust 
RD7 Heatherwood And Wexham Park Hospitals NHS Foundation Trust 
RD8 Milton Keynes Hospital NHS Foundation Trust 
RDD Basildon And Thurrock University Hospitals NHS Foundation Trust 
RDE Colchester Hospital University NHS Foundation Trust 
RDU Frimley Park Hospital NHS Foundation Trust 
RDZ 
The Royal Bournemouth And Christchurch Hospitals NHS 
Foundation Trust 
RE9 South Tyneside NHS Foundation Trust 
REF Royal Cornwall Hospitals NHS Trust 
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REM Aintree University Hospitals NHS Foundation Trust 
RF4 Barking, Havering And Redbridge Hospitals NHS Trust 
RFF Barnsley Hospital NHS Foundation Trust 
RFR The Rotherham NHS Foundation Trust 
RFS Chesterfield Royal Hospital NHS Foundation Trust 
RFW West Middlesex University Hospital NHS Trust 
RG2 Queen Elizabeth Hospital NHS Trust 
RG3 Bromley Hospitals NHS Trust 
RGC Whipps Cross University Hospital NHS Trust 
RGN Peterborough And Stamford Hospitals NHS Foundation Trust 
RGP James Paget University Hospitals NHS Foundation Trust 
RGQ Ipswich Hospital NHS Trust 
RGR West Suffolk Hospitals NHS Trust 
RGT Cambridge University Hospitals NHS Foundation Trust 
RGZ Queen Mary's Sidcup NHS Trust 
RH8 Royal Devon And Exeter NHS Foundation Trust 
RHM Southampton University Hospitals NHS Trust 
RHQ Sheffield Teaching Hospitals NHS Foundation Trust 
RHU Portsmouth Hospitals NHS Trust 
RHW Royal Berkshire NHS Foundation Trust 
RJ1 Guy's And St Thomas' NHS Foundation Trust 
RJ2 The Lewisham Hospital NHS Trust 
RJ5 St Marys 
RJ6 Mayday Healthcare NHS Trust 
RJ7 St George's Healthcare NHS Trust 
RJC South Warwickshire General Hospitals NHS Trust 
RJD Mid Staffordshire NHS Foundation Trust 
RJE University Hospital Of North Staffordshire NHS Trust 
RJF Burton Hospitals NHS Trust 
RJL Northern Lincolnshire And Goole Hospitals NHS Foundation Trust 
RJN East Cheshire NHS Trust 
RJR Countess Of Chester Hospital NHS Foundation Trust 
RJZ King's College Hospital NHS Foundation Trust 
RK5 Sherwood Forest Hospitals NHS Foundation Trust 
RK9 Plymouth Hospitals NHS Trust 
RKB University Hospitals Coventry And Warwickshire NHS Trust 
RKE The Whittington Hospital NHS Trust 
RL4 The Royal Wolverhampton Hospitals NHS Trust 
RLN City Hospitals Sunderland NHS Foundation Trust 
RLQ Hereford Hospitals NHS Trust 
326 
 
RLT George Eliot Hospital NHS Trust 
RM1 Norfolk And Norwich University Hospitals NHS Foundation Trust 
RM2 University Hospital Of South Manchester NHS Foundation Trust 
RM3 Salford Royal NHS Foundation Trust 
RM4 Trafford Healthcare NHS Trust 
RMC Bolton Hospitals NHS Trust 
RMP Tameside Hospital NHS Foundation Trust 
RN1 Winchester And Eastleigh Healthcare NHS Trust 
RN3 Swindon And Marlborough NHS Trust 
RN5 Basingstoke And North Hampshire NHS Foundation Trust 
RN7 Dartford And Gravesham NHS Trust 
RNA Dudley Group Of Hospitals NHS Trust 
RNH Newham University Hospital NHS Trust 
RNJ Bart’s And The London NHS Trust 
RNL North Cumbria University Hospitals NHS Trust 
RNQ Kettering General Hospital NHS Trust 
RNS Northampton General Hospital NHS Trust 
RNZ Salisbury NHS Foundation Trust 
RP5 Doncaster And Bassetlaw Hospitals NHS Foundation Trust 
RPA Medway NHS Foundation Trust 
RPL Worthing And Southlands Hospitals NHS Trust 
RPR Royal West Sussex NHS Trust 
RQ6 Royal Liverpool And Broadgreen University Hospitals NHS Trust 
RQ8 Mid Essex Hospital Services NHS Trust 
RQM Chelsea And Westminster Hospital NHS Foundation Trust 
RQN Hammersmith 
RQQ Hinchingbrooke Health Care NHS Trust 
RQW The Princess Alexandra Hospital NHS Trust 
RQX Homerton University Hospital NHS Foundation Trust 
RR1 Heart Of England NHS Foundation Trust 
RR7 Gateshead Health NHS Foundation Trust 
RR8 Leeds Teaching Hospitals NHS Trust 
RRF Wrightington, Wigan And Leigh NHS Trust 
RRK University Hospital Birmingham NHS Foundation Trust 
RRV University College London Hospitals NHS Foundation Trust 
RTD The Newcastle Upon Tyne Hospitals NHS Foundation Trust 
RTE Gloucestershire Hospitals NHS Foundation Trust 
RTF Northumbria Healthcare NHS Foundation Trust 
RTG Derby Hospitals NHS Foundation Trust 
RTH Oxford Radcliffe Hospitals NHS Trust 
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RTK Ashford And St Peter's Hospitals NHS Trust 
RTP Surrey And Sussex Healthcare NHS Trust 
RTR South Tees Hospitals NHS Trust 
RTX University Hospitals Of Morecambe Bay NHS Trust 
RV8 North West London Hospitals NHS Trust 
RVJ North Bristol NHS Trust 
RVL Barnet And Chase Farm Hospitals NHS Trust 
RVR Epsom And St Helier University Hospitals NHS Trust 
RVV East Kent Hospitals University NHS Trust 
RVW North Tees And Hartlepool NHS Foundation Trust 
RVY Southport And Ormskirk Hospital NHS Trust 
RW3 
Central Manchester And Manchester Children's University 
Hospitals NHS Trust 
RW6 Pennine Acute Hospitals NHS Trust 
RWA Hull And East Yorkshire Hospitals NHS Trust 
RWD United Lincolnshire Hospitals NHS Trust 
RWE University Hospitals Of Leicester NHS Trust 
RWF Maidstone And Tunbridge Wells NHS Trust 
RWG West Hertfordshire Hospitals NHS Trust 
RWH East And North Hertfordshire NHS Trust 
RWJ Stockport NHS Foundation Trust 
RWP Worcestershire Acute Hospitals NHS Trust 
RWW North Cheshire Hospitals NHS Trust 
RWY Calderdale And Huddersfield NHS Foundation Trust 
RX1 Nottingham University Hospitals NHS Trust 
RXC East Sussex Hospitals NHS Trust 
RXF Mid Yorkshire Hospitals NHS Trust 
RXH Brighton And Sussex University Hospitals NHS Trust 
RXK Sandwell And West Birmingham Hospitals NHS Trust 
RXL Blackpool, Fylde And Wyre Hospitals NHS Foundation Trust 
RXN Lancashire Teaching Hospitals NHS Foundation Trust 
RXP County Durham And Darlington NHS Foundation Trust 
RXQ Buckinghamshire Hospitals NHS Trust 
RXR East Lancashire Hospitals NHS Trust 
RXW Shrewsbury And Telford Hospital NHS Trust 
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7.3. Comorbidity codes 
ICD Code Decode diagnosis 
C000 Malignant neoplasm of external upper lip 
C001 Malignant neoplasm of external lower lip 
C002 Malignant neoplasm of external lip, unspecified 
C003 Malignant neoplasm of upper lip, inner aspect 
C004 Malignant neoplasm of lower lip, inner aspect 
C005 Malignant neoplasm of lip, unspecified, inner aspect 
C006 Malignant neoplasm of commissure of lip 
C008 Malignant neoplasm of overlapping lesion of lip 
C009 Malignant neoplasm of lip, unspecified 
C01X Malignant neoplasm of base of tongue 
C020 Malignant neoplasm of dorsal surface tongue 
C021 Malignant neoplasm of border of tongue 
C022 Malignant neoplasm of ventral surface of tongue 
C023 Malignant neo of anterior two-thirds of tongue, part unspecified 
C024 Malignant neoplasm of lingual tonsil 
C028 Malignant neoplasm of overlapping lesion of tongue 
C029 Malignant neoplasm of tongue, unspecified 
C030 Malignant neoplasm of upper gum 
C031 Malignant neoplasm of lower gum 
C039 Malignant neoplasm of gum unspecified 
C040 Malignant neoplasm of floor of anterior floor of mouth 
C041 Malignant neoplasm of lateral floor of mouth 
C048 Malignant neoplasm, overlapping lesion of floor of mouth 
C049 Malignant neoplasm of floor of mouth, floor of mouth, unspecified 
C050 Malignant neoplasm of hard palate 
C051 Malignant neoplasm of soft palate 
C052 Malignant neoplasm of uvula 
C058 Malignant neoplasm, overlapping lesion of palate 
C059 Malignant neoplasm of palate, unspecified 
C060 Malignant neoplasm cheek mucosa 
C061 Malignant neoplasm of vestibule of mouth 
C062 Malignant neoplasm of retromolar area 
C068 Malignant neoplasm, overlap les of oth & unsp part of mouth 
C069 Malignant neoplasm of part of mouth, unspecified 
C07X Malignant neoplasm of parotid gland 
C080 Malignant neoplasm of submandibular gland 
C081 Malignant neoplasm of sublingual gland 
C088 Malignant neoplasm, overlapping lesion of major saliv gland 
C089 Malignant neoplasm of major salivary gland, unspecified 
C090 Malignant neoplasm tonsillar fossa 
C091 Malig neo of tonsillar pillar (anterior)(posterior) 
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C098 Malignant neoplasm of overlapping lesion of tonsil 
C099 Malignant neoplasm of tonsil unspecified 
C100 Malignant neoplasm of vallecula 
C101 Malignant neoplasm of anterior surface of epiglottis 
C102 Malignant neoplasm of lateral wall of oropharynx 
C103 Malignant neoplasm of posterior wall of oropharynx 
C104 Malignant neoplasm of branchial cleft 
C108 Malignant neoplasm overlapping lesion of oropharynx 
C109 Malignant neoplasm of oropharynx unspecified 
C110 Malignant neoplasm of superior wall of nasopharynx 
C111 Malignant neoplasm of posterior wall of nasopharynx 
C112 Malignant neoplasm of lateral wall of nasopharynx 
C113 Malignant neoplasm of anterior wall of nasopharynx 
C118 Malignant neoplasm overlapping lesion of nasopharynx 
C119 Malignant neoplasm of nasopharynx unspecified 
C12X Malignant neoplasm of pyriform sinus 
C130 Malignant neoplasm of hypopharynx, postcricoid region 
C131 Malig neoplasm aryepiglottic fold, hypopharyngeal aspect 
C132 Malignant neoplasm posterior wall of hypopharynx 
C138 Malignant neoplasm overlapping lesion of hypopharynx 
C139 Malignant neoplasm of hypopharynx unspecified 
C140 Malignant neoplasm of pharynx, unsp 
C142 Malignant neoplasm of Waldeyer's ring 
C148 Malig neo, overlapping lesion of lip, oral cavity & pharynx 
C150 Malignant neoplasm of cervical part of oesophagus 
C151 Malignant neoplasm of thoracic part of oesophagus 
C152 Malignant neo of abdominal part of oesophagus 
C153 Malignant neoplasm of upper third of oesophagus 
C154 Malignant neoplasm of middle third of oesophagus 
C155 Malignant neoplasm of lower third of oesophagus 
C158 Malignant neoplasm overlapping lesion of oesophagus 
C159 Malignant neoplasm of oesophagus unspecified 
C160 Malignant neoplasm of cardia of stomach 
C161 Malignant neoplasm of fundus of stomach 
C162 Malignant neoplasm of body of stomach 
C163 Malignant neoplasm of pyloric antrum 
C164 Malignant neoplasm of pylorus 
C165 Malignant neoplasm of lesser curvature of stomach, unsp 
C166 Malignant neoplasm of greater curvature of stomach, unsp 
C168 Malignant neoplasm overlapping lesion of stomach 
C169 Malignant neoplasm of stomach, unspecified 
C170 Malignant neoplasm of small intestine, duodenum 
C171 Malignant neoplasm of small intestine, jejunum 
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C172 Malignant neoplasm of small intestine, ileum 
C173 Malignant neoplasm of small intestine, Meckel's diverticulum 
C178 Malignant neoplasm overlapping lesion of small intestine 
C179 Malignant neoplasm of small intestine, unspecified 
C180 Malignant neoplasm of caecum 
C181 Malignant neoplasm of appendix 
C182 Malignant neoplasm of ascending colon 
C183 Malignant neoplasm of hepatic flexure 
C184 Malignant neoplasm of transverse colon 
C185 Malignant neoplasm of splenic flexure 
C186 Malignant neoplasm of descending colon 
C187 Malignant neoplasm of sigmoid colon 
C188 Malignant neoplasm overlapping lesion of colon 
C189 Malignant neoplasm of colon, unspecified 
C19X Malignant neoplasm of rectosigmoid junction 
C20X Malignant neoplasm of rectum 
C210 Malignant neoplasm of anus, unspecified 
C211 Malignant neoplasm of anal canal 
C212 Malignant neoplasm of cloacogenic zone 
C218 Malig neo, overlapping lesion of rectum, anus and anal canal 
C220 Malignant neoplasm, liver cell carcinoma 
C221 Malignant neoplasm, intrahep bile duct carcinoma 
C222 Malignant neoplasm, hepatoblastoma 
C223 Malignant neoplasm, angiosarcoma of liver 
C224 Malignant neoplasm, other sarcomas of liver 
C227 Malignant neoplasm, oth spec carcinomas of liver 
C229 Malignant neoplasm, liver, unspecified 
C23X Malignant neoplasm of gallbladder 
C240 Malignant neoplasm of extrahepatic bile duct 
C241 Malignant neoplasm of Ampulla of Vater 
C248 Malignant neoplasm overlapping lesion of biliary tract 
C249 Malignant neoplasm of biliary tract, unspecified 
C250 Malignant neoplasm of head of pancreas 
C251 Malignant neoplasm of body of pancreas 
C252 Malignant neoplasm of tail of pancreas 
C253 Malignant neoplasm of pancreatic duct 
C254 Malignant neoplasm of endocrine pancreas 
C257 Malignant neoplasm of other parts of pancreas 
C258 Malignant neoplasm, overlapping lesion of pancreas 
C259 Malignant neoplasm of pancreas, unspecified 
C260 Malignant neoplasm of intestinal tract, part unsp 
C261 Malignant neoplasm of spleen 
C268 Malignant neoplasm, overlapping lesion of digestive system 
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C269 Malignant neoplasm of ill-def sites within digestive system 
C300 Malignant neoplasm of nasal cavity 
C301 Malignant neoplasm of middle ear 
C310 Malignant neoplasm of maxillary sinus 
C311 Malignant neoplasm of ethmoidal sinus 
C312 Malignant neoplasm of frontal sinus 
C313 Malignant neoplasm of sphenoidal sinus 
C318 Malignant neoplasm, overlapping lesion accessory sinuses 
C319 Malignant neoplasm of accessory sinus, unsp 
C320 Malignant neoplasm of glottis 
C321 Malignant neoplasm of supraglottis 
C322 Malignant neoplasm of subglottis 
C323 Malignant neoplasm of laryngeal cartilage 
C328 Malignant neoplasm, overlapping lesion of larynx 
C329 Malignant neoplasm of larynx, unspecified 
C33X Malignant neoplasm of trachea 
C340 Malignant neoplasm of main bronchus 
C341 Malignant neoplasm of upper lobe, bronchus or lung 
C342 Malignant neoplasm of middle lobe, bronchus or lung 
C343 Malignant neoplasm of lower lobe, bronchus or lung 
C348 Malignant neoplasm of overlap les of bronchus & lung 
C349 Malignant neoplasm of bronchus or lung, unspec 
C37X Malignant neoplasm of thymus 
C380 Malignant neoplasm of heart, mediastinum & pleura, heart 
C381 Malignant neoplasm of anterior mediastinum 
C382 Malignant neoplasm of posterior mediastinum 
C383 Malig neo heart, mediastinum & pleura,mediastinum,part unsp 
C384 Malignant neoplasm of pleura 
C388 Malig neo, overlapping lesion of heart, mediastinum & pleur 
C390 Malignant neoplasm of upper respiratory tract, part unsp 
C398 Malignant neoplasm, overlap lesion of resp & intrathor orgs 
C399 Malignant neoplasm of ill-def sites within the resp sys 
C400 Malignant neoplasm of scapula and long bones of upper limb 
C401 Malignant neoplasm of short bones of upper limb 
C402 Malignant neoplasm of long bones of lower limb 
C403 Malignant neoplasm of short bones of lower limb 
C408 Malignant neoplasm, overlap les bone and artic cart of limb 
C409 Malignant neoplasm of bone and artic cart of limb, unsp 
C410 Malignant neoplasm of bones of skull and face 
C411 Malignant neoplasm of mandible 
C412 Malignant neoplasm of vertebral column 
C413 Malignant neoplasm of ribs, sternum and clavicle 
C414 Malignant neoplasm of sacrum and coccyx 
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C418 Malignant neoplasm, overlap lesion bon and articular cart 
C419 Malignant neoplasm of bone and articular cartilage, unsp 
C430 Malignant melanoma of lip 
C431 Malignant melanoma of eyelid, including canthus 
C432 Malignant melanoma of ear and ext auricular canal 
C433 Malignant melanoma of other and unspecified parts of face 
C434 Malignant melanoma of scalp and neck 
C435 Malignant melanoma of trunk 
C436 Malignant melanoma of upper limb, including shoulder 
C437 Malignant melanoma of lower limb, including hip 
C438 Malignant melanoma of skin 
C439 Malignant melanoma of skin, unsp 
C450 Mesothelioma of pleura 
C451 Mesothelioma of peritoneum 
C452 Mesothelioma of pericardium 
C457 Mesothelioma of other sites 
C459 Mesothelioma, unspecified 
C460 Kaposi's sarcoma of skin 
C461 Kaposi's sarcoma of soft tissue 
C462 Kaposi's sarcoma of palate 
C463 Kaposi's sarcoma of lymph nodes 
C467 Kaposi's sarcoma of other sites 
C468 Kaposi's sarcoma of multiple organs 
C469 Kaposi's sarcoma, unspecified 
C470 Malignant neoplasm of peripheral nerve of head, face & neck 
C471 Malignant neoplasm of peripheral nerve, upp limb, incl should 
C472 Malignant neoplasm of peripheral nerve of low limb, incl hi 
C473 Malignant neoplasm of peripheral nerve of thorax 
C474 Malignant neoplasm of peripheral nerve of abdomen 
C475 Malignant neoplasm of peripheral nerve of pelvis 
C476 Malignant neoplasm of peripheral nerve of trunk, unspec 
C478 Malignant neoplasm, overlap lesion periph nerve & auton ns 
C479 Malignant neoplasm periph nerve & autonomic ns, unspec 
C480 Malignant neoplasm of retroperitoneum 
C481 Malignant neoplasm of spec parts of peritoneum 
C482 Malignant neoplasm of peritoneum, unsp 
C488 Malignant neoplasm of overlap lesion retroperit & peritoneu 
C490 Malignant neoplasm of conn and soft tiss head, face & neck 
C491 Malignant neoplasm of conn and soft tiss upp limb,inc shoul 
C492 Malignant neoplasm of conn and soft tiss,lower limb,inc hip 
C493 Malignant neoplasm of conn and soft tiss of thorax 
C494 Malignant neoplasm of conn and soft tiss of abdomen 
C495 Malignant neoplasm of conn and soft tiss of pelvis 
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C496 Malignant neoplasm of conn and soft tiss of trunk, unsp 
C498 Malignant neoplasm, overlap lesion connective & soft tiss 
C499 Malignant neoplasm of connective and soft tissue, unsp 
C500 Malignant neoplasm of nipple and areola 
C501 Malignant neoplasm of central portion of breast 
C502 Malignant neoplasm of upper-inner quadrant of breast 
C503 Malignant neoplasm of lower-inner quadrant of breast 
C504 Malignant neoplasm of upper-outer quadrant of breast 
C505 Malignant neoplasm of lower-outer quadrant of breast 
C506 Malignant neoplasm of axillary tail of breast 
C508 Malignant neoplasm, overlapping lesion of breast 
C509 Malignant neoplasm of breast, unspecified 
C510 Malignant neoplasm of labium majus 
C511 Malignant neoplasm of labium minus 
C512 Malignant neoplasm of clitoris 
C518 Malignant neoplasm of overlapping lesion of vulva 
C519 Malignant neoplasm of vulva, unspecified 
C52X Malignant neoplasm of vagina 
C530 Malignant neoplasm of endocervix 
C531 Malignant neoplasm of exocervix 
C538 Malignant neoplasm, overlapping lesion of cervix uteri 
C539 Malignant neoplasm of cervix uteri, unsp 
C540 Malignant neoplasm of isthmus uteri 
C541 Malignant neoplasm of endometrium 
C542 Malignant neoplasm of myometrium 
C543 Malignant neoplasm of fundus uteri 
C548 Malignant neoplasm overlapping lesion of corpus uteri 
C549 Malignant neoplasm of corpus uteri, unsp 
C55X Malignant neoplasm of uterus, part unspecified 
C56X Malignant neoplasm of ovary 
C570 Malignant neoplasm of fallopian tube 
C571 Malignant neoplasm of broad ligament 
C572 Malignant neoplasm of round ligament 
C573 Malignant neoplasm of parametrium 
C574 Malignant neoplasm of uterine adenexa, unsp 
C577 Malignant neoplasm of other specified female genital organs 
C578 Malignant neoplasm, overlapping lesion female genital organ 
C579 Malignant neoplasm of female genital organ, unspecified 
C58X Malignant neoplasm of placenta 
C600 Malignant neoplasm of prepuce 
C601 Malignant neoplasm of glans penis 
C602 Malignant neoplasm of body of penis 
C608 Malignant neoplasm, overlapping lesion of penis 
334 
 
C609 Malignant neoplasm of penis, unspecified 
C61X Malignant neoplasm of prostate 
C620 Malignant neoplasm of undescended testis 
C621 Malignant neoplasm of descended testis 
C629 Malignant neoplasm of testis, unspecified 
C630 Malignant neoplasm of epididymis 
C631 Malignant neoplasm of spermatic cord 
C632 Malignant neoplasm of scrotum 
C637 Malignant neoplasm of other specified male genital orgs 
C638 Malignant neoplasm, overlapping lesion male genital orgs 
C639 Malignant neoplasm of male genital organ, unspecified 
C64X Malignant neoplasm of kidney, except renal pelvis 
C65X Malignant neoplasm of renal pelvis 
C66X Malignant neoplasm of ureter 
C670 Malignant neoplasm of trigone of bladder 
C671 Malignant neoplasm of dome of bladder 
C672 Malignant neoplasm of lateral wall of bladder 
C673 Malignant neoplasm of anterior wall of bladder 
C674 Malignant neoplasm of posterior wall of bladder 
C675 Malignant neoplasm of bladder neck 
C676 Malignant neoplasm of ureteric orifice 
C677 Malignant neoplasm of urachus 
C678 Malignant neoplasm, overlapping lesion of bladder 
C679 Malignant neoplasm of bladder, unspecified 
C680 Malignant neoplasm of urethra 
C681 Malignant neoplasm of paraurethral gland 
C688 Malignant neoplasm of overlapping lesion urinary organs 
C689 Malignant neoplasm of urinary organ, unspecified 
C690 Malignant neoplasm of conjunctiva 
C691 Malignant neoplasm of cornea 
C692 Malignant neoplasm of retina 
C693 Malignant neoplasm of choroid 
C694 Malignant neoplasm of ciliary body 
C695 Malignant neoplasm of lacrimal gland and duct 
C696 Malignant neoplasm of orbit 
C698 Malignant neoplasm, overlapping lesion eye and adnexa 
C699 Malignant neoplasm of eye, unspecified 
C700 Malignant neoplasm of, cerebral meninges 
C701 Malignant neoplasm of spinal meninges 
C709 Malignant neoplasm of meninges, unspecified 
C710 Malignant neoplasm of cerebrum, except lobes & ventricles 
C711 Malignant neoplasm of cerebrum, frontal lobe 
C712 Malignant neoplasm of cerebrum, temporal lobe 
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C713 Malignant neoplasm of cerebrum, parietal lobe 
C714 Malignant neoplasm of cerebrum, occipital lobe 
C715 Malignant neoplasm of cerebrum, cerebral ventricle 
C716 Malignant neoplasm of cerebrum, cerebellum 
C717 Malignant neoplasm of cerebrum, brain stem 
C718 Malignant neoplasm of cerebrum, overlapping lesion of brain 
C719 Malignant neoplasm of cerebrum, brain, unspecified 
C720 Malignant neoplasm of spinal cord 
C721 Malignant neoplasm of cauda equina 
C722 Malignant neoplasm of Olfactory nerve 
C723 Malignant neoplasm of Optic nerve 
C724 Malignant neoplasm of Acoustic nerve 
C725 Malignant neoplasm of other and unspecified cranial nerves 
C728 Malignant neoplasm, overlapping lesion brain & other part CNS 
C729 Malignant neoplasm of Central Nervous System, unspecified 
C73X Malignant neoplasm of thyroid gland 
C740 Malignant neoplasm of cortex of adrenal gland 
C741 Malignant neoplasm of medulla of adrenal gland 
C749 Malignant neoplasm of adrenal gland, unsp 
C750 Malignant neoplasm of parathyroid gland 
C751 Malignant neoplasm of pituitary gland 
C752 Malignant neoplasm of craniopharyngeal duct 
C753 Malignant neoplasm of pineal gland 
C754 Malignant neoplasm of carotid body 
C755 Malignant neoplasm of aortic body and other paraganglia 
C758 Malignant neoplasm, pluriglandular involvement, unspecified 
C759 Malignant neoplasm of endocrine gland, unspecified 
C760 Malignant neoplasm of head, face & neck 
C761 Malignant neoplasm of thorax 
C762 Malignant neoplasm of abdomen 
C763 Malignant neoplasm of pelvis 
C764 Malignant neoplasm of upper limb 
C765 Malignant neoplasm of lower limb 
C767 Malignant neoplasm of other ill-defined sites 
C768 Malignant neoplasm, overlap lesion oth & ill-defined sites 
C770 Sec & uns malig neoplasm of lymph nodes of head, face & nec 
C771 Sec & uns malignant neoplasm of intrathoracic lymph nodes 
C772 Sec & uns malignant neoplasm of intra-abdominal lymph nodes 
C773 Sec & uns malig neoplasm of axillary & upp limb lymph nodes 
C774 Sec & uns malig neoplasm of inguinal & low limb lymph nodes 
C775 Sec & uns malignant neoplasm of intrapelvic lymph nodes 
C778 Sec & uns malig neoplasm of lymph nodes of multiple regions 
C779 Sec & uns malignant neoplasm of lymph node, unspecified 
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C780 Secondary malignant neoplasm of lung 
C781 Secondary malignant neoplasm of mediastinum 
C782 Secondary malignant neoplasm of pleura 
C783 Secondary malignant neoplasm of oth & unsp respiratory orgs 
C784 Secondary malignant neoplasm of small intestine 
C785 Secondary malignant neoplasm of large intest & rectum 
C786 Secondary malignant neoplasm of retroperitoneum & peritoneu 
C787 Secondary malignant neoplasm of liver 
C788 Secondary malignant neoplasm of other & unsp digestive orgs 
C790 Secondary malignant neoplasm of kidney & renal pelvis 
C791 Secondary malignant neoplasm of oth & uns urinary organs 
C792 Secondary malignant neoplasm of skin 
C793 Secondary malignant neoplasm of brain & cerebral meninges 
C794 Secondary malignant neoplasm of oth & unsp parts nervous sy 
C795 Secondary malignant neoplasm of bone and bone marrow 
C796 Secondary malignant neoplasm of ovary 
C797 Secondary malignant neoplasm of adrenal gland 
C798 Secondary malignant neoplasm of other specified sites 
C80X Malignant neoplasm without specification of site 
C810 Hodgkin's disease, lymphocytic predominance 
C811 Hodgkin's disease, nodular sclerosis 
C812 Hodgkin's disease, mixed cellularity 
C813 Hodgkin's disease, lymphocytic depletion 
C817 Hodgkin's disease, other Hodgkin's disease 
C819 Hodgkin's disease, Hodgkin's disease, unspecified 
C820 Follicular non-Hodgkin's small cleaved cell lymphoma 
C821 Follicular non-Hodg mixed sml cleavd & lge cell lymphoma 
C822 Follicular non-Hodgkin's large cell lymphoma 
C827 Follicular non-Hodgkin's other types of lymphoma 
C829 Follicular non-Hodgkin's unspecified lymphoma 
C830 Diffuse non-Hodgkin's small cell (diffuse)lymphoma 
C831 Diffuse non-Hodgkin's small cleaved cell (diffuse) lymphoma 
C832 Diffuse non-Hodgkin mixed sml & lge cell (diffuse) lymphoma 
C833 Diffuse non-Hodgkin's large cell (diffuse) lymphoma 
C834 Diffuse non-Hodgkin's immunoblastic (diffuse) lymphoma 
C835 Diffuse non-Hodgkin's lymphoblastic (diffuse) lymphoma 
C836 Diffuse non-Hodgkin's lymphoma undifferentiated (diffuse) 
C837 Diffuse non-Hodgkin's lymphoma, Burkitt's tumour 
C838 Other types of diffuse non-Hodgkin's lymphoma 
C839 Diffuse non-Hodgkin's lymphoma, unspecified 
C840 Peripheral and cutaneous T-cell lymphomas, mycosis fungoides 
C841 Peripheral and cutaneous T-cell lymphomas, Sezary's disease 
C842 Peripheral and cutaneous T-cell lymphomas, T-zone lymphoma 
337 
 
C843 Periph & cutan T-cell lymphomas, lymphoepithelioid lymphoma 
C844 Periph & cutan T-cell lymphomas, peripheral T-cell lymphoma 
C845 Periph & cutan T-cell lymphomas, oth & unsp T-cell lymphoma 
C850 Oth & unspec types of non-Hodgkin's lymphoma, lymphosarcoma 
C851 Oth & unsp types non-Hodgkin's B-cell lymphoma, unsp 
C857 Oth specified types of non-Hodgkin's lymphoma 
C859 Non-Hodgkin's lymphoma, unspecified type 
C883 Malignant immunoproliferative small intestinal disease 
C887 Other malignant immunoproliferative diseases 
C889 Malignant immunoproliferative disease, unspecified 
C900 Multiple myeloma 
C901 Plasma cell leukaemia 
C902 Malignant plasma cell neoplasm, extramedullary plasmacytoma 
C910 Acute lymphoblastic leukaemia 
C911 Chronic lymphocytic leukaemia 
C912 Subacute lymphocytic leukaemia 
C913 Prolymphocytic leukaemia 
C914 Hairy-cell leukaemia 
C915 Adult T-cell leukaemia 
C917 Other lymphoid leukaemia 
C919 Lymphoid leukaemia, unspecified 
C920 Acute myeloid leukaemia 
C921 Chronic myeloid leukaemia 
C922 Subacute myeloid leukaemia 
C923 Myeloid sarcoma 
C924 Acute promyelocytic leukaemia 
C925 Acute myelomonocytic leukaemia 
C927 Other myeloid leukaemia 
C929 Myeloid leukaemia, unspecified 
C930 Acute monocytic leukaemia 
C931 Chronic monocytic leukaemia 
C932 Subacute monocytic leukaemia 
C937 Other monocytic leukaemia 
C939 Monocytic leukaemia, unspecified 
C940 Acute erythraemia & erythroleukaemia 
C941 Chronic erythraemia 
C942 Acute megakaryoblastic leukaemia 
C943 Mast cell leukaemia 
C947 Other specified leukaemias 
C950 Acute leukaemia of unsp cell type 
C951 Chronic leukaemia unsp cell type 
C952 Subacute leukaemia unsp cell type 
C957 Other leukaemia unspecified cell type 
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C959 Leukaemia, unspecified 
C960 Letterer-Siwe disease 
C961 Malignant histiocytosis 
C962 Malignant mast cell tumour 
C963 True histiocyt lymphoma 
C967 Oth spec malig neop lymphoid h'poietic & related tissue 
C969 Malig neop lymphoid haematopoietic and related tissue unspe 
C97X Malignant neoplasms of independent (primary) multiple sites 
I210 Acute transmural myocardial infarction of anterior wall 
I211 Acute transmural myocardial infarction of inferior wall 
I212 Acute transmural myocardial infarction of other sites 
I213 Acute transmural myocardial infarction of unspecified site 
I214 Acute subendocardial myocardial infarction 
I219 Acute myocardial infarction, unspecified 
I220 Subsequent myocardial infarction of anterior wall 
I221 Subsequent myocardial infarction of inferior wall 
I228 Subsequent myocardial infarction of other sites 
I229 Subsequent myocardial infarction of unspecified site 
I252 Old myocardial infarction 
I500 Congestive heart failure 
I710 Dissection of aorta [any part] 
I711 Thoracic aortic aneurysm, ruptured 
I712 Thoracic aortic aneurysm, without mention of rupture 
I713 Abdominal aortic aneurysm, ruptured 
I714 Abdominal aortic aneurysm, without mention of rupture 
I715 Thoracoabdominal aortic aneurysm, ruptured 
I716 Thoracoabdominal aortic aneurysm, without mention of ruptur 
I718 Aortic aneurysm of unspecified site, ruptured 
I719 Aortic aneurysm of unspec site, without mention of rupture 
I738 Other specified peripheral vascular diseases 
I739 Peripheral vascular disease, unspecified 
I600 Subarachnoid haemorrhage from carotid siphon and bifurcatio 
I601 Subarachnoid haemorrhage from middle cerebral artery 
I602 Subarachnoid haemorrhage from anterior communicating artery 
I603 Subarachnoid haemorrhage from posterior communicating arter 
I604 Subarachnoid haemorrhage from basilar artery 
I605 Subarachnoid haemorrhage from vertebral artery 
I606 Subarachnoid haemorrhage from other intracranial arteries 
I607 Subarachnoid haemorrhage from intracranial artery, unspec 
I608 Other subarachnoid haemorrhage 
I609 Subarachnoid haemorrhage, unspecified 
I610 Intracerebral haemorrhage in hemisphere, subcortical 
I611 Intracerebral haemorrhage in hemisphere, cortical 
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I612 Intracerebral haemorrhage in hemisphere, unspecified 
I613 Intracerebral haemorrhage in brain stem 
I614 Intracerebral haemorrhage in cerebellum 
I615 Intracerebral haemorrhage, intraventricular 
I616 Intracerebral haemorrhage, multiple localized 
I618 Other intracerebral haemorrhage 
I619 Intracerebral haemorrhage, unspecified 
I620 Subdural haemorrhage (acute)(nontraumatic) 
I621 Nontraumatic extradural haemorrhage 
I629 Intracranial haemorrhage (nontraumatic), unspecified 
I630 Cerebral infarct due to thrombosis of precerebral arteries 
I631 Cerebral infarction due to embolism of precerebral arteries 
I632 Cereb infarct due unsp occlusion or stenos precerebrl arts 
I633 Cerebral infarction due to thrombosis of cerebral arteries 
I634 Cerebral infarction due to embolism of cerebral arteries 
I635 Cerebrl infarct due unspec occlusion or stenos cerebrl arts 
I636 Cereb infarct due cerebral venous thrombosis, nonpyogenic 
I638 Other cerebral infarction 
I639 Cerebral infarction, unspecified 
I64X Stroke, not specified as haemorrhage or infarction 
I650 Occlusion and stenosis of vertebral artery 
I651 Occlusion and stenosis of basilar artery 
I652 Occlusion and stenosis of carotid artery 
I653 Occlusion and stenosis of multip and bilat precerebrl arts 
I658 Occlusion and stenosis of other precerebral artery 
I659 Occlusion and stenosis of unspecified precerebral artery 
I660 Occlusion and stenosis of middle cerebral artery 
I661 Occlusion and stenosis of anterior cerebral artery 
I662 Occlusion and stenosis of posterior cerebral artery 
I663 Occlusion and stenosis of cerebellar arteries 
I664 Occlusion and stenosis of multiple and bilat cerebrl arts 
I668 Occlusion and stenosis of other cerebral artery 
I669 Occlusion and stenosis of unspecified cerebral artery 
I670 Dissection of cerebral arteries, nonruptured 
I671 Cerebral aneurysm, nonruptured 
I672 Cerebral atherosclerosis 
I673 Progressive vascular leukoencephalopathy 
I674 Hypertensive encephalopathy 
I675 Moyamoya disease 
I676 Nonpyogenic thrombosis of intracranial venous system 
I677 Cerebral arteritis, not elsewhere classified 
I678 Other specified cerebrovascular diseases 
I679 Cerebrovascular disease, unspecified 
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I680 Cerebral amyloid angiopathy 
I681 Cerebral arteritis in infect & parasit dis classif elsewh 
I682 Cerebral arteritis in other diseases classified elsewhere 
I688 Other cerebrovascular disorders in diseases EC 
I690 Sequelae of subarachnoid haemorrhage 
I691 Sequelae of intracerebral haemorrhage 
I692 Sequelae of other nontraumatic intracranial haemorrhage 
I693 Sequelae of cerebral infarction 
I694 Sequelae of stroke, not spec as haemorrhage or infarction 
I698 Sequelae of other and unspecified cerebrovascular diseases 
F000 Dementia in Alzheimer's disease with early onset 
F001 Dementia in Alzheimer's disease with late onset 
F002 Dementia in Alzheimer's disease, atypical or mixed type 
F009 Dementia in Alzheimer's disease, unspecified 
F010 Vascular dementia of acute onset 
F011 Multi-infarct dementia 
F012 Subcortical vascular dementia 
F013 Mixed cortical and subcortical vascular dementia 
F018 Other vascular dementia 
F019 Vascular dementia, unspecified 
F020 Dementia in Pick's disease 
F021 Dementia in Creutzfeldt-Jakob disease 
F022 Dementia in Huntington's disease 
F023 Dementia in Parkinson's disease 
F024 Dementia in human immunodef virus [HIV] disease 
F028 Dementia in other specified diseases classified elsewhere 
F03X Unspecified dementia 
F051 Delirium superimposed on dementia 
J40X Bronchitis, not specified as acute or chronic 
J410 Simple chronic bronchitis 
J411 Mucopurulent chronic bronchitis 
J418 Mixed simple and mucopurulent chronic bronchitis 
J42X Unspecified chronic bronchitis 
J430 MacLeod's syndrome 
J431 Panlobular emphysema 
J432 Centrilobular emphysema 
J438 Other emphysema 
J439 Emphysema, unspecified 
J440 Chronic obstruct pulmonary dis with acute lower resp infec 
J441 Chron obstruct pulmonary dis wth acute exacerbation, unspec 
J448 Other specified chronic obstructive pulmonary disease 
J449 Chronic obstructive pulmonary disease, unspecified 
J450 Predominantly allergic asthma 
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J451 Nonallergic asthma 
J458 Mixed asthma 
J459 Asthma, unspecified 
J46X Status asthmaticus 
J47X Bronchiectasis 
J60X Coal worker’s pneumoconiosis 
J61X Pneumoconiosis due to asbestos and other mineral fibres 
J620 Pneumoconiosis due to talc dust 
J628 Pneumoconiosis due to other dust containing silica 
J630 Aluminosis (of lung) 
J631 Bauxite fibrosis (of lung) 
J632 Berylliosis 
J633 Graphite fibrosis (of lung) 
J634 Siderosis 
J635 Stannosis 
J638 Pneumoconiosis due to other specified inorganic dusts 
J64X Unspecified pneumoconiosis 
J65X Pneumoconiosis associated with tuberculosis 
J660 Byssinosis 
J661 Flax-dresser's disease 
J662 Cannabinosis 
J668 Airway disease due to other specific organic dusts 
J670 Farmer's lung 
J671 Bagassosis 
J672 Bird fancier's lung 
J673 Suberosis 
J674 Maltworker's lung 
J675 Mushroom-worker's lung 
J676 Maple-bark-stripper's lung 
J677 Air-conditioner and humidifier lung 
J678 Hypersensitivity pneumonitis due to other organic dusts 
J679 Hypersensitivity pneumonitis due to unspecified organic dus 
M050 Felty's syndrome 
M051 Rheumatoid lung disease 
M052 Rheumatoid vasculitis 
M059 Seropositive rheumatoid arthritis, unspecified 
M060 Seronegative rheumatoid arthritis 
M063 Rheumatoid nodule 
M069 Rheumatoid arthritis, unspecified 
M300 Polyarteritis nodosa 
M301 Polyarteritis with lung involvement [Churg-Strauss] 
M302 Juvenile polyarteritis 
M303 Mucocutaneous lymph node syndrome [Kawasaki] 
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M308 Other conditions related to polyarteritis nodosa 
M310 Hypersensitivity angiitis 
M311 Thrombotic microangiopathy 
M312 Lethal midline granuloma 
M313 Wegener's granulomatosis 
M314 Aortic arch syndrome [Takayasu] 
M315 Giant cell arteritis with polymyalgia rheumatica 
M316 Other giant cell arteritis 
M318 Other specified necrotizing vasculopathies 
M319 Necrotizing vasculopathy, unspecified 
M320 Drug-induced systemic lupus erythematosus 
M321 Systemic lupus erythematosus with organ or sys involv 
M328 Other forms of systemic lupus erythematosus 
M329 Systemic lupus erythematosus, unspecified 
M332 Polymyositis 
M339 Dermatopolymyositis, unspecified 
M340 Progressive systemic sclerosis 
M341 CR(E)ST syndrome 
M342 Systemic sclerosis induced by drugs and chemicals 
M348 Other forms of systemic sclerosis 
M349 Systemic sclerosis, unspecified 
M350 Sicca syndrome [Sjogren] 
M351 Other overlap syndromes 
M352 Behcet's disease 
M353 Polymyalgia rheumatica 
M354 Diffuse (eosinophilic) fasciitis 
M355 Multifocal fibrosclerosis 
M356 Relapsing panniculitis [Weber-Christian] 
M357 Hypermobility syndrome 
K250 Gastric ulcer, acute with haemorrhage 
K251 Gastric ulcer, acute with perforation 
K252 Gastric ulcer, acute with both haemorrhage and perforation 
K253 Gastric ulcer, acute without haemorrhage or perforation 
K254 Gastric ulcer, chronic or unspecified with haemorrhage 
K255 Gastric ulcer, chronic or unspecified with perforation 
K256 Chronic or unspecified with both haemorrhage and perforatio 
K257 Gastric ulcer, chronic without haemorrhage or perforation 
K259 Unspec as acute or chronic w'out haemorrhage or perforation 
K260 Duodenal ulcer, acute with haemorrhage 
K261 Duodenal ulcer, acute with perforation 
K262 Duodenal ulcer, acute with both haemorrhage and perforation 
K263 Duodenal ulcer, acute without haemorrhage or perforation 
K264 Duodenal ulcer, chronic or unspecified with haemorrhage 
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K265 Duodenal ulcer, chronic or unspecified with perforation 
K266 Chronic or unspecified with both haemorrhage and perforatio 
K267 Duodenal ulcer, chronic without haemorrhage or perforation 
K269 Unspec as acute or chronic w'out haemorrhage or perforation 
K270 Peptic ulcer, acute with haemorrhage 
K271 Peptic ulcer, acute with perforation 
K272 Peptic ulcer, acute with both haemorrhage and perforation 
K273 Peptic ulcer, acute without haemorrhage or perforation 
K274 Peptic ulcer, chronic or unspecified with haemorrhage 
K275 Peptic ulcer, chronic or unspecified with perforation 
K276 Chronic or unspecified with both haemorrhage and perforatio 
K277 Peptic ulcer, chronic without haemorrhage or perforation 
K279 Unspec as acute or chronic w'out haemorrhage or perforation 
K280 Gastrojejunal ulcer, acute with haemorrhage 
K281 Gastrojejunal ulcer, acute with perforation 
K282 Acute with both haemorrhage and perforation 
K283 Acute without haemorrhage or perforation 
K284 Gastrojejunal ulcer, chronic or unspecified with haemorrhag 
K285 Gastrojejunal ulcer, chronic or unspecified with perforatio 
K286 Chronic or unspecified with both haemorrhage and perforatio 
K287 Chronic without haemorrhage or perforation 
K289 Unspec as acute or chronic w'out haemorrhage or perforation 
K701 Alcoholic hepatitis 
K702 Alcoholic fibrosis and sclerosis of liver 
K703 Alcoholic cirrhosis of liver 
K704 Alcoholic hepatic failure 
K709 Alcoholic liver disease, unspecified 
K710 Toxic liver disease with cholestasis 
K711 Toxic liver disease with hepatic necrosis 
K712 Toxic liver disease with acute hepatitis 
K713 Toxic liver disease with chronic persistent hepatitis 
K714 Toxic liver disease with chronic lobular hepatitis 
K715 Toxic liver disease with chronic active hepatitis 
K716 Toxic liver disease with hepatitis, not elsewhere classifie 
K717 Toxic liver disease with fibrosis and cirrhosis of liver 
K718 Toxic liver disease with other disorders of liver 
K719 Toxic liver disease, unspecified 
K721 Chronic hepatic failure 
K729 Hepatic failure, unspecified 
K730 Chronic persistent hepatitis, not elsewhere classified 
K731 Chronic lobular hepatitis, not elsewhere classified 
K732 Chronic active hepatitis, not elsewhere classified 
K738 Other chronic hepatitis, not elsewhere classified 
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K739 Chronic hepatitis, unspecified 
K740 Hepatic fibrosis 
K741 Hepatic sclerosis 
K742 Hepatic fibrosis with hepatic sclerosis 
K743 Primary biliary cirrhosis 
K744 Secondary biliary cirrhosis 
K745 Biliary cirrhosis, unspecified 
K746 Other and unspecified cirrhosis of liver 
K753 Granulomatous hepatitis, not elsewhere classified 
K754 Autoimmune hepatitis 
K758 Other specified inflammatory liver diseases 
K764 Peliosis hepatis 
K765 Hepatic veno-occlusive disease 
K766 Portal hypertension 
K767 Hepatorenal syndrome 
K768 Other specified diseases of liver 
E102 Insulin-dependent diabetes mellitus with renal complication 
E103 Insulin-dependent diabetes mellitus with ophthalmic comps 
E104 Insulin-dependent diabetes mellitus with neurological comps 
E105 Insulin-dependent diabetes mellitus with periph circ comps 
E106 Insulin-dependent diabetes mellitus with other spec comps 
E107 Insulin-dependent diabetes mellitus with multiple comps 
E108 Insulin-dependent diabetes mellitus with unspec comps 
E109 Insulin-dependent diabetes mellitus without complications 
E112 Non-insulin-dependent diabetes mellitus with renal comps 
E113 Non-insulin-dependent diabetes mellitus with ophthalm comps 
E114 Non-insulin-dependent diabetes mellitus with neuro comps 
E115 Non-insulin-depend diabetes mellitus with periph circ comp 
E116 Non-insulin-depend diabetes mellitus with other spec comp 
E117 Non-insulin-dependent diabetes mellitus with multiple comps 
E118 Non-insulin-dependent diabetes mellitus with unspec comps 
E119 Non-insulin-depend diabetes mellitus without complication 
E132 Other specified diabetes mellitus with renal complications 
E133 Other specified diabetes mellitus with ophthalmic comps 
E134 Other specified diabetes mellitus with neurological comps 
E135 Other specified diabetes mellitus with periph circ comps 
E136 Other specified diabetes mellitus with other spec comps 
E137 Other specified diabetes mellitus with multiple comps 
E138 Other specified diabetes mellitus with unspecified comps 
E139 Other specified diabetes mellitus without complications 
E142 Unspecified diabetes mellitus with renal complications 
E143 Unspecified diabetes mellitus with ophthalmic complications 
E144 Unspecified diabetes mellitus with neurological comps 
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E145 Unspecified diabetes mellitus with periph circulatory comps 
E146 Unspecified diabetes mellitus with other specified comps 
E147 Unspecified diabetes mellitus with multiple complications 
E148 Unspecified diabetes mellitus with unspecified complication 
E149 Unspecified diabetes mellitus without complications 
G810 Flaccid hemiplegia 
G811 Spastic hemiplegia 
G819 Hemiplegia, unspecified 
G820 Flaccid paraplegia 
G821 Spastic paraplegia 
G822 Paraplegia, unspecified 
N001 Focal and segmental glomerular lesions 
N002 Diffuse membranous glomerulonephritis 
N003 Diffuse mesangial proliferative glomerulonephritis 
N004 Diffuse endocapillary proliferative glomerulonephritis 
N005 Diffuse mesangiocapillary glomerulonephritis 
N007 Diffuse concentric glomerulonephritis 
N010 Minor glomerular abnormality 
N011 Focal and segmental glomerular lesions 
N012 Diffuse membranous glomerulonephritis 
N013 Diffuse mesangial proliferative glomerulonephritis 
N014 Diffuse endocapillary proliferative glomerulonephritis 
N015 Diffuse mesangiocapillary glomerulonephritis 
N016 Dense deposit disease 
N017 Diffuse concentric glomerulonephritis 
N018 Rapidly progressive nephritic syndrome, other 
N019 Rapidly progressive nephritic syndrome, unspecified 
N020 Minor glomerular abnormality 
N021 Focal and segmental glomerular lesions 
N022 Diffuse membranous glomerulonephritis 
N023 Diffuse mesangial proliferative glomerulonephritis 
N024 Diffuse endocapillary proliferative glomerulonephritis 
N025 Diffuse mesangiocapillary glomerulonephritis 
N026 Recurrent and persistent haematuria, dense deposit disease 
N027 Diffuse concentric glomerulonephritis 
N030 Chronic nephritic syndrome, minor glomerular abnormality 
N031 Focal and segmental glomerular lesions 
N032 Diffuse membranous glomerulonephritis 
N033 Diffuse mesangial proliferative glomerulonephritis 
N034 Diffuse endocapillary proliferative glomerulonephritis 
N035 Diffuse mesangiocapillary glomerulonephritis 
N036 Chronic nephritic syndrome, dense deposit disease 
N037 Diffuse concentric glomerulonephritis 
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N038 Chronic nephritic syndrome, other 
N039 Chronic nephritic syndrome, unspecified 
N040 Nephrotic syndrome, minor glomerular abnormality 
N041 Nephrotic syndrome, focal and segmental glomerular lesions 
N042 Nephrotic syndrome, diffuse membranous glomerulonephritis 
N043 Diffuse mesangial proliferative glomerulonephritis 
N044 Diffuse endocapillary proliferative glomerulonephritis 
N045 Diffuse mesangiocapillary glomerulonephritis 
N046 Nephrotic syndrome, dense deposit disease 
N047 Nephrotic syndrome, diffuse crescentic glomerulonephritis 
N048 Nephrotic syndrome, other 
N049 Nephrotic syndrome, unspecified 
N050 Unspecified nephritic syndrome, minor glomerular abnormalit 
N051 Focal and segmental glomerular lesions 
N052 Diffuse membranous glomerulonephritis 
N053 Diffuse mesangial proliferative glomerulonephritis 
N054 Diffuse endocapillary proliferative glomerulonephritis 
N055 Diffuse mesangiocapillary glomerulonephritis 
N056 Unspecified nephritic syndrome, dense deposit disease 
N057 Diffuse concentric glomerulonephritis 
N071 Focal and segmental glomerular lesions 
N072 Diffuse membranous glomerulonephritis 
N073 Diffuse mesangial proliferative glomerulonephritis 
N074 Diffuse endocapillary proliferative glomerulonephritis 
N075 Diffuse mesangiocapillary glomerulonephritis 
N180 End-stage renal disease 
N188 Other chronic renal failure 
N189 Chronic renal failure, unspecified 
N19X Unspecified renal failure 
N250 Renal osteodystrophy 
Z992 Dependence on renal dialysis 
B200 HIV disease resulting in mycobacterial infection 
B201 HIV disease resulting in other bacterial infections 
B202 HIV disease resulting in cytomegaloviral disease 
B203 HIV disease resulting in other viral infections 
B204 HIV disease resulting in candidiasis 
B205 HIV disease resulting in other mycoses 
B206 HIV disease resulting in Pneumocystis carinii pneumonia 
B207 HIV disease resulting in multiple infections 
B208 HIV dis resulting in oth infectious and parasitic dis 
B209 HIV disease resulting in unspec infectious or parasitic dis 
B210 HIV disease resulting in Kaposi's sarcoma 
B211 HIV disease resulting in Burkitt's lymphoma 
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B212 HIV dis resulting oth types of non-Hodgkin's lymphoma 
B213 HIV dis result oth mal neo lymphoid haematopoietic rel tis 
B217 HIV disease resulting in multiple malignant neoplasms 
B218 HIV disease resulting in other malignant neoplasms 
B219 HIV disease resulting in unspecified malignant neoplasm 
B220 HIV disease resulting in encephalopathy 
B221 HIV disease resulting in lymphoid interstitial pneumonitis 
B222 HIV disease resulting in wasting syndrome 
B227 HIV dis resulting in multiple diseases classif elsewhere 
B230 Acute HIV infection syndrome 
B231 HIV dis result (persistent) generalized lymphadenopathy 
B232 HIV dis result haematologic / immunologic abnorm NEC 
B238 HIV disease resulting in other specified conditions 
B24X Unspecified human immunodeficiency virus [HIV] disease 
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7.5. Additional Data Tables 
 
Table A3.1 Table showing Trusts that contributed to the BSG ERCP audit and how many 
cases each Trust entered 
Trust 
Code Trust Name 
Number of 
procedures 
entered into 
BSG audit from 
each TRUST 
RAL ROYAL FREE HAMPSTEAD NHS TRUST 100 
RBL WIRRAL UNIVERSITY TEACHING HOSPITAL NHS FOUNDATION 
TRUST 
99 
RBN ST HELENS AND KNOWSLEY HOSPITALS NHS TRUST 54 
RDD BASILDON AND THURROCK UNIVERSITY HOSPITALS NHS 
FOUNDATION TRUST 
147 
RDE COLCHESTER HOSPITAL UNIVERSITY NHS FOUNDATION TRUST 54 
REM AINTREE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST 12 
RF4 BARKING, HAVERING AND REDBRIDGE HOSPITALS NHS TRUST 83 
RFS CHESTERFIELD ROYAL HOSPITAL NHS FOUNDATION TRUST 74 
RFW WEST MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST 39 
RG2 QUEEN ELIZABETH HOSPITAL NHS TRUST 82 
RG3 BROMLEY HOSPITALS NHS TRUST 97 
RJ1 GUY'S AND ST THOMAS' NHS FOUNDATION TRUST 249 
RJ2 THE LEWISHAM HOSPITAL NHS TRUST 54 
RJC SOUTH WARWICKSHIRE GENERAL HOSPITALS NHS TRUST 59 
RJN EAST CHESHIRE NHS TRUST 36 
RKB UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS 
TRUST 
152 
RL4 THE ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST 81 
RLQ HEREFORD HOSPITALS NHS TRUST 30 
RLT GEORGE ELIOT HOSPITAL NHS TRUST 31 
RM2 UNIVERSITY HOSPITAL OF SOUTH MANCHESTER NHS 
FOUNDATION TRUST 
186 
RM3 SALFORD ROYAL NHS FOUNDATION TRUST 57 
RMC BOLTON HOSPITALS NHS TRUST 37 
RMP TAMESIDE HOSPITAL NHS FOUNDATION TRUST 55 
RN7 DARTFORD AND GRAVESHAM NHS TRUST 127 
RNA DUDLEY GROUP OF HOSPITALS NHS TRUST 235 
RNJ BARTS AND THE LONDON NHS TRUST 79 
RP5 DONCASTER AND BASSETLAW HOSPITALS NHS FOUNDATION 
TRUST 
93 
RQ6 ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS 
NHS TRUST 
292 
RQ8 MID ESSEX HOSPITAL SERVICES NHS TRUST 74 
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RQM CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION 
TRUST 
216 
RR1 HEART OF ENGLAND NHS FOUNDATION TRUST 103 
RRK UNIVERSITY HOSPITAL BIRMINGHAM NHS FOUNDATION 
TRUST 
137 
RTG DERBY HOSPITALS NHS FOUNDATION TRUST 38 
RV8 NORTH WEST LONDON HOSPITALS NHS TRUST 93 
RVV EAST KENT HOSPITALS UNIVERSITY NHS TRUST 170 
RVY SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST 24 
RW3 CENTRAL MANCHESTER AND MANCHESTER CHILDREN'S 
UNIVERSITY HOSPITALS NHS TRUST 
65 
RW6 PENNINE ACUTE HOSPITALS NHS TRUST 137 
RWE UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST 84 
RWF MAIDSTONE AND TUNBRIDGE WELLS NHS TRUST 24 
RWG WEST HERTFORDSHIRE HOSPITALS NHS TRUST 73 
RWH EAST AND NORTH HERTFORDSHIRE NHS TRUST 126 
RWJ STOCKPORT NHS FOUNDATION TRUST 145 
RWP WORCESTERSHIRE ACUTE HOSPITALS NHS TRUST 49 
RX1 NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST 242 
RXC EAST SUSSEX HOSPITALS NHS TRUST 77 
RXH BRIGHTON AND SUSSEX UNIVERSITY HOSPITALS NHS TRUST 77 
RXK SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST 52 
RXN LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST 44 
RXR EAST LANCASHIRE HOSPITALS NHS TRUST 98 
RXW SHREWSBURY AND TELFORD HOSPITAL NHS TRUST 105 
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Table A5.1  Comparison of raw data from Sentinel stroke audit 2008 and HES analysis 
Trust 
SINAP 
swallow 
score (%) 
2008 
SINAP 
average all 
9 
indicators 
(%) 2008 
SINAP 
swallow 
rank 
(1=lowest 
score; 
115=highe
st) 
SINAP 
average 
rank 
overall  
(1=lowest 
score; 
115=highe
st) 
SINAP 
average 
score 
tertile 
(1=worst; 
3=best) 
SINAP 
swallow 
score 
tertile 
(1=worst; 
3=best) 
HES data 
PEG7DM 
(%) 2008 
HES data 
PEG7DM 
RANK 
(1=highest 
mortality; 
115 = 
lowest) 
Gateshead health NHS foundation trust 83.0 65.6 82 37 1 3 33.3 1 
Worcestershire acute hospitals NHS 
trust 23.5 40.5 1 1 1 1 27.3 2 
Homerton university hospital NHS 
foundation trust 68.0 84.3 39 100 3 2 25.0 3 
United Lincolnshire hospitals NHS trust 68.3 63.2 44 29 1 2 23.1 4 
Barnsley hospital NHS foundation trust 88.0 74.1 91 63 2 3 22.2 5 
Northern Lincolnshire and Goole 
hospitals NHS foundation trust 62.0 60.4 29 19 1 1 22.2 6 
Dudley group of hospitals NHS trust 98.0 78.0 108 76 2 3 21.4 7 
Ealing hospital NHS trust 100.0 70.2 113 54 2 3 20.0 8 
Bedford hospital NHS trust 62.0 60.3 30 18 1 1 20.0 9 
Southport and Ormskirk hospital NHS 
trust 82.0 75.2 79 67 2 3 16.7 10 
Wirral university teaching hospital NHS 
foundation trust 100.0 85.6 114 102 3 3 16.7 11 
Kingston hospital NHS trust 76.0 80.4 64 83 3 2 16.7 12 
Isle of Wight 81.0 64.4 73 33 1 2 16.7 13 
Mid Essex hospital services NHS trust 67.0 67.7 37 43 2 1 16.7 14 
Bolton hospitals NHS trust 86.0 92.0 89 113 3 3 16.1 15 
Central Manchester and Manchester 
children's university hospitals NHS trust 37.0 59.6 3 15 1 1 15.4 16 
Aintree university hospitals NHS 
foundation trust 98.0 83.6 109 97 3 3 15.4 17 
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Buckinghamshire hospitals NHS trust 58.0 65.1 20 35 1 1 15.4 18 
Peterborough and Stamford hospitals 
NHS foundation trust 90.0 76.7 96 72 2 3 15.4 19 
The Queen Elizabeth Hospital King's 
Lynn NHS trust 50.0 74.3 11 65 2 1 15.4 20 
Northampton general hospital NHS trust 56.0 68.4 17 45 2 1 14.3 21 
Chesterfield royal hospital NHS 
foundation trust 70.0 68.8 49 46 2 2 14.3 22 
St George’s healthcare NHS trust 83.0 88.7 83 111 3 3 14.3 23 
The Lewisham hospital NHS trust 94.0 82.3 104 95 3 3 14.3 24 
Mid Staffordshire NHS foundation trust 69.0 62.1 46 27 1 2 14.3 25 
South Warwickshire general hospitals 
NHS trust 64.0 61.6 33 25 1 1 14.3 26 
Sheffield teaching hospitals NHS 
foundation trust 82.0 76.9 80 74 2 3 13.3 27 
Royal Cornwall hospitals NHS trust 60.0 50.7 26 3 1 1 12.5 28 
Milton Keynes hospital NHS foundation 
trust 89.0 82.1 93 93 3 3 12.5 29 
York hospitals NHS foundation trust 81.0 69.9 74 53 2 2 12.5 30 
Walsall hospitals NHS trust 58.0 69.2 21 49 2 1 11.1 31 
Bromley hospitals NHS trust 54.0 56.7 15 11 1 1 10.0 32 
Colchester hospital university NHS 
foundation trust 59.0 69.4 25 51 2 1 10.0 33 
Brighton and Sussex university hospitals 
NHS trust 93.0 79.7 101 81 3 3 10.0 34 
Sherwood forest hospitals NHS 
foundation trust 74.0 66.0 59 38 1 2 10.0 35 
Mid Cheshire hospitals NHS foundation 
trust 45.0 42.3 8 2 1 1 9.1 36 
Epsom and St Helier university hospitals 
NHS trust 62.0 68.4 31 44 2 1 9.1 37 
Sandwell and west Birmingham 
hospitals NHS trust 81.5 69.1 78 48 2 3 8.8 38 
Harrogate and district NHS foundation 
trust 91.0 89.1 99 112 3 3 8.3 39 
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West Suffolk hospitals NHS trust 69.0 67.6 47 42 2 2 8.3 40 
Kettering general hospital NHS trust 49.0 53.9 9 9 1 1 8.0 41 
County Durham and Darlington NHS 
foundation trust 60.5 61.9 27 26 1 1 7.7 42 
Heatherwood and Wexham park 
hospitals NHS foundation trust 55.0 53.8 16 8 1 1 7.7 43 
ROYAL WEST SUSSEX NHS TRUST 
(Now Western Sussex hospitals) 92.0 73.1 100 58 2 3 7.7 44 
North Cumbria university hospitals NHS 
trust 73.0 74.9 55 66 2 2 7.1 45 
Hull and east Yorkshire hospitals NHS 
trust 98.0 86.3 110 106 3 3 7.1 46 
NORTH CHESHIRE HOSPITALS NHS 
TRUST (Warrington and Halton NHS 
Trust) 65.0 76.9 36 73 2 1 6.7 47 
George Eliot hospital NHS trust 84.0 69.4 86 52 2 3 5.9 48 
Royal free Hampstead NHS trust 100.0 96.1 115 114 3 3 5.9 49 
Mid Yorkshire hospitals NHS trust 58.0 56.7 22 12 1 1 5.6 50 
The royal Wolverhampton hospitals NHS 
trust 69.0 73.2 48 59 2 2 5.6 51 
Derby hospitals NHS foundation trust 68.0 82.1 40 94 3 2 5.4 52 
North Bristol NHS trust 82.0 74.1 81 62 2 3 5.3 53 
Calderdale and Huddersfield NHS 
foundation trust 49.0 63.6 10 30 1 1 4.8 54 
Shrewsbury and tenfold hospital NHS 
trust 42.0 59.6 6 16 1 1 4.8 55 
Oxford Radcliffe hospitals NHS trust 25.5 51.8 2 6 1 1 3.8 56 
University hospitals Coventry and 
Warwickshire NHS trust 74.0 79.9 60 82 3 2 3.7 57 
Salford royal NHS foundation trust 90.0 88.6 97 110 3 3 3.3 58 
Pennine acute hospitals NHS trust 85.2 81.7 88 91 3 3 2.6 59 
Norfolk and Norwich university hospitals 
NHS foundation trust 39.0 56.6 4 10 1 1 2.6 60 
Blackpool, Fylde and Wyre hospitals 
NHS foundation trust 50.0 60.6 12 21 1 1 0.0 61 
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Burton hospitals NHS trust 52.0 66.7 14 39 2 1 0.0 62 
Plymouth hospitals NHS trust 57.0 61.1 19 23 1 1 0.0 63 
Lancashire teaching hospitals NHS 
foundation trust 58.0 51.0 23 4 1 1 0.0 64 
The princess Alexandra hospital NHS 
trust 64.0 63.0 34 28 1 1 0.0 65 
Bradford teaching hospitals NHS 
foundation trust 68.0 63.7 41 31 1 2 0.0 66 
Royal Devon and Exeter NHS 
foundation trust 64.0 82.9 35 96 3 1 0.0 67 
East Lancashire hospitals NHS trust 72.0 60.6 53 20 1 2 0.0 68 
East Sussex hospitals NHS trust 68.0 73.7 42 60 2 2 0.0 69 
Barnet and chase farm hospitals NHS 
trust 72.0 76.9 54 75 2 2 0.0 70 
South tees hospitals NHS trust 73.5 76.0 58 68 2 2 0.0 71 
Wrightington, Wigan and Leigh NHS 
trust 74.0 81.1 61 88 3 2 0.0 72 
The Newcastle upon Tyne hospitals 
NHS foundation trust 78.0 73.0 68 57 2 2 0.0 73 
Ashford and St Peter's hospitals NHS 
trust 79.0 76.0 70 69 2 2 0.0 74 
Barking, Havering and Redbridge 
hospitals NHS trust 80.5 80.8 72 86 3 2 0.0 75 
Tameside hospital NHS foundation trust 81.0 76.1 75 70 2 2 0.0 76 
Countess of Chester hospital NHS 
foundation trust 83.0 79.0 84 78 3 3 0.0 77 
Royal surrey county hospital NHS trust 76.0 85.2 65 101 3 2 0.0 78 
North west London hospitals NHS trust 85.0 79.3 87 80 3 3 0.0 79 
Royal Liverpool and Broadgreen 
university hospitals NHS trust 88.0 83.6 92 98 3 3 0.0 80 
Imperial college healthcare NHS trust 89.0 86.0 94 104 3 3 0.0 81 
Northumbria healthcare NHS foundation 
trust 90.0 86.2 98 105 3 3 0.0 82 
South Devon healthcare NHS foundation 
trust 93.0 85.7 102 103 3 3 0.0 83 
374 
 
Royal Berkshire NHS foundation trust 95.0 81.3 105 90 3 3 0.0 84 
South end university hospital NHS 
foundation trust 96.0 88.6 107 109 3 3 0.0 85 
King's college hospital NHS foundation 
trust 98.0 97.6 111 115 3 3 0.0 86 
North Middlesex university hospital NHS 
trust 86.0 78.4 90 77 2 3 0.0 87 
QUEEN ELIZABETH HOSPITAL NHS 
TRUST (now RG3 - Bromley) 50.0 58.0 13 14 1 1 0.0 88 
QUEEN MARY'S SIDCUP NHS TRUST 
(now RG3 - Bromley) 63.0 53.3 32 7 1 1 0.0 89 
The Whittington hospital NHS trust 68.0 88.1 43 108 3 2 0.0 90 
West Middlesex university hospital NHS 
trust 83.0 79.2 85 79 3 3 0.0 91 
Whipps cross university hospital NHS 
trust  75.0 80.9 62 87 3 2 0.0 92 
Cambridge university hospitals NHS 
foundation trust 70.0 80.8 50 85 3 2 0.0 93 
Dartford and Gravesham NHS trust 58.0 65.1 24 36 1 1 0.0 94 
Doncaster and Bassetlaw hospitals NHS 
foundation trust 41.0 74.2 5 64 2 1 0.0 95 
East Kent hospitals university NHS trust 93.0 82.0 103 92 3 3 0.0 96 
Heart of England NHS foundation trust 70.5 71.1 52 56 2 2 0.0 97 
Ipswich hospital NHS trust 73.0 61.1 56 22 1 2 0.0 98 
James Paget university hospitals NHS 
foundation trust 43.0 67.1 7 41 2 1 0.0 99 
Leeds teaching hospitals NHS trust 81.0 64.0 76 32 1 2 0.0 100 
Luton and Dunstable hospital NHS 
foundation trust 79.0 64.7 71 34 1 2 0.0 101 
Maidstone and Tunbridge wells NHS 
trust 61.5 61.3 28 24 1 1 0.0 102 
North tees and Hartlepool NHS 
foundation trust 78.0 84.3 69 99 3 2 0.0 103 
Nottingham university hospitals NHS 
trust 73.0 68.8 57 47 2 2 0.0 104 
Poole hospital NHS foundation trust 89.0 74.0 95 61 2 3 0.0 105 
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Portsmouth hospitals NHS trust 70.0 57.8 51 13 1 2 0.0 106 
Royal united hospital bath NHS trust 77.0 70.6 67 55 2 2 0.0 107 
Southampton university hospitals NHS 
trust 76.0 76.7 66 71 2 2 0.0 108 
The Rotherham NHS foundation trust 75.0 80.4 63 84 3 2 0.0 109 
University hospital Birmingham NHS 
foundation trust 67.0 66.9 38 40 2 1 0.0 110 
University hospitals of Leicester NHS 
trust 81.0 69.3 77 50 2 2 0.0 111 
University hospitals of Morecambe bay 
NHS trust 68.7 59.9 45 17 1 2 0.0 112 
West Hertfordshire hospitals NHS trust 95.0 81.2 106 89 3 3 0.0 113 
Weston area health NHS trust 56.0 51.2 18 5 1 1 0.0 114 
Winchester and Eastleigh healthcare 
NHS trust 98.0 86.3 112 107 3 3 0.0 115 
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Table A5.2 Comparison of numbers of stroke patients from Sentinel stroke audit 2008 and 
HES analysis 
Trust SINAP 
Total 
strokes 
for 3m 
SINAP 
Total 
strokes 
for 12m 
(historical 
data) 
Our 
Total 
strokes 
for 12m 
Our 
total 
divided 
by 4 
 SINAP data Our data 
King's College Hospital NHS Foundation Trust 219 151 474 119 
Imperial College Healthcare NHS Trust 224 294 810 203 
Northumbria Healthcare NHS Foundation Trust 24 497 974 244 
Salford Royal NHS Foundation Trust 103 871 529 132 
St George's Healthcare NHS Trust 302 967 634 159 
South Tees Hospitals NHS Trust 93 288 915 229 
Aintree University Hospitals NHS Foundation Trust 115 486 547 137 
The Newcastle Upon Tyne Hospitals NHS Foundation 
Trust 
48 18 887 222 
Royal Liverpool And Broadgreen University Hospitals 
NHS Trust 
132 308 586 147 
North West London Hospitals NHS Trust 225 255 602 151 
Barking, Havering And Redbridge Hospitals NHS Trust 181 10 999 250 
Southend University Hospital NHS Foundation Trust 99 86 638 160 
Royal Berkshire NHS Foundation Trust 182 289 595 149 
Blackpool, Fylde And Wyre Hospitals NHS Foundation 
Trust 
77 216 676 169 
The Princess Alexandra Hospital NHS Trust 39 0 349 87 
Chesterfield Royal Hospital NHS Foundation Trust 82 276 510 128 
Wirral University Teaching Hospital NHS Foundation 
Trust 
163 351 827 207 
Hull And East Yorkshire Hospitals NHS Trust 56 55 1018 255 
Ashford And St Peter's Hospitals NHS Trust 100 147 532 133 
Gateshead Health NHS Foundation Trust 60 254 475 119 
Northampton General Hospital NHS Trust 171 437 453 113 
Colchester Hospital University NHS Foundation Trust 32 52 640 160 
Lancashire Teaching Hospitals NHS Foundation Trust 95 233 693 173 
Royal Devon And Exeter NHS Foundation Trust 75 58 673 168 
North Cumbria University Hospitals NHS Trust 64 419 636 159 
Royal Surrey County Hospital NHS Trust 79 10 355 89 
Wrightington, Wigan And Leigh NHS Trust 53 306 619 155 
Sheffield Teaching Hospitals NHS Foundation Trust 225 135 1206 302 
East Lancashire Hospitals NHS Trust 70 69 893 223 
Pennine Acute Hospitals NHS Trust 57 891 1577 394 
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Southport And Ormskirk Hospital NHS Trust 87 301 434 109 
East Sussex Hospitals NHS Trust 20 202 846 212 
Bromley Hospitals NHS Trust 31 no data 
available 
362 91 
South Devon Healthcare NHS Foundation Trust 89 563 702 176 
George Eliot Hospital NHS Trust 22 49 310 78 
Oxford Radcliffe Hospitals NHS Trust 46 5 868 217 
Countess Of Chester Hospital NHS Foundation Trust 38 245 386 97 
Mid Cheshire Hospitals NHS Foundation Trust 73 339 413 103 
Tameside Hospital NHS Foundation Trust 64 331 399 100 
Worcestershire Acute Hospitals NHS Trust 54 117 897 224 
Barnet And Chase Farm Hospitals NHS Trust 21  640 160 
Bolton Hospitals NHS Trust 45 376 562 141 
Burton Hospitals NHS Trust 65 209 275 69 
Central Manchester And Manchester Children's 
University Hospitals NHS Trust 
46 241 373 93 
Kettering General Hospital NHS Trust 22 0 515 129 
Bradford Teaching Hospitals NHS Foundation Trust 96 324 560 140 
Plymouth Hospitals NHS Trust 24 0 755 189 
Royal Cornwall Hospitals NHS Trust 142 800 914 229 
 
 
